Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23412.Phospholipids in VLDL,AGRP,Agouti-related protein,42296,0.255165796687476,0.00485280878338163,0.245654291472048,0.264677301902904,0
NMR metabolomics,X23412.Phospholipids in VLDL,CCN1,CCN family member 1,42047,0.346283006300829,0.00675789231938448,0.333037537354835,0.359528475246822,0
NMR metabolomics,X23412.Phospholipids in VLDL,LDLR,Low-density lipoprotein receptor,42170,0.394522718264498,0.00403085709010414,0.386622238367894,0.402423198161102,0
NMR metabolomics,X23412.Phospholipids in VLDL,MFGE8,Lactadherin,42137,0.209121882571728,0.00431408490740276,0.200666276153219,0.217577488990238,0
NMR metabolomics,X23412.Phospholipids in VLDL,NPY,Pro-neuropeptide Y,42262,0.309625136210331,0.00598310658832057,0.297898247297223,0.32135202512344,0
NMR metabolomics,X23412.Phospholipids in VLDL,PLA2G7,Platelet-activating factor acetylhydrolase,42137,0.191859029637644,0.00287732777499986,0.186219467198644,0.197498592076644,0
NMR metabolomics,X23412.Phospholipids in VLDL,CCL27,C-C motif chemokine 27,42145,0.238954524040958,0.00609681448788284,0.227004767644707,0.250904280437208,1.1125369293692e-308
NMR metabolomics,X23412.Phospholipids in VLDL,LCAT,Phosphatidylcholine-sterol acyltransferase,39990,0.0816067386765051,0.00210715791313471,0.0774767091667611,0.0857367681862491,2.37050889125543e-308
NMR metabolomics,X23412.Phospholipids in VLDL,TFPI,Tissue factor pathway inhibitor,42152,0.115200903202988,0.00305647332976071,0.109210215476657,0.121191590929319,9.7468179620119e-296
NMR metabolomics,X23412.Phospholipids in VLDL,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,42217,0.153523437822576,0.00421186535475251,0.145268181727261,0.161778693917891,1.1903655184252e-277
NMR metabolomics,X23412.Phospholipids in VLDL,APCS,Serum amyloid P-component,39870,0.116097717017819,0.00319237557368084,0.109840660893404,0.122354773142233,6.47627237849344e-274
NMR metabolomics,X23412.Phospholipids in VLDL,GHR,Growth hormone receptor,39736,0.0993711573358083,0.00277356203282701,0.0939349757514673,0.104807338920149,3.6261509549969e-266
NMR metabolomics,X23412.Phospholipids in VLDL,F7,Coagulation factor VII,42194,0.108877294061378,0.0030574127166981,0.10288476513665,0.114869822986107,1.24228529898271e-265
NMR metabolomics,X23412.Phospholipids in VLDL,HHEX,Hematopoietically-expressed homeobox protein HHEX,39929,0.265672304446004,0.00756431981690816,0.250846237604864,0.280498371287144,1.32622264727053e-256
NMR metabolomics,X23412.Phospholipids in VLDL,PROC,Vitamin K-dependent protein C,42199,0.0881929904547505,0.00253501093406581,0.0832243690239815,0.0931616118855195,3.99194248924038e-254
NMR metabolomics,X23412.Phospholipids in VLDL,PTH,Parathyroid hormone,39649,0.281657126308975,0.00818314033529168,0.265618171251803,0.297696081366146,1.03544598276065e-246
NMR metabolomics,X23412.Phospholipids in VLDL,SMOC1,SPARC-related modular calcium-binding protein 1,42262,0.108141405577484,0.00319903027393081,0.10187130624058,0.114411504914389,1.20329807160151e-240
NMR metabolomics,X23412.Phospholipids in VLDL,CES1,Liver carboxylesterase 1,42163,0.276702522164667,0.00842761610205123,0.260184394604647,0.293220649724687,1.43039322051781e-227
NMR metabolomics,X23412.Phospholipids in VLDL,LPL,Lipoprotein lipase,42145,-0.152708731334209,0.0047754983287438,-0.162068708058547,-0.143348754609871,2.22774997396483e-216
NMR metabolomics,X23412.Phospholipids in VLDL,RARRES2,Retinoic acid receptor responder protein 2,42230,0.153537913611811,0.0048050838477377,0.144119949270245,0.162955877953377,4.11907115935655e-216
NMR metabolomics,X23412.Phospholipids in VLDL,FURIN,Furin,42181,0.103735917236587,0.00328550647389783,0.0972963245477477,0.110175509925427,3.30347222217537e-211
NMR metabolomics,X23412.Phospholipids in VLDL,SMAD1,Mothers against decapentaplegic homolog 1,41843,0.259077948012389,0.00836347288282925,0.242685541162044,0.275470354862735,1.80245231720438e-203
NMR metabolomics,X23412.Phospholipids in VLDL,CCL23,C-C motif chemokine 23,42185,0.130212501068147,0.0042085861007311,0.121963672310714,0.13846132982558,3.58763868762715e-203
NMR metabolomics,X23412.Phospholipids in VLDL,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,42262,0.102249621567923,0.00333124693547744,0.095720377574387,0.108778865561459,3.92629232459355e-200
NMR metabolomics,X23412.Phospholipids in VLDL,BCHE,Cholinesterase,39806,0.0821345935544147,0.0026721348354321,0.0768972092769678,0.0873719778318616,2.91078218384111e-199
NMR metabolomics,X23412.Phospholipids in VLDL,ERBB3,Receptor tyrosine-protein kinase erbB-3,42084,0.0590521633782077,0.00193091329554547,0.0552675733189386,0.0628367534374768,1.17221474548184e-198
NMR metabolomics,X23412.Phospholipids in VLDL,CD4,T-cell surface glycoprotein CD4,42100,0.087271850948563,0.00289493024518444,0.0815977876680015,0.0929459142291245,2.817904688451e-193
NMR metabolomics,X23412.Phospholipids in VLDL,IGSF9,Protein turtle homolog A,39958,0.256891270573129,0.00856607504551882,0.240101763483912,0.273680777662346,3.11538942749922e-190
NMR metabolomics,X23412.Phospholipids in VLDL,DNAJB1,DnaJ homolog subfamily B member 1,42070,0.254761884999288,0.00852303775382393,0.238056731001793,0.271467038996783,3.87879752332193e-190
NMR metabolomics,X23412.Phospholipids in VLDL,APOC1,Apolipoprotein C-I,39959,0.114850860839637,0.00384703868823703,0.107310665010693,0.122391056668582,1.32168745050075e-188
NMR metabolomics,X23412.Phospholipids in VLDL,DEFB4A_DEFB4B,Beta-defensin 4A,41921,0.43440759688464,0.0146133802736539,0.405765371548278,0.463049822221002,4.47442396229768e-188
NMR metabolomics,X23412.Phospholipids in VLDL,APOM,Apolipoprotein M,42199,0.0841262509276486,0.00283333361345881,0.0785729170452693,0.0896795848100279,9.04795720717748e-188
NMR metabolomics,X23412.Phospholipids in VLDL,PLA2G10,Group 10 secretory phospholipase A2,42016,-0.170918060089919,0.00581611259636281,-0.18231764077879,-0.159518479401048,5.10475661323455e-184
NMR metabolomics,X23412.Phospholipids in VLDL,NRP1,Neuropilin-1,42230,-0.0802106034643584,0.00273065368674867,-0.0855626846903858,-0.074858522238331,5.95587232723302e-184
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINA5,Plasma serine protease inhibitor,39835,0.0882435588756414,0.00301216482071492,0.0823397158270402,0.0941474019242427,7.26908925419846e-182
NMR metabolomics,X23412.Phospholipids in VLDL,GCG,Pro-glucagon,41843,0.359534943637443,0.0124222979521433,0.335187239651242,0.383882647623643,1.18733596662728e-178
NMR metabolomics,X23412.Phospholipids in VLDL,ERBB2,Receptor tyrosine-protein kinase erbB-2,42181,0.0703207402686516,0.00244239283282749,0.0655336503163097,0.0751078302209935,5.34062996535865e-177
NMR metabolomics,X23412.Phospholipids in VLDL,LAMP2,Lysosome-associated membrane glycoprotein 2,41734,0.0593974565115419,0.00206478586673673,0.0553504762127379,0.0634444368103459,1.55996626813553e-176
NMR metabolomics,X23412.Phospholipids in VLDL,SNCA,Alpha-synuclein,39736,0.336934681401024,0.0117878217058938,0.313830550857473,0.360038811944576,1.80561144297608e-173
NMR metabolomics,X23412.Phospholipids in VLDL,FGFBP1,Fibroblast growth factor-binding protein 1,42181,0.0945890737824874,0.00332507993197176,0.0880719171158228,0.101106230449152,5.91290653645308e-173
NMR metabolomics,X23412.Phospholipids in VLDL,VPS37A,Vacuolar protein sorting-associated protein 37A,42070,0.22710396506978,0.00800994980576989,0.211404463450471,0.242803466689089,8.16615844151861e-172
NMR metabolomics,X23412.Phospholipids in VLDL,CFP,Properdin,39979,0.0664420012255059,0.00237207134305163,0.0617927413931247,0.0710912610578871,5.23075520608244e-167
NMR metabolomics,X23412.Phospholipids in VLDL,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,41900,0.22824227366004,0.00819177177163226,0.21218640098764,0.244298146332439,4.27503100488331e-166
NMR metabolomics,X23412.Phospholipids in VLDL,VMO1,Vitelline membrane outer layer protein 1 homolog,42070,0.190855634410928,0.00688519988860064,0.17736064262927,0.204350626192585,1.59987580466398e-164
NMR metabolomics,X23412.Phospholipids in VLDL,CDKN1A,Cyclin-dependent kinase inhibitor 1,42070,0.295559807479235,0.0107080816459545,0.274571967453164,0.316547647505306,3.53700728379734e-163
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINA4,Kallistatin,39802,0.0650263094501501,0.00234996408778232,0.0604203798380967,0.0696322390622034,4.37834279743213e-163
NMR metabolomics,X23412.Phospholipids in VLDL,PAMR1,Inactive serine protease PAMR1,42137,0.0725067274554672,0.0026529667720979,0.0673069125821553,0.0777065423287791,3.93143778805835e-160
NMR metabolomics,X23412.Phospholipids in VLDL,CHMP6,Charged multivesicular body protein 6,39958,0.156723165581219,0.00573899423068502,0.145474736889077,0.167971594273362,4.31757178673325e-159
NMR metabolomics,X23412.Phospholipids in VLDL,IGFBP2,Insulin-like growth factor-binding protein 2,42286,-0.164068983564104,0.00607428958445821,-0.175974591149642,-0.152163375978566,1.37089179543329e-156
NMR metabolomics,X23412.Phospholipids in VLDL,TTR,Transthyretin,39862,0.0671731765661224,0.00249487455248223,0.0622832224432572,0.0720631306889875,8.46751674911969e-155
NMR metabolomics,X23412.Phospholipids in VLDL,CXCL6,C-X-C motif chemokine 6,42296,0.202594011328776,0.00758705657237889,0.187723380446913,0.217464642210638,3.5436993274284e-153
NMR metabolomics,X23412.Phospholipids in VLDL,SLC39A5,Zinc transporter ZIP5,42119,0.141787143440671,0.00532931610602722,0.131341683872857,0.152232603008484,4.70067891901632e-152
NMR metabolomics,X23412.Phospholipids in VLDL,PLAT,Tissue-type plasminogen activator,42272,0.136121056765089,0.00514616316706856,0.126034576957634,0.146207536572543,2.09590647994457e-150
NMR metabolomics,X23412.Phospholipids in VLDL,CFH,Complement factor H,39418,0.0620030270622837,0.00235603410741328,0.0573852002117537,0.0666208539128138,5.28603751242224e-148
NMR metabolomics,X23412.Phospholipids in VLDL,PROS1,Vitamin K-dependent protein S,39979,0.0670712343250174,0.00255397465857822,0.0620654439942041,0.0720770246558308,1.25434302931045e-147
NMR metabolomics,X23412.Phospholipids in VLDL,GUSB,Beta-glucuronidase,42211,0.159409706014334,0.00614075832589108,0.147373819695587,0.17144559233308,4.70429989256138e-145
NMR metabolomics,X23412.Phospholipids in VLDL,GPR37,Prosaposin receptor GPR37,41900,0.17033265177444,0.00655968761353507,0.157475664051911,0.183189639496968,4.71740537822648e-145
NMR metabolomics,X23412.Phospholipids in VLDL,IGFBP3,Insulin-like growth factor-binding protein 3,42217,0.0837233955740827,0.00324166380270178,0.0773697345207872,0.0900770566273782,1.22397183958167e-143
NMR metabolomics,X23412.Phospholipids in VLDL,CNTN3,Contactin-3,42137,0.0732765331222134,0.00285252737597564,0.0676855794653011,0.0788674867791256,3.90907150501511e-142
NMR metabolomics,X23412.Phospholipids in VLDL,SORT1,Sortilin,42129,0.0984809750425984,0.00383513894612232,0.0909641027081986,0.105997847376998,4.98005285205114e-142
NMR metabolomics,X23412.Phospholipids in VLDL,P4HB,Protein disulfide-isomerase,42073,0.0995825545910081,0.00388429168940298,0.0919693428797783,0.107195766302238,1.41511336321408e-141
NMR metabolomics,X23412.Phospholipids in VLDL,KLKB1,Plasma kallikrein,39759,0.062997644416609,0.00246807227273131,0.0581602227620556,0.0678350660711624,1.01224955084007e-139
NMR metabolomics,X23412.Phospholipids in VLDL,CRIP2,Cysteine-rich protein 2,42016,0.0932257450490839,0.00366485346342227,0.0860426322607763,0.100408857837392,1.89508397156881e-139
NMR metabolomics,X23412.Phospholipids in VLDL,ATRN,"Attractin, Isoform 2",39979,0.0426087117361039,0.00167888241796316,0.0393181021968961,0.0458993212753117,2.8737984553264e-138
NMR metabolomics,X23412.Phospholipids in VLDL,AFM,Afamin,39979,0.0516654212557526,0.00203780347590874,0.0476713264429715,0.0556595160685337,5.33469637509953e-138
NMR metabolomics,X23412.Phospholipids in VLDL,KDR,Vascular endothelial growth factor receptor 2,42181,0.0637536071596377,0.00252608370140333,0.0588024831048872,0.0687047312143882,2.18782249266459e-137
NMR metabolomics,X23412.Phospholipids in VLDL,MEGF9,Multiple epidermal growth factor-like domains protein 9,42272,0.0495103294182815,0.0019793598210653,0.0456307841689935,0.0533898746675695,4.65861075402776e-135
NMR metabolomics,X23412.Phospholipids in VLDL,FLI1,Friend leukemia integration 1 transcription factor,41843,0.28100858223198,0.0112473829104114,0.258963711727573,0.303053452736386,1.15870067950311e-134
NMR metabolomics,X23412.Phospholipids in VLDL,DSG2,Desmoglein-2,42137,-0.0678727377925347,0.00272715853496745,-0.0732179685210709,-0.0625275070639985,1.00159202170207e-133
NMR metabolomics,X23412.Phospholipids in VLDL,INHBC,Inhibin beta C chain,42137,0.0996708054721215,0.00400701730922815,0.0918170515460343,0.107524559398209,1.3865922402972e-133
NMR metabolomics,X23412.Phospholipids in VLDL,C9,Complement component C9,39990,-0.143018547686842,0.00580359988624976,-0.154393603463891,-0.131643491909792,1.11341844605125e-130
NMR metabolomics,X23412.Phospholipids in VLDL,PLTP,Phospholipid transfer protein,42267,-0.0935041978003847,0.003817561805593,-0.100986618939347,-0.0860217766614224,1.07056023278483e-129
NMR metabolomics,X23412.Phospholipids in VLDL,SYAP1,Synapse-associated protein 1,39736,0.144993411464481,0.00590860193234147,0.133412551677091,0.15657427125187,1.49218287983855e-129
NMR metabolomics,X23412.Phospholipids in VLDL,PRAP1,Proline-rich acidic protein 1,39966,0.0966282835385023,0.00393926482164796,0.0889073244880723,0.104349242588932,1.60975502942932e-129
NMR metabolomics,X23412.Phospholipids in VLDL,PSRC1,Proline/serine-rich coiled-coil protein 1,41843,0.147455022825314,0.0060450325818631,0.135606758964863,0.159303286685766,1.3736507767038e-128
NMR metabolomics,X23412.Phospholipids in VLDL,FN1,Fibronectin,39979,0.0668257717367124,0.00275236366112279,0.0614311389609117,0.0722204045125131,5.32442658232235e-127
NMR metabolomics,X23412.Phospholipids in VLDL,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,39736,0.0538876918281233,0.00222677280919814,0.0495232171220949,0.0582521665341516,3.89462267567215e-126
NMR metabolomics,X23412.Phospholipids in VLDL,CFI,Complement factor I,39979,0.0474509996408775,0.00196167033430697,0.0436061257856358,0.0512958734961192,4.28428584921409e-126
NMR metabolomics,X23412.Phospholipids in VLDL,GSTA3,Glutathione S-transferase A3,41843,0.187575840824995,0.00778466830525633,0.172317890946692,0.202833790703297,1.37827350593945e-125
NMR metabolomics,X23412.Phospholipids in VLDL,TNFSF10,Tumor necrosis factor ligand superfamily member 10,42296,0.0619636611752533,0.00257758990739418,0.0569115849567608,0.0670157373937459,4.1387494511403e-125
NMR metabolomics,X23412.Phospholipids in VLDL,CXCL13,C-X-C motif chemokine 13,42249,0.139309672312669,0.00579945140815276,0.12794274755269,0.150676597072649,6.42762496289679e-125
NMR metabolomics,X23412.Phospholipids in VLDL,ELN,Elastin,39958,0.0835789181176737,0.00350432097018988,0.0767104490161015,0.0904473872192458,1.01638619066614e-122
NMR metabolomics,X23412.Phospholipids in VLDL,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,42249,0.124966199424792,0.00525886646721205,0.114658821149057,0.135273577700528,2.42323178977802e-122
NMR metabolomics,X23412.Phospholipids in VLDL,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,42016,0.175239801300571,0.00738357883019255,0.160767986793394,0.189711615807749,5.20114188064868e-122
NMR metabolomics,X23412.Phospholipids in VLDL,ANGPTL2,Angiopoietin-related protein 2,42140,0.0947972230738575,0.00399483594429594,0.0869673446230374,0.102627101524678,5.38543195116426e-122
NMR metabolomics,X23412.Phospholipids in VLDL,ENO3,Beta-enolase,39638,0.15091526155256,0.00635070013279522,0.138467889292282,0.163362633812839,8.81554868536433e-122
NMR metabolomics,X23412.Phospholipids in VLDL,LAT2,Linker for activation of T-cells family member 2,42070,0.301008016242167,0.0127470403148095,0.27602381722514,0.325992215259193,7.77345997914251e-121
NMR metabolomics,X23412.Phospholipids in VLDL,KYNU,Kynureninase,42296,0.108423839162786,0.0045928478359668,0.0994218574042907,0.117425820921281,8.29622482326713e-121
NMR metabolomics,X23412.Phospholipids in VLDL,SOST,Sclerostin,42129,0.0917316847659968,0.00391091992845429,0.0840662817062264,0.0993970878257672,2.76137799178751e-119
NMR metabolomics,X23412.Phospholipids in VLDL,SMAD2,Mothers against decapentaplegic homolog 2,39919,0.168086873034616,0.00717278525423104,0.154028213936323,0.182145532132909,1.25115642769755e-118
NMR metabolomics,X23412.Phospholipids in VLDL,NUMB,Protein numb homolog,39657,0.197503749173268,0.00848276828118301,0.180877523342149,0.214129975004387,4.21373511025943e-117
NMR metabolomics,X23412.Phospholipids in VLDL,F13B,Coagulation factor XIII B chain,39925,0.0602547313288854,0.00259224267107811,0.0551739356935723,0.0653355269641985,8.59124165244402e-117
NMR metabolomics,X23412.Phospholipids in VLDL,GRP,Gastrin-releasing peptide,39638,0.125110349113147,0.00540069215514374,0.114524992489066,0.135695705737229,5.74946511370668e-116
NMR metabolomics,X23412.Phospholipids in VLDL,LATS1,Serine/threonine-protein kinase LATS1,39657,0.202899070160996,0.00877469863356801,0.185700660839203,0.22009747948279,1.45367070576892e-115
NMR metabolomics,X23412.Phospholipids in VLDL,NCS1,Neuronal calcium sensor 1,42262,0.0659224595874937,0.00285883982497674,0.0603191335305393,0.0715257856444481,1.88010936827568e-115
NMR metabolomics,X23412.Phospholipids in VLDL,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,42129,0.28703749284313,0.0125264601823065,0.262485630885809,0.31158935480045,4.87352758580763e-114
NMR metabolomics,X23412.Phospholipids in VLDL,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,39930,0.324692738252248,0.014186465157981,0.296887266542606,0.352498209961891,2.25245344125428e-113
NMR metabolomics,X23412.Phospholipids in VLDL,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,42070,0.0955813824638632,0.00418749455314621,0.0873738931396966,0.10378887178803,3.54984845756454e-113
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINF2,Alpha-2-antiplasmin,39786,0.0309941444579329,0.00135867174025489,0.0283311478470333,0.0336571410688325,1.26169982801572e-112
NMR metabolomics,X23412.Phospholipids in VLDL,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,41843,0.157140000117334,0.00690536430875974,0.143605486072165,0.170674514162503,1.7638276021608e-112
NMR metabolomics,X23412.Phospholipids in VLDL,GH1,Somatotropin,42129,-0.407588330792685,0.0179609772984039,-0.442791846297556,-0.372384815287813,6.37285553563312e-112
NMR metabolomics,X23412.Phospholipids in VLDL,SNAPIN,SNARE-associated protein Snapin,39934,0.133203509112114,0.00590182354841577,0.121635934957219,0.144771083267009,2.26991131988049e-110
NMR metabolomics,X23412.Phospholipids in VLDL,ERP44,Endoplasmic reticulum resident protein 44,42047,0.0592287157934511,0.00263083464848155,0.0540722798824272,0.0643851517044749,3.30832795946117e-110
NMR metabolomics,X23412.Phospholipids in VLDL,CDHR2,Cadherin-related family member 2,42070,0.14951582168337,0.00666412427330626,0.13645413810769,0.16257750525905,1.75935854437229e-109
NMR metabolomics,X23412.Phospholipids in VLDL,F10,Coagulation factor X,39990,0.0658474870402092,0.00293302096494525,0.0600987659489165,0.0715962081315019,2.91771189136622e-109
NMR metabolomics,X23412.Phospholipids in VLDL,EEF1D,Elongation factor 1-delta,39958,0.206578793460923,0.00922752540434479,0.188492843668407,0.224664743253438,1.15232444000245e-108
NMR metabolomics,X23412.Phospholipids in VLDL,AGR3,Anterior gradient protein 3,41827,0.133767957573301,0.00599212501540423,0.122023392543108,0.145512522603493,2.14721483255087e-108
NMR metabolomics,X23412.Phospholipids in VLDL,ADIPOQ,Adiponectin,39979,-0.155945752588879,0.00698353644562579,-0.169633484022305,-0.142258021155452,3.85757552760597e-108
NMR metabolomics,X23412.Phospholipids in VLDL,DTYMK,Thymidylate kinase,39958,0.151881270649913,0.00680718293179195,0.138539192103601,0.165223349196225,5.79813472808612e-108
NMR metabolomics,X23412.Phospholipids in VLDL,SMAD5,Mothers against decapentaplegic homolog 5,42070,0.0448477145861714,0.00201827442377485,0.0408918967155727,0.0488035324567701,1.8232547903361e-107
NMR metabolomics,X23412.Phospholipids in VLDL,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,42217,-0.0868946360466191,0.00391133468925827,-0.0945608520375653,-0.0792284200556729,1.92535059770525e-107
NMR metabolomics,X23412.Phospholipids in VLDL,NOMO1,Nodal modulator 1,42137,0.052273406188295,0.00235641088316292,0.0476548408572957,0.0568919715192944,3.97733522568292e-107
NMR metabolomics,X23412.Phospholipids in VLDL,PTPRB,Receptor-type tyrosine-protein phosphatase beta,39958,0.0668084600283403,0.00301217974625906,0.0609045877256726,0.0727123323310081,9.82113614295303e-107
NMR metabolomics,X23412.Phospholipids in VLDL,FCN2,Ficolin-2,42116,0.0906797012098366,0.00410384711546098,0.0826361608635331,0.0987232415561401,2.59060029115807e-106
NMR metabolomics,X23412.Phospholipids in VLDL,SNAP29,Synaptosomal-associated protein 29,42181,0.203157230868666,0.0092677807718398,0.18499238055586,0.221322081181472,1.06482292788895e-104
NMR metabolomics,X23412.Phospholipids in VLDL,FGFBP3,Fibroblast growth factor-binding protein 3,39929,0.0817790952426768,0.00373472156801673,0.074459040969364,0.0890991495159896,3.9397701705906e-104
NMR metabolomics,X23412.Phospholipids in VLDL,ANGPTL3,Angiopoietin-related protein 3,42189,0.0762070754313484,0.00348827527362086,0.0693700558950515,0.0830440949676453,5.11191868494931e-104
NMR metabolomics,X23412.Phospholipids in VLDL,HEG1,Protein HEG homolog 1,39736,0.0612013508142657,0.00279647260577569,0.0557202645069454,0.0666824371215861,5.48656516646614e-104
NMR metabolomics,X23412.Phospholipids in VLDL,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,42070,0.0725342136955631,0.00332243294662898,0.0660222451201703,0.0790461822709559,7.26932085727482e-104
NMR metabolomics,X23412.Phospholipids in VLDL,TGFBI,Transforming growth factor-beta-induced protein ig-h3,42114,0.0593212632666752,0.00271953367079762,0.0539909772719118,0.0646515492614385,1.06334218999159e-103
NMR metabolomics,X23412.Phospholipids in VLDL,ACY1,Aminoacylase-1,42145,0.13754756879468,0.00636488943296386,0.125072385506071,0.150022752083289,7.46953870525784e-102
NMR metabolomics,X23412.Phospholipids in VLDL,YTHDF3,YTH domain-containing family protein 3,41913,0.187559223773718,0.00868234760235907,0.170541822473094,0.204576625074341,9.44501993959365e-102
NMR metabolomics,X23412.Phospholipids in VLDL,YES1,Tyrosine-protein kinase Yes,42070,0.249650499424943,0.0115684588037158,0.22697632016966,0.272324678680226,1.43211273001786e-101
NMR metabolomics,X23412.Phospholipids in VLDL,MTSS1,Protein MTSS 1,39930,0.24319362833748,0.0113055224682954,0.221034804299621,0.265352452375339,1.24495935110768e-100
NMR metabolomics,X23412.Phospholipids in VLDL,NAA80,N-alpha-acetyltransferase 80,39649,0.268442355613433,0.0124781864114611,0.243985110246969,0.292899600979897,1.34240132511689e-100
NMR metabolomics,X23412.Phospholipids in VLDL,MYH9,Myosin-9,39966,0.247671902849815,0.0115163508294449,0.225099855224103,0.270243950475527,1.35950883031616e-100
NMR metabolomics,X23412.Phospholipids in VLDL,CPM,Carboxypeptidase M,42195,0.0739396514077071,0.00344648365056609,0.0671845434525976,0.0806947593628167,1.9377556277646e-100
NMR metabolomics,X23412.Phospholipids in VLDL,GSTA1,Glutathione S-transferase A1,42119,0.183800968846661,0.00857706045793202,0.166989930349115,0.200612007344208,3.27789186243354e-100
NMR metabolomics,X23412.Phospholipids in VLDL,FYB1,FYN-binding protein 1,42115,0.200587724733991,0.00938149506649853,0.182199994403654,0.218975455064328,8.91247472247297e-100
NMR metabolomics,X23412.Phospholipids in VLDL,TMPRSS15,Enteropeptidase,42070,0.190535712521321,0.0089120509604369,0.173068092638865,0.208003332403778,9.33816004648581e-100
NMR metabolomics,X23412.Phospholipids in VLDL,SKAP1,Src kinase-associated phosphoprotein 1,41997,0.156609755889254,0.0073305031985464,0.142241969620103,0.170977542158405,1.31201426980938e-99
NMR metabolomics,X23412.Phospholipids in VLDL,CPB2,Carboxypeptidase B2,39959,0.0488391816282387,0.0022830368437249,0.0443644294145379,0.0533139338419395,1.43408999767179e-99
NMR metabolomics,X23412.Phospholipids in VLDL,CKB,Creatine kinase B-type,39966,-0.124548162412908,0.00582218266078498,-0.135959640428046,-0.113136684397769,1.43597748598475e-99
NMR metabolomics,X23412.Phospholipids in VLDL,AP1G2,AP-1 complex subunit gamma-like 2,39919,0.171902962548104,0.00805665691572582,0.156111914993282,0.187694010102927,4.55878176073075e-99
NMR metabolomics,X23412.Phospholipids in VLDL,SERPIND1,Heparin cofactor 2,39959,0.0630814457162751,0.00296339259805262,0.057273196224092,0.0688896952084583,1.24993640474466e-98
NMR metabolomics,X23412.Phospholipids in VLDL,SARG,Specifically androgen-regulated gene protein,39915,0.236962933128218,0.0111569149734021,0.21509537978035,0.258830486476086,3.38433948118573e-98
NMR metabolomics,X23412.Phospholipids in VLDL,CDHR5,Cadherin-related family member 5,42145,0.0830757841609449,0.00392358492331551,0.0753855577112465,0.0907660106106433,6.43220138027203e-98
NMR metabolomics,X23412.Phospholipids in VLDL,IL16,Pro-interleukin-16,42296,0.0899621373093284,0.00429237016269875,0.0815490917904389,0.098375182828218,5.00310917680441e-96
NMR metabolomics,X23412.Phospholipids in VLDL,IGFBP1,Insulin-like growth factor-binding protein 1,42287,-0.269402379848513,0.0128792892184125,-0.294645786716602,-0.244158972980424,1.15720355099016e-95
NMR metabolomics,X23412.Phospholipids in VLDL,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,39929,0.0872926413944765,0.00419001994426853,0.0790802023037102,0.0955050804852429,1.26413060521513e-94
NMR metabolomics,X23412.Phospholipids in VLDL,NT5E,5'-nucleotidase,42181,0.113476724393225,0.00545607463005516,0.102782818118317,0.124170630668134,1.3302579554008e-94
NMR metabolomics,X23412.Phospholipids in VLDL,F9,Coagulation factor IX,42199,0.0386827416004459,0.00186043079528583,0.0350362972416857,0.0423291859592061,1.49141354072477e-94
NMR metabolomics,X23412.Phospholipids in VLDL,ABL1,Tyrosine-protein kinase ABL1,42070,0.142181091447551,0.00684660664278786,0.128761742427687,0.155600440467415,2.58619048561565e-94
NMR metabolomics,X23412.Phospholipids in VLDL,ADH1B,All-trans-retinol dehydrogenase,39736,0.160712782971027,0.00775342027267903,0.145516079236576,0.175909486705478,1.12257115810524e-93
NMR metabolomics,X23412.Phospholipids in VLDL,NPPC,C-type natriuretic peptide,42119,0.110312291520807,0.00533951425355392,0.0998468435838416,0.120777739457773,2.20219677207275e-93
NMR metabolomics,X23412.Phospholipids in VLDL,CXCL10,C-X-C motif chemokine 10,42185,0.138044134654366,0.00668744344900929,0.124936745494307,0.151151523814424,3.06898815727537e-93
NMR metabolomics,X23412.Phospholipids in VLDL,NOS3,"Nitric oxide synthase, endothelial",41839,0.105808960060051,0.00513043783540586,0.0957533019026559,0.115864618217447,4.83839122213538e-93
NMR metabolomics,X23412.Phospholipids in VLDL,MLN,Promotilin,42119,0.186857762185421,0.0090651275645985,0.169090112158808,0.204625412212034,5.62903576764696e-93
NMR metabolomics,X23412.Phospholipids in VLDL,GGT1,Glutathione hydrolase 1 proenzyme,42113,0.108419959731898,0.00526445817523536,0.0981016217084363,0.118738297755359,8.10044717099161e-93
NMR metabolomics,X23412.Phospholipids in VLDL,KITLG,Kit ligand,42145,-0.079602508755194,0.00387282237924823,-0.0871932406185205,-0.0720117768918675,1.80955093355103e-92
NMR metabolomics,X23412.Phospholipids in VLDL,TJAP1,Tight junction-associated protein 1,42181,0.173281118529228,0.00843315207347766,0.156752140465212,0.189810096593244,2.04416505751525e-92
NMR metabolomics,X23412.Phospholipids in VLDL,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,39930,0.0627785379241496,0.00305068456778551,0.05679919617129,0.0687578796770092,2.06958067121852e-92
NMR metabolomics,X23412.Phospholipids in VLDL,IL13RA1,Interleukin-13 receptor subunit alpha-1,41936,0.049847554603979,0.00243778132601489,0.0450695032049898,0.0546256060029682,1.57814467246191e-91
NMR metabolomics,X23412.Phospholipids in VLDL,STAB2,Stabilin-2,39966,0.0583607689396115,0.00285391905733508,0.0527670875872347,0.0639544502919882,2.64826201966076e-91
NMR metabolomics,X23412.Phospholipids in VLDL,NOTCH3,Neurogenic locus notch homolog protein 3,42310,-0.0694250332508675,0.00340147511942285,-0.0760919244849363,-0.0627581420167987,3.05916038670261e-91
NMR metabolomics,X23412.Phospholipids in VLDL,APOE,Apolipoprotein E,39979,0.144713600493256,0.00710298435794049,0.130791751151693,0.15863544983482,1.17518531911742e-90
NMR metabolomics,X23412.Phospholipids in VLDL,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,39757,0.235223464771138,0.0115907022355516,0.212505688389457,0.257941241152819,6.02383629585088e-90
NMR metabolomics,X23412.Phospholipids in VLDL,MAPK9,Mitogen-activated protein kinase 9,42119,0.0878616493320149,0.00434943895647605,0.0793367489773219,0.096386549686708,2.00549014031836e-89
NMR metabolomics,X23412.Phospholipids in VLDL,RBP5,Retinol-binding protein 5,42070,0.115462072366014,0.00571647952641151,0.104257772494247,0.12666637223778,2.13264286033118e-89
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINF1,Pigment epithelium-derived factor,39815,0.0540164247498852,0.00267210764384682,0.0487790937679455,0.059253755731825,2.79089192306489e-89
NMR metabolomics,X23412.Phospholipids in VLDL,CCL22,C-C motif chemokine 22,41991,0.106086902549669,0.00526293249477192,0.0957715548599158,0.116402250239422,4.82864577729378e-89
NMR metabolomics,X23412.Phospholipids in VLDL,CCL16,C-C motif chemokine 16,42310,0.105010180334926,0.00521193929270738,0.0947947793212198,0.115225581348633,5.41470587695308e-89
NMR metabolomics,X23412.Phospholipids in VLDL,LDLRAP1,Low density lipoprotein receptor adapter protein 1,39934,0.204513297851941,0.0101357676332279,0.184647193290815,0.224379402413068,5.59722598480373e-89
NMR metabolomics,X23412.Phospholipids in VLDL,LECT2,Leukocyte cell-derived chemotaxin-2,39958,0.13508485519177,0.00670581949841935,0.121941448974868,0.148228261408672,1.05705190331586e-88
NMR metabolomics,X23412.Phospholipids in VLDL,IGSF8,Immunoglobulin superfamily member 8,42145,0.0630999895158471,0.00314904689189165,0.0569278576077394,0.0692721214239547,4.8420989415132e-88
NMR metabolomics,X23412.Phospholipids in VLDL,CSNK2A1,Casein kinase II subunit alpha,39934,-0.090768759862691,0.00452843783612654,-0.0996444980214991,-0.081893021703883,7.48499339581306e-88
NMR metabolomics,X23412.Phospholipids in VLDL,MTSS2,Protein MTSS 2,39919,0.204545484140716,0.0102099481843865,0.184533985699319,0.224556982582114,9.16897892691288e-88
NMR metabolomics,X23412.Phospholipids in VLDL,ISM1,Isthmin-1,42119,0.0800623490811144,0.00401156433004068,0.0721996829942347,0.0879250151679941,2.30811252286491e-87
NMR metabolomics,X23412.Phospholipids in VLDL,DPY30,Protein dpy-30 homolog,42216,0.121761071369183,0.00610463381908275,0.109795989083781,0.133726153654585,2.86754102418026e-87
NMR metabolomics,X23412.Phospholipids in VLDL,LEFTY2,Left-right determination factor 2,42247,0.104289024308479,0.00523580717497313,0.0940268422455314,0.114551206371426,4.83702175809164e-87
NMR metabolomics,X23412.Phospholipids in VLDL,FGF21,Fibroblast growth factor 21,42247,0.242391130572921,0.0121967900352336,0.218485422103863,0.266296839041979,1.15872102543009e-86
NMR metabolomics,X23412.Phospholipids in VLDL,IPCEF1,Interactor protein for cytohesin exchange factors 1,41992,0.181650492093403,0.00914720332392291,0.163721973578514,0.199579010608292,1.62534119055076e-86
NMR metabolomics,X23412.Phospholipids in VLDL,ASGR1,Asialoglycoprotein receptor 1,42016,0.0611923509943376,0.00308301896913544,0.0551496338148321,0.0672350681738431,1.97705835872284e-86
NMR metabolomics,X23412.Phospholipids in VLDL,MASP1,Mannan-binding lectin serine protease 1,41997,0.0464031767579689,0.00234365670703833,0.0418096096121738,0.0509967439037641,5.08422170754983e-86
NMR metabolomics,X23412.Phospholipids in VLDL,BTD,Biotinidase,39979,0.0413536395222717,0.00208940218228931,0.0372584112449846,0.0454488677995587,9.56465713119203e-86
NMR metabolomics,X23412.Phospholipids in VLDL,MXRA8,Matrix remodeling-associated protein 8,39736,-0.062051712255365,0.00313507875039414,-0.0681964666061376,-0.0559069579045925,1.01433603846289e-85
NMR metabolomics,X23412.Phospholipids in VLDL,PDGFC,Platelet-derived growth factor C,41843,0.0560160560788949,0.00283832527726733,0.0504529385354509,0.0615791736223388,1.79570894374672e-85
NMR metabolomics,X23412.Phospholipids in VLDL,PAK4,Serine/threonine-protein kinase PAK 4,41839,0.122477349081737,0.0062247907972064,0.110276759119212,0.134677939044261,5.6701547946477e-85
NMR metabolomics,X23412.Phospholipids in VLDL,FGFR2,Fibroblast growth factor receptor 2,42181,0.0449351301465917,0.00228537720348903,0.0404557908277533,0.0494144694654302,6.88449946952011e-85
NMR metabolomics,X23412.Phospholipids in VLDL,CEP20,Centrosomal protein 20,41843,0.149701710448517,0.00764121574695505,0.134724927584485,0.164678493312549,2.846169398876e-84
NMR metabolomics,X23412.Phospholipids in VLDL,STC1,Stanniocalcin-1,42249,0.0911615635636141,0.0046560911786262,0.0820356248535067,0.100287502273721,3.32639765170268e-84
NMR metabolomics,X23412.Phospholipids in VLDL,MMP10,Stromelysin-2,42124,-0.114486575929858,0.00585568028497997,-0.125963709288418,-0.103009442571297,5.77107315703037e-84
NMR metabolomics,X23412.Phospholipids in VLDL,BANK1,B-cell scaffold protein with ankyrin repeats,42119,0.211336134201407,0.0108100214435194,0.190148492172109,0.232523776230705,5.92734022093474e-84
NMR metabolomics,X23412.Phospholipids in VLDL,CD63,CD63 antigen,41992,0.100275460927018,0.00512926208578016,0.0902221072388885,0.110328814615147,6.11506065615622e-84
NMR metabolomics,X23412.Phospholipids in VLDL,HBEGF,Proheparin-binding EGF-like growth factor,42224,0.14446362657375,0.00741146078450656,0.129937163436117,0.158990089711383,1.75583172846169e-83
NMR metabolomics,X23412.Phospholipids in VLDL,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,39575,0.135893615350046,0.0069696942088912,0.122233014700619,0.149554215999472,2.91255936549077e-83
NMR metabolomics,X23412.Phospholipids in VLDL,CXCL17,C-X-C motif chemokine 17,42296,0.0841815220555853,0.00433130364636875,0.0756921669087025,0.092670877202468,5.04726397400575e-83
NMR metabolomics,X23412.Phospholipids in VLDL,DKK1,Dickkopf-related protein 1,42249,0.116371367486618,0.00599141678684315,0.104628190584405,0.128114544388831,6.46433455235638e-83
NMR metabolomics,X23412.Phospholipids in VLDL,DNAJC6,Putative tyrosine-protein phosphatase auxilin,39638,0.167876358885382,0.00863391544215526,0.150953884618758,0.184798833152006,7.92012041957952e-83
NMR metabolomics,X23412.Phospholipids in VLDL,HJV,Hemojuvelin,39934,0.0831282382902229,0.0042830607186813,0.0747334392816075,0.0915230372988382,1.41825046823436e-82
NMR metabolomics,X23412.Phospholipids in VLDL,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,39909,0.154764150908688,0.00798224205661013,0.139118956477732,0.170409345339644,2.08232809356673e-82
NMR metabolomics,X23412.Phospholipids in VLDL,TCTN3,Tectonic-3,39958,0.0597840113633473,0.00309320901007666,0.0537213217035971,0.0658467010230976,6.47305542659721e-82
NMR metabolomics,X23412.Phospholipids in VLDL,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,42070,0.0722292364430313,0.00374259820912741,0.0648937439531416,0.0795647289329211,6.92615797921778e-82
NMR metabolomics,X23412.Phospholipids in VLDL,DNAJA2,DnaJ homolog subfamily A member 2,42259,0.159605781274121,0.00828901143546593,0.143359318860608,0.175852243687635,1.53470480354336e-81
NMR metabolomics,X23412.Phospholipids in VLDL,EHBP1,EH domain-binding protein 1,39958,0.146992828659018,0.00762405449061556,0.132049681857412,0.161935975460625,1.57258695541195e-81
NMR metabolomics,X23412.Phospholipids in VLDL,VEGFC,Vascular endothelial growth factor C,42181,0.108420158568168,0.00563138534711637,0.09738264328782,0.119457673848516,1.62404342095562e-81
NMR metabolomics,X23412.Phospholipids in VLDL,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",42119,0.195603614636091,0.0101710424716489,0.175668371391659,0.215538857880523,2.45559897087927e-81
NMR metabolomics,X23412.Phospholipids in VLDL,KAZN,Kazrin,39930,0.205384814614943,0.0106761722996312,0.184459516907666,0.22631011232222,3.5037141669437e-81
NMR metabolomics,X23412.Phospholipids in VLDL,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",42070,0.190831992178672,0.00993851209286801,0.171352508476651,0.210311475880693,4.36182211160408e-81
NMR metabolomics,X23412.Phospholipids in VLDL,AXIN1,Axin-1,42119,0.188281182876715,0.009814715004021,0.169044341468834,0.207518024284596,6.02346600790092e-81
NMR metabolomics,X23412.Phospholipids in VLDL,UPB1,Beta-ureidopropionase,39958,0.177084576183035,0.0092208162943876,0.159011776246035,0.195157376120035,6.41813034521356e-81
NMR metabolomics,X23412.Phospholipids in VLDL,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,41966,0.0954458990349937,0.00498762175190249,0.0856701604012648,0.105221637668723,1.4915457803003e-80
NMR metabolomics,X23412.Phospholipids in VLDL,IL1R2,Interleukin-1 receptor type 2,42100,0.0389381055422924,0.00203529464790685,0.034948928032395,0.0429272830521898,1.60210623765922e-80
NMR metabolomics,X23412.Phospholipids in VLDL,GCC1,GRIP and coiled-coil domain-containing protein 1,39929,0.211627140013084,0.0110901087529339,0.189890526857333,0.233363753168834,6.29056890946699e-80
NMR metabolomics,X23412.Phospholipids in VLDL,FTCD,Formimidoyltransferase-cyclodeaminase,39910,0.168159707396974,0.00881710971983281,0.150878172346102,0.185441242447847,7.68337986380091e-80
NMR metabolomics,X23412.Phospholipids in VLDL,TXLNA,Alpha-taxilin,42016,0.170566094515156,0.00895475392384156,0.153014776824426,0.188117412205885,7.76528020468188e-80
NMR metabolomics,X23412.Phospholipids in VLDL,PDLIM7,PDZ and LIM domain protein 7,42185,0.242732027632052,0.0127488568456798,0.21774426821452,0.267719787049584,8.7536078865049e-80
NMR metabolomics,X23412.Phospholipids in VLDL,PRCP,Lysosomal Pro-X carboxypeptidase,42238,0.061508907875001,0.00323123502031474,0.0551756872351841,0.0678421285148179,9.30681436655474e-80
NMR metabolomics,X23412.Phospholipids in VLDL,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",39638,0.111611969918172,0.00585687678512159,0.100132491419334,0.123091448417011,1.09534753579587e-79
NMR metabolomics,X23412.Phospholipids in VLDL,LEP,Leptin,42145,0.134420843932651,0.00707202368000925,0.120559677519833,0.14828201034547,1.60046512740655e-79
NMR metabolomics,X23412.Phospholipids in VLDL,SORD,Sorbitol dehydrogenase,42204,0.132822259558155,0.00698917991123522,0.119123466932134,0.146521052184176,1.68832699662377e-79
NMR metabolomics,X23412.Phospholipids in VLDL,DAB2,Disabled homolog 2,42262,0.213636370407354,0.0112774158338673,0.191532635372974,0.235740105441734,5.10765441250282e-79
NMR metabolomics,X23412.Phospholipids in VLDL,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,42016,0.101014007932721,0.00534727296503787,0.0905333529212471,0.111494662944196,1.41774782665205e-78
NMR metabolomics,X23412.Phospholipids in VLDL,TARBP2,RISC-loading complex subunit TARBP2,41839,0.151881898724248,0.0080401118280598,0.136123279541251,0.167640517907245,1.46834922497664e-78
NMR metabolomics,X23412.Phospholipids in VLDL,CXCL5,C-X-C motif chemokine 5,42101,0.216038340410266,0.0114429359404203,0.193610185967042,0.23846649485349,1.71576425289929e-78
NMR metabolomics,X23412.Phospholipids in VLDL,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,42070,0.072210259188211,0.00382775602155535,0.0647078573859625,0.0797126609904595,2.26254776257994e-78
NMR metabolomics,X23412.Phospholipids in VLDL,RAB11FIP3,Rab11 family-interacting protein 3,39958,0.206505874157756,0.0109647859275852,0.185014893739689,0.227996854575823,6.13708617348989e-78
NMR metabolomics,X23412.Phospholipids in VLDL,DCXR,L-xylulose reductase,42181,0.103561909462609,0.00551838210366502,0.0927458805394252,0.114377938385792,1.35106749612562e-77
NMR metabolomics,X23412.Phospholipids in VLDL,RNF41,E3 ubiquitin-protein ligase NRDP1,41843,0.12650248904048,0.00675925142386552,0.113254356249703,0.139750621831256,3.65451264611513e-77
NMR metabolomics,X23412.Phospholipids in VLDL,GLA,Alpha-galactosidase A,39713,0.0748382062098032,0.00399425145397609,0.0670094733600101,0.0826669390595964,3.83078144226999e-77
NMR metabolomics,X23412.Phospholipids in VLDL,SELPLG,P-selectin glycoprotein ligand 1,42119,0.052901131695967,0.00283151179211825,0.0473513685834152,0.0584508948085188,6.31776823157466e-77
NMR metabolomics,X23412.Phospholipids in VLDL,NFX1,Transcriptional repressor NF-X1,39575,0.128772375945319,0.00688464832731556,0.115278465223781,0.142266286666858,7.1171283773919e-77
NMR metabolomics,X23412.Phospholipids in VLDL,CCL17,C-C motif chemokine 17,42107,0.173681247772697,0.00930600751994795,0.155441473033599,0.191921022511795,9.06172826255761e-77
NMR metabolomics,X23412.Phospholipids in VLDL,CEP85,Centrosomal protein of 85 kDa,41843,0.123649310921755,0.00662544230790948,0.110663443998252,0.136635177845258,9.55940447378572e-77
NMR metabolomics,X23412.Phospholipids in VLDL,ZBTB16,Zinc finger and BTB domain-containing protein 16,41843,0.138966541676378,0.00745271464269379,0.124359220976698,0.153573862376057,1.28829048387885e-76
NMR metabolomics,X23412.Phospholipids in VLDL,CES3,Carboxylesterase 3,42070,0.134770026707203,0.00723199838233969,0.120595309877817,0.148944743536588,1.52182694541613e-76
NMR metabolomics,X23412.Phospholipids in VLDL,ARF6,ADP-ribosylation factor 6,39930,0.206310767269127,0.0110743875089931,0.1846049677515,0.228016566786753,2.54195536551939e-76
NMR metabolomics,X23412.Phospholipids in VLDL,DAAM1,Disheveled-associated activator of morphogenesis 1,39736,0.157364113309449,0.00845936257327658,0.140783762665827,0.173944463953071,4.34833452613414e-76
NMR metabolomics,X23412.Phospholipids in VLDL,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",42310,0.0559533568243904,0.00302181425329885,0.0500306008879246,0.0618761127608561,1.26791179788429e-75
NMR metabolomics,X23412.Phospholipids in VLDL,AP3S2,AP-3 complex subunit sigma-2,39929,0.0910640474931575,0.00491493684496058,0.0814307712770348,0.10069732370928,1.59398293023243e-75
NMR metabolomics,X23412.Phospholipids in VLDL,F11R,Junctional adhesion molecule A,42137,0.104966532096982,0.00567318656670371,0.0938470864262428,0.116085977767721,1.68574678356512e-75
NMR metabolomics,X23412.Phospholipids in VLDL,CREG1,Protein CREG1,41960,0.0760277657266285,0.00411073907583231,0.0679707171379972,0.0840848143152599,1.97825043223489e-75
NMR metabolomics,X23412.Phospholipids in VLDL,COL4A1,Collagen alpha-1(IV) chain,42145,-0.0736267387433228,0.00399695261205581,-0.0814607658629522,-0.0657927116236935,7.33684223184924e-75
NMR metabolomics,X23412.Phospholipids in VLDL,CD6,T-cell differentiation antigen CD6,42284,0.0976717490151043,0.00530520026550634,0.0872735564947119,0.108069941535497,8.62651715991236e-75
NMR metabolomics,X23412.Phospholipids in VLDL,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",39638,0.0480686458608938,0.00260822694049317,0.0429565210575272,0.0531807706642604,9.98670792501503e-75
NMR metabolomics,X23412.Phospholipids in VLDL,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,41900,0.104350205868805,0.00567623855760856,0.0932247782958924,0.115475633441718,1.48417961139106e-74
NMR metabolomics,X23412.Phospholipids in VLDL,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,41843,0.122015030557642,0.00664137663037072,0.108997932362116,0.135032128753169,1.84941808026937e-74
NMR metabolomics,X23412.Phospholipids in VLDL,ERBIN,Erbin,42070,0.191396378391687,0.010433715484285,0.170946296042488,0.211846460740885,2.94798070167119e-74
NMR metabolomics,X23412.Phospholipids in VLDL,PLXNA4,Plexin-A4,42119,0.149954546330985,0.00819097170248964,0.133900241794105,0.166008850867865,5.65466699228821e-74
NMR metabolomics,X23412.Phospholipids in VLDL,MME,Neprilysin,42070,0.144982821012486,0.00792861758581026,0.129442730544298,0.160522911480674,8.33863285128177e-74
NMR metabolomics,X23412.Phospholipids in VLDL,EFCAB14,EF-hand calcium-binding domain-containing protein 14,39930,0.0526532232438731,0.00287964885608239,0.0470091114859516,0.0582973350017946,1.25107641900063e-73
NMR metabolomics,X23412.Phospholipids in VLDL,NTproBNP,N-terminal prohormone of brain natriuretic peptide,42145,-0.205536287948657,0.0112593842478363,-0.227604681074417,-0.183467894822898,1.44453994606791e-73
NMR metabolomics,X23412.Phospholipids in VLDL,PLIN1,Perilipin-1,41839,0.0630221262807873,0.00345200232944843,0.0562562017150684,0.0697880508465062,1.45906596223347e-73
NMR metabolomics,X23412.Phospholipids in VLDL,GHRL,Appetite-regulating hormone,42145,0.153995492499309,0.00845602844561777,0.137421676745898,0.170569308252719,3.13103527929635e-73
NMR metabolomics,X23412.Phospholipids in VLDL,BECN1,Beclin-1,39638,0.110546628560406,0.00606642130985959,0.0986564427930809,0.12243681432773,4.00280175746592e-73
NMR metabolomics,X23412.Phospholipids in VLDL,MFAP5,Microfibrillar-associated protein 5,42310,0.0748325804474236,0.00411875512132085,0.0667598204096347,0.0829053404852124,6.52908092942108e-73
NMR metabolomics,X23412.Phospholipids in VLDL,CLEC1B,C-type lectin domain family 1 member B,42249,0.176252366694887,0.00972385954307094,0.157193601990468,0.195311131399306,1.41360222981105e-72
NMR metabolomics,X23412.Phospholipids in VLDL,TPD52L2,Tumor protein D54,39736,0.201539987537269,0.0111116710211671,0.179761112335782,0.223318862738757,1.76625213696975e-72
NMR metabolomics,X23412.Phospholipids in VLDL,SHBG,Sex hormone-binding globulin,39990,-0.0865475117942887,0.00477539480361527,-0.0959072856093747,-0.0771877379792028,2.14843832955484e-72
NMR metabolomics,X23412.Phospholipids in VLDL,YOD1,Ubiquitin thioesterase OTU1,39575,0.112350769023371,0.00619750089971647,0.100203667259927,0.124497870786816,2.15398862447179e-72
NMR metabolomics,X23412.Phospholipids in VLDL,MINK1,Misshapen-like kinase 1,39929,0.172013868402846,0.00950349542268873,0.153387017374376,0.190640719431316,3.29781313404102e-72
NMR metabolomics,X23412.Phospholipids in VLDL,EZR,Ezrin,42249,0.0447373256821903,0.00247515643216349,0.0398860190751499,0.0495886322892308,3.5050433960768e-72
NMR metabolomics,X23412.Phospholipids in VLDL,PBLD,Phenazine biosynthesis-like domain-containing protein,41839,0.0968667875443216,0.00536889595489253,0.0863437514727322,0.107389823615911,6.58422821539858e-72
NMR metabolomics,X23412.Phospholipids in VLDL,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,42181,0.174217772886087,0.00966692830520756,0.15527059340788,0.193164952364293,8.95296158884473e-72
NMR metabolomics,X23412.Phospholipids in VLDL,APOA2,Apolipoprotein A-II,39990,-0.0908110730079981,0.00503567819337589,-0.100681002267015,-0.0809411437489814,1.05172620511358e-71
NMR metabolomics,X23412.Phospholipids in VLDL,KHK,Ketohexokinase,39638,0.115977841055907,0.0064305781322019,0.103373907916791,0.128581774195023,1.0940704016303e-71
NMR metabolomics,X23412.Phospholipids in VLDL,CCL5,C-C motif chemokine 5,42217,0.184817135892753,0.0102732279157507,0.164681609177881,0.204952662607624,1.56298200835512e-71
NMR metabolomics,X23412.Phospholipids in VLDL,S100A4,Protein S100-A4,42181,0.102449445185139,0.00570587813486348,0.0912659240408064,0.113632966329471,2.91440770143944e-71
NMR metabolomics,X23412.Phospholipids in VLDL,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",39906,0.201943500549324,0.011236227959003,0.179920493749678,0.223966507348969,3.12044942249406e-71
NMR metabolomics,X23412.Phospholipids in VLDL,ATG16L1,Autophagy-related protein 16-1,39930,0.158029960835871,0.00879381303254703,0.140794087292079,0.175265834379663,3.21371224086655e-71
NMR metabolomics,X23412.Phospholipids in VLDL,SUGP1,SURP and G-patch domain-containing protein 1,39930,0.074535584158463,0.00414803944298689,0.0664054268502087,0.0826657414667173,3.31170900548886e-71
NMR metabolomics,X23412.Phospholipids in VLDL,NPL,N-acetylneuraminate lyase,39958,0.0848398012212681,0.00473432212714295,0.0755605298520679,0.0941190725904682,7.72617960383604e-71
NMR metabolomics,X23412.Phospholipids in VLDL,TNIP1,TNFAIP3-interacting protein 1,39929,0.160902501134233,0.00901549524812386,0.14323213044791,0.178572871820555,2.76851818475365e-70
NMR metabolomics,X23412.Phospholipids in VLDL,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,39934,0.153459503596684,0.00860060033115174,0.136602326947627,0.170316680245742,2.98844525373485e-70
NMR metabolomics,X23412.Phospholipids in VLDL,NCK2,Cytoplasmic protein NCK2,42185,0.193838635625099,0.0108845924919906,0.172504834340797,0.2151724369094,3.79835628829868e-70
NMR metabolomics,X23412.Phospholipids in VLDL,RTBDN,Retbindin,42070,0.0542529242600849,0.00305430326896388,0.0482664898529157,0.0602393586672541,8.56373296639107e-70
NMR metabolomics,X23412.Phospholipids in VLDL,PPP1R9B,Neurabin-2,42296,0.171336675856182,0.00965979478094106,0.152403478085538,0.190269873626827,1.29996338016723e-69
NMR metabolomics,X23412.Phospholipids in VLDL,SELP,P-selectin,42217,0.100716188582256,0.00568447009567282,0.0895746271947373,0.111857749969775,1.83725960236757e-69
NMR metabolomics,X23412.Phospholipids in VLDL,BCR,Breakpoint cluster region protein,42119,0.166686483409889,0.00940793156763666,0.148246937537321,0.185126029282457,1.86497417188815e-69
NMR metabolomics,X23412.Phospholipids in VLDL,CANT1,Soluble calcium-activated nucleotidase 1,42084,0.036080716637419,0.00203895584305961,0.0320843631850222,0.0400770700898159,2.74360135626415e-69
NMR metabolomics,X23412.Phospholipids in VLDL,ARHGEF1,Rho guanine nucleotide exchange factor 1,39929,0.161959849350288,0.00915921859130979,0.144007780911321,0.179911917789255,4.8056150893889e-69
NMR metabolomics,X23412.Phospholipids in VLDL,STAT5B,Signal transducer and activator of transcription 5B,42070,0.246697853259472,0.0139711764529081,0.219314347411772,0.274081359107171,5.31547977645384e-69
NMR metabolomics,X23412.Phospholipids in VLDL,FAM20A,Pseudokinase FAM20A,39958,0.0507223581023346,0.00287244073006268,0.0450923742714118,0.0563523419332575,7.28650734862517e-69
NMR metabolomics,X23412.Phospholipids in VLDL,DCTN1,Dynactin subunit 1,42262,0.114613752023439,0.00651093812442022,0.101852313299575,0.127375190747303,1.32772232216669e-68
NMR metabolomics,X23412.Phospholipids in VLDL,CD2AP,CD2-associated protein,42145,0.113029889893437,0.00642549283329052,0.100435923940188,0.125623855846687,1.66943992643062e-68
NMR metabolomics,X23412.Phospholipids in VLDL,SEMA3F,Semaphorin-3F,42145,0.047729089907941,0.00271537023124145,0.0424069642547078,0.0530512155611743,2.10614121055812e-68
NMR metabolomics,X23412.Phospholipids in VLDL,SLA2,Src-like-adapter 2,39934,0.191416696638845,0.0108877297530892,0.17007674632279,0.2127566469549,2.76807428539735e-68
NMR metabolomics,X23412.Phospholipids in VLDL,CLIP2,CAP-Gly domain-containing linker protein 2,42119,0.202234073471008,0.0115187945548305,0.17965723614354,0.224810910798475,3.0083475957065e-68
NMR metabolomics,X23412.Phospholipids in VLDL,SCLY,Selenocysteine lyase,42224,0.0870086504865377,0.00495814466076189,0.0772906869514444,0.096726614021631,3.42185402099144e-68
NMR metabolomics,X23412.Phospholipids in VLDL,PTS,6-pyruvoyl tetrahydrobiopterin synthase,41783,0.0976597411519395,0.00557406337343877,0.0867345769399995,0.108584905363879,5.88593776765132e-68
NMR metabolomics,X23412.Phospholipids in VLDL,CMIP,C-Maf-inducing protein,39919,0.150070155846485,0.00855829418785784,0.133295899238284,0.166844412454686,6.09798621790257e-68
NMR metabolomics,X23412.Phospholipids in VLDL,GP1BA,Platelet glycoprotein Ib alpha chain,42117,0.0593945403087048,0.0033979706621039,0.0527345178109811,0.0660545628064284,1.13909879789413e-67
NMR metabolomics,X23412.Phospholipids in VLDL,RNASE4,Ribonuclease 4,39645,0.0494286025482099,0.00282895886879675,0.0438838431653683,0.0549733619310516,1.87161576503025e-67
NMR metabolomics,X23412.Phospholipids in VLDL,CXCL3,C-X-C motif chemokine 3,42129,0.16936660308064,0.00971648507996499,0.150322292323909,0.188410913837372,2.61292689642005e-67
NMR metabolomics,X23412.Phospholipids in VLDL,CCN2,CCN family member 2,42146,0.100199817466032,0.00575393030892187,0.0889221140605452,0.111477520871519,3.46901083554493e-67
NMR metabolomics,X23412.Phospholipids in VLDL,FOXO1,Forkhead box protein O1,42119,0.153767830158557,0.00883208137830691,0.136456950657075,0.171078709660038,3.72707109047029e-67
NMR metabolomics,X23412.Phospholipids in VLDL,NFKB1,Nuclear factor NF-kappa-B p105 subunit,39575,0.132668004246249,0.00763462429670673,0.117704140624704,0.147631867867794,9.57922636896417e-67
NMR metabolomics,X23412.Phospholipids in VLDL,KLK10,Kallikrein-10,42138,0.0722811216475353,0.00416534379109569,0.0641170478169878,0.0804451954780829,9.85977664358687e-67
NMR metabolomics,X23412.Phospholipids in VLDL,IGF2R,Cation-independent mannose-6-phosphate receptor,42137,0.0424458645827278,0.0024479685324699,0.0376478462590868,0.0472438829063688,1.24637732016312e-66
NMR metabolomics,X23412.Phospholipids in VLDL,C1S,Complement C1s subcomponent,39979,0.0374328006863322,0.00215700569337716,0.033205069527313,0.0416605318453514,1.31956903134386e-66
NMR metabolomics,X23412.Phospholipids in VLDL,ARHGEF12,Rho guanine nucleotide exchange factor 12,42119,0.183526602167881,0.0106067824082827,0.162737308647647,0.204315895688115,2.32166079545428e-66
NMR metabolomics,X23412.Phospholipids in VLDL,ASAH2,Neutral ceramidase,42016,0.0938181593564312,0.00542412729090015,0.0831868698662669,0.104449448846595,2.61640888877198e-66
NMR metabolomics,X23412.Phospholipids in VLDL,RBPMS2,RNA-binding protein with multiple splicing 2,39638,0.181386305075371,0.0105023071598667,0.160801783042032,0.20197082710871,5.69815858421206e-66
NMR metabolomics,X23412.Phospholipids in VLDL,EIF4B,Eukaryotic translation initiation factor 4B,42016,0.0987679502889453,0.00572634662966251,0.0875443108948068,0.109991589683084,5.95022950820591e-66
NMR metabolomics,X23412.Phospholipids in VLDL,IKBKG,NF-kappa-B essential modulator,42119,0.160469819279654,0.00931646606023135,0.142209545801601,0.178730092757708,8.77213556508377e-66
NMR metabolomics,X23412.Phospholipids in VLDL,PDGFB,Platelet-derived growth factor subunit B,42185,0.150061245131774,0.00873572604942874,0.132939222074894,0.167183268188654,1.90740152815692e-65
NMR metabolomics,X23412.Phospholipids in VLDL,BPIFB1,BPI fold-containing family B member 1,42098,-0.113286489254836,0.0065990236018565,-0.126220575514475,-0.100352402995197,2.30850680407782e-65
NMR metabolomics,X23412.Phospholipids in VLDL,IRAK1,Interleukin-1 receptor-associated kinase 1,41913,0.121694762270889,0.00713676107624767,0.107706710561443,0.135682813980334,1.63783264544014e-64
NMR metabolomics,X23412.Phospholipids in VLDL,GPC5,Glypican-5,42016,0.097904577284888,0.00574570624440471,0.0866429930458547,0.109166161523921,1.98556033420121e-64
NMR metabolomics,X23412.Phospholipids in VLDL,TGFB1,Transforming growth factor beta-1 proprotein,42284,0.0674856478204215,0.00396175669943179,0.0597206046895352,0.0752506909513078,2.10658787301761e-64
NMR metabolomics,X23412.Phospholipids in VLDL,TIMP4,Metalloproteinase inhibitor 4,42137,-0.0691952682399916,0.00406262918233772,-0.0771580214373735,-0.0612325150426096,2.21915775845709e-64
NMR metabolomics,X23412.Phospholipids in VLDL,AGRN,Agrin,42185,0.0622546265709996,0.00365530447290159,0.0550902298041124,0.0694190233378867,2.23809241360689e-64
NMR metabolomics,X23412.Phospholipids in VLDL,PAXX,Protein PAXX,39736,0.0804290635344482,0.00473202928927724,0.0711542861274649,0.0897038409414316,5.54683054326512e-64
NMR metabolomics,X23412.Phospholipids in VLDL,ATP6V1G1,V-type proton ATPase subunit G 1,39638,0.126566733341045,0.00745206911217328,0.111960677881185,0.141172788800905,6.95378377273579e-64
NMR metabolomics,X23412.Phospholipids in VLDL,SRPK2,SRSF protein kinase 2,42119,0.147089553974894,0.00868149344038677,0.130073826831736,0.164105281118052,9.86282767606073e-64
NMR metabolomics,X23412.Phospholipids in VLDL,PCBP2,Poly(rC)-binding protein 2,39934,0.12630113575317,0.0074557955281286,0.111687776518038,0.140914494988302,1.37852506109197e-63
NMR metabolomics,X23412.Phospholipids in VLDL,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",39638,0.118651569090439,0.00701546614349741,0.104901255449184,0.132401882731694,2.26533432226215e-63
NMR metabolomics,X23412.Phospholipids in VLDL,DUSP13,Dual specificity protein phosphatase 13 isoform A,39919,0.0745121481456867,0.00440757726589484,0.0658732967045328,0.0831509995868406,2.44790193446676e-63
NMR metabolomics,X23412.Phospholipids in VLDL,DOK2,Docking protein 2,42145,0.210970862637728,0.0125254162840025,0.186421046721083,0.235520678554373,5.12767426738669e-63
NMR metabolomics,X23412.Phospholipids in VLDL,PPY,Pancreatic prohormone,42089,0.176550657115782,0.0104931781579684,0.155984027926164,0.1971172863054,6.96472832163771e-63
NMR metabolomics,X23412.Phospholipids in VLDL,NFE2,Transcription factor NF-E2 45 kDa subunit,39638,0.127681268314126,0.00758722892849128,0.112810299614283,0.142552237013968,9.12328447864778e-63
NMR metabolomics,X23412.Phospholipids in VLDL,NFKBIE,NF-kappa-B inhibitor epsilon,41843,0.0845660276018638,0.00503375931738596,0.0746998593397873,0.0944321958639402,1.09045276360929e-62
NMR metabolomics,X23412.Phospholipids in VLDL,SNAP23,Synaptosomal-associated protein 23,42145,0.148475510247596,0.00885683533222449,0.131116112996436,0.165834907498756,1.90574051392621e-62
NMR metabolomics,X23412.Phospholipids in VLDL,SDCCAG8,Serologically defined colon cancer antigen 8,39919,0.195592401147248,0.0116561830198357,0.172746282428371,0.218438519866126,1.93297723430712e-62
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINH1,Serpin H1,39757,0.220715962822333,0.0131640943038676,0.194914337986752,0.246517587657913,2.47834801213467e-62
NMR metabolomics,X23412.Phospholipids in VLDL,FUOM,Fucose mutarotase,39736,0.11050740764513,0.00659361971721868,0.0975839129993817,0.123430902290879,2.77832006350239e-62
NMR metabolomics,X23412.Phospholipids in VLDL,ITGA5,Integrin alpha-5,42137,0.0424697702376624,0.00253750189252017,0.0374962665283228,0.0474432739470019,2.98041199564662e-62
NMR metabolomics,X23412.Phospholipids in VLDL,TIMP3,Metalloproteinase inhibitor 3,42185,0.217697467210737,0.0130296657292608,0.192159322381386,0.243235612040088,4.77824359288885e-62
NMR metabolomics,X23412.Phospholipids in VLDL,NUCB2,Nucleobindin-2,42231,0.0637992306309666,0.00382356988064945,0.0563050336648937,0.0712934275970395,6.83119272529776e-62
NMR metabolomics,X23412.Phospholipids in VLDL,USO1,General vesicular transport factor p115,42070,0.151570731133089,0.00908443394349655,0.133765240603836,0.169376221662342,7.07377214293957e-62
NMR metabolomics,X23412.Phospholipids in VLDL,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,42296,0.166224924023123,0.00997782137893504,0.146668394120411,0.185781453925836,1.04516972087376e-61
NMR metabolomics,X23412.Phospholipids in VLDL,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,39930,0.184423298673513,0.0110643090334889,0.162737252967874,0.206109344379151,1.20512751253935e-61
NMR metabolomics,X23412.Phospholipids in VLDL,OTUD7B,OTU domain-containing protein 7B,39934,0.107577088979408,0.00645744847334921,0.094920489971644,0.120233687987173,1.39335547929179e-61
NMR metabolomics,X23412.Phospholipids in VLDL,SEC31A,Protein transport protein Sec31A,39638,0.131918620575483,0.00791936043475629,0.116396674123361,0.147440567027605,1.49620479217334e-61
NMR metabolomics,X23412.Phospholipids in VLDL,CDH2,Cadherin-2,42145,0.0597985381692642,0.0035977840033622,0.0527468815226743,0.0668501948158541,1.99309162671974e-61
NMR metabolomics,X23412.Phospholipids in VLDL,CCL13,C-C motif chemokine 13,42275,0.115372861400368,0.00695172591661747,0.101747478603798,0.128998244196939,2.94244106112821e-61
NMR metabolomics,X23412.Phospholipids in VLDL,GFER,FAD-linked sulfhydryl oxidase ALR,41843,0.107862079998095,0.00650266963702203,0.0951168475095318,0.120607312486658,3.55864239039634e-61
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINE1,Plasminogen activator inhibitor 1,42310,0.112314082301469,0.00678191623087301,0.0990215264889575,0.12560663811398,5.2297632059366e-61
NMR metabolomics,X23412.Phospholipids in VLDL,IL18R1,Interleukin-18 receptor 1,42296,0.055731502593342,0.00337147250430598,0.0491234164849022,0.0623395887017817,8.60496386591205e-61
NMR metabolomics,X23412.Phospholipids in VLDL,F2,Prothrombin,39979,0.025152997930945,0.00152199616546645,0.0221698854466307,0.0281361104152592,1.20443825086301e-60
NMR metabolomics,X23412.Phospholipids in VLDL,PDCD5,Programmed cell death protein 5,42249,0.0964147567054448,0.00584281967749672,0.0849628301375513,0.107866683273338,1.38280942985683e-60
NMR metabolomics,X23412.Phospholipids in VLDL,SFRP4,Secreted frizzled-related protein 4,39736,0.0676029044177811,0.00409396310819765,0.0595787367257137,0.0756270721098485,1.55160035814734e-60
NMR metabolomics,X23412.Phospholipids in VLDL,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,41997,0.187415093765747,0.0114133900642655,0.165044849239787,0.209785338291707,5.24480313351786e-60
NMR metabolomics,X23412.Phospholipids in VLDL,GPD1,Glycerol-3-phosphate dehydrogenase,39919,0.0893414310463734,0.00543832881247596,0.0786823065739206,0.100000555518826,5.93407718587545e-60
NMR metabolomics,X23412.Phospholipids in VLDL,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",42056,0.176523505304582,0.0107677848897021,0.155418646920766,0.197628363688398,8.05849073555713e-60
NMR metabolomics,X23412.Phospholipids in VLDL,PLEKHO1,Pleckstrin homology domain-containing family O member 1,39929,0.117149988665569,0.00714054852410208,0.103154513558329,0.131145463772809,8.41686746657761e-60
NMR metabolomics,X23412.Phospholipids in VLDL,GOLM2,Protein GOLM2,42249,0.0379528709407618,0.0023211515634265,0.0334034138764458,0.0425023280050777,1.57637334232984e-59
NMR metabolomics,X23412.Phospholipids in VLDL,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,39736,0.0836516930984551,0.0051118718762091,0.0736324242210853,0.0936709619758249,1.70027283223929e-59
NMR metabolomics,X23412.Phospholipids in VLDL,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,42016,0.158110371140624,0.00968611386577565,0.139125587963703,0.177095154317544,2.50721117547258e-59
NMR metabolomics,X23412.Phospholipids in VLDL,SH2B3,SH2B adapter protein 3,41843,0.164068011391442,0.0100592112827505,0.144351957277251,0.183784065505633,3.15104387147226e-59
NMR metabolomics,X23412.Phospholipids in VLDL,PLSCR3,Phospholipid scramblase 3,39911,0.0962457179351675,0.00589904043394898,0.0846835986846275,0.107807837185708,3.62178432140212e-59
NMR metabolomics,X23412.Phospholipids in VLDL,NAGK,N-acetyl-D-glucosamine kinase,39627,0.0949154809330567,0.00582075755817278,0.0835067961190381,0.106324165747075,4.35771147766943e-59
NMR metabolomics,X23412.Phospholipids in VLDL,FETUB,Fetuin-B,42199,0.0534689169697649,0.00328348556737695,0.0470332852577061,0.0599045486818238,4.62317840281771e-59
NMR metabolomics,X23412.Phospholipids in VLDL,BACH1,Transcription regulator protein BACH1,42119,0.123961191608246,0.00765525251432882,0.108956896680162,0.138965486536331,2.00302954237557e-58
NMR metabolomics,X23412.Phospholipids in VLDL,BIRC2,Baculoviral IAP repeat-containing protein 2,41843,0.104283345403379,0.0064510531337164,0.0916392812612946,0.116927409545463,3.19259877375222e-58
NMR metabolomics,X23412.Phospholipids in VLDL,VPS53,Vacuolar protein sorting-associated protein 53 homolog,42070,0.127982325690143,0.00791906738844323,0.112460953608794,0.143503697771491,3.33242312351382e-58
NMR metabolomics,X23412.Phospholipids in VLDL,DNAJB6,DnaJ homolog subfamily B member 6,39639,0.140755365168255,0.00870720086356546,0.123689251475666,0.157821478860843,4.10273683492599e-58
NMR metabolomics,X23412.Phospholipids in VLDL,RLN2,Prorelaxin H2,39709,0.0851197908684508,0.0052697934487607,0.0747909957088798,0.0954485860280218,4.99373291231762e-58
NMR metabolomics,X23412.Phospholipids in VLDL,HGF,Hepatocyte growth factor,42296,0.0568428497804846,0.00352512498694219,0.0499336048060779,0.0637520947548913,5.80824451020842e-58
NMR metabolomics,X23412.Phospholipids in VLDL,GMPR,GMP reductase 1,42296,0.078315170164985,0.00486282750067107,0.0687840282636697,0.0878463120663003,8.00373501862575e-58
NMR metabolomics,X23412.Phospholipids in VLDL,PHACTR2,Phosphatase and actin regulator 2,39934,0.188178341830268,0.0116803397171929,0.16528487598457,0.211071807675966,9.38059184394812e-58
NMR metabolomics,X23412.Phospholipids in VLDL,OXT,Oxytocin-neurophysin 1,42249,0.237876646319287,0.0147901664823695,0.208887920013843,0.266865372624731,1.12891131173649e-57
NMR metabolomics,X23412.Phospholipids in VLDL,RGCC,Regulator of cell cycle RGCC,39934,0.126039155088487,0.00782914987665034,0.110694021330252,0.141384288846722,1.13374698950305e-57
NMR metabolomics,X23412.Phospholipids in VLDL,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,39958,0.126705009502617,0.00788051320052138,0.111259203629595,0.142150815375639,1.56068083981186e-57
NMR metabolomics,X23412.Phospholipids in VLDL,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,42212,0.167690925854985,0.0104589981852287,0.147191289411936,0.188190562298033,2.50842985350698e-57
NMR metabolomics,X23412.Phospholipids in VLDL,TANK,TRAF family member-associated NF-kappa-B activator,41913,0.116055729958842,0.00724305932387038,0.101859333684056,0.130252126233627,3.02409151828619e-57
NMR metabolomics,X23412.Phospholipids in VLDL,OPHN1,Oligophrenin-1,39929,0.177908692258037,0.0110974012528792,0.156157785802393,0.19965959871368,3.27001913474558e-57
NMR metabolomics,X23412.Phospholipids in VLDL,GDF2,Growth/differentiation factor 2,42145,0.0577667510705157,0.00360710513802101,0.0506968249999945,0.0648366771410369,3.37699762746588e-57
NMR metabolomics,X23412.Phospholipids in VLDL,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,39757,0.172797084866277,0.010788864864271,0.151650909732306,0.193943260000248,4.25316368265201e-57
NMR metabolomics,X23412.Phospholipids in VLDL,CDC42BPB,Serine/threonine-protein kinase MRCK beta,39930,0.167785150820131,0.0105014581369813,0.147202292871647,0.188368008768614,7.66689240401052e-57
NMR metabolomics,X23412.Phospholipids in VLDL,ANG,Angiogenin,42152,0.0534170814744128,0.00334789500502422,0.0468552072645653,0.0599789556842602,8.5864454902863e-57
NMR metabolomics,X23412.Phospholipids in VLDL,ATP5IF1,"ATPase inhibitor, mitochondrial",42185,0.177992103266274,0.0111575426707632,0.156123319631578,0.199860886900969,8.94690967780168e-57
NMR metabolomics,X23412.Phospholipids in VLDL,LAT,Linker for activation of T-cells family member 1,42296,0.123383274518783,0.00774245492514731,0.108208062865494,0.138558486172072,1.15198362501355e-56
NMR metabolomics,X23412.Phospholipids in VLDL,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,39728,0.0792555374328848,0.00497163736851995,0.0695111281905857,0.0889999466751839,1.37758208814181e-56
NMR metabolomics,X23412.Phospholipids in VLDL,GIT1,ARF GTPase-activating protein GIT1,39657,0.158121906121954,0.0099278811918478,0.138663258985932,0.177580553257975,1.7435041146241e-56
NMR metabolomics,X23412.Phospholipids in VLDL,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",39934,0.12723917356135,0.0079998230491753,0.111559520384966,0.142918826737733,2.36771226375697e-56
NMR metabolomics,X23412.Phospholipids in VLDL,CMC1,COX assembly mitochondrial protein homolog,39958,0.148620335280178,0.00934466182556154,0.130304798102078,0.166935872458279,2.39592473963102e-56
NMR metabolomics,X23412.Phospholipids in VLDL,HCLS1,Hematopoietic lineage cell-specific protein,42296,0.0897077514518763,0.00564680237405697,0.0786400187987246,0.100775484105028,2.50258360263207e-56
NMR metabolomics,X23412.Phospholipids in VLDL,MAMDC4,Apical endosomal glycoprotein,39919,0.0919863429114633,0.0057862329550552,0.0806453263195551,0.103327359503371,2.6792706877297e-56
NMR metabolomics,X23412.Phospholipids in VLDL,AKT1S1,Proline-rich AKT1 substrate 1,41839,0.107727286163961,0.0067826339191746,0.0944333236823786,0.121021248645543,2.75673567554726e-56
NMR metabolomics,X23412.Phospholipids in VLDL,AP3B1,AP-3 complex subunit beta-1,39930,0.125316946768724,0.00788593604058126,0.109860512129184,0.140773381408263,2.95004714161388e-56
NMR metabolomics,X23412.Phospholipids in VLDL,PON3,Serum paraoxonase/lactonase 3,42185,-0.04757410038633,0.00299674553210134,-0.0534477216292486,-0.0417004791434114,3.01076607049205e-56
NMR metabolomics,X23412.Phospholipids in VLDL,CIRBP,Cold-inducible RNA-binding protein,39930,0.156719392230731,0.00986717952571524,0.137379720360329,0.176059064101132,3.3578162149076e-56
NMR metabolomics,X23412.Phospholipids in VLDL,TNFSF11,Tumor necrosis factor ligand superfamily member 11,42119,0.0993379887457129,0.00626172698498475,0.0870650038551428,0.111610973636283,3.59295311183563e-56
NMR metabolomics,X23412.Phospholipids in VLDL,AAMDC,Mth938 domain-containing protein,39638,0.0856556060092601,0.00542383255198366,0.0750248942073721,0.0962863178111481,1.42079986103542e-55
NMR metabolomics,X23412.Phospholipids in VLDL,STK11,Serine/threonine-protein kinase STK11,41900,0.117467722075559,0.00745619511770773,0.102853579644852,0.132081864506266,2.02999800418657e-55
NMR metabolomics,X23412.Phospholipids in VLDL,CEP43,Centrosomal protein 43,41797,0.113192562589154,0.00719189294231154,0.0990964524222235,0.127288672756085,2.60375192418712e-55
NMR metabolomics,X23412.Phospholipids in VLDL,RAPGEF2,Rap guanine nucleotide exchange factor 2,39757,0.0869451025823636,0.00552114386077451,0.0761236606152456,0.0977665445494816,2.80161988908809e-55
NMR metabolomics,X23412.Phospholipids in VLDL,TNFSF12,Tumor necrosis factor ligand superfamily member 12,42296,0.0446915992822833,0.00284939964883512,0.0391067759705665,0.0502764225940002,5.79722461140411e-55
NMR metabolomics,X23412.Phospholipids in VLDL,SUSD1,Sushi domain-containing protein 1,41900,0.0779185953231912,0.00497382151549016,0.0681699051528305,0.0876672854935519,8.00989395652258e-55
NMR metabolomics,X23412.Phospholipids in VLDL,TBL1X,F-box-like/WD repeat-containing protein TBL1X,41843,0.136065154037803,0.00870360393158467,0.119006090331897,0.153124217743709,1.32969352852244e-54
NMR metabolomics,X23412.Phospholipids in VLDL,CD300LG,CMRF35-like molecule 9,42137,-0.0595707869114896,0.00381267233493042,-0.0670436246879532,-0.052097949135026,1.4861127014211e-54
NMR metabolomics,X23412.Phospholipids in VLDL,PON2,Serum paraoxonase/arylesterase 2,41900,0.0561559522390496,0.00359387419335973,0.0491119588200645,0.0631999456580346,1.49086128132123e-54
NMR metabolomics,X23412.Phospholipids in VLDL,TOP2B,DNA topoisomerase 2-beta,39657,0.128791846257226,0.00823909884439086,0.112643212522219,0.144940479992232,1.69113671648102e-54
NMR metabolomics,X23412.Phospholipids in VLDL,CRELD1,Protein disulfide isomerase CRELD1,39736,0.0598492820399951,0.00383636528575762,0.0523300060799101,0.06736855800008,2.70697568298969e-54
NMR metabolomics,X23412.Phospholipids in VLDL,SCPEP1,Retinoid-inducible serine carboxypeptidase,39601,0.081704729672063,0.00523770416266805,0.0714388295132337,0.0919706298308924,2.80063757134752e-54
NMR metabolomics,X23412.Phospholipids in VLDL,AZI2,5-azacytidine-induced protein 2,39934,0.0887028635464347,0.00569037543024991,0.0775497277031449,0.0998559993897245,3.19461495744757e-54
NMR metabolomics,X23412.Phospholipids in VLDL,METAP2,Methionine aminopeptidase 2,42247,0.0886128471674864,0.00569525122006119,0.0774501547761665,0.0997755395588064,4.02481602688756e-54
NMR metabolomics,X23412.Phospholipids in VLDL,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,42119,0.16173030413689,0.0103964889355629,0.141353185823186,0.182107422450593,4.24598712342645e-54
NMR metabolomics,X23412.Phospholipids in VLDL,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",39934,0.129036079797159,0.00829488358712605,0.112778107966392,0.145294051627926,5.22366968296719e-54
NMR metabolomics,X23412.Phospholipids in VLDL,SYTL4,Synaptotagmin-like protein 4,39958,0.11574344498116,0.00744239099246581,0.101156358635927,0.130330531326393,5.55429377952136e-54
NMR metabolomics,X23412.Phospholipids in VLDL,SKAP2,Src kinase-associated phosphoprotein 2,42185,0.164994478413375,0.0106213031712175,0.144176724197789,0.185812232628962,5.91419878675775e-54
NMR metabolomics,X23412.Phospholipids in VLDL,FGFBP2,Fibroblast growth factor-binding protein 2,39966,0.0817569300363308,0.00526071288776647,0.0714459327763085,0.092067927296353,6.55345551725426e-54
NMR metabolomics,X23412.Phospholipids in VLDL,ZFYVE19,Abscission/NoCut checkpoint regulator,39930,0.143854119658025,0.00925896515987591,0.125706547944668,0.162001691371382,7.02622073693693e-54
NMR metabolomics,X23412.Phospholipids in VLDL,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,39934,0.124300553380792,0.00800697131396355,0.108606889605424,0.139994217156161,8.52565798583946e-54
NMR metabolomics,X23412.Phospholipids in VLDL,MPRIP,Myosin phosphatase Rho-interacting protein,39892,0.0719670527968921,0.00464840640788792,0.0628561762374318,0.0810779293563524,1.62351300077354e-53
NMR metabolomics,X23412.Phospholipids in VLDL,DBNL,Drebrin-like protein,42185,0.146321802481457,0.00946896257363248,0.127762635837137,0.164880969125776,2.05637401196885e-53
NMR metabolomics,X23412.Phospholipids in VLDL,LYN,Tyrosine-protein kinase Lyn,42070,0.133902641038755,0.00867209855078225,0.116905327879221,0.150899954198288,2.49677625766223e-53
NMR metabolomics,X23412.Phospholipids in VLDL,SNX15,Sorting nexin-15,39736,0.0854454152577148,0.00552895614887289,0.074608661205924,0.0962821693095057,2.52604808017677e-53
NMR metabolomics,X23412.Phospholipids in VLDL,WASF1,Wiskott-Aldrich syndrome protein family member 1,41900,0.149981781941416,0.00972176891470504,0.130927114868594,0.169036449014238,3.09385148413129e-53
NMR metabolomics,X23412.Phospholipids in VLDL,PSIP1,PC4 and SFRS1-interacting protein,42119,0.103636304179744,0.00671848541530571,0.090468072765745,0.116804535593743,3.12961456587093e-53
NMR metabolomics,X23412.Phospholipids in VLDL,C19orf12,Protein C19orf12,41839,0.105115445655632,0.00681725364629238,0.0917536285088988,0.118477262802365,3.53188479523216e-53
NMR metabolomics,X23412.Phospholipids in VLDL,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,39958,0.0988310832045145,0.00640558740590286,0.0862761318889449,0.111386034520084,3.61847305033332e-53
NMR metabolomics,X23412.Phospholipids in VLDL,TBC1D23,TBC1 domain family member 23,42070,0.141839244402837,0.00920531100666631,0.123796834829771,0.159881653975903,4.07667999816478e-53
NMR metabolomics,X23412.Phospholipids in VLDL,DNMBP,Dynamin-binding protein,42016,0.0954216591178909,0.00619713437929485,0.083275275734473,0.107568042501309,4.81707294907785e-53
NMR metabolomics,X23412.Phospholipids in VLDL,VWA1,von Willebrand factor A domain-containing protein 1,42247,0.066431595960212,0.00431513521759221,0.0579739309337312,0.0748892609866927,4.93088405041421e-53
NMR metabolomics,X23412.Phospholipids in VLDL,CDC27,Cell division cycle protein 27 homolog,41843,0.0958016941658063,0.00622599517666077,0.0835987436195512,0.108004644712061,5.71222076285329e-53
NMR metabolomics,X23412.Phospholipids in VLDL,EREG,Proepiregulin,41997,0.126154304428546,0.00820117809484618,0.110079995362647,0.142228613494444,6.08089157840935e-53
NMR metabolomics,X23412.Phospholipids in VLDL,CRELD2,Protein disulfide isomerase CRELD2,42166,0.0819808869213338,0.00533225224956137,0.0715296725121936,0.0924321013304741,6.77113106399957e-53
NMR metabolomics,X23412.Phospholipids in VLDL,THOP1,Thimet oligopeptidase,42081,0.0491836973074736,0.00319939258140324,0.0429128878479232,0.0554545067670239,6.99363075755919e-53
NMR metabolomics,X23412.Phospholipids in VLDL,USP8,Ubiquitin carboxyl-terminal hydrolase 8,41900,0.1495973377435,0.00973103165346289,0.130524515702713,0.168670159784287,7.04838015863637e-53
NMR metabolomics,X23412.Phospholipids in VLDL,KRT5,"Keratin, type II cytoskeletal 5",41839,0.0836887207478236,0.00544714446915081,0.073012317588288,0.0943651239073592,8.1726594987664e-53
NMR metabolomics,X23412.Phospholipids in VLDL,CTBS,Di-N-acetylchitobiase,39860,0.0432574977160667,0.00281831097043866,0.0377336082140069,0.0487813872181265,1.23030641478759e-52
NMR metabolomics,X23412.Phospholipids in VLDL,PDLIM5,PDZ and LIM domain protein 5,39934,0.186262109119402,0.012146117710957,0.162455718405926,0.210068499832877,1.4991302201964e-52
NMR metabolomics,X23412.Phospholipids in VLDL,RABEP1,Rab GTPase-binding effector protein 1,39736,0.121063375422692,0.00789514915790027,0.105588883073207,0.136537867772176,1.55983876118101e-52
NMR metabolomics,X23412.Phospholipids in VLDL,IST1,IST1 homolog,39850,0.154363774034076,0.010086527119082,0.134594180880675,0.174133367187476,2.4190396880236e-52
NMR metabolomics,X23412.Phospholipids in VLDL,MSTN,Growth/differentiation factor 8,41900,0.0844011843419888,0.00552082946382786,0.0735803585928862,0.0952220100910914,2.56747918688443e-52
NMR metabolomics,X23412.Phospholipids in VLDL,NIT2,Omega-amidase NIT2,39903,0.114167443394343,0.00746724067929782,0.0995316516629188,0.128803235125766,3.00790259409176e-52
NMR metabolomics,X23412.Phospholipids in VLDL,MPHOSPH8,M-phase phosphoprotein 8,41900,0.120039338660962,0.00786152055928718,0.10463075836476,0.135447918957165,3.3959118547127e-52
NMR metabolomics,X23412.Phospholipids in VLDL,AMN,Protein amnionless,41913,0.0737441229197692,0.00483053990538069,0.064276264705223,0.0832119811343153,3.54939096347789e-52
NMR metabolomics,X23412.Phospholipids in VLDL,MITD1,MIT domain-containing protein 1,42016,0.150642465684491,0.00987565148975338,0.131286188764575,0.169998742604408,4.23911644489484e-52
NMR metabolomics,X23412.Phospholipids in VLDL,TIA1,Nucleolysin TIA-1 isoform p40,41728,0.192925621700165,0.0126547400017557,0.168122331296724,0.217728912103607,4.93134337748011e-52
NMR metabolomics,X23412.Phospholipids in VLDL,DPP4,Dipeptidyl peptidase 4,41948,0.0434873577646808,0.00285333861833937,0.0378948140727356,0.0490799014566259,5.1859762518639e-52
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINC1,Antithrombin-III,39959,0.0226139900917514,0.00148369862319217,0.0197059407902947,0.025522039393208,6.10163768047526e-52
NMR metabolomics,X23412.Phospholipids in VLDL,ARSB,Arylsulfatase B,42070,0.0863423709873175,0.00567645950101551,0.0752165103653271,0.097468231609308,8.1001965315811e-52
NMR metabolomics,X23412.Phospholipids in VLDL,ACP5,Tartrate-resistant acid phosphatase type 5,42211,0.0515094744386394,0.00338799505748089,0.0448690041259768,0.0581499447513019,8.91733866905161e-52
NMR metabolomics,X23412.Phospholipids in VLDL,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,39919,0.13049350198611,0.00857804910056773,0.113680525748997,0.147306478223223,9.48172255624372e-52
NMR metabolomics,X23412.Phospholipids in VLDL,ARHGAP45,Rho GTPase-activating protein 45,39736,0.129608491097524,0.00852063263665256,0.112908051129685,0.146308931065363,9.86266816341607e-52
NMR metabolomics,X23412.Phospholipids in VLDL,SCAMP3,Secretory carrier-associated membrane protein 3,42070,0.130011919681619,0.00855621333387987,0.113241741547214,0.146782097816023,1.02332423288046e-51
NMR metabolomics,X23412.Phospholipids in VLDL,TACC3,Transforming acidic coiled-coil-containing protein 3,42070,0.180964173632911,0.0119446789345008,0.15755260292129,0.204375744344533,2.00335711333351e-51
NMR metabolomics,X23412.Phospholipids in VLDL,SCGB3A2,Secretoglobin family 3A member 2,42166,-0.121554501046621,0.0080272243377488,-0.137287860748608,-0.105821141344633,2.22298702471837e-51
NMR metabolomics,X23412.Phospholipids in VLDL,CD99L2,CD99 antigen-like protein 2,42137,0.0380673124688297,0.00251439397252921,0.0331391002826724,0.0429955246549869,2.33060520121265e-51
NMR metabolomics,X23412.Phospholipids in VLDL,HDGFL2,Hepatoma-derived growth factor-related protein 2,39929,0.0993225040464727,0.00655543834160826,0.0864738448969205,0.112171163196025,2.36842189688519e-51
NMR metabolomics,X23412.Phospholipids in VLDL,STAMBP,STAM-binding protein,41997,0.0974084694616725,0.00644245696717769,0.0847812538060042,0.110035685117341,3.1731425300462e-51
NMR metabolomics,X23412.Phospholipids in VLDL,EPHA1,Ephrin type-A receptor 1,42162,0.0498325298769378,0.00329627372897712,0.0433718333681427,0.056293226385733,3.22806772002924e-51
NMR metabolomics,X23412.Phospholipids in VLDL,PXN,Paxillin,41839,0.0791877625294237,0.0052375451827803,0.0689221739711744,0.0894533510876731,3.23472880714202e-51
NMR metabolomics,X23412.Phospholipids in VLDL,SH3GLB2,Endophilin-B2,39929,0.101906503126648,0.00673583669556573,0.0887042632033387,0.115108743049956,3.29514718939024e-51
NMR metabolomics,X23412.Phospholipids in VLDL,GASK1A,Golgi-associated kinase 1A,39575,0.0662495149597787,0.00437890825807173,0.0576668547739582,0.0748321751455993,3.40650765248189e-51
NMR metabolomics,X23412.Phospholipids in VLDL,RILPL2,RILP-like protein 2,39958,0.152776466325965,0.0101172016567395,0.132946751078755,0.172606181573174,5.00923266470009e-51
NMR metabolomics,X23412.Phospholipids in VLDL,ACE2,Angiotensin-converting enzyme 2,41900,0.0841331192127731,0.00558110126000889,0.0731941607431557,0.0950720776823906,6.26162645158813e-51
NMR metabolomics,X23412.Phospholipids in VLDL,PLXNB3,Plexin-B3,42099,0.074006171589622,0.00490996545697002,0.0643826392939607,0.0836297038852832,6.36034865603501e-51
NMR metabolomics,X23412.Phospholipids in VLDL,DAG1,Dystroglycan,42185,0.0730445689851734,0.00485077576137417,0.0635370484928801,0.0825520894774668,7.82414168280863e-51
NMR metabolomics,X23412.Phospholipids in VLDL,ANXA11,Annexin A11,42087,0.101876309997076,0.0067687657875149,0.0886095290535471,0.115143090940605,8.79165110088292e-51
NMR metabolomics,X23412.Phospholipids in VLDL,CLEC4G,C-type lectin domain family 4 member G,42119,0.0514543818827105,0.00341873688083384,0.0447536575962762,0.0581551061691449,8.80397736262416e-51
NMR metabolomics,X23412.Phospholipids in VLDL,GYS1,"Glycogen [starch] synthase, muscle",41900,0.142863707339769,0.00949324938222745,0.124256938550603,0.161470476128935,9.17237635621359e-51
NMR metabolomics,X23412.Phospholipids in VLDL,BRAP,BRCA1-associated protein,39813,0.169794257612339,0.0112746321518892,0.147695978594636,0.191892536630042,9.31587955352438e-51
NMR metabolomics,X23412.Phospholipids in VLDL,CLEC4A,C-type lectin domain family 4 member A,42119,-0.0548458930770773,0.00364718699013958,-0.0619943795777509,-0.0476974065764037,1.06546301738065e-50
NMR metabolomics,X23412.Phospholipids in VLDL,MVK,Mevalonate kinase,41913,0.127143725076079,0.00845984047975258,0.110562437735764,0.143725012416394,1.23126756282675e-50
NMR metabolomics,X23412.Phospholipids in VLDL,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,39934,0.163862204215396,0.0109028497820016,0.142492618642673,0.18523178978812,1.44726186938421e-50
NMR metabolomics,X23412.Phospholipids in VLDL,BID,BH3-interacting domain death agonist,42119,0.101653408886874,0.00676949247624514,0.0883852036334338,0.114921614140315,1.46521885860882e-50
NMR metabolomics,X23412.Phospholipids in VLDL,TRIM5,Tripartite motif-containing protein 5,42119,0.133204197526897,0.00887065440539791,0.115817714892317,0.150590680161477,1.46791673227408e-50
NMR metabolomics,X23412.Phospholipids in VLDL,FST,Follistatin,42166,0.0747533104508071,0.00497976129898282,0.0649929783048007,0.0845136425968134,1.57239339409593e-50
NMR metabolomics,X23412.Phospholipids in VLDL,THPO,Thrombopoietin,41900,0.0598268983040369,0.00398715950366329,0.0520120656768568,0.0676417309312169,1.76455046964774e-50
NMR metabolomics,X23412.Phospholipids in VLDL,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,39930,0.136378769062405,0.00909082750220919,0.118560747158075,0.154196790966735,2.17435283162954e-50
NMR metabolomics,X23412.Phospholipids in VLDL,USP25,Ubiquitin carboxyl-terminal hydrolase 25,39919,0.110831314433741,0.00738992462083151,0.096347062176911,0.12531556669057,2.31513620393689e-50
NMR metabolomics,X23412.Phospholipids in VLDL,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,39934,0.101587083452231,0.00677510533298544,0.0883078769995792,0.114866289904882,2.43276671739131e-50
NMR metabolomics,X23412.Phospholipids in VLDL,HEXIM1,Protein HEXIM1,42119,0.123331101219147,0.0082504859519603,0.107160148753305,0.139502053684989,4.01254612505879e-50
NMR metabolomics,X23412.Phospholipids in VLDL,LSP1,Lymphocyte-specific protein 1,42119,0.0618606565152687,0.0041384346554052,0.0537493245906745,0.0699719884398629,4.04255790098473e-50
NMR metabolomics,X23412.Phospholipids in VLDL,CLEC3B,Tetranectin,39726,0.032245868551071,0.00215547840519946,0.02802113087688,0.0364706062252619,4.11232505302719e-50
NMR metabolomics,X23412.Phospholipids in VLDL,SPON2,Spondin-2,42070,-0.0532706540552126,0.00356632032282365,-0.0602606418879469,-0.0462806662224782,4.7495176477744e-50
NMR metabolomics,X23412.Phospholipids in VLDL,EVI5,Ecotropic viral integration site 5 protein homolog,39657,0.139097623305534,0.00930934664390128,0.120851303883487,0.15734394272758,5.41624069989811e-50
NMR metabolomics,X23412.Phospholipids in VLDL,CRKL,Crk-like protein,42143,0.160863024448609,0.0107791190296426,0.139735951150509,0.181990097746708,5.77382148252589e-50
NMR metabolomics,X23412.Phospholipids in VLDL,F11,Coagulation factor XI,39822,0.0480640426120965,0.0032258891319558,0.0417412999134632,0.0543867853107299,9.91393216516823e-50
NMR metabolomics,X23412.Phospholipids in VLDL,FAM13A,Protein FAM13A,39930,0.103596804514681,0.00696068475185123,0.0899538624010523,0.117239746628309,1.24700689593187e-49
NMR metabolomics,X23412.Phospholipids in VLDL,COL18A1,Collagen alpha-1(XVIII) chain,42194,0.0359398302875363,0.00242099305867942,0.0311946838925246,0.040684976682548,1.82610936297128e-49
NMR metabolomics,X23412.Phospholipids in VLDL,FKBPL,FK506-binding protein-like,39930,0.0903071927668026,0.00608057326643995,0.0783892691645803,0.102225116369025,1.9746220498793e-49
NMR metabolomics,X23412.Phospholipids in VLDL,TBCC,Tubulin-specific chaperone C,42016,0.121963622312856,0.00822213196394697,0.10584824366352,0.138079000962192,2.18707088597834e-49
NMR metabolomics,X23412.Phospholipids in VLDL,CNPY4,Protein canopy homolog 4,42070,0.113959229959732,0.00768519786704224,0.0988962421403296,0.129022217779135,2.3508782526036e-49
NMR metabolomics,X23412.Phospholipids in VLDL,TAX1BP1,Tax1-binding protein 1,39929,0.0943705188246147,0.0063604168265412,0.0819041018445939,0.106836935804635,2.44482795836065e-49
NMR metabolomics,X23412.Phospholipids in VLDL,PENK,Proenkephalin-A,39736,0.0471253412812584,0.00317984070958418,0.0408928534904734,0.0533578290720434,3.19753494127851e-49
NMR metabolomics,X23412.Phospholipids in VLDL,FGF19,Fibroblast growth factor 19,42185,0.11727826981086,0.00794234850681959,0.101711266737493,0.132845272884226,5.79691599976372e-49
NMR metabolomics,X23412.Phospholipids in VLDL,KLB,Beta-klotho,41839,-0.112605277481504,0.00763778756694254,-0.127575341112712,-0.0976352138502969,8.29390470379233e-49
NMR metabolomics,X23412.Phospholipids in VLDL,TRIM21,E3 ubiquitin-protein ligase TRIM21,42119,0.109382188709902,0.00743149522161426,0.0948164580755384,0.123947919344266,1.16270805823399e-48
NMR metabolomics,X23412.Phospholipids in VLDL,AMOT,Angiomotin,39736,0.0578556937668509,0.00393074874132292,0.050151426233858,0.0655599612998438,1.39605107244729e-48
NMR metabolomics,X23412.Phospholipids in VLDL,GOLGA3,Golgin subfamily A member 3,39934,0.117016144494924,0.00795551775529587,0.101423329694544,0.132608959295304,1.58368609064184e-48
NMR metabolomics,X23412.Phospholipids in VLDL,HAVCR1,Hepatitis A virus cellular receptor 1,42239,0.0971551125409712,0.00662119242681404,0.0841775753844156,0.110132649697527,2.23150651333803e-48
NMR metabolomics,X23412.Phospholipids in VLDL,IL7,Interleukin-7,42119,0.096806986323188,0.00660334584777032,0.0838644284615582,0.109749544184818,2.71715799333397e-48
NMR metabolomics,X23412.Phospholipids in VLDL,C4BPB,C4b-binding protein beta chain,42181,0.0572273492019718,0.00390603868494594,0.0495715133794777,0.0648831850244658,3.09725331895768e-48
NMR metabolomics,X23412.Phospholipids in VLDL,COCH,Cochlin,39958,0.0688930118750278,0.00470346624947174,0.0596742180260632,0.0781118057239924,3.84908743257739e-48
NMR metabolomics,X23412.Phospholipids in VLDL,KRT18,"Keratin, type I cytoskeletal 18",42070,0.126860030949894,0.00868565963224279,0.109836138070698,0.14388392382909,6.00647041440165e-48
NMR metabolomics,X23412.Phospholipids in VLDL,HS1BP3,HCLS1-binding protein 3,39638,0.136799930647829,0.0093617838779711,0.118450834247006,0.155149027048653,6.53353023966211e-48
NMR metabolomics,X23412.Phospholipids in VLDL,BTN3A2,Butyrophilin subfamily 3 member A2,42119,0.0567388522043986,0.00388769268863071,0.0491189745346824,0.0643587298741148,7.04032947569728e-48
NMR metabolomics,X23412.Phospholipids in VLDL,SDC4,Syndecan-4,42145,0.0705380101584569,0.00484040685832822,0.0610508127161336,0.0800252076007802,9.61766464217416e-48
NMR metabolomics,X23412.Phospholipids in VLDL,MYDGF,Myeloid-derived growth factor,39958,0.148487566369099,0.0101941624222788,0.128507008021433,0.168468124716766,1.24225184303608e-47
NMR metabolomics,X23412.Phospholipids in VLDL,GTPBP2,GTP-binding protein 2,39649,0.12247729476336,0.00840996078242248,0.105993771629812,0.138960817896908,1.32477710388702e-47
NMR metabolomics,X23412.Phospholipids in VLDL,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,42144,0.0382071715899295,0.00262657324849072,0.0330590880228877,0.0433552551569713,1.40573903456058e-47
NMR metabolomics,X23412.Phospholipids in VLDL,HMOX2,Heme oxygenase 2,41839,0.0710260974387337,0.00488477360723183,0.0614519411685593,0.0806002537089081,1.56356716237515e-47
NMR metabolomics,X23412.Phospholipids in VLDL,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,41843,0.114733505657598,0.00790945702357057,0.0992309698913995,0.130236041423796,2.56351728375451e-47
NMR metabolomics,X23412.Phospholipids in VLDL,MSRA,Mitochondrial peptide methionine sulfoxide reductase,42181,0.106258897766355,0.00734899954688551,0.0918548586544594,0.120662936878251,4.91801172283073e-47
NMR metabolomics,X23412.Phospholipids in VLDL,NSFL1C,NSFL1 cofactor p47,42249,0.0928986288188317,0.00642904374645096,0.0802977030757878,0.105499554561876,5.58151494673982e-47
NMR metabolomics,X23412.Phospholipids in VLDL,CNST,Consortin,42145,0.160773998676915,0.0111331362852397,0.138953051557845,0.182594945795985,6.36836821209217e-47
NMR metabolomics,X23412.Phospholipids in VLDL,SMNDC1,Survival of motor neuron-related-splicing factor 30,39930,0.0914900633635195,0.00633827108641496,0.0790670520341462,0.103913074692893,8.15554134915428e-47
NMR metabolomics,X23412.Phospholipids in VLDL,CA5A,"Carbonic anhydrase 5A, mitochondrial",41900,0.135304788285845,0.00938451037355935,0.116911147953669,0.153698428618022,8.99271741319577e-47
NMR metabolomics,X23412.Phospholipids in VLDL,IGSF3,Immunoglobulin superfamily member 3,42070,0.0545583413401919,0.0037875778454493,0.0471346887631113,0.0619819939172725,1.07669198482107e-46
NMR metabolomics,X23412.Phospholipids in VLDL,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,42070,0.0666779274712494,0.00463961040693122,0.0575842910736642,0.0757715638688346,1.72482752005903e-46
NMR metabolomics,X23412.Phospholipids in VLDL,KLK13,Kallikrein-13,41839,0.0659502491511384,0.00458901694184712,0.0569557759451181,0.0749447223571588,1.7516886186206e-46
NMR metabolomics,X23412.Phospholipids in VLDL,AHSG,Alpha-2-HS-glycoprotein,39990,0.0393341368594999,0.00273910244412864,0.0339654960690078,0.0447027776499921,2.33266182379644e-46
NMR metabolomics,X23412.Phospholipids in VLDL,SIAE,Sialate O-acetylesterase,42147,0.0681864416149519,0.00475352853395232,0.0588695256884053,0.0775033575414984,2.52259005815517e-46
NMR metabolomics,X23412.Phospholipids in VLDL,ASPSCR1,Tether containing UBX domain for GLUT4,39934,0.0978489282825317,0.00682422492890771,0.0844734474218726,0.111224409143191,3.18901919181803e-46
NMR metabolomics,X23412.Phospholipids in VLDL,CLUL1,Clusterin-like protein 1,42123,-0.0654497734315795,0.00456803980560045,-0.0744031314505564,-0.0564964154126026,3.19813475060237e-46
NMR metabolomics,X23412.Phospholipids in VLDL,VAMP8,Vesicle-associated membrane protein 8,39657,0.129192819492685,0.0090279975663085,0.11149794426272,0.146887694722649,4.86278915716955e-46
NMR metabolomics,X23412.Phospholipids in VLDL,SULT2A1,Bile salt sulfotransferase,42119,0.0859471097507986,0.00601495617541084,0.0741577956469933,0.0977364238546038,5.54641870416808e-46
NMR metabolomics,X23412.Phospholipids in VLDL,TRIM58,E3 ubiquitin-protein ligase TRIM58,39919,0.126304417492051,0.00883375336210372,0.108990260902328,0.143618574081774,5.66177297668992e-46
NMR metabolomics,X23412.Phospholipids in VLDL,GPKOW,G-patch domain and KOW motifs-containing protein,41839,0.0428607817026911,0.0030013771440038,0.0369780825004436,0.0487434809049385,6.35884954061605e-46
NMR metabolomics,X23412.Phospholipids in VLDL,ADGRD1,Adhesion G-protein coupled receptor D1,39736,0.0601532429847257,0.00421208283448029,0.0518975606291443,0.068408925340307,7.2850378963101e-46
NMR metabolomics,X23412.Phospholipids in VLDL,GAS6,Growth arrest-specific protein 6,42236,-0.036840113074259,0.00258180454639242,-0.0419004499851881,-0.0317797761633299,7.2867161969887e-46
NMR metabolomics,X23412.Phospholipids in VLDL,COMMD1,COMM domain-containing protein 1,39638,0.089364120020598,0.00625937769699798,0.077095739734482,0.101632500306714,7.80109260340491e-46
NMR metabolomics,X23412.Phospholipids in VLDL,LZTFL1,Leucine zipper transcription factor-like protein 1,39736,0.105737189476248,0.00740661395347484,0.0912202261274369,0.120254152825058,7.82406059502649e-46
NMR metabolomics,X23412.Phospholipids in VLDL,IGBP1,Immunoglobulin-binding protein 1,39934,0.0877412088065743,0.00614739016881301,0.0756923240757008,0.0997900935374478,8.04653562769451e-46
NMR metabolomics,X23412.Phospholipids in VLDL,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",39930,0.213325868328174,0.0149718556360667,0.183981031281483,0.242670705374865,1.13578943007642e-45
NMR metabolomics,X23412.Phospholipids in VLDL,NIT1,Deaminated glutathione amidase,39638,0.0648301663895514,0.00455565134076499,0.055901089761652,0.0737592430174508,1.49241545356498e-45
NMR metabolomics,X23412.Phospholipids in VLDL,MED18,Mediator of RNA polymerase II transcription subunit 18,41843,0.110713407167474,0.00778768451755935,0.095449545513058,0.125977268821891,1.56535354365546e-45
NMR metabolomics,X23412.Phospholipids in VLDL,ST13,Hsc70-interacting protein,39736,0.0793116494094269,0.0055796303013457,0.0683755740187893,0.0902477248000644,1.85880924963137e-45
NMR metabolomics,X23412.Phospholipids in VLDL,MGLL,Monoglyceride lipase,42166,0.126643351775453,0.00892399413093272,0.109152323278825,0.144134380272081,2.18922991663031e-45
NMR metabolomics,X23412.Phospholipids in VLDL,TWF2,Twinfilin-2,39966,0.123824605114052,0.00873139512025149,0.106711070678359,0.140938139549745,2.89718650136343e-45
NMR metabolomics,X23412.Phospholipids in VLDL,RAB27B,Ras-related protein Rab-27B,39958,0.119848820439879,0.00845777301545191,0.103271585329593,0.136426055550165,3.39483394448023e-45
NMR metabolomics,X23412.Phospholipids in VLDL,LGALS8,Galectin-8,42249,0.0881115077880639,0.00622566734043035,0.0759091998008205,0.100313815775307,3.73539575553932e-45
NMR metabolomics,X23412.Phospholipids in VLDL,ATXN2L,Ataxin-2-like protein,39934,0.0698359298244775,0.00493069072028908,0.0601717760127109,0.0795000836362441,3.73735364217384e-45
NMR metabolomics,X23412.Phospholipids in VLDL,MAX,Protein max,41839,0.153610317934412,0.0108541068089104,0.132336268588947,0.174884367279876,3.85633351062272e-45
NMR metabolomics,X23412.Phospholipids in VLDL,CNDP1,Beta-Ala-His dipeptidase,42217,0.0668505454970139,0.00472478431665152,0.0575899682363769,0.0761111227576509,3.95934057569726e-45
NMR metabolomics,X23412.Phospholipids in VLDL,RBM17,Splicing factor 45,39934,0.111485658512444,0.00788030742142098,0.0960402559664586,0.126931061058429,4.68350926940974e-45
NMR metabolomics,X23412.Phospholipids in VLDL,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",41976,0.0590862780116684,0.0041803222535587,0.0508928463946933,0.0672797096286434,4.91653082636313e-45
NMR metabolomics,X23412.Phospholipids in VLDL,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,42070,-0.0282435059229022,0.00200155680285961,-0.032166557256507,-0.0243204545892973,6.80535319561575e-45
NMR metabolomics,X23412.Phospholipids in VLDL,HYOU1,Hypoxia up-regulated protein 1,42310,0.0330664270383212,0.00234510496227688,0.0284700213122585,0.0376628327643839,7.78937663876841e-45
NMR metabolomics,X23412.Phospholipids in VLDL,NUDT5,ADP-sugar pyrophosphatase,42137,0.0720236348589092,0.00510875499296856,0.0620104750726908,0.0820367946451275,8.09596134748303e-45
NMR metabolomics,X23412.Phospholipids in VLDL,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",42047,0.10904908779663,0.00774098085062419,0.0938767653294069,0.124221410263854,9.46338312346946e-45
NMR metabolomics,X23412.Phospholipids in VLDL,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,41843,0.0644799787063448,0.00457810334384702,0.0555068961524046,0.0734530612602849,9.95269102810388e-45
NMR metabolomics,X23412.Phospholipids in VLDL,CRHBP,Corticotropin-releasing factor-binding protein,42123,0.0393405336924098,0.00280086627718552,0.0338508357891262,0.0448302315956934,1.67797191610157e-44
NMR metabolomics,X23412.Phospholipids in VLDL,OGFR,Opioid growth factor receptor,42070,0.0461214396412933,0.00328573920788247,0.0396813907938437,0.052561488488743,1.9068427009127e-44
NMR metabolomics,X23412.Phospholipids in VLDL,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,39485,0.0442587770973295,0.00315289966560143,0.0380790937527507,0.0504384604419083,2.23864283899563e-44
NMR metabolomics,X23412.Phospholipids in VLDL,FNDC1,Fibronectin type III domain-containing protein 1,39929,0.0681034615779916,0.00485576360246427,0.0585861649171617,0.0776207582388216,2.56122537635081e-44
NMR metabolomics,X23412.Phospholipids in VLDL,FAP,Prolyl endopeptidase FAP,42310,0.0394847333452973,0.0028180703804952,0.0339613153995267,0.0450081512910679,2.68719193274235e-44
NMR metabolomics,X23412.Phospholipids in VLDL,GORASP2,Golgi reassembly-stacking protein 2,39930,0.0686968350435293,0.00490068657681881,0.0590914893529644,0.0783021807340941,2.84083663240772e-44
NMR metabolomics,X23412.Phospholipids in VLDL,CD36,Platelet glycoprotein 4,39657,0.0669673734556317,0.00477702831487527,0.0576043979584762,0.0763303489527873,2.86738523021681e-44
NMR metabolomics,X23412.Phospholipids in VLDL,MAVS,Mitochondrial antiviral-signaling protein,41843,0.129936168391457,0.0092779187601902,0.111751447621484,0.14812088916143,3.00898205480252e-44
NMR metabolomics,X23412.Phospholipids in VLDL,DOK1,Docking protein 1,39929,0.197159038359479,0.0140775360422914,0.169567067716588,0.224751009002371,3.38121268780559e-44
NMR metabolomics,X23412.Phospholipids in VLDL,APPL2,DCC-interacting protein 13-beta,39736,0.162357227184994,0.0115934315889006,0.139634101270749,0.185080353099239,3.4775523562369e-44
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,42181,0.0532864777467025,0.00381079492277839,0.0458173196980569,0.0607556357953482,4.00129136986889e-44
NMR metabolomics,X23412.Phospholipids in VLDL,FOXJ3,Forkhead box protein J3,39657,0.0648800295080124,0.0046464534842781,0.0557729806788273,0.0739870783371974,6.15482117920039e-44
NMR metabolomics,X23412.Phospholipids in VLDL,SPART,Spartin,39736,0.111363896863401,0.0079868005589261,0.0957097677679054,0.127018025958896,8.04326708362453e-44
NMR metabolomics,X23412.Phospholipids in VLDL,HTRA2,"Serine protease HTRA2, mitochondrial",42181,0.0866489985917823,0.00622483602717507,0.0744483199785191,0.0988496772050454,9.57947980087951e-44
NMR metabolomics,X23412.Phospholipids in VLDL,DIABLO,"Diablo homolog, mitochondrial",42107,0.155692667967828,0.0112026535633466,0.133735466983669,0.177649868951988,1.30296986702254e-43
NMR metabolomics,X23412.Phospholipids in VLDL,AHNAK,Neuroblast differentiation-associated protein AHNAK,39638,0.045529747853095,0.00327386998761812,0.0391129626773634,0.0519465330288265,1.33840248823184e-43
NMR metabolomics,X23412.Phospholipids in VLDL,DDHD2,Phospholipase DDHD2,39934,0.0945183491143464,0.00680205299748027,0.0811863252392851,0.107850372989408,1.53253711377728e-43
NMR metabolomics,X23412.Phospholipids in VLDL,SAMD9L,Sterile alpha motif domain-containing protein 9-like,42119,0.103393896138367,0.00744640957941375,0.0887989333627162,0.117988858914018,1.55247532020804e-43
NMR metabolomics,X23412.Phospholipids in VLDL,AMBP,Protein AMBP,42239,0.0285908290078518,0.00206178604161868,0.0245497283662792,0.0326319296494244,1.97793571988032e-43
NMR metabolomics,X23412.Phospholipids in VLDL,IRAK4,Interleukin-1 receptor-associated kinase 4,42119,0.147957110857295,0.010671303227494,0.127041356531407,0.168872865183184,2.04712830504537e-43
NMR metabolomics,X23412.Phospholipids in VLDL,PRKG1,cGMP-dependent protein kinase 1,39736,0.179921693095912,0.0129674713542264,0.154505449241629,0.205337936950196,2.06584962723483e-43
NMR metabolomics,X23412.Phospholipids in VLDL,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,42070,0.0399585343240697,0.00288267232520033,0.0343084965666771,0.0456085720814623,2.14805182483767e-43
NMR metabolomics,X23412.Phospholipids in VLDL,LBR,Delta(14)-sterol reductase LBR,42249,0.0963253803525465,0.00696370273447677,0.082676522992972,0.109974237712121,3.17574088787377e-43
NMR metabolomics,X23412.Phospholipids in VLDL,NUDC,Nuclear migration protein nudC,42296,0.0899129816600373,0.00650076443876865,0.0771714833600507,0.102654479960024,3.22791098680781e-43
NMR metabolomics,X23412.Phospholipids in VLDL,GIGYF2,GRB10-interacting GYF protein 2,39934,0.108386294998638,0.00783259786684622,0.0930344031796199,0.123738186817657,3.38019530322482e-43
NMR metabolomics,X23412.Phospholipids in VLDL,DLK1,Protein delta homolog 1,42310,0.0819044957190548,0.00592398674190452,0.0702934817049219,0.0935155097331876,3.46558119858845e-43
NMR metabolomics,X23412.Phospholipids in VLDL,PACS2,Phosphofurin acidic cluster sorting protein 2,39575,0.0889886624945721,0.006432209497063,0.0763815318803286,0.101595793108816,3.6147456614356e-43
NMR metabolomics,X23412.Phospholipids in VLDL,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",39958,0.125627480475621,0.00909195117977064,0.107807256163271,0.143447704787971,4.46027960700871e-43
NMR metabolomics,X23412.Phospholipids in VLDL,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,42249,0.079303284711482,0.00574341767822785,0.0680461860621554,0.0905603833608086,4.46144862014915e-43
NMR metabolomics,X23412.Phospholipids in VLDL,VASP,Vasodilator-stimulated phosphoprotein,39990,0.103767324290403,0.00751530271971872,0.0890373309597542,0.118497317621052,5.09928359685051e-43
NMR metabolomics,X23412.Phospholipids in VLDL,NEXN,Nexilin,39990,0.0986436007505773,0.00715336960042572,0.0846229963337429,0.112664205167412,6.48861957891129e-43
NMR metabolomics,X23412.Phospholipids in VLDL,BMP6,Bone morphogenetic protein 6,41886,0.0565233411567665,0.00410219295854497,0.0484830429580184,0.0645636393555147,6.74066621656869e-43
NMR metabolomics,X23412.Phospholipids in VLDL,SIRT2,NAD-dependent protein deacetylase sirtuin-2,42070,0.122777568665339,0.00891367680923915,0.10530676211923,0.140248375211447,7.12616043414059e-43
NMR metabolomics,X23412.Phospholipids in VLDL,CASC3,Protein CASC3,39649,0.0609493664911776,0.00442461576046447,0.0522771196006672,0.0696216133816879,8.126084141609e-43
NMR metabolomics,X23412.Phospholipids in VLDL,PCDH9,Protocadherin-9,39930,0.0478021530190959,0.00347293751229854,0.0409951954949907,0.054609110543201,9.23707743799086e-43
NMR metabolomics,X23412.Phospholipids in VLDL,STAT2,Signal transducer and activator of transcription 2,39657,0.11109819725446,0.00807101288754603,0.0952790119948695,0.12691738251405,9.30236563517195e-43
NMR metabolomics,X23412.Phospholipids in VLDL,BAG4,BAG family molecular chaperone regulator 4,39657,0.0714857832320722,0.00519558391247111,0.0613024387636289,0.0816691277005156,1.01120920754942e-42
NMR metabolomics,X23412.Phospholipids in VLDL,QDPR,Dihydropteridine reductase,42081,0.0592314470296689,0.00431068801343002,0.0507824985233461,0.0676803955359918,1.124141968268e-42
NMR metabolomics,X23412.Phospholipids in VLDL,APOL1,Apolipoprotein L1,39990,0.0752812027936507,0.00547644122660925,0.0645473779894966,0.0860150275978049,1.17207929460287e-42
NMR metabolomics,X23412.Phospholipids in VLDL,CCL4,C-C motif chemokine 4,42148,0.087345610629055,0.00636841301878598,0.0748635211122345,0.0998277001458755,1.5780589649055e-42
NMR metabolomics,X23412.Phospholipids in VLDL,STIP1,Stress-induced-phosphoprotein 1,42105,0.0897490405409354,0.00654378761390391,0.0769232168176837,0.102574864264187,1.58760801609216e-42
NMR metabolomics,X23412.Phospholipids in VLDL,SMAD3,Mothers against decapentaplegic homolog 3,39919,0.0733276474729903,0.00534331741003684,0.0628547453493181,0.0838005495966625,1.6124317447787e-42
NMR metabolomics,X23412.Phospholipids in VLDL,MARS1,"Methionine--tRNA ligase, cytoplasmic",39713,0.121342980787865,0.00884260099815748,0.104011482831476,0.138674478744253,1.6513449423613e-42
NMR metabolomics,X23412.Phospholipids in VLDL,CD207,C-type lectin domain family 4 member K,41832,0.0547161858934849,0.00399444808107781,0.0468870676545724,0.0625453041323975,2.02963113788894e-42
NMR metabolomics,X23412.Phospholipids in VLDL,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",41843,0.115572871271793,0.00844224683391864,0.0990260674773123,0.132119675066273,2.26844024192626e-42
NMR metabolomics,X23412.Phospholipids in VLDL,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,42119,0.0857916090786091,0.00626797759574364,0.0735063729909516,0.0980768451662666,2.3165791590675e-42
NMR metabolomics,X23412.Phospholipids in VLDL,MTDH,Protein LYRIC,39657,0.133897322581831,0.0097865232573367,0.114715736997451,0.153078908166211,2.8787027327872e-42
NMR metabolomics,X23412.Phospholipids in VLDL,PMVK,Phosphomevalonate kinase,41832,0.151937340915011,0.0111169432495473,0.130148132145899,0.173726549684124,3.08507272144122e-42
NMR metabolomics,X23412.Phospholipids in VLDL,RRM2,Ribonucleoside-diphosphate reductase subunit M2,41843,0.0681618487363663,0.00499375618691697,0.058374086610009,0.0779496108627235,3.92226182214521e-42
NMR metabolomics,X23412.Phospholipids in VLDL,VNN1,Pantetheinase,39990,0.102426254779166,0.00750627478523345,0.0877139562001087,0.117138553358224,4.60076811015387e-42
NMR metabolomics,X23412.Phospholipids in VLDL,LPP,Lipoma-preferred partner,39575,0.0924373265368295,0.00677804527988484,0.0791523577882552,0.105722295285404,5.24878892671495e-42
NMR metabolomics,X23412.Phospholipids in VLDL,EGFR,Epidermal growth factor receptor,42310,0.0222811809477387,0.00163556264892433,0.019075478155847,0.0254868837396304,5.4877591741273e-42
NMR metabolomics,X23412.Phospholipids in VLDL,SHMT1,"Serine hydroxymethyltransferase, cytosolic",42166,0.118049581278006,0.00867314967286334,0.101050207919194,0.135048954636818,6.49796513113569e-42
NMR metabolomics,X23412.Phospholipids in VLDL,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,39919,0.0683133974648855,0.00501603670560787,0.0584819655218941,0.0781448294078769,6.60061110527922e-42
NMR metabolomics,X23412.Phospholipids in VLDL,SEMA4D,Semaphorin-4D,42249,0.0418966215954352,0.00307931578134013,0.0358611626640085,0.0479320805268618,6.93472429545823e-42
NMR metabolomics,X23412.Phospholipids in VLDL,TXNDC5,Thioredoxin domain-containing protein 5,42249,0.0958010711310517,0.00704134170376488,0.0820000413916726,0.109602100870431,6.96361097443165e-42
NMR metabolomics,X23412.Phospholipids in VLDL,OGA,Protein O-GlcNAcase,39930,0.0996435207685732,0.0073268815115317,0.0852828330059711,0.114004208531175,8.55052127402729e-42
NMR metabolomics,X23412.Phospholipids in VLDL,GDNF,Glial cell line-derived neurotrophic factor,41839,0.053226112766937,0.00391765987604391,0.0455474994098909,0.0609047261239831,9.21045743022694e-42
NMR metabolomics,X23412.Phospholipids in VLDL,YJU2,Splicing factor YJU2,39919,0.0461064867680964,0.00339195991605794,0.0394582453326228,0.0527547282035699,9.38160347104468e-42
NMR metabolomics,X23412.Phospholipids in VLDL,TRIM40,E3 ubiquitin ligase TRIM40,39649,0.101551135102324,0.00747286903790278,0.0869043117880345,0.116197958416613,1.00229805370523e-41
NMR metabolomics,X23412.Phospholipids in VLDL,SPRY2,Protein sprouty homolog 2,41913,0.129132465839163,0.00951303646599693,0.110486914365809,0.147778017312517,1.07783337504829e-41
NMR metabolomics,X23412.Phospholipids in VLDL,ORM1,Alpha-1-acid glycoprotein 1,39922,0.0280024420854575,0.00206187586552294,0.0239611653890325,0.0320437187818824,1.09953041375285e-41
NMR metabolomics,X23412.Phospholipids in VLDL,SIGLEC7,Sialic acid-binding Ig-like lectin 7,42145,0.0385418954462786,0.00284298212485147,0.0329696504815697,0.0441141404109874,1.34765153844201e-41
NMR metabolomics,X23412.Phospholipids in VLDL,EGLN1,Egl nine homolog 1,42119,0.0775520382542962,0.00572163106275232,0.0663376413713016,0.0887664351372907,1.39859398038211e-41
NMR metabolomics,X23412.Phospholipids in VLDL,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,39736,0.0403106779913075,0.00297189216602947,0.0344857693458898,0.0461355866367253,1.40001738722724e-41
NMR metabolomics,X23412.Phospholipids in VLDL,CTSD,Cathepsin D,41225,0.0574519272226874,0.00423779707111778,0.0491458449632966,0.0657580094820783,1.40654097189006e-41
NMR metabolomics,X23412.Phospholipids in VLDL,CETN3,Centrin-3,39930,0.109474107670326,0.00807202230537702,0.0936529439517875,0.125295271388865,1.41611339331323e-41
NMR metabolomics,X23412.Phospholipids in VLDL,IFNLR1,Interferon lambda receptor 1,42119,0.0504511691848595,0.00372620528216895,0.0431478068318083,0.0577545315379106,1.70235327080692e-41
NMR metabolomics,X23412.Phospholipids in VLDL,FLT4,Vascular endothelial growth factor receptor 3,42181,0.047155160833207,0.00348333504697901,0.0403278241411281,0.0539824975252859,1.74839971378698e-41
NMR metabolomics,X23412.Phospholipids in VLDL,CTSO,Cathepsin O,42296,0.0424167242702155,0.00313364069815,0.0362747885018415,0.0485586600385895,1.77326807638445e-41
NMR metabolomics,X23412.Phospholipids in VLDL,HPSE,Heparanase,39866,0.132443150939221,0.00979577900663942,0.113243424086207,0.151642877792234,2.48733780303204e-41
NMR metabolomics,X23412.Phospholipids in VLDL,SRP14,Signal recognition particle 14 kDa protein,42070,0.0824977813364342,0.00612249694013081,0.0704976873337778,0.0944978753390905,4.07762128732521e-41
NMR metabolomics,X23412.Phospholipids in VLDL,EHD3,EH domain-containing protein 3,39638,0.163499945846916,0.0121260183838607,0.139732949814549,0.187266941879283,4.14087670210162e-41
NMR metabolomics,X23412.Phospholipids in VLDL,CD226,CD226 antigen,39657,0.0588827999798556,0.00437292156456597,0.0503118737133063,0.0674537262464048,5.26233162406464e-41
NMR metabolomics,X23412.Phospholipids in VLDL,TRAF2,TNF receptor-associated factor 2,42119,0.095404091292868,0.00710266802174671,0.0814828619702444,0.109325320615492,7.16389907207244e-41
NMR metabolomics,X23412.Phospholipids in VLDL,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,42145,0.113393337614196,0.00844233776409233,0.096846355596575,0.129940319631817,7.21690400468177e-41
NMR metabolomics,X23412.Phospholipids in VLDL,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,42159,0.0313747513033437,0.00234111758368826,0.0267861608393147,0.0359633417673727,1.07385218259715e-40
NMR metabolomics,X23412.Phospholipids in VLDL,GET3,ATPase GET3,39958,0.0742873445086423,0.00554508798810935,0.0634189720519479,0.0851557169653366,1.28047329532428e-40
NMR metabolomics,X23412.Phospholipids in VLDL,ICA1,Islet cell autoantigen 1,41913,0.109640352882878,0.00819321852884101,0.0935816445663498,0.125699061199407,1.41179345986594e-40
NMR metabolomics,X23412.Phospholipids in VLDL,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,41825,0.0807812971916343,0.00603936209207532,0.0689441474911667,0.0926184468921019,1.53577805138564e-40
NMR metabolomics,X23412.Phospholipids in VLDL,MATN2,Matrilin-2,42144,0.0405355171709629,0.00303459538388064,0.0345877102185569,0.046483324123369,1.92256956286353e-40
NMR metabolomics,X23412.Phospholipids in VLDL,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",42070,0.0605565136587025,0.00453604674389625,0.0516658620406659,0.0694471652767391,2.13697166522284e-40
NMR metabolomics,X23412.Phospholipids in VLDL,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,39638,0.0671398237133159,0.00502747957005845,0.0572859637560013,0.0769936836706304,2.29029844755706e-40
NMR metabolomics,X23412.Phospholipids in VLDL,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,41837,0.108534597336857,0.00813490317950282,0.0925901871050311,0.124479007568682,2.40744222176579e-40
NMR metabolomics,X23412.Phospholipids in VLDL,RWDD1,RWD domain-containing protein 1,42249,0.0849964055980559,0.0063760721659136,0.0724993041528653,0.0974935070432466,2.74670449967809e-40
NMR metabolomics,X23412.Phospholipids in VLDL,TDRKH,Tudor and KH domain-containing protein,41839,0.11595719335701,0.0087027784331781,0.0988997476279807,0.133014639086039,3.0417577700325e-40
NMR metabolomics,X23412.Phospholipids in VLDL,FUS,RNA-binding protein FUS,41831,0.054160676171528,0.00406601921737417,0.0461912785054746,0.0621300738375814,3.20120998846715e-40
NMR metabolomics,X23412.Phospholipids in VLDL,ALDH1A1,Retinal dehydrogenase 1,42137,0.0725566133219919,0.00545342176310513,0.0618679066663059,0.083245319977678,3.87838613614799e-40
NMR metabolomics,X23412.Phospholipids in VLDL,CTF1,Cardiotrophin-1,41900,0.115226484924281,0.00866112111199775,0.0982506875447649,0.132202282303796,3.96571222820838e-40
NMR metabolomics,X23412.Phospholipids in VLDL,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,42216,0.0784910402515513,0.00590343199427616,0.0669203135427701,0.0900617669603326,4.35058867529647e-40
NMR metabolomics,X23412.Phospholipids in VLDL,CFHR5,Complement factor H-related protein 5,39864,0.0569127211912382,0.00427838308898281,0.0485270903368319,0.0652983520456445,4.49448762297525e-40
NMR metabolomics,X23412.Phospholipids in VLDL,RTN4R,Reticulon-4 receptor,42262,0.0458250193908407,0.00345277691710909,0.0390575766333068,0.0525924621483745,5.95117060045236e-40
NMR metabolomics,X23412.Phospholipids in VLDL,NACC1,Nucleus accumbens-associated protein 1,39919,0.0754570096197087,0.00568331344656419,0.0643177152644429,0.0865963039749745,6.26139987935347e-40
NMR metabolomics,X23412.Phospholipids in VLDL,FABP5,Fatty acid-binding protein 5,42218,0.0904383267445269,0.00681975744364435,0.0770716021549839,0.10380505133407,6.86509538720762e-40
NMR metabolomics,X23412.Phospholipids in VLDL,CCL8,C-C motif chemokine 8,42239,0.0820394191636076,0.00620328302856698,0.0698809844276164,0.0941978538995989,1.10204395141917e-39
NMR metabolomics,X23412.Phospholipids in VLDL,MEP1B,Meprin A subunit beta,42145,0.155089928504035,0.0117361211226819,0.132087131103579,0.178092725904492,1.26828431649871e-39
NMR metabolomics,X23412.Phospholipids in VLDL,DGKA,Diacylglycerol kinase alpha,39657,0.0751820576601742,0.00568881098799336,0.0640319881237073,0.0863321271966412,1.41899122320351e-39
NMR metabolomics,X23412.Phospholipids in VLDL,TP53,Cellular tumor antigen p53,41843,0.0601584459134076,0.00455536779161019,0.0512299250418516,0.0690869667849636,1.43970581046134e-39
NMR metabolomics,X23412.Phospholipids in VLDL,EGF,Pro-epidermal growth factor,42081,0.14056520264004,0.010651493590362,0.119688275202931,0.161442130077149,1.60997068052217e-39
NMR metabolomics,X23412.Phospholipids in VLDL,DLG4,Disks large homolog 4,39929,0.0977193841796775,0.00740573345508475,0.0832041466077114,0.112234621751644,1.82940406001487e-39
NMR metabolomics,X23412.Phospholipids in VLDL,FARSA,Phenylalanine--tRNA ligase alpha subunit,39649,0.0948495334361884,0.00718994489963862,0.0807572414328967,0.10894182543948,1.93801685389002e-39
NMR metabolomics,X23412.Phospholipids in VLDL,KIFBP,KIF-binding protein,42070,0.111457194012963,0.0084571798018787,0.0948811216012811,0.128033266424646,2.03232984248962e-39
NMR metabolomics,X23412.Phospholipids in VLDL,GRAP2,GRB2-related adapter protein 2,42145,0.174117335919925,0.0132147044401832,0.148216515217166,0.200018156622684,2.10644363158155e-39
NMR metabolomics,X23412.Phospholipids in VLDL,NID1,Nidogen-1,42189,0.0486209548964887,0.00369094172818513,0.0413867091092458,0.0558552006837315,2.186292492534e-39
NMR metabolomics,X23412.Phospholipids in VLDL,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",42137,0.0623776803802775,0.00474148298639631,0.0530843737269408,0.0716709870336143,2.74748651253864e-39
NMR metabolomics,X23412.Phospholipids in VLDL,AP2B1,AP-2 complex subunit beta,39649,0.0655709727824188,0.00498968743461709,0.0557911854105693,0.0753507601542683,3.75192315846025e-39
NMR metabolomics,X23412.Phospholipids in VLDL,FOXO3,Forkhead box protein O3,41843,0.129157318130002,0.0098414834676397,0.109868010533428,0.148446625726576,4.2202974182371e-39
NMR metabolomics,X23412.Phospholipids in VLDL,PSME1,Proteasome activator complex subunit 1,42002,0.0487970756517667,0.00371896974229421,0.0415078949568701,0.0560862563466634,4.33911558941139e-39
NMR metabolomics,X23412.Phospholipids in VLDL,CHMP1A,Charged multivesicular body protein 1a,42016,0.106625828745362,0.00812806727560101,0.0906948168851839,0.12255684060554,4.50364407617553e-39
NMR metabolomics,X23412.Phospholipids in VLDL,SIGLEC8,Sialic acid-binding Ig-like lectin 8,39638,0.0628893085899455,0.00479205269159406,0.0534968853144211,0.0722817318654698,4.72191257860769e-39
NMR metabolomics,X23412.Phospholipids in VLDL,AFP,Alpha-fetoprotein,41976,0.0875632583550717,0.00667846810470498,0.0744734608698499,0.100653055840293,4.93822342854939e-39
NMR metabolomics,X23412.Phospholipids in VLDL,PPP1R2,Protein phosphatase inhibitor 2,42145,0.108015304459348,0.008246603098034,0.0918519623872011,0.124178646531494,5.81785394425093e-39
NMR metabolomics,X23412.Phospholipids in VLDL,DRG2,Developmentally-regulated GTP-binding protein 2,42070,0.0762034010402945,0.00581906649895698,0.0647980307023388,0.0876087713782502,6.04308618741651e-39
NMR metabolomics,X23412.Phospholipids in VLDL,PARP1,Poly [ADP-ribose] polymerase 1,42119,0.0789226717747374,0.00602939598057735,0.0671050556528058,0.090740287896669,6.50537023323253e-39
NMR metabolomics,X23412.Phospholipids in VLDL,WASHC3,WASH complex subunit 3,39929,0.101964462074323,0.00779952628016323,0.0866773905652035,0.117251533583443,8.94018678558182e-39
NMR metabolomics,X23412.Phospholipids in VLDL,CETN2,Centrin-2,41839,0.0909522972204482,0.00696757557470866,0.0772958490940192,0.104608745346877,1.04990730413973e-38
NMR metabolomics,X23412.Phospholipids in VLDL,ELOA,Elongin-A,42070,0.071888271614968,0.00551060395046799,0.0610874878720507,0.0826890553578853,1.15687939232564e-38
NMR metabolomics,X23412.Phospholipids in VLDL,MAP2,Microtubule-associated protein 2,39929,0.0627090766603651,0.0048092459810276,0.053282954537551,0.0721351987831792,1.3859329746677e-38
NMR metabolomics,X23412.Phospholipids in VLDL,IL1RL2,Interleukin-1 receptor-like 2,41913,0.0503508613005467,0.00386771343981871,0.0427701429585021,0.0579315796425914,1.65530010993491e-38
NMR metabolomics,X23412.Phospholipids in VLDL,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,41839,0.148551324365566,0.0114174428700276,0.126173136340312,0.17092951239082,1.82549611473677e-38
NMR metabolomics,X23412.Phospholipids in VLDL,ESM1,Endothelial cell-specific molecule 1,42123,-0.0461268958939425,0.00355477443173681,-0.0530942537801467,-0.0391595380077384,2.83108435218848e-38
NMR metabolomics,X23412.Phospholipids in VLDL,HNMT,Histamine N-methyltransferase,41961,0.0636982768463432,0.00490888323178927,0.0540768657120363,0.0733196879806502,2.84597549236893e-38
NMR metabolomics,X23412.Phospholipids in VLDL,CXCL1,Growth-regulated alpha protein,42117,0.12353013994157,0.00952523164805487,0.104860685911382,0.142199593971757,3.11157682595338e-38
NMR metabolomics,X23412.Phospholipids in VLDL,TADA3,Transcriptional adapter 3,39919,0.053877116288327,0.00415202777466154,0.0457391418499904,0.0620150907266637,3.13097124094933e-38
NMR metabolomics,X23412.Phospholipids in VLDL,PDGFA,Platelet-derived growth factor subunit A,42310,0.0954571311123592,0.00736384396593494,0.0810239969391267,0.109890265285592,3.32763527468913e-38
NMR metabolomics,X23412.Phospholipids in VLDL,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",42119,0.127100238678203,0.00980948950796059,0.1078736392426,0.146326838113806,3.62490491281186e-38
NMR metabolomics,X23412.Phospholipids in VLDL,UBXN1,UBX domain-containing protein 1,39736,0.0917240435502995,0.0070773367557757,0.0778524635089791,0.10559562359162,3.87758383296521e-38
NMR metabolomics,X23412.Phospholipids in VLDL,SPOCK1,Testican-1,42016,0.0346256111373027,0.0026762945050013,0.0293800739075002,0.0398711483671053,4.64532299322794e-38
NMR metabolomics,X23412.Phospholipids in VLDL,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",39757,0.0661668733960323,0.00511661560735229,0.0561383068056218,0.0761954399864428,5.58149135433176e-38
NMR metabolomics,X23412.Phospholipids in VLDL,RRAS,Ras-related protein R-Ras,39649,0.174474893056106,0.0134958830886991,0.148022962202256,0.200926823909956,5.89242416015307e-38
NMR metabolomics,X23412.Phospholipids in VLDL,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",39929,0.131310314862591,0.0101621192499677,0.111392561132654,0.151228068592527,6.30246248502634e-38
NMR metabolomics,X23412.Phospholipids in VLDL,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,39919,0.0468530872820169,0.00363094153145409,0.0397364418803669,0.0539697326836669,7.91027409250024e-38
NMR metabolomics,X23412.Phospholipids in VLDL,NHLRC3,NHL repeat-containing protein 3,39481,0.0428068270721176,0.00331917044197497,0.0363012530058467,0.0493124011383886,8.86417997115401e-38
NMR metabolomics,X23412.Phospholipids in VLDL,C1R,Complement C1r subcomponent,39979,0.02490719612791,0.0019334543683864,0.0211176255658727,0.0286967666899473,1.03941527769983e-37
NMR metabolomics,X23412.Phospholipids in VLDL,ATP6AP2,Renin receptor,41843,0.0518975912977042,0.00403124457760998,0.0439963519255887,0.0597988306698198,1.06323439498458e-37
NMR metabolomics,X23412.Phospholipids in VLDL,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,39736,0.084595435932191,0.00656838849629742,0.0717213944794481,0.0974694773849339,1.0949336351708e-37
NMR metabolomics,X23412.Phospholipids in VLDL,PLG,Plasminogen,39742,0.0289257558241079,0.00224767216031898,0.0245203183898827,0.0333311932583331,1.24309211585278e-37
NMR metabolomics,X23412.Phospholipids in VLDL,SPARC,SPARC,42181,0.0920322867235779,0.00715963653339818,0.0779993991181175,0.106065174329038,1.34711088094797e-37
NMR metabolomics,X23412.Phospholipids in VLDL,FIS1,Mitochondrial fission 1 protein,42125,0.100889218089364,0.00785901456842354,0.0854855495352537,0.116292886643474,1.67574327068957e-37
NMR metabolomics,X23412.Phospholipids in VLDL,A1BG,Alpha-1B-glycoprotein,39979,0.0218048882692063,0.00169989355010013,0.01847309691101,0.0251366796274025,2.09581636383583e-37
NMR metabolomics,X23412.Phospholipids in VLDL,RABGAP1L,Rab GTPase-activating protein 1-like,41913,0.0781256794623525,0.00609957822960881,0.0661705061323192,0.0900808527923857,2.44471186218587e-37
NMR metabolomics,X23412.Phospholipids in VLDL,MEP1A,Meprin A subunit alpha,39930,0.100068490715024,0.00780922281430132,0.0847624139989933,0.115374567431055,2.48086968337144e-37
NMR metabolomics,X23412.Phospholipids in VLDL,XIAP,E3 ubiquitin-protein ligase XIAP,39657,0.076780980286967,0.00599673997908864,0.0650273699279533,0.0885345906459808,2.87105414170204e-37
NMR metabolomics,X23412.Phospholipids in VLDL,VPS28,Vacuolar protein sorting-associated protein 28 homolog,39757,0.0877152711892702,0.0068529935679718,0.0742834037960455,0.101147138582495,3.01312945704457e-37
NMR metabolomics,X23412.Phospholipids in VLDL,SMOC2,SPARC-related modular calcium-binding protein 2,42185,0.0511484393757974,0.00400062520915562,0.0433072139658524,0.0589896647857425,3.25360174736127e-37
NMR metabolomics,X23412.Phospholipids in VLDL,NECAP2,Adaptin ear-binding coat-associated protein 2,39575,0.0860332423928748,0.00673797028876803,0.0728268206268895,0.0992396641588602,4.51511063487073e-37
NMR metabolomics,X23412.Phospholipids in VLDL,MAPKAPK2,MAP kinase-activated protein kinase 2,39757,0.097325157506843,0.00762397935107598,0.0823821579787341,0.112268157034952,4.6298806757416e-37
NMR metabolomics,X23412.Phospholipids in VLDL,TRIM24,Transcription intermediary factor 1-alpha,39735,0.0864923536663366,0.00678075817035723,0.0732020676524364,0.0997826396802368,5.26756622416817e-37
NMR metabolomics,X23412.Phospholipids in VLDL,FGL1,Fibrinogen-like protein 1,39990,-0.0847631606888868,0.00665417183874125,-0.0978053374928196,-0.0717209838849539,6.46206704411382e-37
NMR metabolomics,X23412.Phospholipids in VLDL,RAB6A,Ras-related protein Rab-6A,42119,0.0578877252427069,0.00454693284730651,0.0489757368619862,0.0667997136234277,6.46514729716493e-37
NMR metabolomics,X23412.Phospholipids in VLDL,HSPA1A,Heat shock 70 kDa protein 1A,42162,0.0916030767424627,0.00719861327927677,0.0774937947150802,0.105712358769845,6.96961891806871e-37
NMR metabolomics,X23412.Phospholipids in VLDL,SELE,E-selectin,42310,0.0657969291456053,0.00517493872493597,0.0556540492447308,0.0759398090464798,7.9249793712365e-37
NMR metabolomics,X23412.Phospholipids in VLDL,TSC22D1,TSC22 domain family protein 1,39934,0.0862220540221879,0.00677798666617964,0.0729372001564758,0.0995069078879,8.07822691338974e-37
NMR metabolomics,X23412.Phospholipids in VLDL,TMED8,Protein TMED8,39930,0.13493103717753,0.0106138824107283,0.114127827652503,0.155734246702558,8.96047600386929e-37
NMR metabolomics,X23412.Phospholipids in VLDL,F12,Coagulation factor XII,39979,0.0538934270309855,0.0042431003040996,0.0455769504349502,0.0622099036270207,1.03025494201259e-36
NMR metabolomics,X23412.Phospholipids in VLDL,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,39736,0.113584527520263,0.00894239465150583,0.0960574340033117,0.131111621037215,1.03818116288022e-36
NMR metabolomics,X23412.Phospholipids in VLDL,LRRC59,Leucine-rich repeat-containing protein 59,39958,0.0630544468326013,0.00496495056298481,0.053323143729151,0.0727857499360515,1.05117687120488e-36
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINE2,Glia-derived nexin,39958,0.0845353601628921,0.00665969896334517,0.0714823501947356,0.0975883701310486,1.13861466659882e-36
NMR metabolomics,X23412.Phospholipids in VLDL,FAM172A,Cotranscriptional regulator FAM172A,39638,0.0797492760208336,0.00628272042597614,0.0674351439859204,0.0920634080557469,1.159550089356e-36
NMR metabolomics,X23412.Phospholipids in VLDL,PPIB,Peptidyl-prolyl cis-trans isomerase B,42155,0.124660944692407,0.00983237330994368,0.105389493004917,0.143932396379897,1.25384428551524e-36
NMR metabolomics,X23412.Phospholipids in VLDL,HARS1,"Histidine--tRNA ligase, cytoplasmic",42137,0.0997269853433032,0.00787257961676264,0.0842967292944484,0.115157241392158,1.44089860662473e-36
NMR metabolomics,X23412.Phospholipids in VLDL,ANGPT1,Angiopoietin-1,42085,0.108385749605599,0.00855923675860159,0.0916096455587398,0.125161853652458,1.53004934743095e-36
NMR metabolomics,X23412.Phospholipids in VLDL,ARHGEF10,Rho guanine nucleotide exchange factor 10,39934,0.122741445483687,0.00969084566233197,0.103747387985517,0.141735502981858,1.61845539377191e-36
NMR metabolomics,X23412.Phospholipids in VLDL,CD1C,T-cell surface glycoprotein CD1c,42181,0.0320758932553356,0.0025346704853821,0.0271079391039867,0.0370438474066845,1.68985608635864e-36
NMR metabolomics,X23412.Phospholipids in VLDL,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,41913,0.0570103662573412,0.00451011397165882,0.0481705428728899,0.0658501896417925,2.04193806109862e-36
NMR metabolomics,X23412.Phospholipids in VLDL,PF4,Platelet factor 4,39914,0.126889305400779,0.0100372001543424,0.107216393098268,0.14656221770329,2.18444043886995e-36
NMR metabolomics,X23412.Phospholipids in VLDL,CASP7,Caspase-7,39929,0.10970886317024,0.00868434975536674,0.0926875376497211,0.126730188690759,2.44245780487511e-36
NMR metabolomics,X23412.Phospholipids in VLDL,ERP29,Endoplasmic reticulum resident protein 29,39736,0.154911708668135,0.0123157590209221,0.130772820987128,0.179050596349142,4.88209547813587e-36
NMR metabolomics,X23412.Phospholipids in VLDL,LRRN1,Leucine-rich repeat neuronal protein 1,41913,0.0520769756585749,0.0041493092086834,0.0439443296095554,0.0602096217075943,6.28806008714823e-36
NMR metabolomics,X23412.Phospholipids in VLDL,ARHGAP25,Rho GTPase-activating protein 25,41843,0.0781186411221448,0.00622779542506377,0.0659121620890198,0.0903251201552698,6.89702474181429e-36
NMR metabolomics,X23412.Phospholipids in VLDL,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,41843,0.125232455030987,0.0100186569131019,0.105595887481307,0.144869022580666,1.18736402464647e-35
NMR metabolomics,X23412.Phospholipids in VLDL,COMT,Catechol O-methyltransferase,41740,0.106746014758169,0.00854189802991416,0.0900038946195369,0.1234881348968,1.23951704832293e-35
NMR metabolomics,X23412.Phospholipids in VLDL,IQGAP2,Ras GTPase-activating-like protein IQGAP2,42070,0.0687097057068486,0.00550021783542505,0.0579292787494156,0.0794901326642817,1.29728642954711e-35
NMR metabolomics,X23412.Phospholipids in VLDL,RFC4,Replication factor C subunit 4,39919,0.0283996170995814,0.00227603836559618,0.0239385819030129,0.0328606522961499,1.69188557082265e-35
NMR metabolomics,X23412.Phospholipids in VLDL,STK24,Serine/threonine-protein kinase 24,41839,0.0793629092539961,0.00636764879582217,0.0668823176141846,0.0918435008938076,1.86754163852808e-35
NMR metabolomics,X23412.Phospholipids in VLDL,ADGRF5,Adhesion G protein-coupled receptor F5,39958,0.0343298140989116,0.00275406882185487,0.028931839208076,0.0397277889897471,1.97213468184938e-35
NMR metabolomics,X23412.Phospholipids in VLDL,SH2D1A,SH2 domain-containing protein 1A,42119,0.0764015486808459,0.00613261559698256,0.0643816221107601,0.0884214752509318,1.97382111407939e-35
NMR metabolomics,X23412.Phospholipids in VLDL,ELAC1,Zinc phosphodiesterase ELAC protein 1,39934,0.109044574335358,0.00874815184642497,0.0918981967163653,0.126190951954351,1.9806040392836e-35
NMR metabolomics,X23412.Phospholipids in VLDL,CD22,B-cell receptor CD22,42296,0.0543756865161486,0.00437251299776919,0.045805561040521,0.0629458119917762,2.59116385673661e-35
NMR metabolomics,X23412.Phospholipids in VLDL,VAV3,Guanine nucleotide exchange factor VAV3,39586,0.126557606589991,0.0101721515918945,0.106620189469877,0.146495023710104,2.68593722794393e-35
NMR metabolomics,X23412.Phospholipids in VLDL,EDAR,Tumor necrosis factor receptor superfamily member EDAR,42119,0.116680831971586,0.00938510248363359,0.0982860311036639,0.135075632839508,2.71254989359443e-35
NMR metabolomics,X23412.Phospholipids in VLDL,CCL18,C-C motif chemokine 18,42020,0.0893320273353751,0.00719437968268244,0.0752310431573175,0.103433011513433,3.30182553617907e-35
NMR metabolomics,X23412.Phospholipids in VLDL,KYAT1,Kynurenine--oxoglutarate transaminase 1,42130,0.0719342241153378,0.0058075880557832,0.0605513515260027,0.0833170967046729,4.80372229025552e-35
NMR metabolomics,X23412.Phospholipids in VLDL,CRADD,Death domain-containing protein CRADD,41997,0.0947513722350428,0.00765508564964311,0.0797474043617423,0.109755340108343,5.36873328646545e-35
NMR metabolomics,X23412.Phospholipids in VLDL,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,39736,0.0733166540220991,0.00591994077269069,0.0617135701076253,0.0849197379365728,5.37441577155096e-35
NMR metabolomics,X23412.Phospholipids in VLDL,GMPR2,GMP reductase 2,39736,0.0846380392249735,0.00683467073487243,0.0712420845846235,0.0980339938653234,5.44511627625231e-35
NMR metabolomics,X23412.Phospholipids in VLDL,PPBP,Platelet basic protein,39908,0.10913584756168,0.0088184746817291,0.0918516371854908,0.126420057937869,5.94623333397832e-35
NMR metabolomics,X23412.Phospholipids in VLDL,LGALS1,Galectin-1,42145,0.0443535497667227,0.0035863410305791,0.0373243213467877,0.0513827781866577,6.0594960803968e-35
NMR metabolomics,X23412.Phospholipids in VLDL,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,39424,0.137604174285655,0.0111426714193688,0.115764538303692,0.159443810267618,8.42506959746498e-35
NMR metabolomics,X23412.Phospholipids in VLDL,MESD,LRP chaperone MESD,42137,0.153812566810595,0.0124926358437324,0.12932700055688,0.178298133064311,1.1923872841849e-34
NMR metabolomics,X23412.Phospholipids in VLDL,STXBP1,Syntaxin-binding protein 1,39934,0.0986202560891765,0.00800997111671834,0.0829207127004085,0.114319799477944,1.2957304373281e-34
NMR metabolomics,X23412.Phospholipids in VLDL,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,42119,0.125190469162434,0.0101798033840974,0.105238054529603,0.145142883795265,1.42201103747107e-34
NMR metabolomics,X23412.Phospholipids in VLDL,LTBP3,Latent-transforming growth factor beta-binding protein 3,41843,0.0671784127323491,0.00546351171554725,0.0564699297698765,0.0778868956948217,1.47184709646632e-34
NMR metabolomics,X23412.Phospholipids in VLDL,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,39919,0.0469154861117885,0.00381568593187708,0.0394367416853094,0.0543942305382675,1.59130801274288e-34
NMR metabolomics,X23412.Phospholipids in VLDL,IDUA,Alpha-L-iduronidase,42262,0.0593671396133479,0.00483143233161219,0.049897532243388,0.0688367469833078,1.60468247935522e-34
NMR metabolomics,X23412.Phospholipids in VLDL,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,41843,0.0845569637137758,0.00688616926004857,0.0710600719640806,0.098053855463471,1.80276699178185e-34
NMR metabolomics,X23412.Phospholipids in VLDL,HSPB1,Heat shock protein beta-1,41949,0.0881272676115597,0.00718006792751906,0.0740543344736223,0.102200200749497,1.91846479886362e-34
NMR metabolomics,X23412.Phospholipids in VLDL,VEGFA,Vascular endothelial growth factor A,42253,0.0712410523569823,0.00580620370548443,0.0598608930942328,0.0826212116197318,1.99707652588256e-34
NMR metabolomics,X23412.Phospholipids in VLDL,MPI,Mannose-6-phosphate isomerase,42070,0.107083296898611,0.00872887399582386,0.089974703866796,0.124191889930426,2.06067536086029e-34
NMR metabolomics,X23412.Phospholipids in VLDL,CXCL16,C-X-C motif chemokine 16,42295,0.0293291479998175,0.00239169220485297,0.0246414312783057,0.0340168647213293,2.16960132468846e-34
NMR metabolomics,X23412.Phospholipids in VLDL,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,41843,0.105724690777355,0.00863836514565587,0.0887934950918693,0.12265588646284,2.946839571428e-34
NMR metabolomics,X23412.Phospholipids in VLDL,CD40,Tumor necrosis factor receptor superfamily member 5,42129,0.0633162060020701,0.00517821607163123,0.0531669025016729,0.0734655095024673,3.36187910825194e-34
NMR metabolomics,X23412.Phospholipids in VLDL,IL1RN,Interleukin-1 receptor antagonist protein,42092,0.0660215841003703,0.00540184195246885,0.0554339738735314,0.0766091943272093,3.59284566122547e-34
NMR metabolomics,X23412.Phospholipids in VLDL,PGF,Placenta growth factor,42296,0.0328157230789747,0.00268514628161256,0.0275528363670141,0.0380786097909353,3.60773935126042e-34
NMR metabolomics,X23412.Phospholipids in VLDL,BAG3,BAG family molecular chaperone regulator 3,41992,0.0508533885030408,0.00416155640058859,0.0426967379578871,0.0590100390481944,3.70395108592847e-34
NMR metabolomics,X23412.Phospholipids in VLDL,TBCB,Tubulin-folding cofactor B,42016,0.12520588095168,0.0102552830960288,0.105105526083463,0.145306235819896,4.22500534958315e-34
NMR metabolomics,X23412.Phospholipids in VLDL,ANKRD54,Ankyrin repeat domain-containing protein 54,41843,0.0707966921070239,0.00580469000899535,0.059419499689393,0.0821738845246548,4.94148520926526e-34
NMR metabolomics,X23412.Phospholipids in VLDL,IL32,Interleukin-32,42119,-0.0555071161740353,0.00455628952169833,-0.064437443636564,-0.0465767887115065,5.80264010918007e-34
NMR metabolomics,X23412.Phospholipids in VLDL,DNM3,Dynamin-3,39934,0.0689889826223569,0.00566185042952688,0.0578917557804843,0.0800862094642296,6.09891246695553e-34
NMR metabolomics,X23412.Phospholipids in VLDL,HPGDS,Hematopoietic prostaglandin D synthase,41843,0.0473703642339843,0.0038987337732142,0.0397288460384845,0.0550118824294842,8.6574808439432e-34
NMR metabolomics,X23412.Phospholipids in VLDL,CCT5,T-complex protein 1 subunit epsilon,41843,0.0563404645579737,0.00463863364998144,0.0472487426040101,0.0654321865119374,9.11676594236354e-34
NMR metabolomics,X23412.Phospholipids in VLDL,RNF5,E3 ubiquitin-protein ligase RNF5,39638,0.0918469882240873,0.00756032602829274,0.0770287492086335,0.106665227239541,9.5851749274022e-34
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINB9,Serpin B9,42016,0.0408391828893238,0.00336616186724524,0.0342415056295232,0.0474368601491245,1.06952884124906e-33
NMR metabolomics,X23412.Phospholipids in VLDL,SCARA5,Scavenger receptor class A member 5,42249,0.0379147487072722,0.00312809150178928,0.0317836893637652,0.0440458080507792,1.22105869688953e-33
NMR metabolomics,X23412.Phospholipids in VLDL,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,41768,0.104203827523422,0.00861381271430652,0.0873207546033815,0.121086900443463,1.64324970241999e-33
NMR metabolomics,X23412.Phospholipids in VLDL,CHRDL2,Chordin-like protein 2,42145,0.0566237566134126,0.00468450653185353,0.0474421238109797,0.0658053894158456,1.82921559349813e-33
NMR metabolomics,X23412.Phospholipids in VLDL,WDR46,WD repeat-containing protein 46,39919,0.0454460132115909,0.00376160516896336,0.0380732670804227,0.0528187593427591,2.12154848055567e-33
NMR metabolomics,X23412.Phospholipids in VLDL,IL18,Interleukin-18,42069,0.0548443668510375,0.00454251383851397,0.0459410397275501,0.0637476939745248,2.16654909994546e-33
NMR metabolomics,X23412.Phospholipids in VLDL,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,41843,0.0807097775316176,0.00668736095186436,0.0676025500659634,0.0938170049972717,2.30431660964424e-33
NMR metabolomics,X23412.Phospholipids in VLDL,IMPACT,Protein IMPACT,39929,0.0672145832363362,0.00557328725899889,0.0562909402086984,0.078138226263974,2.74197769758117e-33
NMR metabolomics,X23412.Phospholipids in VLDL,SSNA1,Sjoegren syndrome nuclear autoantigen 1,39930,0.0637476288798279,0.00528799843286152,0.0533831519514193,0.0741121058082364,2.91049984392098e-33
NMR metabolomics,X23412.Phospholipids in VLDL,CERT,Ceramide transfer protein,41839,0.075719899572453,0.00628913596527701,0.0633931930805101,0.088046606064396,3.27246715826556e-33
NMR metabolomics,X23412.Phospholipids in VLDL,SEPTIN9,Septin-9,42070,0.035487577072446,0.00294959530990055,0.0297063702650409,0.0412687838798511,3.59707372344304e-33
NMR metabolomics,X23412.Phospholipids in VLDL,NARS1,"Asparagine--tRNA ligase, cytoplasmic",39934,0.0579237349634839,0.00481506956634178,0.048486198613454,0.0673612713135137,3.9476756438066e-33
NMR metabolomics,X23412.Phospholipids in VLDL,PKD2,Polycystin-2,39575,0.0723272814473669,0.00601584537677002,0.0605362245088976,0.0841183383858361,4.35109193614581e-33
NMR metabolomics,X23412.Phospholipids in VLDL,FHIT,Bis(5'-adenosyl)-triphosphatase,41839,0.0886743446796465,0.00738625020170151,0.0741972942843115,0.103151395074981,4.94437889008747e-33
NMR metabolomics,X23412.Phospholipids in VLDL,CASP10,Caspase-10,41839,0.087675711650158,0.00730540477657892,0.0733571182880633,0.101994305012253,5.17670019938476e-33
NMR metabolomics,X23412.Phospholipids in VLDL,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,42016,0.0971516535066701,0.00809712115900925,0.081281296035012,0.113022010978328,5.35021341593792e-33
NMR metabolomics,X23412.Phospholipids in VLDL,CACYBP,Calcyclin-binding protein,39713,0.128104967170411,0.0106753732195497,0.107181235660094,0.149028698680729,5.67540612121553e-33
NMR metabolomics,X23412.Phospholipids in VLDL,SUGT1,Protein SGT1 homolog,41843,0.0981921776085144,0.00818900238212839,0.0821417329395428,0.114242622277486,5.885408001237e-33
NMR metabolomics,X23412.Phospholipids in VLDL,ATXN3,Ataxin-3,39929,0.0752462160633369,0.00627647738527698,0.062944320388194,0.0875481117384798,6.44751036050873e-33
NMR metabolomics,X23412.Phospholipids in VLDL,PNMA1,Paraneoplastic antigen Ma1,39638,0.0705301572691968,0.00589166160608903,0.0589825005212623,0.0820778140171313,8.02966866805038e-33
NMR metabolomics,X23412.Phospholipids in VLDL,MOCS2,Molybdopterin synthase catalytic subunit,39736,0.0827385213951093,0.0069171803605731,0.069180847888386,0.0962961949018326,8.99379638258155e-33
NMR metabolomics,X23412.Phospholipids in VLDL,TALDO1,Transaldolase,39948,0.0543228895390551,0.00454205599486798,0.0454204597891139,0.0632253192889964,9.05926740557165e-33
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINB6,Serpin B6,42216,0.0717580018571264,0.00600382728507429,0.0599905003783808,0.083525503335872,9.23819358040892e-33
NMR metabolomics,X23412.Phospholipids in VLDL,TMEM106A,Transmembrane protein 106A,39919,0.0880632287527532,0.00736422336426996,0.073629350958784,0.102497106546722,9.257924328179e-33
NMR metabolomics,X23412.Phospholipids in VLDL,GNPDA2,Glucosamine-6-phosphate isomerase 2,39736,0.0458602157891041,0.003840668484241,0.0383325055599918,0.0533879260182165,1.14907689801505e-32
NMR metabolomics,X23412.Phospholipids in VLDL,BIN2,Bridging integrator 2,42137,0.109125510025821,0.00915194294252255,0.0911877018584764,0.127063318193165,1.29623196310619e-32
NMR metabolomics,X23412.Phospholipids in VLDL,NUB1,NEDD8 ultimate buster 1,42119,0.102799563081906,0.00862587161467616,0.0858928547171404,0.119706271446671,1.39545775347239e-32
NMR metabolomics,X23412.Phospholipids in VLDL,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,42016,0.114369777141369,0.00959772441898769,0.0955582372801533,0.133181317002585,1.42025942930822e-32
NMR metabolomics,X23412.Phospholipids in VLDL,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,39958,0.109731917390633,0.00920452309880527,0.0916910521169743,0.127772782664291,1.42968421370474e-32
NMR metabolomics,X23412.Phospholipids in VLDL,MANF,Mesencephalic astrocyte-derived neurotrophic factor,42185,0.146862982583014,0.0123443094313133,0.12266813609764,0.171057829068388,1.77368404775289e-32
NMR metabolomics,X23412.Phospholipids in VLDL,MYO9B,Unconventional myosin-IXb,41913,0.0804416230120869,0.00676539154613353,0.0671814555816652,0.0937017904425086,1.94296142011951e-32
NMR metabolomics,X23412.Phospholipids in VLDL,C3,Complement C3,39445,0.0563238266515624,0.00473665105542463,0.0470399905829301,0.0656076627201947,2.09352789974887e-32
NMR metabolomics,X23412.Phospholipids in VLDL,TBC1D5,TBC1 domain family member 5,42119,0.0949799229737367,0.0079955735732058,0.0793085987702533,0.11065124717722,2.20336371382925e-32
NMR metabolomics,X23412.Phospholipids in VLDL,BLMH,Bleomycin hydrolase,42310,0.0376526124959933,0.00317080488680061,0.0314378349178641,0.0438673900741225,2.306081610866e-32
NMR metabolomics,X23412.Phospholipids in VLDL,VPS4B,Vacuolar protein sorting-associated protein 4B,39919,0.115471274409959,0.00972920980630631,0.0964020231895981,0.134540525630319,2.68061165105248e-32
NMR metabolomics,X23412.Phospholipids in VLDL,NUDT16,U8 snoRNA-decapping enzyme,39915,0.106641609023166,0.00901467332371407,0.0889728493086866,0.124310368737646,4.23222638205853e-32
NMR metabolomics,X23412.Phospholipids in VLDL,DFFA,DNA fragmentation factor subunit alpha,42296,0.0809589657584757,0.00685171339657741,0.0675296075011839,0.0943883240157674,4.62508800879069e-32
NMR metabolomics,X23412.Phospholipids in VLDL,SETMAR,Histone-lysine N-methyltransferase SETMAR,41976,0.0359340851560406,0.00304415564708834,0.0299675400877475,0.0419006302243337,5.34616352278885e-32
NMR metabolomics,X23412.Phospholipids in VLDL,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,42166,0.0920269439656727,0.00780401851779917,0.0767310676707863,0.107322820260559,6.12786463027541e-32
NMR metabolomics,X23412.Phospholipids in VLDL,ADD1,Alpha-adducin,39736,0.0846037571598618,0.00717705520738331,0.0705367289533906,0.0986707853663331,6.95433475486125e-32
NMR metabolomics,X23412.Phospholipids in VLDL,CES2,Cocaine esterase,42070,0.0672516311334565,0.00571019601446349,0.0560596469451081,0.078443615321805,7.30886590811623e-32
NMR metabolomics,X23412.Phospholipids in VLDL,CD69,Early activation antigen CD69,42082,0.105342049040093,0.00897707202413895,0.0877469878727803,0.122937110207405,1.2079665199185e-31
NMR metabolomics,X23412.Phospholipids in VLDL,TTF2,Transcription termination factor 2,39649,0.0599435216002998,0.00511444591807672,0.0499192076008695,0.0699678355997302,1.53910184362903e-31
NMR metabolomics,X23412.Phospholipids in VLDL,ANXA3,Annexin A3,42224,0.0833513629296769,0.0071225492294289,0.0693911664399963,0.0973115594193576,1.7513822607987e-31
NMR metabolomics,X23412.Phospholipids in VLDL,STXBP3,Syntaxin-binding protein 3,41843,0.0521578385923227,0.00445787882493932,0.0434203960954416,0.0608952810892038,1.81724140573066e-31
NMR metabolomics,X23412.Phospholipids in VLDL,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,42202,0.13636234308223,0.0116583365322102,0.113512003479098,0.159212682685362,1.8774401427534e-31
NMR metabolomics,X23412.Phospholipids in VLDL,LARP1,La-related protein 1,39919,0.0748052605075646,0.00639942525998043,0.0622623869980029,0.0873481340171262,2.18767869264346e-31
NMR metabolomics,X23412.Phospholipids in VLDL,SNCG,Gamma-synuclein,42016,0.0800352435296773,0.00685238962421334,0.0666045598662192,0.0934659271931355,2.29037904634347e-31
NMR metabolomics,X23412.Phospholipids in VLDL,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,39934,0.0587706055788613,0.00502968482791522,0.0489124233161474,0.0686287878415751,2.30726265723846e-31
NMR metabolomics,X23412.Phospholipids in VLDL,AKT2,RAC-beta serine/threonine-protein kinase,39934,0.153189328233598,0.0131339414914289,0.127446802910397,0.178931853556799,2.94920875412431e-31
NMR metabolomics,X23412.Phospholipids in VLDL,GLOD4,Glyoxalase domain-containing protein 4,42106,0.0409895553627548,0.00351801422231771,0.034094247487012,0.0478848632384975,3.18595090672388e-31
NMR metabolomics,X23412.Phospholipids in VLDL,ZNRD2,Protein ZNRD2,39930,0.0835331412367899,0.0071753867025464,0.069469383299799,0.0975968991737809,3.80698791507195e-31
NMR metabolomics,X23412.Phospholipids in VLDL,PSPN,Persephin,42119,0.102937214134766,0.00886532943520404,0.0855611684417658,0.120313259827766,5.07248367691478e-31
NMR metabolomics,X23412.Phospholipids in VLDL,AKT3,RAC-gamma serine/threonine-protein kinase,41791,0.0691778589838276,0.0059628408799737,0.0574906908590792,0.0808650271085761,5.7239949687708e-31
NMR metabolomics,X23412.Phospholipids in VLDL,BCL2L1,Bcl-2-like protein 1,39929,0.1188098878639,0.0102503712545386,0.0987191602050048,0.138900615522796,6.85293858507022e-31
NMR metabolomics,X23412.Phospholipids in VLDL,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,42070,0.111441281455957,0.00962139590545062,0.0925833454812734,0.13029921743064,7.06663330720714e-31
NMR metabolomics,X23412.Phospholipids in VLDL,YWHAQ,14-3-3 protein theta,39736,0.0884513146871906,0.00763355855306563,0.073489539923182,0.103413089451199,7.19476849280941e-31
NMR metabolomics,X23412.Phospholipids in VLDL,AIF1,Allograft inflammatory factor 1,41843,0.0620484994653035,0.00536044706652014,0.0515420232149241,0.072554975715683,7.74172763236332e-31
NMR metabolomics,X23412.Phospholipids in VLDL,CRYBB1,Beta-crystallin B1,39958,0.0786674315046588,0.00679908592378005,0.0653412230940499,0.0919936399152677,8.67063104418719e-31
NMR metabolomics,X23412.Phospholipids in VLDL,PRDX6,Peroxiredoxin-6,42262,-0.0711959494769452,0.00615963232336742,-0.0832688288307454,-0.059123070123145,9.29764872572275e-31
NMR metabolomics,X23412.Phospholipids in VLDL,PDIA4,Protein disulfide-isomerase A4,39966,0.0728447271665249,0.00630049489227097,0.0604957571776738,0.085193697155376,9.56494035833163e-31
NMR metabolomics,X23412.Phospholipids in VLDL,ATOX1,Copper transport protein ATOX1,42181,0.0842018953737459,0.00728715948141716,0.0699190627901683,0.0984847279573235,9.71539682880509e-31
NMR metabolomics,X23412.Phospholipids in VLDL,C2,Complement C2,42199,0.0267713082131576,0.00231776874515254,0.0222284814726587,0.0313141349536566,1.02122259962751e-30
NMR metabolomics,X23412.Phospholipids in VLDL,DNAJB14,DnaJ homolog subfamily B member 14,39930,0.0765057888682161,0.00662297804007054,0.0635247519096778,0.0894868258267544,1.07667215451989e-30
NMR metabolomics,X23412.Phospholipids in VLDL,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,39638,0.0899540161164654,0.00778676704205769,0.0746919527140323,0.105216079518898,1.08048499966326e-30
NMR metabolomics,X23412.Phospholipids in VLDL,CASP2,Caspase-2,42119,0.0808991301956724,0.007007986294575,0.0671634770583054,0.0946347833330394,1.10424884850527e-30
NMR metabolomics,X23412.Phospholipids in VLDL,RP2,Protein XRP2,42070,0.0504379935305303,0.00436989537605652,0.0418729985934596,0.0590029884676011,1.12738581376696e-30
NMR metabolomics,X23412.Phospholipids in VLDL,CEMIP2,Cell surface hyaluronidase,39657,0.0384770152624821,0.00333421265169222,0.0319419584651654,0.0450120720597989,1.24089458506642e-30
NMR metabolomics,X23412.Phospholipids in VLDL,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,41913,0.0648499178521105,0.00562437335797518,0.0538261460704791,0.0758736896337418,1.2992471465892e-30
NMR metabolomics,X23412.Phospholipids in VLDL,GP1BB,Platelet glycoprotein Ib beta chain,39575,0.0823071943376509,0.00713767832422506,0.0683173448221698,0.096297043853132,1.37524501534525e-30
NMR metabolomics,X23412.Phospholipids in VLDL,CCL24,C-C motif chemokine 24,42166,0.0971670206340263,0.00844535381341927,0.0806141271597245,0.113719914108328,1.71651205190553e-30
NMR metabolomics,X23412.Phospholipids in VLDL,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,42119,0.143457944680935,0.0124709003912266,0.119014979914131,0.167900909447739,1.75767595283359e-30
NMR metabolomics,X23412.Phospholipids in VLDL,CHM,Rab proteins geranylgeranyltransferase component A 1,39649,0.0723600202659821,0.00628834899039594,0.060034856244806,0.0846851842871581,1.81372843402706e-30
NMR metabolomics,X23412.Phospholipids in VLDL,KCTD5,BTB/POZ domain-containing protein KCTD5,39739,0.054485405557364,0.00473923536478561,0.0451965042423842,0.0637743068723438,2.0350124732722e-30
NMR metabolomics,X23412.Phospholipids in VLDL,ITGB1BP2,Integrin beta-1-binding protein 2,41900,0.131915724050807,0.0114881029205873,0.109399042326456,0.154432405775158,2.23793011263805e-30
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINB1,Leukocyte elastase inhibitor,42093,0.105471791089315,0.00918687107684067,0.087465523778707,0.123478058399922,2.2817890409818e-30
NMR metabolomics,X23412.Phospholipids in VLDL,UROD,Uroporphyrinogen decarboxylase,39736,0.0801373582629945,0.00698020314531497,0.0664561600981772,0.0938185564278119,2.44407034505219e-30
NMR metabolomics,X23412.Phospholipids in VLDL,BGLAP,Osteocalcin,39966,0.0993211888056855,0.00865701624240185,0.0823534369705778,0.116288940640793,2.6494828242985e-30
NMR metabolomics,X23412.Phospholipids in VLDL,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",39736,0.123575691665905,0.0107867343849063,0.102433692271488,0.144717691060321,3.22931643140752e-30
NMR metabolomics,X23412.Phospholipids in VLDL,RNASEH2A,Ribonuclease H2 subunit A,39934,0.056344504497148,0.00492358195580615,0.0466942838637679,0.065994725130528,3.69741661404552e-30
NMR metabolomics,X23412.Phospholipids in VLDL,OTUD6B,Deubiquitinase OTUD6B,39930,0.0681772170542655,0.00596320064576892,0.0564893437885584,0.0798650903199726,4.18270734647852e-30
NMR metabolomics,X23412.Phospholipids in VLDL,PHLDB1,Pleckstrin homology-like domain family B member 1,39930,0.0622325551470552,0.00544814839829264,0.0515541842864017,0.0729109260077088,4.70259831523767e-30
NMR metabolomics,X23412.Phospholipids in VLDL,GMFG,Glia maturation factor gamma,39958,0.0844674259120304,0.00740318498276076,0.0699571833458193,0.0989776684782415,5.45247838504591e-30
NMR metabolomics,X23412.Phospholipids in VLDL,SCRG1,Scrapie-responsive protein 1,39958,0.032032603566794,0.00280971988278319,0.026525552596539,0.0375396545370491,6.03722761470608e-30
NMR metabolomics,X23412.Phospholipids in VLDL,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,39919,0.126445751288067,0.0110929242528669,0.104703619752448,0.148187882823686,6.17430037366042e-30
NMR metabolomics,X23412.Phospholipids in VLDL,PYY,Peptide YY,39575,0.117055764514947,0.0102936919021093,0.096880128386813,0.137231400643081,8.50087944123466e-30
NMR metabolomics,X23412.Phospholipids in VLDL,HAO1,Hydroxyacid oxidase 1,42262,0.144083394995982,0.0126785572009559,0.119233422882108,0.168933367109855,8.56424601316013e-30
NMR metabolomics,X23412.Phospholipids in VLDL,GGCT,Gamma-glutamylcyclotransferase,39952,0.0555578569487007,0.00488696843150075,0.0459793988229593,0.0651363150744422,8.68701359516823e-30
NMR metabolomics,X23412.Phospholipids in VLDL,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,39958,0.0848098450789012,0.00746393401024151,0.0701805344188278,0.0994391557389745,9.29097676708997e-30
NMR metabolomics,X23412.Phospholipids in VLDL,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,42016,0.0500695536277476,0.00441350146636987,0.0414190907536627,0.0587200165018326,1.07671543440541e-29
NMR metabolomics,X23412.Phospholipids in VLDL,EIF4E,Eukaryotic translation initiation factor 4E,39657,0.105499360205807,0.00930514701667285,0.0872612720531282,0.123737448358486,1.24320542629787e-29
NMR metabolomics,X23412.Phospholipids in VLDL,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,39736,0.0500652259446565,0.00441670499797556,0.0414084841486244,0.0587219677406886,1.27280036449794e-29
NMR metabolomics,X23412.Phospholipids in VLDL,PLA2G4A,Cytosolic phospholipase A2,42185,0.102496066195698,0.00904812230520477,0.0847617464774962,0.120230385913899,1.29642843600478e-29
NMR metabolomics,X23412.Phospholipids in VLDL,ESYT2,Extended synaptotagmin-2,39929,0.0971968365603047,0.00857761835353762,0.0803847045873709,0.114008968533238,1.32287410286617e-29
NMR metabolomics,X23412.Phospholipids in VLDL,BAG6,Large proline-rich protein BAG6,41900,0.0429010705204716,0.00378984936626465,0.0354729657625929,0.0503291752783503,1.42658638034945e-29
NMR metabolomics,X23412.Phospholipids in VLDL,PPCDC,Phosphopantothenoylcysteine decarboxylase,42249,0.0537532282151382,0.00475161572733155,0.0444400613895684,0.0630663950407081,1.53827165459645e-29
NMR metabolomics,X23412.Phospholipids in VLDL,CRLF1,Cytokine receptor-like factor 1,42185,0.0288325393822074,0.00255162474258009,0.0238313548867505,0.0338337238776644,1.78275480239038e-29
NMR metabolomics,X23412.Phospholipids in VLDL,APP,Amyloid-beta precursor protein,42112,0.0764216669470865,0.0067882828635963,0.0631166325344378,0.0897267013597353,2.85894306641908e-29
NMR metabolomics,X23412.Phospholipids in VLDL,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,39862,0.0338557452249948,0.00301070291957624,0.0279547675026254,0.0397567229473642,3.50048209445603e-29
NMR metabolomics,X23412.Phospholipids in VLDL,CEBPB,CCAAT/enhancer-binding protein beta,41900,0.0434133530924471,0.00386334283141428,0.0358412011428751,0.0509855050420191,3.62125710541357e-29
NMR metabolomics,X23412.Phospholipids in VLDL,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,39958,0.0710231281119249,0.0063286143944353,0.0586190438988317,0.0834272123250181,4.49442597511377e-29
NMR metabolomics,X23412.Phospholipids in VLDL,TP53I3,Quinone oxidoreductase PIG3,39513,0.0612857225404285,0.0054691450207009,0.0505661982998548,0.0720052467810023,5.5013192697366e-29
NMR metabolomics,X23412.Phospholipids in VLDL,CFHR4,Complement factor H-related protein 4,39945,0.0843174173223524,0.00753176450394304,0.069555158894624,0.0990796757500808,6.12241193816652e-29
NMR metabolomics,X23412.Phospholipids in VLDL,DCTD,Deoxycytidylate deaminase,39736,0.110403020334824,0.00986543324024037,0.0910667711839524,0.129739269485695,6.44460338761625e-29
NMR metabolomics,X23412.Phospholipids in VLDL,CST3,Cystatin-C,42184,0.0328912913064225,0.0029415137630775,0.0271259243307906,0.0386566582820544,6.69744311137958e-29
NMR metabolomics,X23412.Phospholipids in VLDL,IL17RB,Interleukin-17 receptor B,41934,-0.0620045868230683,0.00554596677159672,-0.0728746816953978,-0.0511344919507387,6.85779727360097e-29
NMR metabolomics,X23412.Phospholipids in VLDL,CPPED1,Serine/threonine-protein phosphatase CPPED1,42249,0.0742334774730287,0.00664480477578106,0.0612096601124978,0.0872572948335596,7.4864446247624e-29
NMR metabolomics,X23412.Phospholipids in VLDL,VSNL1,Visinin-like protein 1,39929,0.0445750943293673,0.00398845163831283,0.0367577291182742,0.0523924595404605,7.55977946238294e-29
NMR metabolomics,X23412.Phospholipids in VLDL,CDC37,Hsp90 co-chaperone Cdc37,42181,0.0957961271575156,0.00858210948868859,0.0789751925596859,0.112617061755345,8.321310459137e-29
NMR metabolomics,X23412.Phospholipids in VLDL,SIT1,Signaling threshold-regulating transmembrane adapter 1,41913,0.0626790825741064,0.00561627347210072,0.051671186568789,0.0736869785794238,8.56230334305052e-29
NMR metabolomics,X23412.Phospholipids in VLDL,SNAP25,Synaptosomal-associated protein 25,39586,0.0552726840010152,0.00495367129426476,0.0455634882642563,0.0649818797377742,9.34851864079891e-29
NMR metabolomics,X23412.Phospholipids in VLDL,VASH1,Tubulinyl-Tyr carboxypeptidase 1,42119,0.0946786605256944,0.00849037937736724,0.0780375169460547,0.111319804105334,9.42063730306611e-29
NMR metabolomics,X23412.Phospholipids in VLDL,ARL13B,ADP-ribosylation factor-like protein 13B,39575,0.0792660224535127,0.00711319152444943,0.0653241670655918,0.0932078778414336,1.09746566388403e-28
NMR metabolomics,X23412.Phospholipids in VLDL,ABRAXAS2,BRISC complex subunit Abraxas 2,39575,0.0760938183294508,0.00683313907186944,0.0627008657485867,0.0894867709103149,1.19312078623891e-28
NMR metabolomics,X23412.Phospholipids in VLDL,PAM,Peptidyl-glycine alpha-amidating monooxygenase,42246,0.0323429611028013,0.0029065355579503,0.0266461514092187,0.0380397707963839,1.22196171596663e-28
NMR metabolomics,X23412.Phospholipids in VLDL,CCL3,C-C motif chemokine 3,42119,0.0677328495980255,0.00608788995697161,0.0558005852823611,0.0796651139136898,1.25043174669967e-28
NMR metabolomics,X23412.Phospholipids in VLDL,DBN1,Drebrin,39657,0.0584175503517649,0.00525307537383632,0.0481215226190457,0.0687135780844841,1.41106360274749e-28
NMR metabolomics,X23412.Phospholipids in VLDL,PLPBP,Pyridoxal phosphate homeostasis protein,42145,0.076502762186349,0.00688745648733153,0.0630033474711792,0.0900021769015188,1.53107323131877e-28
NMR metabolomics,X23412.Phospholipids in VLDL,THTPA,Thiamine-triphosphatase,39897,0.100260646616323,0.00902557192851827,0.0825705256364269,0.117950767596218,1.60223957802787e-28
NMR metabolomics,X23412.Phospholipids in VLDL,MICALL2,MICAL-like protein 2,39649,0.078238875840078,0.00704309093460993,0.0644344176082425,0.0920433340719135,1.61280526108629e-28
NMR metabolomics,X23412.Phospholipids in VLDL,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,42203,-0.0365215810377394,0.00329201173882267,-0.0429739240458318,-0.030069238029647,1.77713817848534e-28
NMR metabolomics,X23412.Phospholipids in VLDL,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,41843,0.0660017140743224,0.00595253201787068,0.0543347513192959,0.0776686768293489,1.91362600127663e-28
NMR metabolomics,X23412.Phospholipids in VLDL,LACTB2,Endoribonuclease LACTB2,42145,0.0749395386950058,0.00675911121118428,0.0616916807210846,0.088187396668927,1.91875353515483e-28
NMR metabolomics,X23412.Phospholipids in VLDL,CIAPIN1,Anamorsin,42181,0.0695643047618366,0.00628849306387276,0.057238858356646,0.0818897511670272,2.52908524448602e-28
NMR metabolomics,X23412.Phospholipids in VLDL,RBKS,Ribokinase,41830,0.0562101632036097,0.00508291101125773,0.0462476576215446,0.0661726687856749,2.64823234165045e-28
NMR metabolomics,X23412.Phospholipids in VLDL,ASRGL1,Isoaspartyl peptidase/L-asparaginase,39638,0.115968707452687,0.0104892426310868,0.0954097918957567,0.136527623009617,2.88586218954379e-28
NMR metabolomics,X23412.Phospholipids in VLDL,BMPER,BMP-binding endothelial regulator protein,39736,0.0262800128718702,0.00238015351985336,0.0216149119729577,0.0309451137707828,3.38144291062854e-28
NMR metabolomics,X23412.Phospholipids in VLDL,AMIGO2,Amphoterin-induced protein 2,42070,0.0264989027195167,0.00240411729013814,0.0217868328308459,0.0312109726081874,3.9346829061755e-28
NMR metabolomics,X23412.Phospholipids in VLDL,DTD1,D-aminoacyl-tRNA deacylase 1,39736,0.0992880716633789,0.00900784024711923,0.0816327047790252,0.116943438547733,4.16311332148194e-28
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINA12,Serpin A12,41751,0.122258091224568,0.0111097606954756,0.100482960261436,0.144033222187701,4.81437989988283e-28
NMR metabolomics,X23412.Phospholipids in VLDL,NPPB,Natriuretic peptides B,41900,-0.158180574234929,0.0144026139723353,-0.186409697620706,-0.129951450849152,6.097492938027e-28
NMR metabolomics,X23412.Phospholipids in VLDL,BPIFB2,BPI fold-containing family B member 2,39927,0.0692215898846739,0.00630402626089268,0.0568656984133243,0.0815774813560236,6.55432998375258e-28
NMR metabolomics,X23412.Phospholipids in VLDL,TPK1,Thiamin pyrophosphokinase 1,39958,0.0315777076022797,0.00287724779226784,0.0259383019294347,0.0372171132751246,6.96020660443232e-28
NMR metabolomics,X23412.Phospholipids in VLDL,CRYZL1,Quinone oxidoreductase-like protein 1,39638,0.102584567188083,0.0093481662441839,0.084262161349483,0.120906973026684,7.11843379927083e-28
NMR metabolomics,X23412.Phospholipids in VLDL,REEP4,Receptor expression-enhancing protein 4,39934,0.0704080480073509,0.00641664951573454,0.0578314149565112,0.0829846810581906,7.13920873024592e-28
NMR metabolomics,X23412.Phospholipids in VLDL,RAB33A,Ras-related protein Rab-33A,39575,0.0750715881422037,0.00684225551975016,0.0616607673234934,0.088482408960914,7.28995587717703e-28
NMR metabolomics,X23412.Phospholipids in VLDL,CBLN4,Cerebellin-4,42262,0.0357014673288833,0.00325732458600538,0.0293171111403127,0.0420858235174538,7.73875290032634e-28
NMR metabolomics,X23412.Phospholipids in VLDL,RAD23B,UV excision repair protein RAD23 homolog B,41843,0.0519974323985208,0.00474676937494678,0.0426937644236251,0.0613011003734165,8.3417649430552e-28
NMR metabolomics,X23412.Phospholipids in VLDL,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",39627,0.0891093711293674,0.00814422623580164,0.0731466877071962,0.105072054551539,1.01403095610121e-27
NMR metabolomics,X23412.Phospholipids in VLDL,GPRC5C,G-protein coupled receptor family C group 5 member C,39919,0.063308778695436,0.00578831745943461,0.0519636764749441,0.0746538809159278,1.05132872943592e-27
NMR metabolomics,X23412.Phospholipids in VLDL,CD244,Natural killer cell receptor 2B4,42296,0.0308679131574678,0.0028255236455705,0.0253298868121496,0.036405939502786,1.14269584009833e-27
NMR metabolomics,X23412.Phospholipids in VLDL,BLNK,B-cell linker protein,39657,0.0469229293218908,0.00430786517255132,0.0384795135836902,0.0553663450600914,1.72802024937721e-27
NMR metabolomics,X23412.Phospholipids in VLDL,GLB1,Beta-galactosidase,42016,0.0481446158367262,0.00442466237183477,0.03947227758793,0.0568169540855223,1.84970457683185e-27
NMR metabolomics,X23412.Phospholipids in VLDL,TXNDC9,Thioredoxin domain-containing protein 9,39929,0.0599961891588716,0.00551326261186278,0.0491901944396205,0.0708021838781226,1.91638388835912e-27
NMR metabolomics,X23412.Phospholipids in VLDL,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,39934,0.112015990163239,0.0102946059906048,0.0918385624216538,0.132193417904825,1.93956320082909e-27
NMR metabolomics,X23412.Phospholipids in VLDL,PRG2,Bone marrow proteoglycan,39966,-0.0573084460391362,0.00527385092207925,-0.0676451938464115,-0.0469716982318608,2.268319103465e-27
NMR metabolomics,X23412.Phospholipids in VLDL,FMNL1,Formin-like protein 1,41839,0.0703855635324385,0.00648293914002992,0.0576790028179799,0.0830921242468971,2.4070774302907e-27
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,42016,0.0643417828857508,0.00592652587404713,0.0527257921726184,0.0759577735988831,2.41094416622629e-27
NMR metabolomics,X23412.Phospholipids in VLDL,JAM3,Junctional adhesion molecule C,39736,0.0567914030168121,0.00523946038761122,0.0465220606570941,0.0670607453765301,3.06988952779358e-27
NMR metabolomics,X23412.Phospholipids in VLDL,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,39657,0.0901305514796509,0.00832259878576456,0.0738182578595523,0.106442845099749,3.4114710347193e-27
NMR metabolomics,X23412.Phospholipids in VLDL,CCS,Copper chaperone for superoxide dismutase,42016,0.0514287383666496,0.00475595073068177,0.0421070749345133,0.0607504017987859,3.84195426765408e-27
NMR metabolomics,X23412.Phospholipids in VLDL,VCAM1,Vascular cell adhesion protein 1,42199,-0.0307615956473966,0.0028468003150864,-0.036341324264966,-0.0251818670298273,4.16918015392666e-27
NMR metabolomics,X23412.Phospholipids in VLDL,CASP3,Caspase-3,42310,0.0976169395724001,0.00903912699163892,0.0799002506687878,0.115333628476012,4.45352260589155e-27
NMR metabolomics,X23412.Phospholipids in VLDL,DYNLT1,Dynein light chain Tctex-type 1,39649,0.0881146508728172,0.00816331548606574,0.0721145525201283,0.104114749225506,5.01209085626478e-27
NMR metabolomics,X23412.Phospholipids in VLDL,MIF,Macrophage migration inhibitory factor,42105,0.0741405592358005,0.00687466127780004,0.0606662231313125,0.0876148953402886,5.24244839344034e-27
NMR metabolomics,X23412.Phospholipids in VLDL,DNAJB2,DnaJ homolog subfamily B member 2,39736,0.0582036600401985,0.00539850436579098,0.0476225914832482,0.0687847285971488,5.7225849807372e-27
NMR metabolomics,X23412.Phospholipids in VLDL,SERPING1,Plasma protease C1 inhibitor,39959,0.0205042454167334,0.00190788121584633,0.0167647982336746,0.0242436925997922,8.2249408680025e-27
NMR metabolomics,X23412.Phospholipids in VLDL,PQBP1,Polyglutamine-binding protein 1,41843,0.0623366920536653,0.00580415187236748,0.050960554383825,0.0737128297235056,8.51301722008284e-27
NMR metabolomics,X23412.Phospholipids in VLDL,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,39736,0.0658863243451975,0.0061346953976412,0.0538623213658207,0.0779103273245742,8.93568895424186e-27
NMR metabolomics,X23412.Phospholipids in VLDL,MIA,Melanoma-derived growth regulatory protein,42181,0.0406505575356567,0.00379432848037085,0.0332136737141298,0.0480874413571836,1.12427186468173e-26
NMR metabolomics,X23412.Phospholipids in VLDL,JPT2,Jupiter microtubule associated homolog 2,39930,0.0969639352762028,0.00904775582874504,0.0792303338518626,0.114697536700543,1.13790184125289e-26
NMR metabolomics,X23412.Phospholipids in VLDL,GPI,Glucose-6-phosphate isomerase,39990,0.0527175690634322,0.00492072888219399,0.043072940454332,0.0623621976725324,1.17999071643098e-26
NMR metabolomics,X23412.Phospholipids in VLDL,TST,Thiosulfate sulfurtransferase,41809,0.0829059455669281,0.00774332585885856,0.0677290268835653,0.0980828642502909,1.21679346550049e-26
NMR metabolomics,X23412.Phospholipids in VLDL,CD164,Sialomucin core protein 24,42137,0.0295782510285056,0.00277328324959963,0.0241426158592903,0.0350138861977209,1.88125089184378e-26
NMR metabolomics,X23412.Phospholipids in VLDL,CCL26,C-C motif chemokine 26,42119,0.0982774900375638,0.00921582945286234,0.0802144643099536,0.116340515765174,1.91098010460786e-26
NMR metabolomics,X23412.Phospholipids in VLDL,CCL11,Eotaxin,42296,0.0409149602329739,0.0038371295508343,0.0333941863133387,0.0484357341526092,1.92710466366867e-26
NMR metabolomics,X23412.Phospholipids in VLDL,PDAP1,28 kDa heat- and acid-stable phosphoprotein,39958,0.107981463906529,0.0101361004628297,0.0881147069993832,0.127848220813675,2.24486117885939e-26
NMR metabolomics,X23412.Phospholipids in VLDL,MRI1,Methylthioribose-1-phosphate isomerase,39649,0.0734410595095837,0.00689365621155041,0.0599294933349449,0.0869526256842225,2.25631261229709e-26
NMR metabolomics,X23412.Phospholipids in VLDL,LAMP1,Lysosome-associated membrane glycoprotein 1,39661,0.0300080226248092,0.00281980867690405,0.0244811976180773,0.0355348476315412,2.5505951838688e-26
NMR metabolomics,X23412.Phospholipids in VLDL,PRDX1,Peroxiredoxin-1,41742,-0.100172251091902,0.00941707344197367,-0.118629715038171,-0.0817147871456338,2.5567814787273e-26
NMR metabolomics,X23412.Phospholipids in VLDL,PCSK9,Proprotein convertase subtilisin/kexin type 9,42310,0.0434037531721256,0.00408409009043761,0.0353989365948679,0.0514085697493833,2.80845202048391e-26
NMR metabolomics,X23412.Phospholipids in VLDL,MUC13,Mucin-13,41839,0.0573763682831735,0.00540415494819033,0.0467842245847204,0.0679685119816265,3.16402565800381e-26
NMR metabolomics,X23412.Phospholipids in VLDL,INPP1,Inositol polyphosphate 1-phosphatase,42070,0.0579516389228671,0.00546162944117411,0.0472468452181659,0.0686564326275684,3.37242140785873e-26
NMR metabolomics,X23412.Phospholipids in VLDL,TRIAP1,TP53-regulated inhibitor of apoptosis 1,42262,0.0677324308486779,0.00638602413022803,0.055215823553431,0.0802490381439249,3.51940562768538e-26
NMR metabolomics,X23412.Phospholipids in VLDL,NRGN,Neurogranin,39990,0.1008368297385,0.00950740103750168,0.0822023237049968,0.119471335772003,3.69508657770868e-26
NMR metabolomics,X23412.Phospholipids in VLDL,SFRP1,Secreted frizzled-related protein 1,41968,0.0467227561611384,0.00441723589704723,0.0380649738029258,0.0553805385193509,4.80895476244537e-26
NMR metabolomics,X23412.Phospholipids in VLDL,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,39657,0.0534525959518143,0.00505579007197818,0.0435432474107371,0.0633619444928915,5.31543059889294e-26
NMR metabolomics,X23412.Phospholipids in VLDL,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,39657,0.0602966947790243,0.0057086985459552,0.0491076456289521,0.0714857439290965,5.9259177928401e-26
NMR metabolomics,X23412.Phospholipids in VLDL,PARK7,Parkinson disease protein 7,42137,0.0548705301839153,0.00519793301811441,0.044682581468411,0.0650584788994195,5.99651742068892e-26
NMR metabolomics,X23412.Phospholipids in VLDL,PPP3R1,Calcineurin subunit B type 1,42016,0.0437324953777124,0.00414519394402226,0.0356079152474288,0.0518570755079961,6.40556087119838e-26
NMR metabolomics,X23412.Phospholipids in VLDL,GRK5,G protein-coupled receptor kinase 5,41900,0.0557206939458944,0.00528405078874959,0.0453639543999452,0.0660774334918436,6.77324757376153e-26
NMR metabolomics,X23412.Phospholipids in VLDL,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",39958,0.0787056566266153,0.00747357134927831,0.0640574567820298,0.0933538564712008,8.15818865217079e-26
NMR metabolomics,X23412.Phospholipids in VLDL,STX8,Syntaxin-8,42119,0.0516929934519347,0.00491052336284891,0.0420683676607509,0.0613176192431186,8.16533999810853e-26
NMR metabolomics,X23412.Phospholipids in VLDL,REN,Renin,42145,-0.0874212418735418,0.00832947152203054,-0.103747006056722,-0.071095477690362,1.13763547736546e-25
NMR metabolomics,X23412.Phospholipids in VLDL,RILP,Rab-interacting lysosomal protein,42224,0.0631272122403589,0.00601508788143369,0.0513376399927488,0.0749167844879689,1.14334921411872e-25
NMR metabolomics,X23412.Phospholipids in VLDL,CLTA,Clathrin light chain A,41900,0.0504152419392834,0.00480650821316149,0.0409944858414869,0.0598359980370799,1.22252748489008e-25
NMR metabolomics,X23412.Phospholipids in VLDL,GIPC3,PDZ domain-containing protein GIPC3,39930,0.106407857830712,0.0101834283575496,0.0864483382499152,0.12636737741151,1.92987326019996e-25
NMR metabolomics,X23412.Phospholipids in VLDL,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,41839,0.0689260661585594,0.00660603777568335,0.0559782321182201,0.0818739001988988,2.18012569846367e-25
NMR metabolomics,X23412.Phospholipids in VLDL,RASSF2,Ras association domain-containing protein 2,41843,0.0610723881354549,0.00586023251169186,0.0495863324125388,0.0725584438583709,2.47863154036915e-25
NMR metabolomics,X23412.Phospholipids in VLDL,ITGA2,Integrin alpha-2,39736,0.0371410459499153,0.00356702132009737,0.0301496841625245,0.0441324077373062,2.84451591234463e-25
NMR metabolomics,X23412.Phospholipids in VLDL,CA13,Carbonic anhydrase 13,41967,0.11239736714006,0.0108027916896503,0.0912238954283457,0.133570838851775,2.95363721707909e-25
NMR metabolomics,X23412.Phospholipids in VLDL,BAP18,Chromatin complexes subunit BAP18,39929,0.0730320045980422,0.00701687413946642,0.059278931284688,0.0867850779113964,2.96089114308202e-25
NMR metabolomics,X23412.Phospholipids in VLDL,BRSK2,Serine/threonine-protein kinase BRSK2,39934,0.0399159921096363,0.0038377062205773,0.0323940879173048,0.0474378963019678,3.18581236836352e-25
NMR metabolomics,X23412.Phospholipids in VLDL,MGMT,Methylated-DNA--protein-cysteine methyltransferase,42119,0.127956712176711,0.0123247436933172,0.103800214537809,0.152113209815612,3.71863870576258e-25
NMR metabolomics,X23412.Phospholipids in VLDL,TREH,Trehalase,39966,0.0804481544337531,0.00774834862891862,0.0652613911210726,0.0956349177464335,3.85331563684426e-25
NMR metabolomics,X23412.Phospholipids in VLDL,CFB,Complement factor B,39794,0.0350452245594061,0.0033792824269283,0.0284218310026266,0.0416686181161856,4.38164869112265e-25
NMR metabolomics,X23412.Phospholipids in VLDL,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,39958,0.0425769138400359,0.00413550988529129,0.034471314464865,0.0506825132152069,9.48976549337592e-25
NMR metabolomics,X23412.Phospholipids in VLDL,CCDC80,Coiled-coil domain-containing protein 80,42145,0.037138328224327,0.00361019441513967,0.0300623471706533,0.0442143092780008,9.93723936530814e-25
NMR metabolomics,X23412.Phospholipids in VLDL,CCL7,C-C motif chemokine 7,42119,0.0593360187127607,0.0057682592621412,0.048030230558964,0.0706418068665575,9.9852976946219e-25
NMR metabolomics,X23412.Phospholipids in VLDL,FRMD4B,FERM domain-containing protein 4B,39575,0.0745390729977541,0.00724337693476207,0.0603420542056205,0.0887360917898878,1.0056386894123e-24
NMR metabolomics,X23412.Phospholipids in VLDL,FUT8,"Alpha-(1,6)-fucosyltransferase",42016,0.0611515554903336,0.00595444121901326,0.0494808507010676,0.0728222602795996,1.18813570344562e-24
NMR metabolomics,X23412.Phospholipids in VLDL,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",39638,0.0467265138549814,0.00454829772880317,0.0378118503065272,0.0556411774034356,1.19891941053538e-24
NMR metabolomics,X23412.Phospholipids in VLDL,ERMAP,Erythroid membrane-associated protein,39657,0.0471731316636368,0.00459517388742225,0.0381665908442892,0.0561796724829844,1.29576047159121e-24
NMR metabolomics,X23412.Phospholipids in VLDL,DTX3,Probable E3 ubiquitin-protein ligase DTX3,42070,0.0256400540486419,0.00250265680715873,0.0207348467066108,0.030545261390673,1.53117848930673e-24
NMR metabolomics,X23412.Phospholipids in VLDL,SDHB,Succinate dehydrogenase,39930,0.0692157558118627,0.00675803664369675,0.055970003990217,0.0824615076335083,1.64401208731157e-24
NMR metabolomics,X23412.Phospholipids in VLDL,SMTN,Smoothelin,39897,0.0977008512619833,0.0095426325883728,0.0789972913887726,0.116404411135194,1.70763140932506e-24
NMR metabolomics,X23412.Phospholipids in VLDL,LRG1,Leucine-rich alpha-2-glycoprotein,39979,-0.0280665759323351,0.00274354967419252,-0.0334439332937524,-0.0226892185709177,1.85636554594782e-24
NMR metabolomics,X23412.Phospholipids in VLDL,RBP2,Retinol-binding protein 2,42070,-0.0817792050239436,0.00800417567111477,-0.0974673893393286,-0.0660910207085587,2.04141461895558e-24
NMR metabolomics,X23412.Phospholipids in VLDL,SPINK2,Serine protease inhibitor Kazal-type 2,39736,0.0376585343531127,0.00368436964266276,0.0304371698534936,0.0448798988527317,2.04321840940696e-24
NMR metabolomics,X23412.Phospholipids in VLDL,CPXM2,Inactive carboxypeptidase-like protein X2,39958,0.0267676493068359,0.0026199932627033,0.0216324625119375,0.0319028361017344,2.12854457786714e-24
NMR metabolomics,X23412.Phospholipids in VLDL,POMC,Pro-opiomelanocortin,39638,0.0772829056035546,0.00756407731453221,0.0624573140670715,0.0921084971400377,2.13453578307763e-24
NMR metabolomics,X23412.Phospholipids in VLDL,ATG4A,Cysteine protease ATG4A,41843,0.0610048514515455,0.00597492895516562,0.0492939906994209,0.0727157122036702,2.19903975769207e-24
NMR metabolomics,X23412.Phospholipids in VLDL,PKN3,Serine/threonine-protein kinase N3,39757,0.0774146309028483,0.00758071708771316,0.0625564254109306,0.0922728363947661,2.24159825287008e-24
NMR metabolomics,X23412.Phospholipids in VLDL,GNAS,Neuroendocrine secretory protein 55,39934,0.0908167681162066,0.00890030664207487,0.0733721670977399,0.108261369134673,2.42967552861696e-24
NMR metabolomics,X23412.Phospholipids in VLDL,SUOX,"Sulfite oxidase, mitochondrial",39934,0.0665529129804253,0.00653509469949844,0.0537441273694083,0.0793616985914422,2.97490151271991e-24
NMR metabolomics,X23412.Phospholipids in VLDL,SWAP70,Switch-associated protein 70,39930,0.0384031314628212,0.00377444333718632,0.031005222521936,0.0458010404037063,3.27431163905957e-24
NMR metabolomics,X23412.Phospholipids in VLDL,CD40LG,CD40 ligand,42296,0.0827084961665575,0.00813985053873937,0.0667543891106283,0.0986626032224866,3.60842640306267e-24
NMR metabolomics,X23412.Phospholipids in VLDL,PRSS27,Serine protease 27,42107,0.0417706611552562,0.00412401625642619,0.0336875892926609,0.0498537330178515,5.02441672496029e-24
NMR metabolomics,X23412.Phospholipids in VLDL,CALCA,Calcitonin,41997,0.0722518332018189,0.00713662908477286,0.0582640401956641,0.0862396262079737,5.27041483049466e-24
NMR metabolomics,X23412.Phospholipids in VLDL,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",39958,0.0309274119680317,0.00305807712681248,0.0249335807994792,0.0369212431365841,6.08754567981615e-24
NMR metabolomics,X23412.Phospholipids in VLDL,PTPRM,Receptor-type tyrosine-protein phosphatase mu,42100,0.0253416588559609,0.00250684109580985,0.0204282503081736,0.0302550674037481,6.13183225417212e-24
NMR metabolomics,X23412.Phospholipids in VLDL,PRSS2,Trypsin-2,42217,0.0592971735520142,0.00586895745440127,0.0477940169413877,0.0708003301626407,6.47045591676702e-24
NMR metabolomics,X23412.Phospholipids in VLDL,CEP170,Centrosomal protein of 170 kDa,39638,0.0804627142361922,0.00796071822291628,0.0648597065192763,0.0960657219531081,6.50435023772286e-24
NMR metabolomics,X23412.Phospholipids in VLDL,STX4,Syntaxin-4,42070,0.0611855892484642,0.00605952299137154,0.049308924185376,0.0730622543115524,6.89709892778117e-24
NMR metabolomics,X23412.Phospholipids in VLDL,NT5C3A,Cytosolic 5'-nucleotidase 3A,42087,0.0895152658422288,0.00887142463827229,0.0721272735512151,0.106903258133242,7.41140117479573e-24
NMR metabolomics,X23412.Phospholipids in VLDL,RAB2B,Ras-related protein Rab-2B,39919,0.0646111143907138,0.00641559648182951,0.052036545286328,0.0771856834950996,9.34932221230501e-24
NMR metabolomics,X23412.Phospholipids in VLDL,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,39930,-0.0371444675950615,0.00369360486497925,-0.0443839331304208,-0.0299050020597021,1.08188169126753e-23
NMR metabolomics,X23412.Phospholipids in VLDL,FABP2,"Fatty acid-binding protein, intestinal",42145,-0.0824813007613819,0.00821002884559502,-0.0985729572987481,-0.0663896442240156,1.15304313759095e-23
NMR metabolomics,X23412.Phospholipids in VLDL,NT5C1A,Cytosolic 5'-nucleotidase 1A,39929,0.0319438791594553,0.00317993684715144,0.0257112029390385,0.0381765553798721,1.20827374699629e-23
NMR metabolomics,X23412.Phospholipids in VLDL,NFAT5,Nuclear factor of activated T-cells 5,39657,0.0882668204374114,0.00879300111229139,0.0710325382573203,0.105501102617503,1.30539756173437e-23
NMR metabolomics,X23412.Phospholipids in VLDL,CD5,T-cell surface glycoprotein CD5,42239,0.0366503218366273,0.003652676323644,0.029491076242285,0.0438095674309695,1.3069644590994e-23
NMR metabolomics,X23412.Phospholipids in VLDL,NBN,Nibrin,41913,0.0559891542329945,0.00558518812066417,0.0450421855164927,0.0669361229494963,1.44089090568054e-23
NMR metabolomics,X23412.Phospholipids in VLDL,TNFSF14,Tumor necrosis factor ligand superfamily member 14,42016,0.0594038371247932,0.00592856455134495,0.0477838506041571,0.0710238236454293,1.50745221954647e-23
NMR metabolomics,X23412.Phospholipids in VLDL,GP5,Platelet glycoprotein V,39736,0.0377965090867906,0.00377139491034728,0.0304045750625099,0.0451884431110713,1.53665638072048e-23
NMR metabolomics,X23412.Phospholipids in VLDL,GSR,"Glutathione reductase, mitochondrial",39949,0.0236649231503142,0.00236145961816846,0.019036462298704,0.0282933840019243,1.53900456775034e-23
NMR metabolomics,X23412.Phospholipids in VLDL,DYNLT3,Dynein light chain Tctex-type 3,39919,0.0452097748794889,0.00451466826759379,0.0363610250750051,0.0540585246839727,1.6574721129228e-23
NMR metabolomics,X23412.Phospholipids in VLDL,PRDX5,"Peroxiredoxin-5, mitochondrial",42296,0.0678915787031148,0.00678385128890079,0.0545952301768693,0.0811879272293604,1.69578042474784e-23
NMR metabolomics,X23412.Phospholipids in VLDL,GBP1,Guanylate-binding protein 1,39911,0.0665408555424524,0.00665746078826288,0.0534922323974572,0.0795894786874477,2.00604297900303e-23
NMR metabolomics,X23412.Phospholipids in VLDL,F2R,Proteinase-activated receptor 1,42166,0.0587546955679939,0.00588337765460326,0.0472232753649715,0.0702861157710163,2.10225321842669e-23
NMR metabolomics,X23412.Phospholipids in VLDL,MCFD2,Multiple coagulation factor deficiency protein 2,42062,0.0465301800269607,0.00466173629399754,0.0373931768907255,0.0556671831631959,2.21906569673996e-23
NMR metabolomics,X23412.Phospholipids in VLDL,FGF23,Fibroblast growth factor 23,42250,0.0517326092638225,0.00519047760973169,0.0415592731487484,0.0619059453788966,2.55791946932846e-23
NMR metabolomics,X23412.Phospholipids in VLDL,PEBP1,Phosphatidylethanolamine-binding protein 1,42137,0.0569990205453463,0.00572918099562274,0.0457698257939257,0.0682282152967668,3.06414663560481e-23
NMR metabolomics,X23412.Phospholipids in VLDL,ARFIP1,Arfaptin-1,39934,0.0709148493090898,0.00712764740992177,0.0569446603856431,0.0848850382325365,3.16320653230708e-23
NMR metabolomics,X23412.Phospholipids in VLDL,IFT20,Intraflagellar transport protein 20 homolog,39649,0.0446576844762071,0.0044899329197158,0.0358574159535641,0.05345795299885,3.28022563620391e-23
NMR metabolomics,X23412.Phospholipids in VLDL,INSL3,Insulin-like 3,39929,0.0921535886828347,0.00927371702941846,0.0739771033051745,0.110330074060495,3.57177665550816e-23
NMR metabolomics,X23412.Phospholipids in VLDL,SCRIB,Protein scribble homolog,39638,0.0896522372036134,0.0090259682897757,0.071961339355653,0.107343135051574,3.75186603208921e-23
NMR metabolomics,X23412.Phospholipids in VLDL,GGACT,Gamma-glutamylaminecyclotransferase,39958,0.0726097571460174,0.00731223933467877,0.0582777680500471,0.0869417462419878,3.83396813397626e-23
NMR metabolomics,X23412.Phospholipids in VLDL,ROBO2,Roundabout homolog 2,42249,0.0230645549915585,0.00232447360520917,0.0185085867253486,0.0276205232577685,3.98036137484005e-23
NMR metabolomics,X23412.Phospholipids in VLDL,MZT1,Mitotic-spindle organizing protein 1,41843,0.0535559842461954,0.00539723968009456,0.0429773944732101,0.0641345740191808,3.98793022362896e-23
NMR metabolomics,X23412.Phospholipids in VLDL,CD72,B-cell differentiation antigen CD72,39736,0.0444208478186702,0.004477195959435,0.0356455437381776,0.0531961518991628,4.18217695964117e-23
NMR metabolomics,X23412.Phospholipids in VLDL,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,39930,0.0655065964010239,0.00661101950435776,0.0525489981724827,0.0784641946295651,4.73481730801541e-23
NMR metabolomics,X23412.Phospholipids in VLDL,ECHS1,"Enoyl-CoA hydratase, mitochondrial",39638,0.0989073447217896,0.00998728161007317,0.0793322727660461,0.118482416677533,5.02212552411301e-23
NMR metabolomics,X23412.Phospholipids in VLDL,DXO,Decapping and exoribonuclease protein,39929,0.0462176551295377,0.00466824478981234,0.0370678953415055,0.0553674149175699,5.1392678657726e-23
NMR metabolomics,X23412.Phospholipids in VLDL,FAS,Tumor necrosis factor receptor superfamily member 6,42272,0.0337654529838936,0.00341676625599726,0.027068591122139,0.0404623148456483,5.93151876401975e-23
NMR metabolomics,X23412.Phospholipids in VLDL,KLK7,Kallikrein-7,39475,0.0403400329915762,0.00408202775764642,0.0323392585865892,0.0483408073965632,6.20212216137709e-23
NMR metabolomics,X23412.Phospholipids in VLDL,CDNF,Cerebral dopamine neurotrophic factor,42070,0.0332595196473706,0.0033678817141323,0.0266584714876713,0.0398605678070699,6.3605370453375e-23
NMR metabolomics,X23412.Phospholipids in VLDL,DCTN6,Dynactin subunit 6,41839,0.073123623964992,0.00741318321310644,0.0585937848673034,0.0876534630626807,7.14965431701691e-23
NMR metabolomics,X23412.Phospholipids in VLDL,MDH1,"Malate dehydrogenase, cytoplasmic",39950,0.0398010425245285,0.00403934772459641,0.0318839209843195,0.0477181640647374,8.18577836347549e-23
NMR metabolomics,X23412.Phospholipids in VLDL,BDNF,Brain-derived neurotrophic factor,39966,0.085164937832461,0.00864572584959087,0.0682193151672629,0.102110560497659,8.41336715291255e-23
NMR metabolomics,X23412.Phospholipids in VLDL,FABP4,"Fatty acid-binding protein, adipocyte",42310,0.0509051056185204,0.00517059708732495,0.0407707353273635,0.0610394759096773,8.56366952196582e-23
NMR metabolomics,X23412.Phospholipids in VLDL,PTP4A3,Protein tyrosine phosphatase type IVA 3,39657,0.0523512952266115,0.00531601596129283,0.0419319039424775,0.0627706865107454,8.68938048368933e-23
NMR metabolomics,X23412.Phospholipids in VLDL,EGFL7,Epidermal growth factor-like protein 7,41843,0.039186239953563,0.0039832943554709,0.0313789830168401,0.046993496890286,9.27490311292494e-23
NMR metabolomics,X23412.Phospholipids in VLDL,ARHGAP1,Rho GTPase-activating protein 1,41843,0.047056983837872,0.00478417980194304,0.0376799914260636,0.0564339762496803,9.43078782863427e-23
NMR metabolomics,X23412.Phospholipids in VLDL,AKR1B1,Aldo-keto reductase family 1 member B1,41843,0.0749346823400159,0.0076238830440281,0.0599918715737208,0.0898774931063109,1.0106419598005e-22
NMR metabolomics,X23412.Phospholipids in VLDL,NPDC1,Neural proliferation differentiation and control protein 1,42145,0.0335635017468726,0.00341537737151576,0.0268693620987017,0.0402576413950435,1.02432251576274e-22
NMR metabolomics,X23412.Phospholipids in VLDL,FXYD5,FXYD domain-containing ion transport regulator 5,41913,0.0656946732188843,0.00669128550504651,0.0525797536289931,0.0788095928087754,1.12520029050437e-22
NMR metabolomics,X23412.Phospholipids in VLDL,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,39638,0.0539426165031711,0.00549566290464348,0.0431711172100699,0.0647141157962724,1.19533710652581e-22
NMR metabolomics,X23412.Phospholipids in VLDL,LGALS9,Galectin-9,42129,0.031636136188622,0.00322466086451983,0.0253158008941631,0.0379564714830809,1.20514535655726e-22
NMR metabolomics,X23412.Phospholipids in VLDL,B4GAT1,"Beta-1,4-glucuronyltransferase 1",42137,0.024240050390898,0.00247443078873021,0.0193901660449868,0.0290899347368092,1.38933518064643e-22
NMR metabolomics,X23412.Phospholipids in VLDL,CCL2,C-C motif chemokine 2,41992,0.0522076055806694,0.00532960460169545,0.0417615805613464,0.0626536305999925,1.39792913282966e-22
NMR metabolomics,X23412.Phospholipids in VLDL,UNC79,Protein unc-79 homolog,39560,0.056370474291727,0.00575352929837764,0.0450935568669069,0.0676473917165472,1.42779070740673e-22
NMR metabolomics,X23412.Phospholipids in VLDL,GP6,Platelet glycoprotein VI,42115,0.0886038474132319,0.00905136003177378,0.0708631817509554,0.106344513075509,1.49162278444354e-22
NMR metabolomics,X23412.Phospholipids in VLDL,CDC26,Anaphase-promoting complex subunit CDC26,39911,0.0707778073298368,0.00722900504938079,0.0566089574330505,0.0849466572266231,1.51536195733258e-22
NMR metabolomics,X23412.Phospholipids in VLDL,LGALS4,Galectin-4,42123,-0.0565086841707454,0.00579346292514239,-0.0678638715040245,-0.0451534968374663,2.10479156006418e-22
NMR metabolomics,X23412.Phospholipids in VLDL,FRZB,Secreted frizzled-related protein 3,41973,0.0247353704498405,0.00253746312269669,0.019761942729355,0.029708798170326,2.23187232321059e-22
NMR metabolomics,X23412.Phospholipids in VLDL,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,42249,-0.046626866413073,0.0047854472890584,-0.0560063430996275,-0.0372473897265185,2.3265075815978e-22
NMR metabolomics,X23412.Phospholipids in VLDL,DNER,Delta and Notch-like epidermal growth factor-related receptor,42089,0.025986005009449,0.00266896668240478,0.0207548303119356,0.0312171797069623,2.49900269018522e-22
NMR metabolomics,X23412.Phospholipids in VLDL,SRC,Proto-oncogene tyrosine-protein kinase Src,42166,0.119270708217465,0.0122637648270745,0.0952337291563992,0.143307687278531,2.77690549958796e-22
NMR metabolomics,X23412.Phospholipids in VLDL,MMP7,Matrilysin,41881,0.0518195864125187,0.00532961649168138,0.0413735380888232,0.0622656347362142,2.85588210070559e-22
NMR metabolomics,X23412.Phospholipids in VLDL,BTC,Probetacellulin,41843,0.0732140241608972,0.00753578219769029,0.0584438910534242,0.0879841572683702,3.07198507537671e-22
NMR metabolomics,X23412.Phospholipids in VLDL,RGS10,Regulator of G-protein signaling 10,39934,0.0594710972584548,0.00612894285119533,0.0474583692701119,0.0714838252467976,3.5595210412286e-22
NMR metabolomics,X23412.Phospholipids in VLDL,ABHD14B,Protein ABHD14B,41976,0.0557201892083381,0.00574506466379645,0.0444598624672971,0.0669805159493792,3.60934649714527e-22
NMR metabolomics,X23412.Phospholipids in VLDL,C5,Complement C5,39979,0.0150010218874849,0.00154988670173853,0.0119632439520774,0.0180387998228924,4.5137264399548e-22
NMR metabolomics,X23412.Phospholipids in VLDL,DNAJC9,DnaJ homolog subfamily C member 9,39930,0.0752766800551228,0.0077796916759634,0.0600284843702345,0.090524875740011,4.63904481871094e-22
NMR metabolomics,X23412.Phospholipids in VLDL,PROK1,Prokineticin-1,42119,0.0493260026626871,0.00510667194453851,0.0393169256513917,0.0593350796739826,5.2962665586751e-22
NMR metabolomics,X23412.Phospholipids in VLDL,SOD1,Superoxide dismutase [Cu-Zn],41874,0.0469649870570167,0.00486655606510376,0.0374265371694133,0.05650343694462,5.77209508345956e-22
NMR metabolomics,X23412.Phospholipids in VLDL,TREM2,Triggering receptor expressed on myeloid cells 2,42123,0.0535074615731101,0.00554770512737699,0.0426339595234512,0.064380963622769,6.07442574018437e-22
NMR metabolomics,X23412.Phospholipids in VLDL,SLMAP,Sarcolemmal membrane-associated protein,39930,0.0828587098124876,0.00859875005815385,0.0660051596985061,0.0997122599264691,6.82642814567694e-22
NMR metabolomics,X23412.Phospholipids in VLDL,CCDC134,Coiled-coil domain-containing protein 134,39919,0.0479165890420368,0.00498080977800776,0.0381542018771416,0.057678976206932,7.95956644178272e-22
NMR metabolomics,X23412.Phospholipids in VLDL,SH3BP1,SH3 domain-binding protein 1,39930,0.0489703467705083,0.0050909976438541,0.0389919913885543,0.0589487021524623,8.05325366182448e-22
NMR metabolomics,X23412.Phospholipids in VLDL,PAGR1,PAXIP1-associated glutamate-rich protein 1,39638,0.041990289334222,0.00436926647800277,0.0334265270373365,0.0505540516311074,8.79612255857739e-22
NMR metabolomics,X23412.Phospholipids in VLDL,ACYP1,Acylphosphatase-1,39701,0.0644018297879095,0.00670917509911944,0.0512518465936354,0.0775518129821836,9.79673820831403e-22
NMR metabolomics,X23412.Phospholipids in VLDL,TSNAX,Translin-associated protein X,39575,0.0388726923246572,0.0040507194542258,0.0309332821943746,0.0468121024549397,1.00649533993067e-21
NMR metabolomics,X23412.Phospholipids in VLDL,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,42119,0.0600972762858033,0.00626502659746719,0.0478178241547676,0.072376728416839,1.00816154228085e-21
NMR metabolomics,X23412.Phospholipids in VLDL,PCYT2,Ethanolamine-phosphate cytidylyltransferase,39930,0.074820707176255,0.00780733136853363,0.0595183376939291,0.0901230766585809,1.13462516596232e-21
NMR metabolomics,X23412.Phospholipids in VLDL,FADD,FAS-associated death domain protein,42145,0.0749035765596958,0.0078350354801808,0.0595469070185415,0.0902602461008502,1.37642910170708e-21
NMR metabolomics,X23412.Phospholipids in VLDL,DBI,Acyl-CoA-binding protein,42085,0.0764695501248388,0.00800242796091009,0.0607847913214551,0.0921543089282226,1.4352362425046e-21
NMR metabolomics,X23412.Phospholipids in VLDL,DDT,D-dopachrome decarboxylase,39966,0.0400314222779764,0.00418993613246497,0.0318191474583451,0.0482436970976078,1.50066353950423e-21
NMR metabolomics,X23412.Phospholipids in VLDL,ITGB6,Integrin beta-6,41913,0.0301684901619737,0.00315868850039669,0.0239774607011962,0.0363595196227512,1.50645553845395e-21
NMR metabolomics,X23412.Phospholipids in VLDL,BPIFA2,BPI fold-containing family A member 2,39281,-0.10894386139623,0.0114363288157807,-0.13135906587516,-0.0865286569172994,1.98595737989773e-21
NMR metabolomics,X23412.Phospholipids in VLDL,LAMA4,Laminin subunit alpha-4,42185,0.0333529920351575,0.00351378026587774,0.0264659827140371,0.0402400013562778,2.63718036502488e-21
NMR metabolomics,X23412.Phospholipids in VLDL,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,41843,0.0560583127626171,0.00592034702137749,0.0444544326007173,0.067662192924517,3.3049028778442e-21
NMR metabolomics,X23412.Phospholipids in VLDL,DEFB103A_DEFB103B,Beta-defensin 103,39596,0.0406214716948893,0.0042894190898827,0.0322142102787192,0.0490287331110594,3.36516816484127e-21
NMR metabolomics,X23412.Phospholipids in VLDL,MSR1,Macrophage scavenger receptor types I and II,42249,0.0459441856952848,0.00485812604107855,0.0364222586547708,0.0554661127357988,3.67227915514313e-21
NMR metabolomics,X23412.Phospholipids in VLDL,SPINT2,Kunitz-type protease inhibitor 2,42185,0.0383535041045836,0.00405575608158606,0.0304042221846749,0.0463027860244922,3.69661923230242e-21
NMR metabolomics,X23412.Phospholipids in VLDL,CCN4,CCN family member 4,42262,0.0379706116810422,0.00401874059574679,0.0300938801133785,0.0458473432487059,3.99159510349663e-21
NMR metabolomics,X23412.Phospholipids in VLDL,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",42119,0.0801359570556966,0.00849456661106932,0.0634866064980007,0.0967853076133924,4.59126529484778e-21
NMR metabolomics,X23412.Phospholipids in VLDL,LRP11,Low-density lipoprotein receptor-related protein 11,42145,0.0358429268718279,0.00380171527501899,0.0283915649327907,0.0432942888108651,4.84443562031224e-21
NMR metabolomics,X23412.Phospholipids in VLDL,AK2,"Adenylate kinase 2, mitochondrial",39929,0.103962639522443,0.0110366170354029,0.0823308701330533,0.125594408911833,5.39350402251043e-21
NMR metabolomics,X23412.Phospholipids in VLDL,KLF4,Krueppel-like factor 4,39586,0.0393280290095657,0.00418230041607271,0.0311307201940632,0.0475253378250683,6.32809605514911e-21
NMR metabolomics,X23412.Phospholipids in VLDL,IFNAR1,Interferon alpha/beta receptor 1,39930,0.0237866780999636,0.00253440007307842,0.0188192539567299,0.0287541022431973,7.45150225870002e-21
NMR metabolomics,X23412.Phospholipids in VLDL,OPLAH,5-oxoprolinase,39638,0.0671650552766748,0.00715806814819661,0.0531352417062095,0.0811948688471402,7.65679109204274e-21
NMR metabolomics,X23412.Phospholipids in VLDL,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,39930,0.0473432031558104,0.00505079834157782,0.0374436384063178,0.0572427679053029,8.3514723067784e-21
NMR metabolomics,X23412.Phospholipids in VLDL,DSC2,Desmocollin-2,41984,-0.0338655341208469,0.00361594142422842,-0.0409527793123346,-0.0267782889293592,8.75193663390307e-21
NMR metabolomics,X23412.Phospholipids in VLDL,ING1,Inhibitor of growth protein 1,41820,0.0458378016732684,0.0048953405888531,0.0362429341191163,0.0554326692274204,8.93957878905104e-21
NMR metabolomics,X23412.Phospholipids in VLDL,CPXM1,Probable carboxypeptidase X1,42181,0.065971449668329,0.00706582637434636,0.0521224299746102,0.0798204693620479,1.14609203442292e-20
NMR metabolomics,X23412.Phospholipids in VLDL,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,42231,0.0292413077805311,0.0031341457406555,0.0230983821288463,0.0353842334322159,1.22069065732136e-20
NMR metabolomics,X23412.Phospholipids in VLDL,PCDH7,Protocadherin-7,39930,0.0335322559902038,0.00359519707518208,0.0264856697228469,0.0405788422575606,1.29133038300893e-20
NMR metabolomics,X23412.Phospholipids in VLDL,LAP3,Cytosol aminopeptidase,41913,0.0459489460349373,0.00493605357258285,0.0362742810326749,0.0556236110371997,1.49193232970657e-20
NMR metabolomics,X23412.Phospholipids in VLDL,DNM1,Dynamin-1,39930,0.11070342067003,0.0119219846666826,0.0873363307233325,0.134070510616728,1.89926201069568e-20
NMR metabolomics,X23412.Phospholipids in VLDL,CPA1,Carboxypeptidase A1,42310,0.0616897890195981,0.00665105814801629,0.0486537150494862,0.07472586298971,2.03449735131019e-20
NMR metabolomics,X23412.Phospholipids in VLDL,RAB10,Ras-related protein Rab-10,39958,0.0509504321608967,0.00550618782623629,0.0401583040214736,0.0617425603003198,2.56523952112697e-20
NMR metabolomics,X23412.Phospholipids in VLDL,TBCA,Tubulin-specific chaperone A,39736,0.0800760445830232,0.00866923821801459,0.0630843376757146,0.0970677514903318,2.99947729854475e-20
NMR metabolomics,X23412.Phospholipids in VLDL,VGF,Neurosecretory protein VGF,39934,0.0287005319083322,0.0031082179778417,0.0226084246717625,0.034792639144902,3.07645574134126e-20
NMR metabolomics,X23412.Phospholipids in VLDL,BST2,Bone marrow stromal antigen 2,42249,0.0483511108859863,0.00523918900653977,0.0380823004331683,0.0586199213388042,3.13542207585049e-20
NMR metabolomics,X23412.Phospholipids in VLDL,LAMB1,Laminin subunit beta-1,39638,0.0298756347623763,0.00323632591604089,0.0235324359669362,0.0362188335578165,3.15980830623567e-20
NMR metabolomics,X23412.Phospholipids in VLDL,LRRC37A2,Leucine-rich repeat-containing protein 37A2,39930,0.041570587981725,0.00450999640722955,0.032730995023555,0.0504101809398949,3.5788406896392e-20
NMR metabolomics,X23412.Phospholipids in VLDL,CRIM1,Cysteine-rich motor neuron 1 protein,42185,-0.0192855640110341,0.00209370222785696,-0.0233892203776337,-0.0151819076444344,3.69033367453245e-20
NMR metabolomics,X23412.Phospholipids in VLDL,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,41843,0.0410474095830985,0.00446840769838197,0.0322893304942698,0.0498054886719271,4.66994975171388e-20
NMR metabolomics,X23412.Phospholipids in VLDL,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,39641,0.0342701818221287,0.00373220983268664,0.0269550505500629,0.0415853130941945,4.97259889729262e-20
NMR metabolomics,X23412.Phospholipids in VLDL,CARHSP1,Calcium-regulated heat-stable protein 1,41839,0.0468353406664629,0.00510970266499795,0.0368203234430669,0.0568503578898589,5.62538995056356e-20
NMR metabolomics,X23412.Phospholipids in VLDL,PARD3,Partitioning defective 3 homolog,39757,0.0699969691030656,0.00764696564325532,0.0550089164422852,0.084985021763846,6.46609744400761e-20
NMR metabolomics,X23412.Phospholipids in VLDL,PTPRR,Receptor-type tyrosine-protein phosphatase R,39929,0.0356412441886513,0.00389592991080868,0.0280052215634663,0.0432772668138363,6.76827542128574e-20
NMR metabolomics,X23412.Phospholipids in VLDL,STX16,Syntaxin-16,41843,0.0534962895586718,0.00586478546628355,0.0420013100447561,0.0649912690725876,8.45666721909902e-20
NMR metabolomics,X23412.Phospholipids in VLDL,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",42070,0.032264401078851,0.00353928484764563,0.0253274027774655,0.0392013993802364,8.87677555454379e-20
NMR metabolomics,X23412.Phospholipids in VLDL,MTIF3,"Translation initiation factor IF-3, mitochondrial",39930,0.0828501201548943,0.00910855570906689,0.0649973509651232,0.100702889344665,1.09459164304296e-19
NMR metabolomics,X23412.Phospholipids in VLDL,SLAMF6,SLAM family member 6,41843,0.0361238682727398,0.00397303529572176,0.0283367190931251,0.0439110174523544,1.1064250345799e-19
NMR metabolomics,X23412.Phospholipids in VLDL,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,39575,0.0262753483146606,0.00290339575536131,0.0205846926341524,0.0319660039951687,1.67262790991522e-19
NMR metabolomics,X23412.Phospholipids in VLDL,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,42217,0.039712607399234,0.00440146491039644,0.0310857361748569,0.048339478623611,2.07978391798876e-19
NMR metabolomics,X23412.Phospholipids in VLDL,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",39958,0.0707463141154985,0.00784915407859573,0.0553619721214509,0.0861306561095461,2.31995050832625e-19
NMR metabolomics,X23412.Phospholipids in VLDL,AMOTL2,Angiomotin-like protein 2,39882,0.0453544016111658,0.00503222418889089,0.0354912422009396,0.0552175610213919,2.33165971363485e-19
NMR metabolomics,X23412.Phospholipids in VLDL,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,39934,0.0610411676048531,0.00677381686940344,0.0477644865408223,0.0743178486688838,2.36096007004259e-19
NMR metabolomics,X23412.Phospholipids in VLDL,LGALS3BP,Galectin-3-binding protein,39979,0.0290254880366027,0.00322274960305911,0.0227088988146069,0.0353420772585986,2.46669722243464e-19
NMR metabolomics,X23412.Phospholipids in VLDL,SCARF1,Scavenger receptor class F member 1,42310,0.0392443867614452,0.00436820160303733,0.030682711619492,0.0478060619033984,2.94470901237543e-19
NMR metabolomics,X23412.Phospholipids in VLDL,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,39757,0.0806737573292195,0.00897680585328943,0.0630792178567722,0.0982682968016668,2.95144822155467e-19
NMR metabolomics,X23412.Phospholipids in VLDL,FGF2,Fibroblast growth factor 2,42119,0.0637764527270809,0.00710020117686757,0.0498600584204205,0.0776928470337413,2.99707898880704e-19
NMR metabolomics,X23412.Phospholipids in VLDL,CCL19,C-C motif chemokine 19,42249,0.104204989311975,0.0116034663663651,0.0814621952338993,0.12694778339005,3.04376129647025e-19
NMR metabolomics,X23412.Phospholipids in VLDL,MAGED1,Melanoma-associated antigen D1,41843,0.0445134318132511,0.00495930552369555,0.0347931929868078,0.0542336706396943,3.18946951139727e-19
NMR metabolomics,X23412.Phospholipids in VLDL,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,42262,0.024458954077144,0.00272729256157555,0.0191134606564559,0.0298044474978321,3.4005301150668e-19
NMR metabolomics,X23412.Phospholipids in VLDL,GFRA1,GDNF family receptor alpha-1,42247,0.026300822527421,0.00293378634548911,0.0205506012902623,0.0320510437645796,3.50733309359071e-19
NMR metabolomics,X23412.Phospholipids in VLDL,ENAH,Protein enabled homolog,41913,0.0444270845876337,0.00495564575452547,0.0347140189087638,0.0541401502665036,3.51354047827831e-19
NMR metabolomics,X23412.Phospholipids in VLDL,LONP1,"Lon protease homolog, mitochondrial",39638,0.0811084694044223,0.00905256196014478,0.0633654479625385,0.098851490846306,3.77731025719951e-19
NMR metabolomics,X23412.Phospholipids in VLDL,VIT,Vitrin,39958,0.035470982196331,0.00395996196129118,0.0277094567522003,0.0432325076404617,3.84099942159839e-19
NMR metabolomics,X23412.Phospholipids in VLDL,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",42181,-0.0323029344940557,0.00360760534221859,-0.0393738409648042,-0.0252320280233073,3.86421771324707e-19
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,42144,0.0290249975147192,0.00324280684604884,0.0226690960964635,0.035380898932975,3.99082408632993e-19
NMR metabolomics,X23412.Phospholipids in VLDL,COL15A1,Collagen alpha-1(XV) chain,39966,0.0249011972053883,0.00278266748687002,0.0194471689311231,0.0303552254796535,4.15434298499738e-19
NMR metabolomics,X23412.Phospholipids in VLDL,LTBP2,Latent-transforming growth factor beta-binding protein 2,42310,-0.0294979266184379,0.00329820490940389,-0.0359624082408695,-0.0230334449960063,4.24225796110788e-19
NMR metabolomics,X23412.Phospholipids in VLDL,ENO2,Gamma-enolase,42249,0.0597512992582476,0.00669043072650266,0.0466380550343024,0.0728645434821928,4.76112843821813e-19
NMR metabolomics,X23412.Phospholipids in VLDL,CORO1A,Coronin-1A,41883,0.0814681213509445,0.00912284138604436,0.0635873522342976,0.0993488904675915,4.8083108981677e-19
NMR metabolomics,X23412.Phospholipids in VLDL,CLU,Clusterin,39979,0.0277344557187481,0.00310646487068395,0.0216457845722075,0.0338231268652886,5.00260494246401e-19
NMR metabolomics,X23412.Phospholipids in VLDL,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",41913,0.0662318644637936,0.0074206552572535,0.0516873801595768,0.0807763487680105,5.01820406261171e-19
NMR metabolomics,X23412.Phospholipids in VLDL,PVR,Poliovirus receptor,42249,0.0342246940503263,0.00384266955715219,0.026693061718308,0.0417563263823446,5.92531218483838e-19
NMR metabolomics,X23412.Phospholipids in VLDL,DNAJC21,DnaJ homolog subfamily C member 21,39929,0.0361821662038769,0.00406198819056715,0.0282206693503653,0.0441436630573885,6.01440306228255e-19
NMR metabolomics,X23412.Phospholipids in VLDL,TCOF1,Treacle protein,39958,0.0297803489835447,0.00334366223159292,0.0232267710096226,0.0363339269574668,6.06605157203169e-19
NMR metabolomics,X23412.Phospholipids in VLDL,IGF1R,Insulin-like growth factor 1 receptor,42070,0.0196175338387341,0.00220395132221051,0.0152977892472015,0.0239372784302667,6.22960546530462e-19
NMR metabolomics,X23412.Phospholipids in VLDL,ZHX2,Zinc fingers and homeoboxes protein 2,39929,0.0309841367978214,0.00348214695670713,0.0241591287626754,0.0378091448329674,6.5483399118349e-19
NMR metabolomics,X23412.Phospholipids in VLDL,MCEMP1,Mast cell-expressed membrane protein 1,39657,0.0812403708451902,0.00914156359465427,0.0633229061996678,0.0991578354907126,7.25477846215143e-19
NMR metabolomics,X23412.Phospholipids in VLDL,RARRES1,Retinoic acid receptor responder protein 1,41843,0.0287845274223163,0.00324959482794082,0.0224153215595523,0.0351537332850803,9.18265486284761e-19
NMR metabolomics,X23412.Phospholipids in VLDL,IL17D,Interleukin-17D,41913,0.0310515727735245,0.00350626735925885,0.0241792887493772,0.0379238567976718,9.33057011262225e-19
NMR metabolomics,X23412.Phospholipids in VLDL,BOLA2_BOLA2B,BolA-like protein 2,39638,0.0480647781147875,0.00544244724188935,0.0373975815206843,0.0587319747088906,1.18914871192435e-18
NMR metabolomics,X23412.Phospholipids in VLDL,CHGA,Chromogranin-A,39966,-0.0773028901614953,0.00876048702215254,-0.0944734447249143,-0.0601323355980763,1.265039385939e-18
NMR metabolomics,X23412.Phospholipids in VLDL,PPM1F,Protein phosphatase 1F,39958,0.0484897412913967,0.00549686408492694,0.0377158876849399,0.0592635948978535,1.29576515009152e-18
NMR metabolomics,X23412.Phospholipids in VLDL,PECAM1,Platelet endothelial cell adhesion molecule,42137,0.0274060582688366,0.00310771974055854,0.0213149275773418,0.0334971889603313,1.29790285501875e-18
NMR metabolomics,X23412.Phospholipids in VLDL,PALM2,Paralemmin-2,39929,0.0352175948876862,0.00399616037431769,0.0273851205540235,0.0430500692213489,1.39753553869751e-18
NMR metabolomics,X23412.Phospholipids in VLDL,ANGPTL7,Angiopoietin-related protein 7,42262,0.0332631607605248,0.00377776788085254,0.0258587357140539,0.0406675858069958,1.46446140510311e-18
NMR metabolomics,X23412.Phospholipids in VLDL,TSHB,Thyrotropin subunit beta,42145,0.0615787629540342,0.00699588788130575,0.047866822706675,0.0752907032013935,1.50325329131485e-18
NMR metabolomics,X23412.Phospholipids in VLDL,EPPK1,Epiplakin,39638,0.0672548622682214,0.00763877700750038,0.0522828593335206,0.0822268652029221,1.51161113391313e-18
NMR metabolomics,X23412.Phospholipids in VLDL,SNX9,Sorting nexin-9,42145,0.0614085827382261,0.00698189141515711,0.0477240755645181,0.075093089911934,1.59559105639765e-18
NMR metabolomics,X23412.Phospholipids in VLDL,ANXA2,Annexin A2,39492,0.0639653871844066,0.00727507058519808,0.0497062488374184,0.0782245255313948,1.68393620114584e-18
NMR metabolomics,X23412.Phospholipids in VLDL,IL10RB,Interleukin-10 receptor subunit beta,42185,0.0268967939606821,0.00306224077978059,0.0208948020323121,0.032898785889052,1.77437539213791e-18
NMR metabolomics,X23412.Phospholipids in VLDL,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,39575,0.0362321542140968,0.00414225637027623,0.0281133317283554,0.0443509766998383,2.51150272231093e-18
NMR metabolomics,X23412.Phospholipids in VLDL,DPT,Dermatopontin,42310,0.0228308236468425,0.00261137597666799,0.0177125267325732,0.0279491205611118,2.53494428889474e-18
NMR metabolomics,X23412.Phospholipids in VLDL,LEPR,Leptin receptor,42145,-0.028204668903384,0.0032297142561371,-0.0345349088454127,-0.0218744289613553,2.77092411755887e-18
NMR metabolomics,X23412.Phospholipids in VLDL,IFNGR2,Interferon gamma receptor 2,42016,0.0473369567620233,0.00542783799536883,0.0366983942911004,0.0579755192329462,3.07490601153724e-18
NMR metabolomics,X23412.Phospholipids in VLDL,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,39979,0.0220567773049442,0.00252871962412803,0.0171004868416532,0.0270130677682351,3.09858504449749e-18
NMR metabolomics,X23412.Phospholipids in VLDL,TMSB10,Thymosin beta-10,42137,0.0681220762119411,0.00781326518558377,0.0528080764481969,0.0834360759756853,3.13655991044101e-18
NMR metabolomics,X23412.Phospholipids in VLDL,CDCP1,CUB domain-containing protein 1,42016,0.0500717596136381,0.00575767816986805,0.0387867104006967,0.0613568088265794,3.81622731387743e-18
NMR metabolomics,X23412.Phospholipids in VLDL,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",41900,0.0795414624536233,0.00914878195769085,0.0616098498165492,0.0974730750906974,3.89776895901311e-18
NMR metabolomics,X23412.Phospholipids in VLDL,SLIT2,Slit homolog 2 protein,41839,0.0461429996372443,0.00530749305039594,0.0357403132584683,0.0565456860160204,3.90925113548259e-18
NMR metabolomics,X23412.Phospholipids in VLDL,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,39657,0.0414599657750924,0.00477194721663628,0.0321069492304853,0.0508129823196995,4.19774512203167e-18
NMR metabolomics,X23412.Phospholipids in VLDL,GZMA,Granzyme A,42296,0.0302924698872136,0.00348831461376607,0.0234553732442321,0.0371295665301951,4.24938840839593e-18
NMR metabolomics,X23412.Phospholipids in VLDL,ECE1,Endothelin-converting enzyme 1,41839,0.0315046540544469,0.0036305788571275,0.0243887194944769,0.0386205886144168,4.51039377154124e-18
NMR metabolomics,X23412.Phospholipids in VLDL,CTSZ,Cathepsin Z,42168,0.0287359085121375,0.0033163725985539,0.0222358182189719,0.0352359988053032,5.02727396010362e-18
NMR metabolomics,X23412.Phospholipids in VLDL,ITGAL,Integrin alpha-L,39657,0.0390839691584189,0.00450957376254725,0.0302452045838263,0.0479227337330115,5.05928554362824e-18
NMR metabolomics,X23412.Phospholipids in VLDL,IMPA1,Inositol monophosphatase 1,42016,0.054400102870447,0.00628563250515729,0.0420802631603387,0.0667199425805553,5.50107069427719e-18
NMR metabolomics,X23412.Phospholipids in VLDL,NGRN,Neugrin,39929,0.0200041219488662,0.00231152437751861,0.0154735341689297,0.0245347097288027,5.63903543995133e-18
NMR metabolomics,X23412.Phospholipids in VLDL,C7orf50,Uncharacterized protein C7orf50,39929,0.020334933739463,0.00235039436237175,0.0157281607892144,0.0249417066897116,5.75666157469167e-18
NMR metabolomics,X23412.Phospholipids in VLDL,CCN5,CCN family member 5,42137,0.0337568774757378,0.00390342557721675,0.0261061633443929,0.0414075916070826,5.82433621256052e-18
NMR metabolomics,X23412.Phospholipids in VLDL,SDK2,Protein sidekick-2,39736,0.0351253612412107,0.00406070240160503,0.0271663845340649,0.0430843379483566,5.85223825027212e-18
NMR metabolomics,X23412.Phospholipids in VLDL,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",39736,0.0795512448580163,0.00920990263561593,0.0614998356922091,0.0976026540238236,6.52402921753975e-18
NMR metabolomics,X23412.Phospholipids in VLDL,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,42145,0.0556399229894678,0.0064468434784774,0.0430041097716521,0.0682757362072835,6.77899822349366e-18
NMR metabolomics,X23412.Phospholipids in VLDL,SCRN1,Secernin-1,42119,0.0490968981896165,0.00568939450222228,0.0379456849652608,0.0602481114139721,6.84082943797156e-18
NMR metabolomics,X23412.Phospholipids in VLDL,IL6R,Interleukin-6 receptor subunit alpha,42114,0.0302652471234489,0.00350806433795043,0.023389441021066,0.0371410532258317,6.97391625409315e-18
NMR metabolomics,X23412.Phospholipids in VLDL,CYB5R2,NADH-cytochrome b5 reductase 2,39803,0.0498263723474229,0.00578204042783866,0.0384935731088592,0.0611591715859867,7.76479183257226e-18
NMR metabolomics,X23412.Phospholipids in VLDL,TIMP1,Metalloproteinase inhibitor 1,42032,0.0254901614457415,0.00295928350872192,0.0196899657686465,0.0312903571228365,7.86078048395382e-18
NMR metabolomics,X23412.Phospholipids in VLDL,DHPS,Deoxyhypusine synthase,39919,0.0357350535017577,0.00415148619245644,0.0275981405645431,0.0438719664389724,8.43248727706915e-18
NMR metabolomics,X23412.Phospholipids in VLDL,PTX3,Pentraxin-related protein PTX3,42119,-0.0439436303997032,0.00511097550126281,-0.0539611423821783,-0.0339261184172281,9.00361217121481e-18
NMR metabolomics,X23412.Phospholipids in VLDL,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,42016,0.0323337403024314,0.00376410113139526,0.0249561020848967,0.0397113785199661,9.64584963772327e-18
NMR metabolomics,X23412.Phospholipids in VLDL,ADGRG2,Adhesion G-protein coupled receptor G2,42145,0.0238357784154812,0.00277579032817733,0.0183952293722537,0.0292763274587088,9.89030709296103e-18
NMR metabolomics,X23412.Phospholipids in VLDL,LBP,Lipopolysaccharide-binding protein,42217,-0.0516785573699938,0.00602677554433222,-0.0634910374368849,-0.0398660773031026,1.09845699350075e-17
NMR metabolomics,X23412.Phospholipids in VLDL,HRG,Histidine-rich glycoprotein,39925,0.0275391893983671,0.00321233607944992,0.0212430106826453,0.0338353681140889,1.13950768209957e-17
NMR metabolomics,X23412.Phospholipids in VLDL,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,39929,0.0421841488444004,0.00492745591688213,0.0325263352473114,0.0518419624414894,1.26270108114321e-17
NMR metabolomics,X23412.Phospholipids in VLDL,CTRB1,Chymotrypsinogen B,42137,0.0513525574733295,0.00600614677684544,0.0395805097907124,0.0631246051559465,1.3617140382998e-17
NMR metabolomics,X23412.Phospholipids in VLDL,TPMT,Thiopurine S-methyltransferase,41843,0.0628641163314719,0.00735433066781168,0.048449628222561,0.0772786044403828,1.38962733462819e-17
NMR metabolomics,X23412.Phospholipids in VLDL,SCG2,Secretogranin-2,42193,0.0289744440224425,0.00339190677102409,0.0223263067512353,0.0356225812936497,1.4553874073826e-17
NMR metabolomics,X23412.Phospholipids in VLDL,KLK6,Kallikrein-6,42158,0.027125206340043,0.00317556533646409,0.0209010982805734,0.0333493143995127,1.46050529618724e-17
NMR metabolomics,X23412.Phospholipids in VLDL,SFTPA2,Pulmonary surfactant-associated protein A2,41843,0.0455376067045798,0.00533122541128771,0.0350884048984559,0.0559868085107038,1.4661805781611e-17
NMR metabolomics,X23412.Phospholipids in VLDL,CD274,Programmed cell death 1 ligand 1,42016,0.0296118311498971,0.00347032373443527,0.022809996630404,0.0364136656693902,1.57948326632626e-17
NMR metabolomics,X23412.Phospholipids in VLDL,DMP1,Dentin matrix acidic phosphoprotein 1,39638,-0.0497054035207281,0.00583280319937107,-0.0611376977914954,-0.0382731092499609,1.77659734087962e-17
NMR metabolomics,X23412.Phospholipids in VLDL,ACRBP,Acrosin-binding protein,39919,0.0350466020008274,0.00411338970795887,0.026984358173228,0.0431088458284268,1.79532189824301e-17
NMR metabolomics,X23412.Phospholipids in VLDL,CPB1,Carboxypeptidase B,42310,0.054315075118204,0.00638123370295818,0.041807857060406,0.066822293176002,1.89066914020744e-17
NMR metabolomics,X23412.Phospholipids in VLDL,MOG,Myelin-oligodendrocyte glycoprotein,42262,0.0290863649975138,0.00341809796596242,0.0223868929842274,0.0357858370108001,1.92687768977471e-17
NMR metabolomics,X23412.Phospholipids in VLDL,TEK,Angiopoietin-1 receptor,42181,0.0193591261927547,0.00227549194304131,0.0148991619843937,0.0238190904011157,1.95886303712957e-17
NMR metabolomics,X23412.Phospholipids in VLDL,PSG1,Pregnancy-specific beta-1-glycoprotein 1,42016,-0.0985396410169728,0.0115895202394454,-0.121255100686286,-0.0758241813476599,2.05044243220782e-17
NMR metabolomics,X23412.Phospholipids in VLDL,HEPH,Hephaestin,39958,0.0244349254259468,0.00287619250599029,0.0187975881142058,0.0300722627376878,2.21462280137721e-17
NMR metabolomics,X23412.Phospholipids in VLDL,PER3,Period circadian protein homolog 3,39657,0.107493564697346,0.0126793737077287,0.0826419922301979,0.132345137164494,2.58561227759843e-17
NMR metabolomics,X23412.Phospholipids in VLDL,REG1A,Lithostathine-1-alpha,42105,-0.0432762371465938,0.00512652020040647,-0.0533242167393905,-0.0332282575537971,3.44545585247561e-17
NMR metabolomics,X23412.Phospholipids in VLDL,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",39930,0.0905292465665391,0.0107251038466868,0.069508043027033,0.111550450106045,3.53240614520747e-17
NMR metabolomics,X23412.Phospholipids in VLDL,TF,Serotransferrin,39979,0.0186716176741595,0.00221298453440332,0.014334167986729,0.02300906736159,3.63953377019755e-17
NMR metabolomics,X23412.Phospholipids in VLDL,CD34,Hematopoietic progenitor cell antigen CD34,42211,0.0207849892234686,0.00246612293918107,0.0159513882626737,0.0256185901842635,3.859685112903e-17
NMR metabolomics,X23412.Phospholipids in VLDL,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",39934,0.080391827344914,0.0095471472152214,0.0616794188030801,0.099104235886748,4.19924370869423e-17
NMR metabolomics,X23412.Phospholipids in VLDL,ANGPTL1,Angiopoietin-related protein 1,41920,0.0248541103291058,0.00295371857847415,0.0190648219152965,0.0306433987429151,4.34445333890416e-17
NMR metabolomics,X23412.Phospholipids in VLDL,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,39657,0.0316595611809457,0.00376162647598111,0.0242867732880227,0.0390323490738686,4.35838005659093e-17
NMR metabolomics,X23412.Phospholipids in VLDL,PTPRC,Receptor-type tyrosine-protein phosphatase C,39966,0.0201092716752767,0.00239164654187879,0.0154216444531943,0.0247968988973592,4.6623837461872e-17
NMR metabolomics,X23412.Phospholipids in VLDL,SPAG1,Sperm-associated antigen 1,39934,0.0506176942399657,0.00602197491177245,0.0388146234128917,0.0624207650670397,4.76896496741557e-17
NMR metabolomics,X23412.Phospholipids in VLDL,PTN,Pleiotrophin,41900,0.0430254496503211,0.00512243722994093,0.0329854726796369,0.0530654266210053,4.93871091732607e-17
NMR metabolomics,X23412.Phospholipids in VLDL,MARCO,Macrophage receptor MARCO,42145,0.0222890337269547,0.00265557847697082,0.0170840999120919,0.0274939675418175,5.19253123938183e-17
NMR metabolomics,X23412.Phospholipids in VLDL,ITGA6,Integrin alpha-6,42119,0.0439323003665351,0.0052348679548137,0.0336719591751002,0.0541926415579699,5.23944846404967e-17
NMR metabolomics,X23412.Phospholipids in VLDL,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",39966,0.0545054040747828,0.00649475105879113,0.0417756919995521,0.0672351161500134,5.33419260665473e-17
NMR metabolomics,X23412.Phospholipids in VLDL,FXN,"Frataxin, mitochondrial",42262,0.0626816367010597,0.00747272350211931,0.0480350986369058,0.0773281747652135,5.42316565698146e-17
NMR metabolomics,X23412.Phospholipids in VLDL,MYOM3,Myomesin-3,39736,-0.0839534925959626,0.0100119532942743,-0.10357692105274,-0.064330064139185,5.66740138223853e-17
NMR metabolomics,X23412.Phospholipids in VLDL,FEN1,Flap endonuclease 1,41843,0.0554334245671065,0.00661245920406584,0.0424730045271374,0.0683938446070756,5.66819842889152e-17
NMR metabolomics,X23412.Phospholipids in VLDL,DSCAM,Down syndrome cell adhesion molecule,39934,0.0313853381678571,0.00374350362519566,0.0240480710624736,0.0387226052732406,5.72246071396076e-17
NMR metabolomics,X23412.Phospholipids in VLDL,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,39736,0.0605812179217476,0.00723010371314557,0.0464102146439823,0.0747522211995129,5.97715714011194e-17
NMR metabolomics,X23412.Phospholipids in VLDL,MMP3,Stromelysin-1,42137,-0.0427901613838186,0.00511048911784154,-0.052806720054788,-0.0327736027128492,6.16418014815388e-17
NMR metabolomics,X23412.Phospholipids in VLDL,SLITRK2,SLIT and NTRK-like protein 2,42262,0.0349126735416666,0.00416989517979995,0.0267396789892587,0.0430856680940745,6.18255237751021e-17
NMR metabolomics,X23412.Phospholipids in VLDL,ARSA,Arylsulfatase A,42137,0.0388366952238768,0.00463961822704829,0.0297430434988622,0.0479303469488915,6.2872421881362e-17
NMR metabolomics,X23412.Phospholipids in VLDL,C1RL,Complement C1r subcomponent-like protein,39958,0.0170225783385355,0.00203630877553265,0.0130314131384915,0.0210137435385795,7.02990797965697e-17
NMR metabolomics,X23412.Phospholipids in VLDL,COX6B1,Cytochrome c oxidase subunit 6B1,39958,0.027887200118466,0.00333768683677367,0.0213453339183896,0.0344290663185424,7.28789672205452e-17
NMR metabolomics,X23412.Phospholipids in VLDL,LGMN,Legumain,42185,0.0311767189724408,0.00373305093303096,0.0238599391437001,0.0384934988011815,7.38550045333372e-17
NMR metabolomics,X23412.Phospholipids in VLDL,ASGR2,Asialoglycoprotein receptor 2,39990,0.0227200912527988,0.00272431353474142,0.0173804367247056,0.028059745780892,8.30029378892088e-17
NMR metabolomics,X23412.Phospholipids in VLDL,CHRDL1,Chordin-like protein 1,42166,0.0280252484636731,0.00336239879987685,0.0214349468159145,0.0346155501114317,8.49698479646187e-17
NMR metabolomics,X23412.Phospholipids in VLDL,ITPA,Inosine triphosphate pyrophosphatase,39575,0.0577785132868982,0.00693509855600184,0.0441857201171346,0.0713713064566618,8.94592073123644e-17
NMR metabolomics,X23412.Phospholipids in VLDL,PSMG3,Proteasome assembly chaperone 3,42119,0.042227825132899,0.00508025230193775,0.0322705306211011,0.052185119644697,1.02885791347107e-16
NMR metabolomics,X23412.Phospholipids in VLDL,DARS1,"Aspartate--tRNA ligase, cytoplasmic",41997,0.0616774070915563,0.00742084038700206,0.0471325599330322,0.0762222542500803,1.03640401886954e-16
NMR metabolomics,X23412.Phospholipids in VLDL,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,39958,0.0265125827636817,0.00319076197496965,0.0202586892927412,0.0327664762346222,1.07312614180482e-16
NMR metabolomics,X23412.Phospholipids in VLDL,PPL,Periplakin,39657,0.0276646599470463,0.00333127248336745,0.0211353658796461,0.0341939540144465,1.1188638094198e-16
NMR metabolomics,X23412.Phospholipids in VLDL,ASPN,Asporin,39958,0.0238148715141456,0.0028680957141869,0.0181934039143393,0.0294363391139519,1.1264829860514e-16
NMR metabolomics,X23412.Phospholipids in VLDL,XCL1,Lymphotactin,42262,0.0465353105643257,0.00560818965233447,0.0355432588457501,0.0575273622829012,1.15980414346624e-16
NMR metabolomics,X23412.Phospholipids in VLDL,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,39640,0.022969491138166,0.00276831930451003,0.0175435853013264,0.0283953969750057,1.18915493379748e-16
NMR metabolomics,X23412.Phospholipids in VLDL,CXCL11,C-X-C motif chemokine 11,42249,0.0664806154207661,0.00802549942105588,0.0507506365554966,0.0822105942860356,1.30477731685372e-16
NMR metabolomics,X23412.Phospholipids in VLDL,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,41843,0.0400128668102426,0.00483558855183204,0.0305351132486518,0.0494906203718334,1.41057811107006e-16
NMR metabolomics,X23412.Phospholipids in VLDL,DGKZ,Diacylglycerol kinase zeta,41913,0.0307112748874324,0.00371580306290074,0.023428300884147,0.0379942488907179,1.52774785505675e-16
NMR metabolomics,X23412.Phospholipids in VLDL,LGALS7_LGALS7B,Galectin-7,42076,0.0373487726488115,0.00452507728073819,0.0284796211785646,0.0462179241190583,1.67698679918526e-16
NMR metabolomics,X23412.Phospholipids in VLDL,ICAM1,Intercellular adhesion molecule 1,42126,0.0246917793340637,0.00299360783528243,0.0188243079769101,0.0305592506912172,1.75593647707366e-16
NMR metabolomics,X23412.Phospholipids in VLDL,CTSS,Cathepsin S,39358,0.0205737289592903,0.00249548094540616,0.0156825863062942,0.0254648716122864,1.85308039743204e-16
NMR metabolomics,X23412.Phospholipids in VLDL,ASS1,Argininosuccinate synthase,39575,0.0657561008019152,0.00797798121413104,0.0501192576222184,0.0813929439816121,1.88312680341407e-16
NMR metabolomics,X23412.Phospholipids in VLDL,GIP,Gastric inhibitory polypeptide,39638,0.0429724490499679,0.00522377181767611,0.0327338562873227,0.0532110418126131,2.14702130949976e-16
NMR metabolomics,X23412.Phospholipids in VLDL,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",42070,0.058519144424087,0.00711993864499547,0.0445640646798959,0.0724742241682781,2.23740199040809e-16
NMR metabolomics,X23412.Phospholipids in VLDL,SNRPB2,U2 small nuclear ribonucleoprotein B'',39929,0.0375350378866215,0.00457134892509653,0.0285751939934323,0.0464948817798106,2.43253139662578e-16
NMR metabolomics,X23412.Phospholipids in VLDL,ASAH1,Acid ceramidase,39876,0.0398746303443512,0.00487412365470667,0.0303213479811261,0.0494279127075763,3.1198676435351e-16
NMR metabolomics,X23412.Phospholipids in VLDL,NID2,Nidogen-2,42137,0.0612921971777379,0.00749866600482019,0.0465948118082903,0.0759895825471854,3.25351977099129e-16
NMR metabolomics,X23412.Phospholipids in VLDL,SF3B4,Splicing factor 3B subunit 4,42070,0.0607767064232606,0.00744903871597662,0.0461765905399464,0.0753768223065747,3.67568052515209e-16
NMR metabolomics,X23412.Phospholipids in VLDL,NTRK2,BDNF/NT-3 growth factors receptor,42145,0.0211374505798708,0.00259160872522282,0.0160578974784341,0.0262170036813076,3.7624090514898e-16
NMR metabolomics,X23412.Phospholipids in VLDL,XRCC4,DNA repair protein XRCC4,41839,0.0308662781996792,0.00379353225418374,0.0234309549814791,0.0383016014178793,4.42754942496484e-16
NMR metabolomics,X23412.Phospholipids in VLDL,GRPEL1,"GrpE protein homolog 1, mitochondrial",42070,0.0511660504505221,0.0062890232610789,0.0388395648588074,0.0634925360422367,4.44965162063594e-16
NMR metabolomics,X23412.Phospholipids in VLDL,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,39657,0.0373563343420252,0.00459720323004866,0.0283458160111298,0.0463668526729205,4.91389023997861e-16
NMR metabolomics,X23412.Phospholipids in VLDL,STK4,Serine/threonine-protein kinase 4,42145,0.0729431082518391,0.00898291550580569,0.0553365938604599,0.0905496226432183,5.05372766805409e-16
NMR metabolomics,X23412.Phospholipids in VLDL,REG3A,Regenerating islet-derived protein 3-alpha,42310,-0.0528497172192243,0.00651077728271028,-0.0656108406933364,-0.0400885937451121,5.1717967130951e-16
NMR metabolomics,X23412.Phospholipids in VLDL,ERI1,3'-5' exoribonuclease 1,39757,0.0287008621556542,0.00354316537832255,0.021756258014142,0.0356454662971664,6.05072414355435e-16
NMR metabolomics,X23412.Phospholipids in VLDL,XPNPEP2,Xaa-Pro aminopeptidase 2,42181,0.0913391378673555,0.011286947993131,0.0692167198008187,0.113461555933892,6.3411821094089e-16
NMR metabolomics,X23412.Phospholipids in VLDL,ENTR1,Endosome-associated-trafficking regulator 1,39638,0.0516570065391194,0.00638574151684058,0.0391409531661119,0.064173059912127,6.62189220279274e-16
NMR metabolomics,X23412.Phospholipids in VLDL,CD84,SLAM family member 5,42119,0.0264892308522096,0.00327627898711697,0.0200677240374603,0.0329107376669588,6.73331482952631e-16
NMR metabolomics,X23412.Phospholipids in VLDL,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,39934,0.0548532852017677,0.00678302920269151,0.0415585479644923,0.068148022439043,6.74572882051667e-16
NMR metabolomics,X23412.Phospholipids in VLDL,TREML2,Trem-like transcript 2 protein,42137,0.0286553898348074,0.00354535869590766,0.0217064867908284,0.0356042928787864,6.87980668391683e-16
NMR metabolomics,X23412.Phospholipids in VLDL,THBS4,Thrombospondin-4,42189,0.0377306217014765,0.0046743499680644,0.0285688957640703,0.0468923476388828,7.50286253799001e-16
NMR metabolomics,X23412.Phospholipids in VLDL,CLEC5A,C-type lectin domain family 5 member A,42107,-0.0252391978881265,0.00312749031539112,-0.0313690789062931,-0.0191093168699599,7.61320190346595e-16
NMR metabolomics,X23412.Phospholipids in VLDL,PDZD2,PDZ domain-containing protein 2,39575,0.0489937446899157,0.00607818322970344,0.037080505559697,0.0609069838201345,8.38044609879643e-16
NMR metabolomics,X23412.Phospholipids in VLDL,C7,Complement component C7,39722,-0.0277430834612969,0.00344440286467972,-0.0344941130760692,-0.0209920538465246,8.79151846515498e-16
NMR metabolomics,X23412.Phospholipids in VLDL,FCN1,Ficolin-1,39978,0.0460977566215543,0.0057479435675065,0.0348317872292415,0.057363726013867,1.16215821299477e-15
NMR metabolomics,X23412.Phospholipids in VLDL,MEGF10,Multiple epidermal growth factor-like domains protein 10,42123,0.0327898159934934,0.0040902207563013,0.0247729833111429,0.040806648675844,1.1755083865746e-15
NMR metabolomics,X23412.Phospholipids in VLDL,SLC27A4,Long-chain fatty acid transport protein 4,41839,0.0556578833725721,0.00701800385156911,0.0419025958234967,0.0694131709216476,2.35259963048968e-15
NMR metabolomics,X23412.Phospholipids in VLDL,NOTCH1,Neurogenic locus notch homolog protein 1,42310,0.0131613961761232,0.00166023136170491,0.00990734270718154,0.0164154496450648,2.40894788010184e-15
NMR metabolomics,X23412.Phospholipids in VLDL,TNF,Tumor necrosis factor,41880,0.0296644948078155,0.00374248638430251,0.0223292214945826,0.0369997681210484,2.43478999081967e-15
NMR metabolomics,X23412.Phospholipids in VLDL,ANXA4,Annexin A4,42088,0.0589905973692587,0.00745016848159865,0.0443882671453253,0.073592927593192,2.60096123136798e-15
NMR metabolomics,X23412.Phospholipids in VLDL,PCDH1,Protocadherin-1,42264,0.0167320144005216,0.00211925266657149,0.0125782791740415,0.0208857496270017,3.11736129694676e-15
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINA6,Corticosteroid-binding globulin,39979,0.0125452256334218,0.00159214338460863,0.0094246245995889,0.0156658266672547,3.58723250443192e-15
NMR metabolomics,X23412.Phospholipids in VLDL,GLO1,Lactoylglutathione lyase,41900,0.0457704312147986,0.00581270019548373,0.0343775388316505,0.0571633235979467,3.69363738370738e-15
NMR metabolomics,X23412.Phospholipids in VLDL,EPCAM,Epithelial cell adhesion molecule,42125,-0.0752614263462115,0.00962341894476617,-0.0941233274779532,-0.0563995252144698,5.6426536320144e-15
NMR metabolomics,X23412.Phospholipids in VLDL,WAS,Wiskott-Aldrich syndrome protein,41913,0.0528179922770063,0.00675372258689423,0.0395806960066936,0.066055288547319,5.65255923559279e-15
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINA9,Serpin A9,42025,0.0581543862811265,0.00743767544661825,0.0435765424057547,0.0727322301564982,5.72480249604156e-15
NMR metabolomics,X23412.Phospholipids in VLDL,CTSL,Cathepsin L1,42145,0.0196413944452811,0.00251583484186212,0.0147103581552313,0.0245724307353308,6.27950665152166e-15
NMR metabolomics,X23412.Phospholipids in VLDL,CD14,Monocyte differentiation antigen CD14,41932,0.0330098458663321,0.00424061605411482,0.0246982384002671,0.0413214533323972,7.53038134509552e-15
NMR metabolomics,X23412.Phospholipids in VLDL,ADM,Pro-adrenomedullin,42262,0.0209445840980187,0.00269113889806904,0.0156699518578034,0.0262192163382341,7.60171314327076e-15
NMR metabolomics,X23412.Phospholipids in VLDL,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,39410,0.0397028068191142,0.00511885812025129,0.0296698449034217,0.0497357687348068,9.53964396602185e-15
NMR metabolomics,X23412.Phospholipids in VLDL,GLRX,Glutaredoxin-1,42057,0.0442743735124666,0.00571015063369516,0.0330824782704241,0.0554662687545091,9.56996543300277e-15
NMR metabolomics,X23412.Phospholipids in VLDL,DTNB,Dystrobrevin beta,39900,0.03630043812643,0.00468658684520097,0.0271147279098361,0.0454861483430239,1.03256942024169e-14
NMR metabolomics,X23412.Phospholipids in VLDL,SMARCA2,Probable global transcription activator SNF2L2,41839,0.0585795800608204,0.00756633578494667,0.0437495619223249,0.0734095981993159,1.04838888969823e-14
NMR metabolomics,X23412.Phospholipids in VLDL,FGA,Fibrinogen alpha chain,39735,0.0248892698895268,0.00321447039764313,0.0185889079101462,0.0311896318689073,1.05605641050695e-14
NMR metabolomics,X23412.Phospholipids in VLDL,NCAN,Neurocan core protein,42249,0.0298230845583671,0.00385367352817995,0.0222698844431344,0.0373762846735998,1.0732642938804e-14
NMR metabolomics,X23412.Phospholipids in VLDL,FLT3LG,Fms-related tyrosine kinase 3 ligand,42296,0.027983084884051,0.00361853446175039,0.0208907573390202,0.0350754124290818,1.12115426816558e-14
NMR metabolomics,X23412.Phospholipids in VLDL,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,42145,0.0392136583189608,0.00507269625679126,0.0292711736556499,0.0491561429822716,1.14797355496976e-14
NMR metabolomics,X23412.Phospholipids in VLDL,DAPK2,Death-associated protein kinase 2,39657,0.0440216732788418,0.00571669058210334,0.0328169597379193,0.0552263868197643,1.47038876095486e-14
NMR metabolomics,X23412.Phospholipids in VLDL,PRELP,Prolargin,42123,0.0184910497433575,0.00240762197864565,0.013772110665212,0.0232099888215029,1.69710432638548e-14
NMR metabolomics,X23412.Phospholipids in VLDL,EFCAB2,Dynein regulatory complex protein 8,39757,0.02799913726103,0.00364487493549626,0.0208551823874573,0.0351430921346027,1.70019580462664e-14
NMR metabolomics,X23412.Phospholipids in VLDL,DNAJB8,DnaJ homolog subfamily B member 8,41900,0.0444068933551551,0.00578780958060526,0.0330627865771688,0.0557510001331415,1.80407693240601e-14
NMR metabolomics,X23412.Phospholipids in VLDL,NADK,NAD kinase,42145,0.0430512311970868,0.00562008433621079,0.0320358658981137,0.05406659649606,1.98141677264798e-14
NMR metabolomics,X23412.Phospholipids in VLDL,NEK7,Serine/threonine-protein kinase Nek7,39757,0.0586453065104075,0.00765605797498089,0.0436394328794449,0.07365118014137,2.01333768179004e-14
NMR metabolomics,X23412.Phospholipids in VLDL,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,42310,0.0183931223353838,0.00240254068823887,0.0136841425864356,0.023102102084332,2.05093117507737e-14
NMR metabolomics,X23412.Phospholipids in VLDL,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,39934,0.046885243339796,0.00612649201712891,0.0348773189862233,0.0588931676933687,2.12478232320193e-14
NMR metabolomics,X23412.Phospholipids in VLDL,ADAMTSL4,ADAMTS-like protein 4,39638,0.0194582856580049,0.00255108664471311,0.0144581558343672,0.0244584154816426,2.59125957480769e-14
NMR metabolomics,X23412.Phospholipids in VLDL,CD101,Immunoglobulin superfamily member 2,39930,0.0340118528901845,0.00445980084780291,0.0252706432284908,0.0427530625518782,2.60871647253736e-14
NMR metabolomics,X23412.Phospholipids in VLDL,MCAM,Cell surface glycoprotein MUC18,42217,-0.0249902338777088,0.00329384498112696,-0.0314461700407176,-0.0185342977146999,3.48737919401663e-14
NMR metabolomics,X23412.Phospholipids in VLDL,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,42162,0.0387704621447777,0.00511447063189353,0.0287460997062664,0.048794824583289,3.6641567761927e-14
NMR metabolomics,X23412.Phospholipids in VLDL,CSNK1D,Casein kinase I isoform delta,39657,0.0503612704932671,0.00664254675218324,0.037341878858988,0.0633806621275463,3.68587444978158e-14
NMR metabolomics,X23412.Phospholipids in VLDL,DENR,Density-regulated protein,39657,0.0449693826066263,0.00593648071997905,0.0333338803954674,0.0566048848177852,3.87507646686248e-14
NMR metabolomics,X23412.Phospholipids in VLDL,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,41820,0.0376541448040461,0.00497689483008632,0.027899430937077,0.0474088586710153,4.10961857152693e-14
NMR metabolomics,X23412.Phospholipids in VLDL,IDS,Iduronate 2-sulfatase,42296,0.00715688504289595,0.000946535259815153,0.00530167593365825,0.00901209415213365,4.24924393760756e-14
NMR metabolomics,X23412.Phospholipids in VLDL,ARAF,Serine/threonine-protein kinase A-Raf,39757,0.0533974852805143,0.00706241393202189,0.0395551539737514,0.0672398165872772,4.32025796862046e-14
NMR metabolomics,X23412.Phospholipids in VLDL,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,39649,0.0420489392478348,0.00556273744674256,0.0311459738522193,0.0529519046434502,4.38205647424285e-14
NMR metabolomics,X23412.Phospholipids in VLDL,NAP1L4,Nucleosome assembly protein 1-like 4,39911,0.03132296309564,0.00415394725380695,0.0231812264781784,0.0394646997131017,5.03868627136617e-14
NMR metabolomics,X23412.Phospholipids in VLDL,PODXL,Podocalyxin,42070,0.0117121795674961,0.00155743390478691,0.00865960911411378,0.0147647500208785,5.81583722471651e-14
NMR metabolomics,X23412.Phospholipids in VLDL,CA9,Carbonic anhydrase 9,42262,-0.0360414869878315,0.00480341678269628,-0.0454561838819162,-0.0266267900937468,6.60702404073383e-14
NMR metabolomics,X23412.Phospholipids in VLDL,DCTN2,Dynactin subunit 2,42070,0.0731044126588088,0.00976301123468234,0.0539689106388314,0.0922399146787862,7.43324092051414e-14
NMR metabolomics,X23412.Phospholipids in VLDL,PNLIPRP1,Inactive pancreatic lipase-related protein 1,39929,0.0645360479175715,0.00861893126236446,0.0476429426433372,0.0814291531918059,7.52874713515242e-14
NMR metabolomics,X23412.Phospholipids in VLDL,OCLN,Occludin,39934,0.0341311271139557,0.00456368033639511,0.0251863136546213,0.0430759405732901,8.05043844359671e-14
NMR metabolomics,X23412.Phospholipids in VLDL,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,42016,0.0559370187215228,0.0074829967258428,0.0412703451388709,0.0706036923041747,8.18502132761475e-14
NMR metabolomics,X23412.Phospholipids in VLDL,CTSV,Cathepsin L2,42200,0.0307865307913018,0.00412087328183771,0.0227096191588999,0.0388634424237037,8.45164591119379e-14
NMR metabolomics,X23412.Phospholipids in VLDL,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,41900,-0.0241761970235514,0.00323617474055422,-0.0305190995150377,-0.0178332945320651,8.47995889082576e-14
NMR metabolomics,X23412.Phospholipids in VLDL,DMD,Dystrophin,39638,0.0396534580871801,0.00531146299105209,0.029242990624718,0.0500639255496422,8.91412565670753e-14
NMR metabolomics,X23412.Phospholipids in VLDL,ACAN,Aggrecan core protein,41994,0.0209791012744448,0.00281314508813402,0.0154653369017021,0.0264928656471875,9.35792592847601e-14
NMR metabolomics,X23412.Phospholipids in VLDL,C2orf69,UPF0565 protein C2orf69,39649,0.0453203227555663,0.00607907078377707,0.0334053440193633,0.0572353014917694,9.64890005655218e-14
NMR metabolomics,X23412.Phospholipids in VLDL,PEPD,Xaa-Pro dipeptidase,39990,0.020272808581487,0.00271982408332244,0.014941953378175,0.025603663784799,9.73183810668493e-14
NMR metabolomics,X23412.Phospholipids in VLDL,SPP1,Osteopontin,42286,-0.033659986450661,0.00452746614443874,-0.0425338200937609,-0.0247861528075611,1.11093938610532e-13
NMR metabolomics,X23412.Phospholipids in VLDL,BRDT,Bromodomain testis-specific protein,39575,0.0279058787578686,0.00377527451088467,0.0205063407165346,0.0353054167992025,1.55455325594308e-13
NMR metabolomics,X23412.Phospholipids in VLDL,IL12A_IL12B,Interleukin-12,42070,0.0585386649603115,0.00792174330583614,0.0430120480808726,0.0740652818397503,1.5591841848713e-13
NMR metabolomics,X23412.Phospholipids in VLDL,TCL1A,T-cell leukemia/lymphoma protein 1A,42005,0.0776471315210427,0.0105078542937743,0.0570517371052452,0.0982425259368403,1.56173844230361e-13
NMR metabolomics,X23412.Phospholipids in VLDL,PTGR1,Prostaglandin reductase 1,39958,0.0637158384803783,0.00862738456947387,0.0468061647242095,0.080625512236547,1.6275377433237e-13
NMR metabolomics,X23412.Phospholipids in VLDL,LAMP3,Lysosome-associated membrane glycoprotein 3,42284,0.0394466050564181,0.00534349313338552,0.0289733585149825,0.0499198515978537,1.64706971023119e-13
NMR metabolomics,X23412.Phospholipids in VLDL,CD276,CD276 antigen,42123,-0.0272684479647832,0.00369454874321458,-0.0345097635014838,-0.0200271324280826,1.66615509050476e-13
NMR metabolomics,X23412.Phospholipids in VLDL,TSPYL1,Testis-specific Y-encoded-like protein 1,39657,0.0308840580788187,0.00418375122923245,0.0226839056695231,0.0390842104881143,1.67246126590655e-13
NMR metabolomics,X23412.Phospholipids in VLDL,CLC,Galectin-10,42119,-0.0509174660215971,0.00690378133262405,-0.0644488774335402,-0.0373860546096539,1.73515939357505e-13
NMR metabolomics,X23412.Phospholipids in VLDL,CLSTN3,Calsyntenin-3,39929,0.0230206212886018,0.00312131874031891,0.0169028365575768,0.0291384060196269,1.75436051671614e-13
NMR metabolomics,X23412.Phospholipids in VLDL,LACRT,Extracellular glycoprotein lacritin,39895,0.0345310439622374,0.00469102331890875,0.0253366382571763,0.0437254496672986,1.95085126946713e-13
NMR metabolomics,X23412.Phospholipids in VLDL,APOB,Apolipoprotein B-100,39990,0.0173107978440868,0.00235182144864772,0.0127012278047372,0.0219203678834363,1.95701510358867e-13
NMR metabolomics,X23412.Phospholipids in VLDL,TLR3,Toll-like receptor 3,42296,0.0462647234096789,0.00629087463993314,0.0339346091154099,0.0585948377039478,2.0288640927201e-13
NMR metabolomics,X23412.Phospholipids in VLDL,RELT,Tumor necrosis factor receptor superfamily member 19L,42137,0.0228041130253608,0.00310521402569628,0.0167178935349961,0.0288903325157255,2.19449298303072e-13
NMR metabolomics,X23412.Phospholipids in VLDL,GGH,Gamma-glutamyl hydrolase,41933,0.0256593007386775,0.00349670416405812,0.0188057605771236,0.0325128409002314,2.29110139783992e-13
NMR metabolomics,X23412.Phospholipids in VLDL,DDX58,Antiviral innate immune response receptor RIG-I,41843,0.0427020537322845,0.00582934656396579,0.0312765344669116,0.0541275729976575,2.52038970307839e-13
NMR metabolomics,X23412.Phospholipids in VLDL,AGXT,Serine--pyruvate aminotransferase,42145,0.0577726695652045,0.00789231223023645,0.042303737593941,0.0732416015364679,2.61709159663246e-13
NMR metabolomics,X23412.Phospholipids in VLDL,EDF1,Endothelial differentiation-related factor 1,39934,0.050127869608042,0.00684772353264894,0.0367063314840501,0.0635494077320339,2.64023097321473e-13
NMR metabolomics,X23412.Phospholipids in VLDL,MANSC1,MANSC domain-containing protein 1,42181,-0.020840739404565,0.00285864929324098,-0.0264436920193173,-0.0152377867898126,3.26082657930192e-13
NMR metabolomics,X23412.Phospholipids in VLDL,SAA4,Serum amyloid A-4 protein,39979,0.0247586599895,0.00340461893712509,0.0180856068727348,0.0314317131062652,3.77222264222632e-13
NMR metabolomics,X23412.Phospholipids in VLDL,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,39657,0.043965119845918,0.00604964385907971,0.0321078178821218,0.0558224218097143,3.91204729403493e-13
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINI1,Neuroserpin,39713,0.0216927162335538,0.00299040593775613,0.0158315205955518,0.0275539118715558,4.31241659364786e-13
NMR metabolomics,X23412.Phospholipids in VLDL,CD300LF,CMRF35-like molecule 1,42262,0.044754356954397,0.00617834000214587,0.0326448105501911,0.0568639033586029,4.59808728843511e-13
NMR metabolomics,X23412.Phospholipids in VLDL,FOLR2,Folate receptor beta,42249,-0.0216382968246216,0.00298873894245349,-0.0274962251518304,-0.0157803684974127,4.72881220858085e-13
NMR metabolomics,X23412.Phospholipids in VLDL,CD27,CD27 antigen,42181,-0.0317734623667433,0.00439341083511315,-0.040384547603565,-0.0231623771299215,5.01137696634429e-13
NMR metabolomics,X23412.Phospholipids in VLDL,NAA10,N-alpha-acetyltransferase 10,39575,0.0378242298278074,0.00523315102744471,0.0275672538140157,0.048081205841599,5.23449959858235e-13
NMR metabolomics,X23412.Phospholipids in VLDL,PRSS22,Brain-specific serine protease 4,39657,0.0257717708419201,0.00357619488753433,0.0187624288623529,0.0327811128214874,6.11581274176972e-13
NMR metabolomics,X23412.Phospholipids in VLDL,CASP9,Caspase-9,39657,0.0474988146449044,0.00659342481278263,0.0345757020118504,0.0604219272779583,6.22904056684726e-13
NMR metabolomics,X23412.Phospholipids in VLDL,WFDC1,WAP four-disulfide core domain protein 1,39699,0.0403016747874486,0.00559697243127082,0.0293316088221578,0.0512717407527394,6.3816097692139e-13
NMR metabolomics,X23412.Phospholipids in VLDL,SMS,Spermine synthase,39586,0.0477199849998495,0.00663377214582635,0.0347177915940298,0.0607221784056691,6.72666754810097e-13
NMR metabolomics,X23412.Phospholipids in VLDL,COL1A1,Collagen alpha-1(I) chain,42310,-0.0172889186818793,0.00241711373505006,-0.0220264616025775,-0.0125513757611812,8.93935554460548e-13
NMR metabolomics,X23412.Phospholipids in VLDL,SGSH,N-sulphoglucosamine sulphohydrolase,39807,0.0412909849065927,0.00578688830449042,0.0299486838297914,0.0526332859833939,1.02563056112081e-12
NMR metabolomics,X23412.Phospholipids in VLDL,MCTS1,Malignant T-cell-amplified sequence 1,39930,0.0192250177364265,0.00269961783357974,0.0139337667826102,0.0245162686902428,1.13318457860807e-12
NMR metabolomics,X23412.Phospholipids in VLDL,SCGN,Secretagogin,41913,-0.0325657814539938,0.00457378137261273,-0.0415303929443148,-0.0236011699636729,1.13380946111513e-12
NMR metabolomics,X23412.Phospholipids in VLDL,ATP6V1F,V-type proton ATPase subunit F,41820,0.0488730625091404,0.00686571726738061,0.0354162566650744,0.0623298683532064,1.14805932537969e-12
NMR metabolomics,X23412.Phospholipids in VLDL,PMM2,Phosphomannomutase 2,39575,0.0441002542483997,0.00619419451822038,0.0319596329926878,0.0562408755041117,1.14997639921188e-12
NMR metabolomics,X23412.Phospholipids in VLDL,ABCA2,ATP-binding cassette sub-family A member 2,39575,0.0264459352243714,0.00371552165021824,0.0191635127899436,0.0337283576587991,1.16602831414479e-12
NMR metabolomics,X23412.Phospholipids in VLDL,NPHS1,Nephrin,39657,0.0244633306873444,0.00343823213656699,0.0177243956996731,0.0312022656750157,1.18759801925507e-12
NMR metabolomics,X23412.Phospholipids in VLDL,SLITRK6,SLIT and NTRK-like protein 6,41900,-0.0253219298181537,0.00356145738967185,-0.0323023863019105,-0.0183414733343969,1.21975594490755e-12
NMR metabolomics,X23412.Phospholipids in VLDL,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,39929,0.0637436610752742,0.00896622435721625,0.0461698613351303,0.081317460815418,1.23640290893933e-12
NMR metabolomics,X23412.Phospholipids in VLDL,RPL14,60S ribosomal protein L14,39638,0.0286724411793388,0.00403351931860621,0.0207667433148706,0.036578139043807,1.24517309337214e-12
NMR metabolomics,X23412.Phospholipids in VLDL,CRYM,Ketimine reductase mu-crystallin,39586,0.0555158035721423,0.00781044069628211,0.0402073398074294,0.0708242673368552,1.25133591043288e-12
NMR metabolomics,X23412.Phospholipids in VLDL,IMMT,MICOS complex subunit MIC60,39919,0.0326269250141259,0.00459853452872912,0.0236137973378168,0.0416400526904349,1.37006859817719e-12
NMR metabolomics,X23412.Phospholipids in VLDL,TAFA5,Chemokine-like protein TAFA-5,42070,0.0268053768823687,0.00378174806435449,0.0193931506762339,0.0342176030885035,1.42742200035646e-12
NMR metabolomics,X23412.Phospholipids in VLDL,KIF22,Kinesin-like protein KIF22,39575,0.0908614422949474,0.0128252282709775,0.0657239948838315,0.115998889706063,1.48005342362632e-12
NMR metabolomics,X23412.Phospholipids in VLDL,LAG3,Lymphocyte activation gene 3 protein,42070,-0.0296151220805644,0.00418307250195321,-0.0378139441843927,-0.0214162999767361,1.51565495078209e-12
NMR metabolomics,X23412.Phospholipids in VLDL,GPR15L,Protein GPR15L,39930,0.0455528316249134,0.00643526267011612,0.0329397167914858,0.058165946458341,1.54193430153724e-12
NMR metabolomics,X23412.Phospholipids in VLDL,ELOB,Elongin-B,39575,0.0286307840265798,0.004048936343654,0.0206948687930179,0.0365666992601416,1.62955722865403e-12
NMR metabolomics,X23412.Phospholipids in VLDL,FES,Tyrosine-protein kinase Fes/Fps,41843,0.0344142389468904,0.0048815718622355,0.0248463580969088,0.043982119796872,1.8801798202729e-12
NMR metabolomics,X23412.Phospholipids in VLDL,ACOT13,Acyl-coenzyme A thioesterase 13,39930,0.0833535357403947,0.0118323215641092,0.0601621854747406,0.106544886006049,1.96828731895709e-12
NMR metabolomics,X23412.Phospholipids in VLDL,HPCAL1,Hippocalcin-like protein 1,42296,0.0533164355609118,0.00757662546884193,0.0384662496419816,0.068166621479842,2.05814195650267e-12
NMR metabolomics,X23412.Phospholipids in VLDL,ARID4B,AT-rich interactive domain-containing protein 4B,41839,0.0300106536482085,0.00427374740354877,0.0216341087372529,0.0383871985591641,2.29233679848389e-12
NMR metabolomics,X23412.Phospholipids in VLDL,CTSC,Dipeptidyl peptidase 1,42123,0.032041256551952,0.00456541541224923,0.0230930423439436,0.0409894707599605,2.35357612004423e-12
NMR metabolomics,X23412.Phospholipids in VLDL,RABEPK,Rab9 effector protein with kelch motifs,41843,0.0416568962065352,0.00594081115224928,0.0300129063481266,0.0533008860649437,2.46350938532465e-12
NMR metabolomics,X23412.Phospholipids in VLDL,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,39657,0.0270455288493915,0.00385900772828283,0.0194818737019571,0.0346091839968258,2.5506431199679e-12
NMR metabolomics,X23412.Phospholipids in VLDL,CASP8,Caspase-8,42224,0.0440323329082562,0.0062855429251319,0.0317126687749977,0.0563519970415147,2.57960949826392e-12
NMR metabolomics,X23412.Phospholipids in VLDL,PPM1A,Protein phosphatase 1A,41843,0.022541912786524,0.00322670781716643,0.0162175654648778,0.0288662601081702,2.96262920502756e-12
NMR metabolomics,X23412.Phospholipids in VLDL,ECI2,Enoyl-CoA delta isomerase 2,39575,0.0438072878249474,0.00627983715292254,0.0314988070052192,0.0561157686446756,3.21499139768167e-12
NMR metabolomics,X23412.Phospholipids in VLDL,GDF15,Growth/differentiation factor 15,42310,-0.0328553821241507,0.00471210623862672,-0.042091110351859,-0.0236196538964423,3.25499189044199e-12
NMR metabolomics,X23412.Phospholipids in VLDL,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",39934,0.0342823726840557,0.00491743326677739,0.024644203481172,0.0439205418869393,3.30771134370609e-12
NMR metabolomics,X23412.Phospholipids in VLDL,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",41843,0.0358575769476792,0.00515460668222403,0.0257545478505201,0.0459606060448383,3.65440961267575e-12
NMR metabolomics,X23412.Phospholipids in VLDL,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,39934,-0.0272620578920685,0.00391904199563393,-0.034943380203511,-0.019580735580626,3.68548422152622e-12
NMR metabolomics,X23412.Phospholipids in VLDL,SCGB3A1,Secretoglobin family 3A member 1,39736,-0.018822843461967,0.00270977312374795,-0.024133998784513,-0.013511688139421,3.95954778521025e-12
NMR metabolomics,X23412.Phospholipids in VLDL,IL5RA,Interleukin-5 receptor subunit alpha,42119,-0.0406399537913454,0.00585534010714752,-0.0521164204013546,-0.0291634871813363,4.08047965035944e-12
NMR metabolomics,X23412.Phospholipids in VLDL,LPA,Apolipoprotein(a),39775,-0.130124837530903,0.0188679237232811,-0.167105968028533,-0.0931437070332717,5.61302457932457e-12
NMR metabolomics,X23412.Phospholipids in VLDL,AMFR,E3 ubiquitin-protein ligase AMFR,41839,0.0447795219105686,0.00651569619836856,0.0320087573617663,0.057550286459371,6.58820556395864e-12
NMR metabolomics,X23412.Phospholipids in VLDL,MNDA,Myeloid cell nuclear differentiation antigen,42119,0.0692903239802295,0.0100826092637568,0.0495284098232661,0.0890522381371928,6.59606920060572e-12
NMR metabolomics,X23412.Phospholipids in VLDL,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,39638,0.0306480420256086,0.00446045215679162,0.021905555798297,0.0393905282529202,6.71577239081856e-12
NMR metabolomics,X23412.Phospholipids in VLDL,LY75,Lymphocyte antigen 75,42119,0.0272745206979857,0.00398064798119825,0.0194724506548371,0.0350765907411343,7.60947090391064e-12
NMR metabolomics,X23412.Phospholipids in VLDL,HDGF,Hepatoma-derived growth factor,42243,0.0643015655757562,0.00940185337117522,0.0458739329682528,0.0827291981832596,8.30021610651578e-12
NMR metabolomics,X23412.Phospholipids in VLDL,FASLG,Tumor necrosis factor ligand superfamily member 6,42296,0.0258842507077835,0.00378980320516733,0.0184562364256556,0.0333122649899115,8.85135491610109e-12
NMR metabolomics,X23412.Phospholipids in VLDL,GC,Vitamin D-binding protein,39979,0.0182289148409645,0.00266931676017152,0.0129970539910283,0.0234607756909007,8.98285561647363e-12
NMR metabolomics,X23412.Phospholipids in VLDL,BCAN,Brevican core protein,42016,0.0242450431855084,0.00355304633874232,0.0172810723615734,0.0312090140094433,9.25113189246339e-12
NMR metabolomics,X23412.Phospholipids in VLDL,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",39919,0.0262572064385793,0.00385828254885581,0.0186949726428219,0.0338194402343366,1.05848382011402e-11
NMR metabolomics,X23412.Phospholipids in VLDL,PRSS53,Serine protease 53,39929,0.0268081769204327,0.00394150011672194,0.0190828366916577,0.0345335171492077,1.0873530850929e-11
NMR metabolomics,X23412.Phospholipids in VLDL,TFPI2,Tissue factor pathway inhibitor 2,42142,0.0266962870425268,0.00392609112989103,0.0190011484279403,0.0343914256571132,1.09223213789489e-11
NMR metabolomics,X23412.Phospholipids in VLDL,WARS,"Tryptophan--tRNA ligase, cytoplasmic",42137,0.0270171581725551,0.00397704290814897,0.0192221540725832,0.0348121622725271,1.14193167786709e-11
NMR metabolomics,X23412.Phospholipids in VLDL,MENT,Protein MENT,39736,-0.0166684546652722,0.00245675923788322,-0.0214837027715233,-0.0118532065590211,1.22201468401754e-11
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,41913,0.0300114260362879,0.00443248875958392,0.0213237480675034,0.0386991040050724,1.33457073061173e-11
NMR metabolomics,X23412.Phospholipids in VLDL,TREML1,Trem-like transcript 1 protein,39990,0.0370293712887542,0.00546851676752562,0.026311078424404,0.0477476641531044,1.33839189151348e-11
NMR metabolomics,X23412.Phospholipids in VLDL,CR1,Complement receptor type 1,39970,0.0247680235029543,0.00366061123483241,0.0175932254826828,0.0319428215232258,1.38808328651723e-11
NMR metabolomics,X23412.Phospholipids in VLDL,ESAM,Endothelial cell-selective adhesion molecule,42310,0.0226498123288933,0.00335056902484638,0.0160826970401944,0.0292169276175922,1.43582163644085e-11
NMR metabolomics,X23412.Phospholipids in VLDL,ANPEP,Aminopeptidase N,42187,0.018960209479335,0.00280703212260972,0.01345842651902,0.0244619924396501,1.49118704800717e-11
NMR metabolomics,X23412.Phospholipids in VLDL,PKD1,Polycystin-1,39958,0.018910885876261,0.00280631937524523,0.0134104999007803,0.0244112718517416,1.67565146997231e-11
NMR metabolomics,X23412.Phospholipids in VLDL,CFHR2,Complement factor H-related protein 2,39904,0.0397099124545241,0.00589728185584594,0.0281512400170661,0.0512685848919821,1.73542750979337e-11
NMR metabolomics,X23412.Phospholipids in VLDL,FGR,Tyrosine-protein kinase Fgr,41839,0.0406206255153158,0.00603786673589741,0.0287864067129569,0.0524548443176747,1.79519214858876e-11
NMR metabolomics,X23412.Phospholipids in VLDL,EPHB4,Ephrin type-B receptor 4,42310,-0.0175544300182932,0.00261165786759228,-0.0226732794387741,-0.0124355805978124,1.86888875294948e-11
NMR metabolomics,X23412.Phospholipids in VLDL,CDA,Cytidine deaminase,39946,0.0330334835754275,0.00491581290875086,0.0233984902742758,0.0426684768765792,1.9063451327562e-11
NMR metabolomics,X23412.Phospholipids in VLDL,AFAP1,Actin filament-associated protein 1,39736,0.0580433929533494,0.00863856401758827,0.0411118074788764,0.0749749784278225,1.91769062198341e-11
NMR metabolomics,X23412.Phospholipids in VLDL,CILP,Cartilage intermediate layer protein 1,39966,0.0382372852658788,0.005701029184722,0.0270632680638237,0.0494113024679339,2.07970625273657e-11
NMR metabolomics,X23412.Phospholipids in VLDL,CTSE,Cathepsin E,39736,0.0367641988070273,0.00548365589018552,0.0260162332622637,0.0475121643517909,2.121283142527e-11
NMR metabolomics,X23412.Phospholipids in VLDL,BGN,Biglycan,41820,-0.0812487497133659,0.0121448141110168,-0.105052585370959,-0.0574449140557729,2.32162398224072e-11
NMR metabolomics,X23412.Phospholipids in VLDL,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",41997,0.0669573474203594,0.0100129767800211,0.0473319129315181,0.0865827819092007,2.36730879550467e-11
NMR metabolomics,X23412.Phospholipids in VLDL,NXPH1,Neurexophilin-1,41839,0.0266939798152266,0.00399469797769495,0.0188643717789445,0.0345235878515087,2.44545970706046e-11
NMR metabolomics,X23412.Phospholipids in VLDL,HGFAC,Hepatocyte growth factor activator,39897,0.0186245049509519,0.00279114566887019,0.0131538594399663,0.0240951504619374,2.62866617553928e-11
NMR metabolomics,X23412.Phospholipids in VLDL,ROBO1,Roundabout homolog 1,42144,0.0164360753633912,0.00246499717120077,0.0116046809078377,0.0212674698189447,2.69755693314691e-11
NMR metabolomics,X23412.Phospholipids in VLDL,CSF3R,Granulocyte colony-stimulating factor receptor,39657,0.020808178569817,0.00312528795068226,0.0146826141864798,0.0269337429531543,2.90723678359355e-11
NMR metabolomics,X23412.Phospholipids in VLDL,PDIA3,Protein disulfide-isomerase A3,39736,0.0168981994512601,0.0025402042153054,0.0119193991892615,0.0218769997132587,3.02075039666231e-11
NMR metabolomics,X23412.Phospholipids in VLDL,IDO1,"Indoleamine 2,3-dioxygenase 1",39638,0.0429849076082685,0.00647422478124276,0.0302954270370326,0.0556743881795043,3.29766612384307e-11
NMR metabolomics,X23412.Phospholipids in VLDL,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",41913,0.0421257650849996,0.00635406703154559,0.0296717937031702,0.054579736466829,3.492616980348e-11
NMR metabolomics,X23412.Phospholipids in VLDL,NFASC,Neurofascin,42296,0.0198753706222139,0.00300020047521974,0.0139949776907832,0.0257557635536446,3.60995707892909e-11
NMR metabolomics,X23412.Phospholipids in VLDL,S100A12,Protein S100-A12,41910,0.0499195993502792,0.00755892836481718,0.0351040997552375,0.0647350989453209,4.152448127406e-11
NMR metabolomics,X23412.Phospholipids in VLDL,TPR,Nucleoprotein TPR,39575,0.0332789982946287,0.00504452594092692,0.0233917274504119,0.0431662691388455,4.38715568185033e-11
NMR metabolomics,X23412.Phospholipids in VLDL,PRSS8,Prostasin,42080,0.0282196564363928,0.00429651493381951,0.0197984871661066,0.036640825706679,5.2853910122486e-11
NMR metabolomics,X23412.Phospholipids in VLDL,C2CD2L,Phospholipid transfer protein C2CD2L,41820,0.0275264452118927,0.00420036762054081,0.0192937246756327,0.0357591657481527,5.83497370924893e-11
NMR metabolomics,X23412.Phospholipids in VLDL,ADA,Adenosine deaminase,42296,0.0239114762474699,0.00365538382374569,0.0167469239529284,0.0310760285420115,6.30928287699881e-11
NMR metabolomics,X23412.Phospholipids in VLDL,FCRL1,Fc receptor-like protein 1,42145,0.0308254029454521,0.00471319082188057,0.0215875489345662,0.040063256956338,6.36241807701764e-11
NMR metabolomics,X23412.Phospholipids in VLDL,STX6,Syntaxin-6,41843,0.0441395758042015,0.006751653755675,0.0309063344430785,0.0573728171653245,6.48080175908105e-11
NMR metabolomics,X23412.Phospholipids in VLDL,GAS2,Growth arrest-specific protein 2,39757,0.0351214713875413,0.00538293871962497,0.0245709114970764,0.0456720312780063,7.11401122095423e-11
NMR metabolomics,X23412.Phospholipids in VLDL,BOLA1,BolA-like protein 1,39586,0.0367368669492746,0.00563053359009919,0.0257010211126802,0.047772712785869,7.11919549457697e-11
NMR metabolomics,X23412.Phospholipids in VLDL,GIMAP8,GTPase IMAP family member 8,39560,0.033787434264743,0.00518336001914823,0.0236280486272125,0.0439468199022735,7.41618975187936e-11
NMR metabolomics,X23412.Phospholipids in VLDL,CD83,CD83 antigen,42119,0.0231394927095956,0.00355157750891328,0.0161784007921256,0.0301005846270656,7.51279351831206e-11
NMR metabolomics,X23412.Phospholipids in VLDL,NELL1,Protein kinase C-binding protein NELL1,42181,0.0282319725868736,0.00433595950240971,0.0197334919621505,0.0367304532115966,7.72130850752967e-11
NMR metabolomics,X23412.Phospholipids in VLDL,MAN2B2,Epididymis-specific alpha-mannosidase,39958,0.0399912144231227,0.00614102367865427,0.0279548080129603,0.052027620833285,7.72132521954308e-11
NMR metabolomics,X23412.Phospholipids in VLDL,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,39930,0.0804393604594083,0.0123887491830976,0.056157412060537,0.10472130885828,8.7698675101933e-11
NMR metabolomics,X23412.Phospholipids in VLDL,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,39757,0.0264462102759662,0.00408226387336846,0.018444973084164,0.0344474474677684,9.66534609219097e-11
NMR metabolomics,X23412.Phospholipids in VLDL,MMP1,Interstitial collagenase,41693,0.0600217689031131,0.00927717095167396,0.0418385138378321,0.078205023968394,1.01600802914041e-10
NMR metabolomics,X23412.Phospholipids in VLDL,COL2A1,Collagen alpha-1(II) chain,39638,0.0525713820532587,0.008139241160658,0.036618469378369,0.0685242947281484,1.09826733352765e-10
NMR metabolomics,X23412.Phospholipids in VLDL,LEO1,RNA polymerase-associated protein LEO1,39934,0.0194031096398664,0.00300424614740002,0.0135147871909624,0.0252914320887705,1.10027887657048e-10
NMR metabolomics,X23412.Phospholipids in VLDL,PALM,Paralemmin-1,39859,0.0204031361342212,0.00315934473322301,0.0142108204571041,0.0265954518113383,1.10444778361613e-10
NMR metabolomics,X23412.Phospholipids in VLDL,LTB,Lymphotoxin-beta,39919,0.0229075768488484,0.00354865472247013,0.0159522135928069,0.0298629401048898,1.12432490723521e-10
NMR metabolomics,X23412.Phospholipids in VLDL,CD46,Membrane cofactor protein,42107,0.0190330424093429,0.00294987722120887,0.0132512830557736,0.0248148017629123,1.14037091918648e-10
NMR metabolomics,X23412.Phospholipids in VLDL,ADGRG1,Adhesion G-protein coupled receptor G1,42070,-0.0532997346590686,0.00827211058491219,-0.0695130714054965,-0.0370863979126408,1.20875198281923e-10
NMR metabolomics,X23412.Phospholipids in VLDL,MDM1,Nuclear protein MDM1,39649,0.0209060022965279,0.00324480131184926,0.0145461917253033,0.0272658128677524,1.22068918560011e-10
NMR metabolomics,X23412.Phospholipids in VLDL,CD300A,CMRF35-like molecule 8,39736,0.0203525230623619,0.00316034771937116,0.0141582415323944,0.0265468045923294,1.24424011007175e-10
NMR metabolomics,X23412.Phospholipids in VLDL,MYOM2,Myomesin-2,39575,-0.0369843671648613,0.00575506524739803,-0.0482642950497615,-0.0257044392799612,1.36074641764088e-10
NMR metabolomics,X23412.Phospholipids in VLDL,RCOR1,REST corepressor 1,41900,0.0295207714609052,0.00459721707187765,0.020510226000025,0.0385313169217854,1.39576281261998e-10
NMR metabolomics,X23412.Phospholipids in VLDL,MDK,Midkine,42129,0.0338100231417664,0.00526581168936646,0.0234890322306081,0.0441310140529246,1.40209184720131e-10
NMR metabolomics,X23412.Phospholipids in VLDL,CD200R1,Cell surface glycoprotein CD200 receptor 1,42076,0.023371150543301,0.00364347460493372,0.0162299403176309,0.0305123607689711,1.45982754947982e-10
NMR metabolomics,X23412.Phospholipids in VLDL,VSIG4,V-set and immunoglobulin domain-containing protein 4,42113,-0.0284997692269708,0.00445240702382345,-0.0372264869936648,-0.0197730514602768,1.59481442155415e-10
NMR metabolomics,X23412.Phospholipids in VLDL,RGMB,RGM domain family member B,42249,0.0184405436989173,0.00288539361970774,0.0127851722042901,0.0240959151935445,1.70161846379379e-10
NMR metabolomics,X23412.Phospholipids in VLDL,TPM3,Tropomyosin alpha-3 chain,39575,-0.0305222971139892,0.00478045518438533,-0.0398919892753844,-0.0211526049525939,1.78542157702318e-10
NMR metabolomics,X23412.Phospholipids in VLDL,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",39638,0.0606843283800664,0.00950912893927959,0.0420464356590784,0.0793222211010544,1.82161838274973e-10
NMR metabolomics,X23412.Phospholipids in VLDL,LTA,Lymphotoxin-alpha,42119,0.0262794010250332,0.00412017545790498,0.0182038571275394,0.0343549449225269,1.84984952604899e-10
NMR metabolomics,X23412.Phospholipids in VLDL,SCT,Secretin,39649,0.0316774730322716,0.0049666471905935,0.0219428445387083,0.0414121015258348,1.86534219920326e-10
NMR metabolomics,X23412.Phospholipids in VLDL,TFF3,Trefoil factor 3,42143,-0.0236378430536387,0.00371366208787619,-0.0309166207458761,-0.0163590653614014,2.014475368715e-10
NMR metabolomics,X23412.Phospholipids in VLDL,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,41900,0.0375190692378258,0.00589617172404343,0.0259625726587007,0.0490755658169509,2.03947749138718e-10
NMR metabolomics,X23412.Phospholipids in VLDL,KLRD1,Natural killer cells antigen CD94,42296,0.0308130230191774,0.00485695483995282,0.0212933915328699,0.0403326545054849,2.30760178496953e-10
NMR metabolomics,X23412.Phospholipids in VLDL,CD28,T-cell-specific surface glycoprotein CD28,41843,0.0242518672679042,0.00383108781146907,0.0167429351574248,0.0317607993783836,2.52606930049006e-10
NMR metabolomics,X23412.Phospholipids in VLDL,ACP6,Lysophosphatidic acid phosphatase type 6,42247,0.0438431116330108,0.00696187945512668,0.0301978279009625,0.0574883953650591,3.11561738209164e-10
NMR metabolomics,X23412.Phospholipids in VLDL,EBI3_IL27,Interleukin-27,42247,-0.0198537718214079,0.00315277528107367,-0.0260332113723123,-0.0136743322705035,3.12284797694561e-10
NMR metabolomics,X23412.Phospholipids in VLDL,MUC16,Mucin-16,42070,0.123680730466693,0.01965763146056,0.0851517728039956,0.162209688129391,3.236399198194e-10
NMR metabolomics,X23412.Phospholipids in VLDL,TSPAN1,Tetraspanin-1,41900,0.0471913821954234,0.00750215355002449,0.0324871612373754,0.0618956031534714,3.2661330508914e-10
NMR metabolomics,X23412.Phospholipids in VLDL,S100A13,Protein S100-A13,39657,0.0231204722604225,0.00367872958588456,0.0159101622720887,0.0303307822487562,3.40401535171439e-10
NMR metabolomics,X23412.Phospholipids in VLDL,UXS1,UDP-glucuronic acid decarboxylase 1,41843,0.0331882417422241,0.00528147668264894,0.0228365474442321,0.043539936040216,3.40540294659039e-10
NMR metabolomics,X23412.Phospholipids in VLDL,REG1B,Lithostathine-1-beta,42310,-0.0368733170273394,0.00587548077422401,-0.0483892593448185,-0.0253573747098604,3.58319421526178e-10
NMR metabolomics,X23412.Phospholipids in VLDL,CA4,Carbonic anhydrase 4,42310,-0.0156666426614673,0.00249845752870696,-0.0205636194177329,-0.0107696659052016,3.70624002933577e-10
NMR metabolomics,X23412.Phospholipids in VLDL,TPP1,Tripeptidyl-peptidase 1,42057,0.0305230044161633,0.00487488271057384,0.0209682343034386,0.040077774528888,3.93434226352399e-10
NMR metabolomics,X23412.Phospholipids in VLDL,MTUS1,Microtubule-associated tumor suppressor 1,39757,0.0368520965170386,0.0058886379892164,0.0253103660581745,0.0483938269759028,4.03809271386229e-10
NMR metabolomics,X23412.Phospholipids in VLDL,ITGB1BP1,Integrin beta-1-binding protein 1,41843,0.025856281728417,0.00413374482188021,0.0177541418775318,0.0339584215793022,4.09930116171971e-10
NMR metabolomics,X23412.Phospholipids in VLDL,IL1B,Interleukin-1 beta,41825,0.0363015650026093,0.00581341983670886,0.02490726212266,0.0476958678825587,4.38329834217e-10
NMR metabolomics,X23412.Phospholipids in VLDL,APRT,Adenine phosphoribosyltransferase,42002,0.0302385930739194,0.0048440827546377,0.0207441908748295,0.0397329952730093,4.43963983025143e-10
NMR metabolomics,X23412.Phospholipids in VLDL,TSPAN8,Tetraspanin-8,39930,0.0614412327939054,0.00984909831256732,0.0421370001012734,0.0807454654865373,4.58242997031524e-10
NMR metabolomics,X23412.Phospholipids in VLDL,MEPE,Matrix extracellular phosphoglycoprotein,42123,0.0150663737462235,0.00242040889760438,0.0103223723069189,0.0198103751855281,4.96662225277246e-10
NMR metabolomics,X23412.Phospholipids in VLDL,CLEC14A,C-type lectin domain family 14 member A,42137,-0.0205415685411969,0.00330746821108874,-0.0270242062349308,-0.014058930847463,5.43050934013396e-10
NMR metabolomics,X23412.Phospholipids in VLDL,ACVRL1,Serine/threonine-protein kinase receptor R3,41992,0.0164149327302858,0.00265193828466339,0.0112171336923456,0.021612731768226,6.20036792144271e-10
NMR metabolomics,X23412.Phospholipids in VLDL,CTSH,Pro-cathepsin H,41865,0.0475428832770468,0.00768756568473905,0.0324752545349583,0.0626105120191353,6.41747518288907e-10
NMR metabolomics,X23412.Phospholipids in VLDL,CCL20,C-C motif chemokine 20,42296,0.0549295860507785,0.00890924442483996,0.0374674669780922,0.0723917051234649,7.2252527253291e-10
NMR metabolomics,X23412.Phospholipids in VLDL,C1QA,Complement C1q subcomponent subunit A,42230,-0.014197963436576,0.00230352882273673,-0.01871287992914,-0.009683046944012,7.3127315168713e-10
NMR metabolomics,X23412.Phospholipids in VLDL,IGHMBP2,DNA-binding protein SMUBP-2,39575,0.0356781470117266,0.00579483395302029,0.0243202724638068,0.0470360215596464,7.67816051729722e-10
NMR metabolomics,X23412.Phospholipids in VLDL,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",39638,0.0310444835842593,0.0050537033356502,0.0211392250463849,0.0409497421221337,8.38100509550454e-10
NMR metabolomics,X23412.Phospholipids in VLDL,DDC,Aromatic-L-amino-acid decarboxylase,42129,-0.0300330489428966,0.00489243149763873,-0.0396222146782685,-0.0204438832075247,8.55382603443675e-10
NMR metabolomics,X23412.Phospholipids in VLDL,WASF3,Wiskott-Aldrich syndrome protein family member 3,41839,0.0537161365407957,0.00875143873337799,0.0365633166233748,0.0708689564582165,8.59653732580645e-10
NMR metabolomics,X23412.Phospholipids in VLDL,PVALB,Parvalbumin alpha,42208,0.0705735836722957,0.0115018396575328,0.0480299779435314,0.09311718940106,8.70534667533999e-10
NMR metabolomics,X23412.Phospholipids in VLDL,CSDE1,Cold shock domain-containing protein E1,39575,0.0763549891167377,0.012453993972168,0.0519451609312885,0.100764817302187,9.03511872717482e-10
NMR metabolomics,X23412.Phospholipids in VLDL,CELA3A,Chymotrypsin-like elastase family member 3A,42293,0.0379163977979147,0.00619852969789401,0.0257672795900425,0.050065516005787,9.79505794399111e-10
NMR metabolomics,X23412.Phospholipids in VLDL,ACTN2,Alpha-actinin-2,39575,-0.040722735056611,0.00667192829561965,-0.0537997145160256,-0.0276457555971965,1.07213071648553e-09
NMR metabolomics,X23412.Phospholipids in VLDL,CWC15,Spliceosome-associated protein CWC15 homolog,39872,0.0395475966842905,0.00647973925248429,0.0268473077494213,0.0522478856191597,1.07335733691505e-09
NMR metabolomics,X23412.Phospholipids in VLDL,ITGA11,Integrin alpha-11,42119,-0.0212469644597428,0.00348510816258325,-0.028077776458406,-0.0144161524610796,1.11366568867182e-09
NMR metabolomics,X23412.Phospholipids in VLDL,CA7,Carbonic anhydrase 7,39757,-0.0211076568617548,0.00346476944633082,-0.0278986049765632,-0.0143167087469464,1.1512667271569e-09
NMR metabolomics,X23412.Phospholipids in VLDL,IGSF21,Immunoglobulin superfamily member 21,39638,0.0252970096453759,0.00415459535040695,0.0171540027585783,0.0334400165321736,1.17454025924426e-09
NMR metabolomics,X23412.Phospholipids in VLDL,SFTPD,Pulmonary surfactant-associated protein D,42145,0.0423350413757972,0.00695459319271269,0.0287040387180804,0.0559660440335141,1.17895252093279e-09
NMR metabolomics,X23412.Phospholipids in VLDL,AGER,Advanced glycosylation end product-specific receptor,42093,0.0256936357833703,0.00422618616088221,0.0174103109080412,0.0339769606586995,1.23712059405698e-09
NMR metabolomics,X23412.Phospholipids in VLDL,GCLM,Glutamate--cysteine ligase regulatory subunit,39575,0.0277045886097844,0.00456022019894868,0.018766557019845,0.0366426201997238,1.27880332525119e-09
NMR metabolomics,X23412.Phospholipids in VLDL,ICAM4,Intercellular adhesion molecule 4,42119,-0.0328213952805222,0.00540632296865557,-0.0434177882990871,-0.0222250022619573,1.30578265747481e-09
NMR metabolomics,X23412.Phospholipids in VLDL,AGT,Angiotensinogen,39990,0.0136411830217118,0.00224746539897151,0.00923615083972762,0.0180462152036959,1.32321171588467e-09
NMR metabolomics,X23412.Phospholipids in VLDL,ZBTB17,Zinc finger and BTB domain-containing protein 17,41900,0.0262167249839002,0.0043315875256255,0.0177268134336742,0.0347066365341261,1.46494110467414e-09
NMR metabolomics,X23412.Phospholipids in VLDL,AKR7L,Aflatoxin B1 aldehyde reductase member 4,39657,0.0433101694703189,0.00715543963113467,0.029285507793295,0.0573348311473429,1.47001159405378e-09
NMR metabolomics,X23412.Phospholipids in VLDL,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,39575,0.0407251359762314,0.0067569587775693,0.0274814967721955,0.0539687751802672,1.72248965502941e-09
NMR metabolomics,X23412.Phospholipids in VLDL,CD302,CD302 antigen,42070,0.0192864795435126,0.00320670753269862,0.0130013327794233,0.0255716263076019,1.85209494021464e-09
NMR metabolomics,X23412.Phospholipids in VLDL,RPE,Ribulose-phosphate 3-epimerase,39757,0.0444638573505143,0.0073950142626668,0.0299696293956874,0.0589580853053412,1.88192651800022e-09
NMR metabolomics,X23412.Phospholipids in VLDL,EFHD1,EF-hand domain-containing protein D1,39934,0.0223217738634449,0.0037148479155693,0.0150406719489291,0.0296028757779607,1.92646108201905e-09
NMR metabolomics,X23412.Phospholipids in VLDL,SNX5,Sorting nexin-5,39638,0.018491213457092,0.00307787515576772,0.0124585781517872,0.0245238487623967,1.94006908849343e-09
NMR metabolomics,X23412.Phospholipids in VLDL,MYL3,Myosin light chain 3,39638,-0.0487485253087473,0.00811727712469541,-0.0646583884731503,-0.0328386621443443,1.96718277387745e-09
NMR metabolomics,X23412.Phospholipids in VLDL,AK1,Adenylate kinase isoenzyme 1,42145,0.0379699194512076,0.00632931306134818,0.0255644658509651,0.05037537305145,2.03524532251363e-09
NMR metabolomics,X23412.Phospholipids in VLDL,SCARF2,Scavenger receptor class F member 2,42249,-0.0175545282573715,0.00292774955409962,-0.0232929173834068,-0.0118161391313363,2.07455124530336e-09
NMR metabolomics,X23412.Phospholipids in VLDL,L1CAM,Neural cell adhesion molecule L1,42181,0.0183117433902712,0.00305568116366167,0.0123226083094944,0.0243008784710481,2.11626785618417e-09
NMR metabolomics,X23412.Phospholipids in VLDL,ZBP1,Z-DNA-binding protein 1,39657,0.0255584464114484,0.00427246765340298,0.0171844098107786,0.0339324830121182,2.27060293675534e-09
NMR metabolomics,X23412.Phospholipids in VLDL,PRKD2,Serine/threonine-protein kinase D2,39575,0.0269967283398228,0.00451547675475054,0.0181463939005118,0.0358470627791339,2.31910863421176e-09
NMR metabolomics,X23412.Phospholipids in VLDL,SLAMF7,SLAM family member 7,42119,-0.0367220878952737,0.00614392634254098,-0.048764183526654,-0.0246799922638934,2.33043302171136e-09
NMR metabolomics,X23412.Phospholipids in VLDL,INSR,Insulin receptor,39657,0.0105636385519363,0.00177060558097765,0.0070932516132201,0.0140340254906525,2.5041028765705e-09
NMR metabolomics,X23412.Phospholipids in VLDL,TGFA,Protransforming growth factor alpha,42119,0.0277753892983747,0.00465770857058932,0.0186462805000196,0.0369044980967297,2.5333601426567e-09
NMR metabolomics,X23412.Phospholipids in VLDL,TDO2,"Tryptophan 2,3-dioxygenase",39649,0.0241591798010553,0.00405303075522834,0.0162152395208077,0.0321031200813028,2.58722830959528e-09
NMR metabolomics,X23412.Phospholipids in VLDL,PRTG,Protogenin,42262,0.014985192422065,0.00252941639217635,0.0100275362933994,0.0199428485507307,3.21043240125519e-09
NMR metabolomics,X23412.Phospholipids in VLDL,PTGES2,Prostaglandin E synthase 2,39579,0.0341045469366522,0.00576331674690042,0.0228084461127274,0.045400647760577,3.36593980219835e-09
NMR metabolomics,X23412.Phospholipids in VLDL,RANBP1,Ran-specific GTPase-activating protein,39638,0.0314984875117181,0.00532789240870923,0.021055818390648,0.0419411566327882,3.47988412850119e-09
NMR metabolomics,X23412.Phospholipids in VLDL,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],42070,0.0344209072379702,0.00582689802627619,0.0230001871064688,0.0458416273694715,3.56271740006721e-09
NMR metabolomics,X23412.Phospholipids in VLDL,SV2A,Synaptic vesicle glycoprotein 2A,39649,0.0380181331991913,0.00643984459583993,0.025396037791345,0.0506402286070375,3.66158448391132e-09
NMR metabolomics,X23412.Phospholipids in VLDL,XG,Glycoprotein Xg,42261,0.0210180061381967,0.00356761142485886,0.0140254877454733,0.0280105245309201,3.92095769240196e-09
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINB8,Serpin B8,42296,0.0354412895783002,0.00601923940269557,0.0236435803490169,0.0472389988075836,4.0004927568373e-09
NMR metabolomics,X23412.Phospholipids in VLDL,NAGA,Alpha-N-acetylgalactosaminidase,39636,0.0349554625762918,0.00594493257259751,0.0233033947340007,0.0466075304185829,4.2247320697559e-09
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,42137,-0.0223267607521066,0.00380270574736411,-0.0297800640169403,-0.014873457487273,4.42570331848118e-09
NMR metabolomics,X23412.Phospholipids in VLDL,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,39757,0.0426164320494631,0.00727673983203662,0.0283540219786713,0.0568788421202549,4.85978459904499e-09
NMR metabolomics,X23412.Phospholipids in VLDL,CXCL12,Stromal cell-derived factor 1,41913,0.0238131854173793,0.00406837184415147,0.0158391766028425,0.0317871942319162,4.93418565601071e-09
NMR metabolomics,X23412.Phospholipids in VLDL,FABP6,Gastrotropin,41881,0.0342571345543712,0.00585396269458571,0.0227833676729832,0.0457309014357592,4.97281602565319e-09
NMR metabolomics,X23412.Phospholipids in VLDL,PTGDS,Prostaglandin-H2 D-isomerase,42083,0.019030587505909,0.00325899301204046,0.0126429612023097,0.0254182138095083,5.35934300219974e-09
NMR metabolomics,X23412.Phospholipids in VLDL,SCARB2,Lysosome membrane protein 2,41777,0.0198214057467651,0.00339440410261467,0.0131683737056404,0.0264744377878899,5.36124872857516e-09
NMR metabolomics,X23412.Phospholipids in VLDL,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,39958,0.0206458655834193,0.00353843480697025,0.0137105333617576,0.027581197805081,5.53438101010822e-09
NMR metabolomics,X23412.Phospholipids in VLDL,SMPD1,Sphingomyelin phosphodiesterase,42176,-0.03066816487046,0.00527228834871953,-0.0410018500339503,-0.0203344797069697,6.13140177900226e-09
NMR metabolomics,X23412.Phospholipids in VLDL,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",41843,0.0470015877281213,0.0080875519757963,0.0311499858555605,0.062853189600682,6.33041958660907e-09
NMR metabolomics,X23412.Phospholipids in VLDL,CDH5,Cadherin-5,42310,-0.0181831509072917,0.00312913947026339,-0.024316264269008,-0.0120500375455755,6.35141331093958e-09
NMR metabolomics,X23412.Phospholipids in VLDL,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,39575,0.0305116029091644,0.00525052446690464,0.0202205749540313,0.0408026308642975,6.37700333753897e-09
NMR metabolomics,X23412.Phospholipids in VLDL,CXCL8,Interleukin-8,42035,0.0405799366614496,0.00698500285945611,0.0268893310569156,0.0542705422659836,6.40483837895744e-09
NMR metabolomics,X23412.Phospholipids in VLDL,LXN,Latexin,41960,-0.0408810069795352,0.0070612708219103,-0.0547210977904794,-0.027040916168591,7.21962670618295e-09
NMR metabolomics,X23412.Phospholipids in VLDL,CCL14,C-C motif chemokine 14,42152,0.024088764916912,0.00416318937276431,0.0159289137462939,0.03224861608753,7.36174086351192e-09
NMR metabolomics,X23412.Phospholipids in VLDL,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,39930,0.0240081967068422,0.00414971462204904,0.0158747560476261,0.0321416373660584,7.42085668125488e-09
NMR metabolomics,X23412.Phospholipids in VLDL,VSIG10,V-set and immunoglobulin domain-containing protein 10,39919,0.020627504866988,0.00357346149062526,0.0136235203453624,0.0276314893886135,8.01955388788486e-09
NMR metabolomics,X23412.Phospholipids in VLDL,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",39638,0.018744477246272,0.00325128879239069,0.0123719512131862,0.0251170032793577,8.37252528765735e-09
NMR metabolomics,X23412.Phospholipids in VLDL,CFC1,Cryptic protein,41843,0.0283872140078297,0.00492731169166646,0.0187296830921634,0.038044744923496,8.53771168625223e-09
NMR metabolomics,X23412.Phospholipids in VLDL,GPNMB,Transmembrane glycoprotein NMB,41802,0.0172392265407385,0.00299777048441862,0.011363596391278,0.023114856690199,9.08528826312526e-09
NMR metabolomics,X23412.Phospholipids in VLDL,CCL15,C-C motif chemokine 15,42310,0.0257846359844875,0.00448418346354746,0.0169956363959345,0.0345736355730405,9.10759854633269e-09
NMR metabolomics,X23412.Phospholipids in VLDL,NXPH3,Neurexophilin-3,39657,0.0178202527296498,0.0031005700171532,0.0117431354960295,0.0238973699632701,9.30157438763448e-09
NMR metabolomics,X23412.Phospholipids in VLDL,IL12B,Interleukin-12 subunit beta,42296,0.0324231886001506,0.00564399822917292,0.0213609520709717,0.0434854251293295,9.4030770929657e-09
NMR metabolomics,X23412.Phospholipids in VLDL,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,39657,0.0184758225746495,0.00321581866592776,0.0121728179894311,0.0247788271598679,9.41841739299925e-09
NMR metabolomics,X23412.Phospholipids in VLDL,NFIC,Nuclear factor 1 C-type,39934,0.0270395712065294,0.00472113310177999,0.0177861503270406,0.0362929920860181,1.04607460526665e-08
NMR metabolomics,X23412.Phospholipids in VLDL,CD93,Complement component C1q receptor,41654,-0.0185552683144613,0.0032434373445641,-0.0249124055098069,-0.0121981311191156,1.08309573057103e-08
NMR metabolomics,X23412.Phospholipids in VLDL,CA2,Carbonic anhydrase 2,42103,0.0390492315684212,0.00683027939101161,0.0256618839620384,0.0524365791748039,1.10665542093903e-08
NMR metabolomics,X23412.Phospholipids in VLDL,CALB2,Calretinin,41839,0.0172821599750985,0.00302758215675832,0.0113480989478521,0.0232162210023448,1.16600988055772e-08
NMR metabolomics,X23412.Phospholipids in VLDL,DDR1,Epithelial discoidin domain-containing receptor 1,42249,0.0139210180511046,0.00243922771936618,0.00914013172114694,0.0187019043810623,1.17277872814265e-08
NMR metabolomics,X23412.Phospholipids in VLDL,NTF4,Neurotrophin-4,41843,0.0222522338438985,0.00389950592989534,0.0146092022213037,0.0298952654664934,1.17846215196825e-08
NMR metabolomics,X23412.Phospholipids in VLDL,CAT,Catalase,39827,0.0308239532644054,0.0054010500197205,0.0202378952257532,0.0414100113030575,1.17875850406257e-08
NMR metabolomics,X23412.Phospholipids in VLDL,SFTPA1,Pulmonary surfactant-associated protein A1,41843,0.033342342021496,0.00585846935427113,0.0218597420871246,0.0448249419558674,1.28744268496921e-08
NMR metabolomics,X23412.Phospholipids in VLDL,SEL1L,Protein sel-1 homolog 1,39638,0.0183786347926028,0.00324778975668538,0.0120129668694995,0.0247443027157062,1.56221279841429e-08
NMR metabolomics,X23412.Phospholipids in VLDL,ADAMTSL2,ADAMTS-like protein 2,39966,0.0202567741801145,0.00358175153335596,0.0132365411747368,0.0272770071854921,1.59097437037811e-08
NMR metabolomics,X23412.Phospholipids in VLDL,CST5,Cystatin-D,41846,0.0326856791579444,0.00579134104487683,0.0213346507099858,0.044036707605903,1.69662727919247e-08
NMR metabolomics,X23412.Phospholipids in VLDL,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,39919,0.0313567095799732,0.00556478596715847,0.0204497290843426,0.0422636900756038,1.79401034968899e-08
NMR metabolomics,X23412.Phospholipids in VLDL,GUCA2A,Guanylin,42083,-0.0204201332252924,0.00362634226969746,-0.0275277640738995,-0.0133125023766854,1.82687334314784e-08
NMR metabolomics,X23412.Phospholipids in VLDL,TOR1AIP1,Torsin-1A-interacting protein 1,39638,0.0304904240747477,0.00542441901113999,0.0198585628129133,0.041122285336582,1.94511367715558e-08
NMR metabolomics,X23412.Phospholipids in VLDL,PECR,Peroxisomal trans-2-enoyl-CoA reductase,39638,0.0160622032333909,0.00286149507941227,0.0104536728777428,0.0216707335890389,2.03388492757866e-08
NMR metabolomics,X23412.Phospholipids in VLDL,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,39638,0.0370465191643148,0.00659990648642886,0.0241107024509143,0.0499823358777154,2.03426183286083e-08
NMR metabolomics,X23412.Phospholipids in VLDL,HIP1R,Huntingtin-interacting protein 1-related protein,39904,0.0264695397643366,0.00471674972464337,0.0172247103040356,0.0357143692246377,2.04925212315264e-08
NMR metabolomics,X23412.Phospholipids in VLDL,CXADR,Coxsackievirus and adenovirus receptor,42119,0.0282424366050829,0.00504065662473688,0.0183627496205986,0.0381221235895672,2.1487674960658e-08
NMR metabolomics,X23412.Phospholipids in VLDL,NPC2,NPC intracellular cholesterol transporter 2,39820,0.0191089218521724,0.00341574919465026,0.0124140534306579,0.0258037902736869,2.26628591376092e-08
NMR metabolomics,X23412.Phospholipids in VLDL,C8B,Complement component C8 beta chain,39979,0.0174875865344459,0.00312684511766457,0.0113589701038233,0.0236162029650685,2.28689962483682e-08
NMR metabolomics,X23412.Phospholipids in VLDL,GNLY,Granulysin,42137,0.0310555317862482,0.0055568912537142,0.0201640249289683,0.041947038643528,2.33257700787074e-08
NMR metabolomics,X23412.Phospholipids in VLDL,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,39919,0.0375323984038727,0.00673008552012528,0.0243414307844271,0.0507233660233182,2.50590408061797e-08
NMR metabolomics,X23412.Phospholipids in VLDL,TMPRSS11D,Transmembrane protease serine 11D,39906,0.0220576265616984,0.00395838613861666,0.0142991897300098,0.0298160633933871,2.5703718751613e-08
NMR metabolomics,X23412.Phospholipids in VLDL,IGFBP4,Insulin-like growth factor-binding protein 4,41930,0.0261527452708957,0.00469460842666237,0.0169513127546375,0.035354177787154,2.58476857298373e-08
NMR metabolomics,X23412.Phospholipids in VLDL,ODAM,Odontogenic ameloblast-associated protein,41814,0.0308221449815237,0.00554260656297892,0.0199586361180851,0.0416856538449624,2.73520038917635e-08
NMR metabolomics,X23412.Phospholipids in VLDL,COPB2,Coatomer subunit beta',39575,0.0246078602633392,0.00444538985662327,0.0158948961443576,0.0333208243823208,3.17310237577819e-08
NMR metabolomics,X23412.Phospholipids in VLDL,TXN,Thioredoxin,39854,0.0245506997066071,0.00443676416711599,0.0158546419390598,0.0332467574741544,3.20982746554097e-08
NMR metabolomics,X23412.Phospholipids in VLDL,PCSK7,Proprotein convertase subtilisin/kexin type 7,39919,0.0255343908766878,0.00462097560546075,0.0164772786899847,0.0345915030633908,3.35325655707014e-08
NMR metabolomics,X23412.Phospholipids in VLDL,BSG,Basigin,42284,0.0118710833264423,0.00215116891813033,0.00765479224690685,0.0160873744059777,3.48251786343692e-08
NMR metabolomics,X23412.Phospholipids in VLDL,ICOSLG,ICOS ligand,42070,0.010856546454515,0.00196957760590612,0.00699617434693905,0.014716918562091,3.61057544397687e-08
NMR metabolomics,X23412.Phospholipids in VLDL,HSD17B3,Testosterone 17-beta-dehydrogenase 3,39575,0.027261685104254,0.00494721240239668,0.0175651487955565,0.0369582214129515,3.65865427358281e-08
NMR metabolomics,X23412.Phospholipids in VLDL,NCF2,Neutrophil cytosol factor 2,42097,0.0471475795606277,0.00855862476430693,0.0303726750225861,0.0639224840986693,3.67944038737982e-08
NMR metabolomics,X23412.Phospholipids in VLDL,KLRF1,Killer cell lectin-like receptor subfamily F member 1,39657,0.0252576787236356,0.0045884509643685,0.0162643148334733,0.0342510426137979,3.78222126201055e-08
NMR metabolomics,X23412.Phospholipids in VLDL,POSTN,Periostin,39966,-0.0215035304342752,0.00390750191386366,-0.0291622341854479,-0.0138448266831024,3.81175070015626e-08
NMR metabolomics,X23412.Phospholipids in VLDL,CABP2,Calcium-binding protein 2,39649,0.0371250902930915,0.00675278695085166,0.0238896278694222,0.0503605527167607,3.93231376095517e-08
NMR metabolomics,X23412.Phospholipids in VLDL,DGCR6,Protein DGCR6,39586,0.0237667780992157,0.00432655338469412,0.0152867334652153,0.0322468227332162,4.0342825825105e-08
NMR metabolomics,X23412.Phospholipids in VLDL,PLA2G15,Phospholipase A2 group XV,42181,0.0155203104816143,0.00282975954668326,0.00997398177011506,0.0210666391931135,4.21638650101203e-08
NMR metabolomics,X23412.Phospholipids in VLDL,CNTN5,Contactin-5,42170,0.0208982108429835,0.00381288387798871,0.0134249584421256,0.0283714632438414,4.30609000993707e-08
NMR metabolomics,X23412.Phospholipids in VLDL,EDA2R,Tumor necrosis factor receptor superfamily member 27,42262,-0.0234043337498803,0.0042737506272704,-0.0317808849793303,-0.0150277825204303,4.4198943507277e-08
NMR metabolomics,X23412.Phospholipids in VLDL,PBK,Lymphokine-activated killer T-cell-originated protein kinase,39560,-0.0176324907973481,0.00322582765968497,-0.0239551130103306,-0.0113098685843655,4.702911406205e-08
NMR metabolomics,X23412.Phospholipids in VLDL,BRD1,Bromodomain-containing protein 1,39757,-0.0171667407402638,0.00314263985187731,-0.0233263148499434,-0.0110071666305843,4.79490006810292e-08
NMR metabolomics,X23412.Phospholipids in VLDL,CA1,Carbonic anhydrase 1,41890,0.0316586093199925,0.00580408515124092,0.0202826024235603,0.0430346162164247,4.99783291060813e-08
NMR metabolomics,X23412.Phospholipids in VLDL,KRT19,"Keratin, type I cytoskeletal 19",42094,-0.0380754909879661,0.00698194307510419,-0.0517600994151703,-0.0243908825607618,5.02789366765435e-08
NMR metabolomics,X23412.Phospholipids in VLDL,ENSA,Alpha-endosulfine,39919,0.0298164904257802,0.00547030070333671,0.0190947010472403,0.0405382798043202,5.12492385455657e-08
NMR metabolomics,X23412.Phospholipids in VLDL,INSL5,Insulin-like peptide INSL5,39930,0.0573564165490056,0.0105788554910759,0.0366218597864968,0.0780909733115144,6.0213305074457e-08
NMR metabolomics,X23412.Phospholipids in VLDL,ITGAM,Integrin alpha-M,42137,-0.0176271059360503,0.00325286811223589,-0.0240027274360327,-0.011251484436068,6.09786516944354e-08
NMR metabolomics,X23412.Phospholipids in VLDL,GRN,Progranulin,42077,0.0139570852485738,0.00258911659004415,0.00888241673208732,0.0190317537650604,7.13760484054094e-08
NMR metabolomics,X23412.Phospholipids in VLDL,TCN2,Transcobalamin-2,42286,-0.0167484269092301,0.00311663133135838,-0.0228570243186926,-0.0106398294997677,7.83194334064337e-08
NMR metabolomics,X23412.Phospholipids in VLDL,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",41820,0.0259394337685863,0.00483872357479883,0.0164555355619806,0.035423331975192,8.42462385602176e-08
NMR metabolomics,X23412.Phospholipids in VLDL,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,42296,0.0194321515989506,0.00362715400583823,0.0123229297475077,0.0265413734503936,8.5789151346817e-08
NMR metabolomics,X23412.Phospholipids in VLDL,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,39966,-0.0225753752543064,0.00421655876105722,-0.0308398304259785,-0.0143109200826342,8.77153373090466e-08
NMR metabolomics,X23412.Phospholipids in VLDL,EFNA4,Ephrin-A4,41992,0.0178248038071392,0.00333046432276872,0.0112970937345125,0.0243525138797659,8.83979492707013e-08
NMR metabolomics,X23412.Phospholipids in VLDL,THBD,Thrombomodulin,42145,0.0162486854075414,0.00304239283069755,0.0102855954593742,0.0222117753557086,9.40544390685986e-08
NMR metabolomics,X23412.Phospholipids in VLDL,STAM,Signal transducing adapter molecule 1,39919,0.0199266503320507,0.00373280327578057,0.0126103559115208,0.0272429447525806,9.56602608869387e-08
NMR metabolomics,X23412.Phospholipids in VLDL,IL1RL1,Interleukin-1 receptor-like 1,42272,-0.0261863011279341,0.00491429724550397,-0.0358183237291219,-0.0165542785267464,1.00545947104675e-07
NMR metabolomics,X23412.Phospholipids in VLDL,ATP6V1G2,V-type proton ATPase subunit G 2,39575,0.0537580581900326,0.0100910029078438,0.0339796924906588,0.0735364238894065,1.01641101821246e-07
NMR metabolomics,X23412.Phospholipids in VLDL,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,39649,0.0299642264692282,0.00563871225621903,0.0189123504470389,0.0410161024914174,1.09319713433532e-07
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINI2,Serpin I2,39930,0.0316696350196153,0.00596961490821061,0.0199691897995225,0.0433700802397081,1.14709421068714e-07
NMR metabolomics,X23412.Phospholipids in VLDL,IGFBP6,Insulin-like growth factor-binding protein 6,42129,0.017051224545211,0.00322112501340907,0.0107378195189292,0.0233646295714928,1.21831684606266e-07
NMR metabolomics,X23412.Phospholipids in VLDL,IL17C,Interleukin-17C,41913,-0.0386629273510942,0.0073050953946872,-0.0529809143246811,-0.0243449403775072,1.22505739554471e-07
NMR metabolomics,X23412.Phospholipids in VLDL,LCP1,Plastin-2,39966,0.026163491687669,0.00494573482448155,0.0164698514316852,0.0358571319436528,1.24512789809241e-07
NMR metabolomics,X23412.Phospholipids in VLDL,SIL1,Nucleotide exchange factor SIL1,39638,0.0179329114376478,0.00339008393676618,0.0112883469215861,0.0245774759537096,1.24783925371524e-07
NMR metabolomics,X23412.Phospholipids in VLDL,CD86,T-lymphocyte activation antigen CD86,39930,0.0165398437725573,0.00313772887444439,0.0103898951786463,0.0226897923664683,1.37966943388949e-07
NMR metabolomics,X23412.Phospholipids in VLDL,CA6,Carbonic anhydrase 6,42103,-0.0339795844527097,0.00645055838614289,-0.0466226788895497,-0.0213364900158696,1.40268840149078e-07
NMR metabolomics,X23412.Phospholipids in VLDL,S100P,Protein S100-P,41900,0.0290375457640337,0.00551423595577107,0.0182296432907224,0.039845448237345,1.41659536307637e-07
NMR metabolomics,X23412.Phospholipids in VLDL,LUZP2,Leucine zipper protein 2,39919,0.0244026713741133,0.00463878935969569,0.0153106442291098,0.0334946985191169,1.46232017408374e-07
NMR metabolomics,X23412.Phospholipids in VLDL,S100A11,Protein S100-A11,42027,0.0250279964351328,0.00476466547967909,0.0156892520949617,0.0343667407753038,1.52065724375103e-07
NMR metabolomics,X23412.Phospholipids in VLDL,TDP1,Tyrosyl-DNA phosphodiesterase 1,39919,0.0388028111242289,0.00739338019344768,0.0243117859450715,0.0532938363033864,1.56270857806061e-07
NMR metabolomics,X23412.Phospholipids in VLDL,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",42119,0.0222122484724745,0.00424273292135129,0.0138964919466259,0.030528004998323,1.67127779584642e-07
NMR metabolomics,X23412.Phospholipids in VLDL,VAMP5,Vesicle-associated membrane protein 5,41900,0.0278214957654766,0.00534136046290559,0.0173524292581816,0.0382905622727715,1.93017286913888e-07
NMR metabolomics,X23412.Phospholipids in VLDL,GRSF1,G-rich sequence factor 1,39486,0.0448339642215347,0.00860738930261797,0.0279634811884035,0.0617044472546659,1.93562973288463e-07
NMR metabolomics,X23412.Phospholipids in VLDL,PLXNB2,Plexin-B2,42255,0.0131197210954046,0.00252039209843791,0.00817975258246634,0.0180596896083429,1.96356967950567e-07
NMR metabolomics,X23412.Phospholipids in VLDL,SCN4B,Sodium channel subunit beta-4,39638,0.0234120207485109,0.00449781603330428,0.0145963013232345,0.0322277401737873,1.97272251440016e-07
NMR metabolomics,X23412.Phospholipids in VLDL,GLYR1,Putative oxidoreductase GLYR1,39919,0.0311251266021199,0.00598333556669569,0.0193977888913964,0.0428524643128435,2.00634022155569e-07
NMR metabolomics,X23412.Phospholipids in VLDL,KIF1C,Kinesin-like protein KIF1C,39575,0.0187217615708635,0.00360285000551821,0.0116601755600478,0.0257833475816792,2.06859610973467e-07
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,42144,0.0186121145884679,0.00358302476182924,0.0115893860552826,0.0256348431216532,2.08219680130953e-07
NMR metabolomics,X23412.Phospholipids in VLDL,MUC2,Mucin-2,39966,0.0496475528838077,0.00957897012130009,0.0308727714460595,0.0684223343215558,2.22122099072446e-07
NMR metabolomics,X23412.Phospholipids in VLDL,LRRC38,Leucine-rich repeat-containing protein 38,39649,0.025178678212587,0.00486039751756699,0.0156522990781557,0.0347050573470183,2.25342480194783e-07
NMR metabolomics,X23412.Phospholipids in VLDL,CBS,Cystathionine beta-synthase,39638,0.0276913516582142,0.00534596631764689,0.0172132576756263,0.0381694456408021,2.25968228626585e-07
NMR metabolomics,X23412.Phospholipids in VLDL,GFAP,Glial fibrillary acidic protein,41820,0.0242964636694744,0.00469214897882495,0.0150998516709775,0.0334930756679713,2.27436019236133e-07
NMR metabolomics,X23412.Phospholipids in VLDL,TNFSF13,Tumor necrosis factor ligand superfamily member 13,42185,0.0147058504014026,0.00284375752311634,0.00913208565609453,0.0202796151467106,2.35807315266811e-07
NMR metabolomics,X23412.Phospholipids in VLDL,IL34,Interleukin-34,41814,0.0194507384803187,0.00376222831393728,0.0120767709850016,0.0268247059756358,2.37505623146852e-07
NMR metabolomics,X23412.Phospholipids in VLDL,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,39638,-0.0180645222534657,0.00349622467593546,-0.0249171226182992,-0.0112119218886322,2.42208305174327e-07
NMR metabolomics,X23412.Phospholipids in VLDL,CHCHD6,MICOS complex subunit MIC25,39919,0.0154473231337099,0.00299663003326863,0.00957392826850341,0.0213207179989165,2.58049107770685e-07
NMR metabolomics,X23412.Phospholipids in VLDL,BMP10,Bone morphogenetic protein 10,39736,0.015016341892184,0.00292439149142039,0.00928453456900001,0.0207481492153679,2.87122271187545e-07
NMR metabolomics,X23412.Phospholipids in VLDL,LYAR,Cell growth-regulating nucleolar protein,41843,0.0281403154523944,0.0054930111862532,0.0173740135273381,0.0389066173774506,3.05052185979242e-07
NMR metabolomics,X23412.Phospholipids in VLDL,RNASE3,Eosinophil cationic protein,42081,0.0574212758317707,0.0112093697815364,0.0354509110599592,0.0793916406035821,3.05488721512381e-07
NMR metabolomics,X23412.Phospholipids in VLDL,CA12,Carbonic anhydrase 12,42070,-0.01721125433504,0.00337214642887539,-0.0238206613356358,-0.0106018473344442,3.3717413306315e-07
NMR metabolomics,X23412.Phospholipids in VLDL,FABP9,Fatty acid-binding protein 9,42119,0.0294992373232374,0.00580415498548272,0.0181230935516913,0.0408753810947835,3.77603270100875e-07
NMR metabolomics,X23412.Phospholipids in VLDL,NFYA,Nuclear transcription factor Y subunit alpha,39575,0.0202051684972983,0.00398488470167332,0.0123947944820186,0.0280155425125781,4.03346863150587e-07
NMR metabolomics,X23412.Phospholipids in VLDL,ITGB1,Integrin beta-1,42167,0.0110070640858727,0.0021725488333359,0.0067488683725343,0.015265259799211,4.10675528896928e-07
NMR metabolomics,X23412.Phospholipids in VLDL,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",39638,0.0373520427253338,0.0073771709025883,0.0228927877562607,0.0518112976944069,4.18942975713285e-07
NMR metabolomics,X23412.Phospholipids in VLDL,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,39736,0.0192442353055549,0.00380283839399836,0.0117906720533182,0.0266977985577917,4.24847819914405e-07
NMR metabolomics,X23412.Phospholipids in VLDL,CIT,Citron Rho-interacting kinase,39649,0.0239113386956098,0.00472888245725852,0.0146427290793831,0.0331799483118366,4.339905555333e-07
NMR metabolomics,X23412.Phospholipids in VLDL,FCRL3,Fc receptor-like protein 3,41913,0.0279020133137313,0.00551885455147154,0.0170850583928471,0.0387189682346155,4.34371652124534e-07
NMR metabolomics,X23412.Phospholipids in VLDL,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,42217,-0.0223706686851002,0.00442888172472555,-0.0310512768655623,-0.0136900605046382,4.44986981323887e-07
NMR metabolomics,X23412.Phospholipids in VLDL,CD55,Complement decay-accelerating factor,41714,0.0136791738490429,0.00271319236829827,0.00836131680717833,0.0189970308909076,4.67506446463611e-07
NMR metabolomics,X23412.Phospholipids in VLDL,CD79B,B-cell antigen receptor complex-associated protein beta chain,42296,-0.0236889070071604,0.00470315468750927,-0.0329070901946785,-0.0144707238196422,4.79372295065757e-07
NMR metabolomics,X23412.Phospholipids in VLDL,VIPR1,Vasoactive intestinal polypeptide receptor 1,39638,-0.0122413808676773,0.00244031285224739,-0.0170243940580822,-0.00745836767727242,5.34912340047755e-07
NMR metabolomics,X23412.Phospholipids in VLDL,SUSD2,Sushi domain-containing protein 2,42137,-0.0146193148052215,0.00292114223687319,-0.0203447535894929,-0.00889387602095001,5.66644647014829e-07
NMR metabolomics,X23412.Phospholipids in VLDL,PPME1,Protein phosphatase methylesterase 1,42070,0.0299307639813808,0.00598968298496252,0.0181909853308543,0.0416705426319074,5.89435187851108e-07
NMR metabolomics,X23412.Phospholipids in VLDL,APLP1,Amyloid-like protein 1,42145,-0.0261459839773796,0.00523233001808351,-0.0364013508128233,-0.0158906171419359,5.89538519001773e-07
NMR metabolomics,X23412.Phospholipids in VLDL,MRPL46,"39S ribosomal protein L46, mitochondrial",41839,0.0142385752611585,0.00286060115951428,0.00863179698851055,0.0198453535338065,6.52286774994896e-07
NMR metabolomics,X23412.Phospholipids in VLDL,DIPK2B,Divergent protein kinase domain 2B,39736,0.0154017660907157,0.00309425900416429,0.00933701844255371,0.0214665137388777,6.53646811784388e-07
NMR metabolomics,X23412.Phospholipids in VLDL,SLC16A1,Monocarboxylate transporter 1,41839,0.0282311949833488,0.00567661180910643,0.0171050358375002,0.0393573541291974,6.66658053234967e-07
NMR metabolomics,X23412.Phospholipids in VLDL,DKK4,Dickkopf-related protein 4,41992,0.0236153318045644,0.0047510471733461,0.0143032793448061,0.0329273842643228,6.75876764179515e-07
NMR metabolomics,X23412.Phospholipids in VLDL,HLA_E,,42119,0.014992358664441,0.00302173238739383,0.00906976318514906,0.0209149541437329,7.07975458565294e-07
NMR metabolomics,X23412.Phospholipids in VLDL,CD74,HLA class II histocompatibility antigen gamma chain,42249,0.0176972325231598,0.00356878601864313,0.0107024119266192,0.0246920531197003,7.17477392685807e-07
NMR metabolomics,X23412.Phospholipids in VLDL,IL1R1,Interleukin-1 receptor type 1,42113,-0.0121859090191306,0.00245835036693218,-0.0170042757383177,-0.00736754229994356,7.24781908896583e-07
NMR metabolomics,X23412.Phospholipids in VLDL,CTSF,Cathepsin F,42181,0.0205609835251948,0.00415096456727693,0.012425092973332,0.0286968740770576,7.3842017528799e-07
NMR metabolomics,X23412.Phospholipids in VLDL,TACSTD2,Tumor-associated calcium signal transducer 2,40518,-0.0159460566527612,0.00322173021289822,-0.0222606478700417,-0.00963146543548069,7.54095091523338e-07
NMR metabolomics,X23412.Phospholipids in VLDL,PSMD9,26S proteasome non-ATPase regulatory subunit 9,42070,0.0271991028522984,0.00550173309671498,0.016415705982737,0.0379824997218598,7.75629622227446e-07
NMR metabolomics,X23412.Phospholipids in VLDL,ADA2,Adenosine deaminase 2,42096,-0.0222672365251562,0.00451841334796947,-0.0311233266871763,-0.013411146363136,8.4014375526556e-07
NMR metabolomics,X23412.Phospholipids in VLDL,AARSD1,Alanyl-tRNA editing protein Aarsd1,42070,0.0272214598796186,0.00552498203141268,0.0163924950980498,0.0380504246611875,8.45036747193039e-07
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,42249,-0.0227676969029895,0.00462338861815447,-0.0318295385945723,-0.0137058552114068,8.55829815705975e-07
NMR metabolomics,X23412.Phospholipids in VLDL,STX7,Syntaxin-7,39657,0.0249825466081548,0.00507381228358738,0.0150378745323235,0.034927218683986,8.60967370631027e-07
NMR metabolomics,X23412.Phospholipids in VLDL,MMP13,Collagenase 3,41839,-0.0163509112709107,0.00332303563458935,-0.0228640611147058,-0.00983776142711556,8.73730895676407e-07
NMR metabolomics,X23412.Phospholipids in VLDL,EGFLAM,Pikachurin,39930,0.015683894209432,0.00319329267403203,0.00942504056832921,0.0219427478505348,9.16390721232546e-07
NMR metabolomics,X23412.Phospholipids in VLDL,C1QL2,Complement C1q-like protein 2,39657,0.0218420314238362,0.00445131945860428,0.0131174452849718,0.0305666175627006,9.38625146618355e-07
NMR metabolomics,X23412.Phospholipids in VLDL,SNU13,NHP2-like protein 1,39575,0.0319884289091609,0.00651911950833417,0.0192109546728259,0.0447659031454959,9.38740281403536e-07
NMR metabolomics,X23412.Phospholipids in VLDL,DSG3,Desmoglein-3,42196,0.0177370248083497,0.00362000020718104,0.0106418244022748,0.0248322252144245,9.70738021822505e-07
NMR metabolomics,X23412.Phospholipids in VLDL,ECM1,Extracellular matrix protein 1,39720,0.0184832655809766,0.00377421724135681,0.0110857997879172,0.0258807313740359,9.85573367246192e-07
NMR metabolomics,X23412.Phospholipids in VLDL,LETM1,Mitochondrial proton/calcium exchanger protein,39934,0.0271319441700839,0.00554046818931323,0.0162726265190299,0.0379912618211378,9.86293361834475e-07
NMR metabolomics,X23412.Phospholipids in VLDL,REPS1,RalBP1-associated Eps domain-containing protein 1,39657,0.0192651013231788,0.00393442507412842,0.0115536281778871,0.0269765744684705,9.89143604664002e-07
NMR metabolomics,X23412.Phospholipids in VLDL,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,42295,0.0141082735545434,0.00288185632605086,0.00845983515548373,0.0197567119536031,9.91482274966983e-07
NMR metabolomics,X23412.Phospholipids in VLDL,TINAGL1,Tubulointerstitial nephritis antigen-like,42126,0.0111899161983915,0.00228572289612719,0.00670989932198222,0.0156699330748008,9.9152555425519e-07
NMR metabolomics,X23412.Phospholipids in VLDL,SART1,U4/U6.U5 tri-snRNP-associated protein 1,39575,0.0190108105563684,0.00388648946012359,0.0113932912145262,0.0266283298982107,1.01484474173911e-06
NMR metabolomics,X23412.Phospholipids in VLDL,CHAD,Chondroadherin,39736,0.0236983412161838,0.00485143557475222,0.0141895274896694,0.0332071549426982,1.04969033013412e-06
NMR metabolomics,X23412.Phospholipids in VLDL,NEO1,Neogenin,39934,0.0113671496334909,0.00233251472542026,0.00679542077166716,0.0159388784953146,1.11210423874118e-06
NMR metabolomics,X23412.Phospholipids in VLDL,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,39662,0.0198013186317193,0.00406695070802946,0.0118300952439815,0.027772542019457,1.13809703206095e-06
NMR metabolomics,X23412.Phospholipids in VLDL,DUSP3,Dual specificity protein phosphatase 3,41839,0.0430340890787499,0.00884438542776341,0.0256990936403337,0.0603690845171662,1.15368382375932e-06
NMR metabolomics,X23412.Phospholipids in VLDL,PDGFRA,Platelet-derived growth factor receptor alpha,42145,-0.0142178958963555,0.00293406138649334,-0.0199686562138825,-0.00846713557882859,1.27494901718083e-06
NMR metabolomics,X23412.Phospholipids in VLDL,CYTL1,Cytokine-like protein 1,39966,0.0127720547525203,0.00263625466149076,0.0076049956159984,0.0179391138890422,1.28430213052533e-06
NMR metabolomics,X23412.Phospholipids in VLDL,VWC2,Brorin,41973,0.0204165650807097,0.00421972341137443,0.0121459071944158,0.0286872229670036,1.32371450885845e-06
NMR metabolomics,X23412.Phospholipids in VLDL,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",39657,0.0223279646309555,0.00462032197759944,0.0132721335548606,0.0313837957070504,1.36603014119575e-06
NMR metabolomics,X23412.Phospholipids in VLDL,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",39930,0.0517975816686409,0.0107458130602863,0.0307357880704798,0.072859375266802,1.45235392535576e-06
NMR metabolomics,X23412.Phospholipids in VLDL,PTPRH,Receptor-type tyrosine-protein phosphatase H,39930,0.0249932948719318,0.00518610416527881,0.0148285307079853,0.0351580590358783,1.45946012309729e-06
NMR metabolomics,X23412.Phospholipids in VLDL,CR2,Complement receptor type 2,42217,0.0231500316141756,0.00480577283469931,0.013730716858165,0.0325693463701862,1.4720644969828e-06
NMR metabolomics,X23412.Phospholipids in VLDL,SDC1,Syndecan-1,42145,0.0200575701564284,0.00416757821118771,0.0118891168625005,0.0282260234503563,1.50463175939232e-06
NMR metabolomics,X23412.Phospholipids in VLDL,PNLIP,Pancreatic triacylglycerol lipase,39990,0.0330225937626005,0.00686159709505494,0.0195738634562928,0.0464713240689082,1.50840318463058e-06
NMR metabolomics,X23412.Phospholipids in VLDL,STC2,Stanniocalcin-2,42113,0.01186854453883,0.00247218377102673,0.00702306434761766,0.0167140247300424,1.59698562899236e-06
NMR metabolomics,X23412.Phospholipids in VLDL,COL24A1,Collagen alpha-1(XXIV) chain,39930,0.0279293821757892,0.00582429101921134,0.016513771778135,0.0393449925734434,1.64476796781694e-06
NMR metabolomics,X23412.Phospholipids in VLDL,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",39638,0.0187268427697254,0.00390641796572408,0.0110702635569062,0.0263834219825446,1.65733291669505e-06
NMR metabolomics,X23412.Phospholipids in VLDL,SNX2,Sorting nexin-2,39919,0.0422562972961263,0.00881934314468455,0.0249703847325446,0.059542209859708,1.67791826891803e-06
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINA7,Thyroxine-binding globulin,39979,0.00908786689916826,0.00189928758939188,0.00536526322396016,0.0128104705743764,1.73238130894072e-06
NMR metabolomics,X23412.Phospholipids in VLDL,TRAF3,"TNF receptor-associated factor 3, Isoform 2",39657,0.0184786208293713,0.00386680134054784,0.0108996902018976,0.0260575514568451,1.78625845171755e-06
NMR metabolomics,X23412.Phospholipids in VLDL,AHCY,Adenosylhomocysteinase,42145,0.0330609151116692,0.00692395170937409,0.019489969761296,0.0466318604620424,1.81712304671071e-06
NMR metabolomics,X23412.Phospholipids in VLDL,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,42085,0.0940059014521689,0.0197737198897046,0.0552494104683479,0.13276239243599,2.01409877457525e-06
NMR metabolomics,X23412.Phospholipids in VLDL,SCGB2A2,Mammaglobin-A,39575,-0.0152996777837562,0.0032179055525998,-0.0216067726668518,-0.00899258290066056,2.01422811322266e-06
NMR metabolomics,X23412.Phospholipids in VLDL,RALY,RNA-binding protein Raly,39919,0.0235187352922112,0.0049669314508406,0.0137835496485636,0.0332539209358587,2.21643932086832e-06
NMR metabolomics,X23412.Phospholipids in VLDL,RAB37,Ras-related protein Rab-37,41913,0.0395751463919234,0.00837057072153088,0.0231688277777229,0.0559814650061239,2.29189109884753e-06
NMR metabolomics,X23412.Phospholipids in VLDL,CDH17,Cadherin-17,42145,-0.033193710244415,0.00702404347802675,-0.0469608354613474,-0.0194265850274825,2.31599471314529e-06
NMR metabolomics,X23412.Phospholipids in VLDL,SPINK6,Serine protease inhibitor Kazal-type 6,42262,0.0260799632942177,0.00552238585328709,0.015256087021775,0.0369038395666604,2.35175644320418e-06
NMR metabolomics,X23412.Phospholipids in VLDL,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",39638,0.0373613066637542,0.00791311365248713,0.0218516039048794,0.0528710094226289,2.37060576479109e-06
NMR metabolomics,X23412.Phospholipids in VLDL,CRYGD,Gamma-crystallin D,39929,0.0477801907500292,0.0101281781006162,0.0279289616728214,0.067631419827237,2.41554115102834e-06
NMR metabolomics,X23412.Phospholipids in VLDL,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,42129,0.0280295144212055,0.00595730400368037,0.016353198573992,0.0397058302684191,2.56294754406339e-06
NMR metabolomics,X23412.Phospholipids in VLDL,VEGFB,Vascular endothelial growth factor B,39657,0.0143456356277411,0.00305332955932641,0.00836110969146135,0.0203301615640209,2.6542308366961e-06
NMR metabolomics,X23412.Phospholipids in VLDL,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",41839,0.0146042360846894,0.00311025231343558,0.00850814155035567,0.0207003306190232,2.68605325032746e-06
NMR metabolomics,X23412.Phospholipids in VLDL,SIGLEC9,Sialic acid-binding Ig-like lectin 9,42239,0.0147632592799534,0.00314784773393498,0.00859347772144087,0.020933040838466,2.75917285990919e-06
NMR metabolomics,X23412.Phospholipids in VLDL,HMBS,Porphobilinogen deaminase,42262,0.0194200405658358,0.00414114008634651,0.0113034059965966,0.0275366751350749,2.76470422078158e-06
NMR metabolomics,X23412.Phospholipids in VLDL,NECTIN1,Nectin-1,39657,0.0159367120682587,0.00341171571034616,0.00924974927598024,0.0226236748605372,3.0301612778953e-06
NMR metabolomics,X23412.Phospholipids in VLDL,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",42094,0.0326631328080564,0.00699342284091641,0.0189560240398602,0.0463702415762526,3.03291854682591e-06
NMR metabolomics,X23412.Phospholipids in VLDL,OMG,Oligodendrocyte-myelin glycoprotein,42070,0.0330915771407536,0.00709266273875059,0.0191899581728024,0.0469931961087047,3.10668896590231e-06
NMR metabolomics,X23412.Phospholipids in VLDL,ACE,Angiotensin-converting enzyme,39990,-0.0130145859204635,0.00279057223847146,-0.0184841075078676,-0.00754506433305946,3.13999947459887e-06
NMR metabolomics,X23412.Phospholipids in VLDL,ITGAV,Integrin alpha-V,42262,0.00796648310907097,0.00171201098870144,0.00461094157121615,0.0113220246469258,3.29749240003452e-06
NMR metabolomics,X23412.Phospholipids in VLDL,VIM,Vimentin,41900,0.0550724573689879,0.0118368408108157,0.0318722493797891,0.0782726653581866,3.30886423838047e-06
NMR metabolomics,X23412.Phospholipids in VLDL,SPINK4,Serine protease inhibitor Kazal-type 4,42119,-0.0315653067187621,0.00679387923215849,-0.0448813100137927,-0.0182493034237314,3.41396795787608e-06
NMR metabolomics,X23412.Phospholipids in VLDL,NRCAM,Neuronal cell adhesion molecule,42145,0.0137310154124302,0.00295779854205878,0.00793373026999496,0.0195283005548654,3.47771428582341e-06
NMR metabolomics,X23412.Phospholipids in VLDL,CAPG,Macrophage-capping protein,42015,0.0281418838140791,0.00606537475162784,0.0162537493008886,0.0400300183272697,3.52113567485022e-06
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,42262,0.0160140348698069,0.0034531672737762,0.00924582701320552,0.0227822427264082,3.55932051884203e-06
NMR metabolomics,X23412.Phospholipids in VLDL,FAM3C,Protein FAM3C,42129,0.0144925945424476,0.00312933264019094,0.00835910256767341,0.0206260865172219,3.66921853446366e-06
NMR metabolomics,X23412.Phospholipids in VLDL,TK1,"Thymidine kinase, cytosolic",39757,0.0225531095769715,0.00487525070631549,0.0129976181925931,0.0321086009613498,3.76916045890971e-06
NMR metabolomics,X23412.Phospholipids in VLDL,MTPN,Myotrophin,41900,0.0154909876135891,0.00334912311738488,0.00892670630351473,0.0220552689236634,3.77426547466424e-06
NMR metabolomics,X23412.Phospholipids in VLDL,PDCD6,Programmed cell death protein 6,42145,-0.0334861206656788,0.00726608768150122,-0.0477276525214211,-0.0192445888099364,4.09190418004712e-06
NMR metabolomics,X23412.Phospholipids in VLDL,CSTB,Cystatin-B,41959,0.0206028951498202,0.00447128208692328,0.0118391822594506,0.0293666080401898,4.10662598760985e-06
NMR metabolomics,X23412.Phospholipids in VLDL,PSAP,Prosaposin,39886,0.0135853521896844,0.00294864852485303,0.00780600108097245,0.0193647032983963,4.12369436908933e-06
NMR metabolomics,X23412.Phospholipids in VLDL,CD300C,CMRF35-like molecule 6,42249,0.0167143767286582,0.00362879103348006,0.00960194630303732,0.0238268071542792,4.14108449417295e-06
NMR metabolomics,X23412.Phospholipids in VLDL,RSPO1,R-spondin-1,42016,0.0161487404666756,0.00351139941104449,0.00926639762102843,0.0230310833123228,4.28513730163549e-06
NMR metabolomics,X23412.Phospholipids in VLDL,SORCS2,VPS10 domain-containing receptor SorCS2,41843,0.0169173466033365,0.00367897330194765,0.00970655893151911,0.0241281342751539,4.29714509982027e-06
NMR metabolomics,X23412.Phospholipids in VLDL,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,41913,0.0174436808847229,0.00379978599044804,0.00999610034344473,0.024891261426001,4.45802356099553e-06
NMR metabolomics,X23412.Phospholipids in VLDL,COLEC12,Collectin-12,42123,0.0129388333108112,0.00281929851970749,0.00741300821218456,0.0184646584094379,4.48563802889561e-06
NMR metabolomics,X23412.Phospholipids in VLDL,IL6ST,Interleukin-6 receptor subunit beta,42145,0.0082698546017446,0.00180710895621689,0.00472792104755949,0.0118117881559297,4.77499654120467e-06
NMR metabolomics,X23412.Phospholipids in VLDL,NELL2,Protein kinase C-binding protein NELL2,42185,0.0136342489108024,0.00298246619954593,0.00778861515969237,0.0194798826619124,4.88592307015108e-06
NMR metabolomics,X23412.Phospholipids in VLDL,NPTXR,Neuronal pentraxin receptor,42145,0.0160629629609514,0.00351536538481598,0.00917284680671207,0.0229530791151907,4.93541984223606e-06
NMR metabolomics,X23412.Phospholipids in VLDL,COL6A3,Collagen alpha-3(VI) chain,42310,0.0167829521695428,0.00369312753147437,0.00954442220785308,0.0240214821312326,5.55696007676601e-06
NMR metabolomics,X23412.Phospholipids in VLDL,CRTAP,Cartilage-associated protein,39649,0.0230296035852814,0.00509285207594175,0.0130476135164356,0.0330115936541273,6.19115320396347e-06
NMR metabolomics,X23412.Phospholipids in VLDL,GALNT7,N-acetylgalactosaminyltransferase 7,42070,0.00968270810304183,0.00214152578913562,0.00548531755633602,0.0138800986497476,6.19541538918531e-06
NMR metabolomics,X23412.Phospholipids in VLDL,ANGPT2,Angiopoietin-2,42262,-0.0173717966336407,0.00384603987671684,-0.0249100347920057,-0.00983355847527566,6.33067630586462e-06
NMR metabolomics,X23412.Phospholipids in VLDL,CLIC5,Chloride intracellular channel protein 5,39649,-0.0146908515156517,0.00325253200690482,-0.0210658142491851,-0.00831588878211821,6.34489218638428e-06
NMR metabolomics,X23412.Phospholipids in VLDL,SATB1,DNA-binding protein SATB1,39934,0.0136475858441316,0.0030228391314169,0.00772282114655451,0.0195723505417087,6.40086581427075e-06
NMR metabolomics,X23412.Phospholipids in VLDL,COMP,Cartilage oligomeric matrix protein,42042,0.0154780070353016,0.00343221235146277,0.00875087082643454,0.0222051432441686,6.54904183992896e-06
NMR metabolomics,X23412.Phospholipids in VLDL,TMEM25,Transmembrane protein 25,39934,-0.0218135401248915,0.0048395673036269,-0.0312990920400003,-0.0123279882097828,6.63056193385822e-06
NMR metabolomics,X23412.Phospholipids in VLDL,CPA4,Carboxypeptidase A4,39518,0.0204968755996604,0.00455150071713567,0.0115759341940745,0.0294178170052463,6.75930357294985e-06
NMR metabolomics,X23412.Phospholipids in VLDL,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,39979,0.00854876874576947,0.00189895819617697,0.00482681068126261,0.0122707268102763,6.80433445140407e-06
NMR metabolomics,X23412.Phospholipids in VLDL,UBAC1,Ubiquitin-associated domain-containing protein 1,42070,0.0153198431197936,0.00340433153012053,0.0086473533207574,0.0219923329188299,6.84894281817213e-06
NMR metabolomics,X23412.Phospholipids in VLDL,LMNB1,Lamin-B1,39908,0.0284083172606983,0.00631277199478065,0.0160352841509282,0.0407813503704684,6.85888228394803e-06
NMR metabolomics,X23412.Phospholipids in VLDL,CST1,Cystatin-SN,38503,0.0495530054070471,0.0110316515728263,0.0279309683243075,0.0711750424897867,7.13922896400112e-06
NMR metabolomics,X23412.Phospholipids in VLDL,AKR1C4,Aldo-keto reductase family 1 member C4,41900,0.0235307755461744,0.0052479469576558,0.013244799509169,0.0338167515831798,7.39368319179163e-06
NMR metabolomics,X23412.Phospholipids in VLDL,LYPD3,Ly6/PLAUR domain-containing protein 3,42082,0.0155982798634946,0.0034810461895193,0.00877542933203679,0.0224211303949524,7.49348277474986e-06
NMR metabolomics,X23412.Phospholipids in VLDL,GSTT2B,Glutathione S-transferase theta-2B,39929,0.111698039092369,0.0249270358887379,0.0628410487504423,0.160555029434295,7.50226198086808e-06
NMR metabolomics,X23412.Phospholipids in VLDL,FGFR4,Fibroblast growth factor receptor 4,39736,0.0242872743818286,0.00542549486565438,0.013653304445146,0.0349212443185111,7.66275191307256e-06
NMR metabolomics,X23412.Phospholipids in VLDL,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,41973,0.0159145714723504,0.00355917950135688,0.00893857964969089,0.0228905632950099,7.83431779838154e-06
NMR metabolomics,X23412.Phospholipids in VLDL,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,39757,0.02908552424898,0.00651576273600932,0.0163146292864017,0.0418564192115583,8.12817043870101e-06
NMR metabolomics,X23412.Phospholipids in VLDL,APOA1,Apolipoprotein A-I,39979,-0.0126395204982502,0.00283863650104254,-0.0182032480402936,-0.00707579295620683,8.5615691477882e-06
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,42178,-0.0223274097071587,0.00503335248225459,-0.0321927805723777,-0.0124620388419397,9.24127271583182e-06
NMR metabolomics,X23412.Phospholipids in VLDL,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",42085,-0.0291178619185595,0.00657122463634643,-0.0419974622057985,-0.0162382616313205,9.44856777650184e-06
NMR metabolomics,X23412.Phospholipids in VLDL,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,42166,0.0409366224336701,0.00925281710927088,0.0228011008994992,0.059072143967841,9.75394875341407e-06
NMR metabolomics,X23412.Phospholipids in VLDL,NME3,Nucleoside diphosphate kinase 3,42144,0.0108333597792873,0.00246145737961245,0.00600890331524691,0.0156578162433277,1.08478701096977e-05
NMR metabolomics,X23412.Phospholipids in VLDL,CPQ,Carboxypeptidase Q,39960,0.0170075407713942,0.00386752422242585,0.00942719329543953,0.0245878882473488,1.10487463748439e-05
NMR metabolomics,X23412.Phospholipids in VLDL,CENPF,Centromere protein F,39757,0.0244798695486858,0.00557174885794229,0.0135592417871189,0.0354004973102527,1.12533460765795e-05
NMR metabolomics,X23412.Phospholipids in VLDL,IL17A,Interleukin-17A,41877,-0.0194353606987638,0.00442594043526379,-0.0281102039518808,-0.0107605174456468,1.13578752881127e-05
NMR metabolomics,X23412.Phospholipids in VLDL,TGFB2,Transforming growth factor beta-2 proprotein,39919,0.0235376440177037,0.00536853385361165,0.0130153176646249,0.0340599703707825,1.17371262062697e-05
NMR metabolomics,X23412.Phospholipids in VLDL,MZB1,Marginal zone B- and B1-cell-specific protein,42163,-0.0231286015390755,0.00528892994899211,-0.0334949042391001,-0.012762298839051,1.23452319317417e-05
NMR metabolomics,X23412.Phospholipids in VLDL,IL22RA1,Interleukin-22 receptor subunit alpha-1,41913,0.0191856362404747,0.00439301395089741,0.0105753288967158,0.0277959435842336,1.26738905740115e-05
NMR metabolomics,X23412.Phospholipids in VLDL,TPPP3,Tubulin polymerization-promoting protein family member 3,41839,0.0174309453313969,0.00399816897472706,0.00959453414093189,0.025267356521862,1.31204748103228e-05
NMR metabolomics,X23412.Phospholipids in VLDL,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,39649,0.046409848930505,0.0107102651536264,0.0254177292293972,0.0674019686316128,1.48248602286689e-05
NMR metabolomics,X23412.Phospholipids in VLDL,FGF16,Fibroblast growth factor 16,39657,0.0208318437994812,0.00480806947605706,0.0114080276264094,0.0302556599725531,1.48603386069582e-05
NMR metabolomics,X23412.Phospholipids in VLDL,PIGR,Polymeric immunoglobulin receptor,41987,0.0165623254252357,0.00382633911077216,0.0090627007681223,0.0240619500823492,1.51215586366262e-05
NMR metabolomics,X23412.Phospholipids in VLDL,CD80,T-lymphocyte activation antigen CD80,39958,0.0152976827017735,0.00353772674759601,0.00836373827648533,0.0222316271270617,1.54423020118712e-05
NMR metabolomics,X23412.Phospholipids in VLDL,PRUNE2,Protein prune homolog 2,39757,0.0128638628652455,0.00298430930906132,0.00701461661948536,0.0187131091110057,1.64284027899458e-05
NMR metabolomics,X23412.Phospholipids in VLDL,CBLIF,Cobalamin binding intrinsic factor,42129,0.0338029099261795,0.00785963700378213,0.0183980213987665,0.0492077984535925,1.71357813597815e-05
NMR metabolomics,X23412.Phospholipids in VLDL,SELL,L-selectin,39979,0.010363403986707,0.00241019126916843,0.00563942909913687,0.0150873788742771,1.72356337010819e-05
NMR metabolomics,X23412.Phospholipids in VLDL,MILR1,Allergin-1,41913,-0.0226626552666681,0.00527277355322842,-0.0329972914309958,-0.0123280191023404,1.73530436979629e-05
NMR metabolomics,X23412.Phospholipids in VLDL,FBP1,"Fructose-1,6-bisphosphatase 1",42145,0.0325027886545004,0.00757764184667398,0.0176506106350194,0.0473549666739813,1.80478536353933e-05
NMR metabolomics,X23412.Phospholipids in VLDL,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",39958,0.0232537962160094,0.00542625636825971,0.0126183337342204,0.0338892586977985,1.83896241138584e-05
NMR metabolomics,X23412.Phospholipids in VLDL,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,42310,-0.0107912593596984,0.00252613624776412,-0.0157424864053161,-0.00584003231408074,1.95170460127644e-05
NMR metabolomics,X23412.Phospholipids in VLDL,AOC3,Membrane primary amine oxidase,42217,-0.0130089080182965,0.00305557641525636,-0.018997837792199,-0.00701997824439405,2.08174527704613e-05
NMR metabolomics,X23412.Phospholipids in VLDL,IL2RA,Interleukin-2 receptor subunit alpha,42041,-0.0178407600935898,0.00420199676349564,-0.0260766737500413,-0.00960484643713839,2.19296379127807e-05
NMR metabolomics,X23412.Phospholipids in VLDL,LYZL2,Lysozyme-like protein 2,39560,0.0159715923004604,0.00376366307950757,0.0085948126646256,0.0233483719362953,2.21742848729428e-05
NMR metabolomics,X23412.Phospholipids in VLDL,CSF2,Granulocyte-macrophage colony-stimulating factor,39575,0.0158520954172469,0.00373916193254382,0.00852333802946098,0.0231808528050328,2.2587402060637e-05
NMR metabolomics,X23412.Phospholipids in VLDL,SPRR3,Small proline-rich protein 3,39929,0.0275928433773982,0.00651027376972492,0.0148327067887373,0.040352979966059,2.26948452463736e-05
NMR metabolomics,X23412.Phospholipids in VLDL,SELENOP,Selenoprotein P,39979,0.00990832860669549,0.00234010416460783,0.00532172444406413,0.0144949327693268,2.31230597080621e-05
NMR metabolomics,X23412.Phospholipids in VLDL,CLPS,Colipase,42115,0.0321418609746121,0.0076003413370206,0.0172451919540517,0.0470385299951724,2.36274835614587e-05
NMR metabolomics,X23412.Phospholipids in VLDL,GZMB,Granzyme B,42119,0.0294357870995823,0.00698690940942481,0.0157414446571096,0.0431301295420549,2.53645315189983e-05
NMR metabolomics,X23412.Phospholipids in VLDL,LCN2,Neutrophil gelatinase-associated lipocalin,41747,-0.0169986989471412,0.00403624903043056,-0.0249097470467851,-0.00908765084749729,2.55359956523205e-05
NMR metabolomics,X23412.Phospholipids in VLDL,FAM3B,Protein FAM3B,42070,0.0152585486080199,0.00362527925974966,0.00815300125891059,0.0223640959571293,2.58246128820538e-05
NMR metabolomics,X23412.Phospholipids in VLDL,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,42070,0.0194902511225097,0.00463399819430119,0.0104076146616793,0.02857288758334,2.61697466182639e-05
NMR metabolomics,X23412.Phospholipids in VLDL,YAP1,Transcriptional coactivator YAP1,39929,0.0119868357721103,0.0028513533727465,0.0063981831615272,0.0175754883826935,2.64356606036471e-05
NMR metabolomics,X23412.Phospholipids in VLDL,FOSB,Protein fosB,41839,0.0166552606130176,0.00396227102491785,0.00888920940417856,0.0244213118218565,2.64587704688961e-05
NMR metabolomics,X23412.Phospholipids in VLDL,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",39929,0.0180569732837729,0.00430796889788976,0.00961335424390895,0.0265005923236368,2.79185532410849e-05
NMR metabolomics,X23412.Phospholipids in VLDL,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",39934,0.0175114788679797,0.00419077735629432,0.00929755524964285,0.0257254024863166,2.95541025614976e-05
NMR metabolomics,X23412.Phospholipids in VLDL,DPP10,Inactive dipeptidyl peptidase 10,42119,0.0157792060723299,0.00377857895268519,0.0083731913250669,0.0231852208195928,2.9858860793892e-05
NMR metabolomics,X23412.Phospholipids in VLDL,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,41900,0.0135444560533492,0.00324629383489772,0.00718172013694971,0.0199071919697488,3.03478664525804e-05
NMR metabolomics,X23412.Phospholipids in VLDL,RPA2,Replication protein A 32 kDa subunit,39657,0.0133405099806929,0.0032014286942818,0.00706570973990056,0.0196153102214852,3.10915983386402e-05
NMR metabolomics,X23412.Phospholipids in VLDL,PMS1,PMS1 protein homolog 1,39649,0.0212590876249696,0.00510389127893933,0.0112554607182485,0.0312627145316906,3.13347591828572e-05
NMR metabolomics,X23412.Phospholipids in VLDL,COL9A2,Collagen alpha-2(IX) chain,39757,0.0191975823887909,0.0046104486097101,0.0101611031137591,0.0282340616638227,3.15168810264782e-05
NMR metabolomics,X23412.Phospholipids in VLDL,ROBO4,Roundabout homolog 4,39638,-0.00782749314697351,0.00188610022150588,-0.011524249581125,-0.00413073671282198,3.34832664006138e-05
NMR metabolomics,X23412.Phospholipids in VLDL,F3,Tissue factor,42174,-0.0111510789712912,0.00269279475337001,-0.0164289566878964,-0.005873201254686,3.47764941185875e-05
NMR metabolomics,X23412.Phospholipids in VLDL,CEP112,Centrosomal protein of 112 kDa,39575,0.0189888834910186,0.00458948508785551,0.0099934927188218,0.0279842742632154,3.53767056150427e-05
NMR metabolomics,X23412.Phospholipids in VLDL,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,39560,0.028756042223896,0.00695970252940017,0.0151150252662717,0.0423970591815203,3.62621161244165e-05
NMR metabolomics,X23412.Phospholipids in VLDL,CLASP1,CLIP-associating protein 1,39560,0.0320168316216707,0.00777623910080937,0.0167754029840843,0.047258260259257,3.86207483248552e-05
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINA1,Alpha-1-antitrypsin,39795,-0.00348049179013375,0.000846357602820667,-0.00513935269166226,-0.00182163088860524,3.94504689904092e-05
NMR metabolomics,X23412.Phospholipids in VLDL,ICAM5,Intercellular adhesion molecule 5,42145,0.0194825239891411,0.00474060548492076,0.0101909372386964,0.0287741107395857,3.98485427594664e-05
NMR metabolomics,X23412.Phospholipids in VLDL,IL31RA,Interleukin-31 receptor subunit alpha,39616,0.0159500554675882,0.00388250273088633,0.00834035011505101,0.0235597608201254,4.0165820490946e-05
NMR metabolomics,X23412.Phospholipids in VLDL,CNPY2,Protein canopy homolog 2,41900,0.025753321330492,0.00627746649972602,0.013449486991029,0.038057155669955,4.11140479510635e-05
NMR metabolomics,X23412.Phospholipids in VLDL,BRD3,Bromodomain-containing protein 3,39575,0.0200111084653264,0.00490966217455498,0.0103881706031986,0.0296340463274542,4.6167100066152e-05
NMR metabolomics,X23412.Phospholipids in VLDL,DDX25,ATP-dependent RNA helicase DDX25,39649,-0.0150000751773754,0.00370096906519151,-0.0222539745451508,-0.00774617580960005,5.09086102859049e-05
NMR metabolomics,X23412.Phospholipids in VLDL,NPTX1,Neuronal pentraxin-1,42137,0.0174234795144302,0.00430335936841544,0.00898889515233595,0.0258580638765245,5.1765554028315e-05
NMR metabolomics,X23412.Phospholipids in VLDL,SSH3,Protein phosphatase Slingshot homolog 3,39560,0.0123939378453332,0.00306500300395969,0.00638653195757219,0.0184013437330942,5.29755393512502e-05
NMR metabolomics,X23412.Phospholipids in VLDL,PDGFRB,Platelet-derived growth factor receptor beta,42310,0.0144814275669375,0.00358166076469628,0.00746137246813282,0.0215014826657422,5.30113272192677e-05
NMR metabolomics,X23412.Phospholipids in VLDL,IL12RB1,Interleukin-12 receptor subunit beta-1,41913,0.0156959071613266,0.00388258255114388,0.00808604536108464,0.0233057689615687,5.3148825621699e-05
NMR metabolomics,X23412.Phospholipids in VLDL,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,42137,0.0148792933569672,0.00368681687756787,0.00765313227693415,0.0221054544370002,5.47134319252667e-05
NMR metabolomics,X23412.Phospholipids in VLDL,ERC2,ERC protein 2,39649,0.0307026262816301,0.0076131785225204,0.0157807963774901,0.0456244561857701,5.54804707180481e-05
NMR metabolomics,X23412.Phospholipids in VLDL,LGALS3,Galectin-3,42196,0.0123061500083121,0.00305340726043291,0.00632147177786356,0.0182908282387606,5.60089413469591e-05
NMR metabolomics,X23412.Phospholipids in VLDL,ATXN2,Ataxin-2,39586,0.0441030748999693,0.0109599282583591,0.0226216155135855,0.0655845342863531,5.75943236269639e-05
NMR metabolomics,X23412.Phospholipids in VLDL,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",39575,-0.0168600850296761,0.00419037559232591,-0.0250732211906349,-0.00864694886871731,5.77178664523656e-05
NMR metabolomics,X23412.Phospholipids in VLDL,DCC,Netrin receptor DCC,39649,0.00928243654930335,0.00230848923957675,0.00475779763973292,0.0138070754588738,5.83366906391181e-05
NMR metabolomics,X23412.Phospholipids in VLDL,FGF5,Fibroblast growth factor 5,41913,-0.0140595377357693,0.00351487457185477,-0.0209486918966047,-0.00717038357493399,6.3681911109851e-05
NMR metabolomics,X23412.Phospholipids in VLDL,STX3,Syntaxin-3,39929,0.0157572185177708,0.00394051233527921,0.0080338143406236,0.0234806226949181,6.40755943927206e-05
NMR metabolomics,X23412.Phospholipids in VLDL,METAP1,Methionine aminopeptidase 1,41839,0.0119395317213208,0.00299113308828569,0.00607691086828083,0.0178021525743607,6.59713578615676e-05
NMR metabolomics,X23412.Phospholipids in VLDL,SEMA7A,Semaphorin-7A,42272,0.0117002946083507,0.00294356293623711,0.00593091125332591,0.0174696779633754,7.07781621233954e-05
NMR metabolomics,X23412.Phospholipids in VLDL,COL28A1,Collagen alpha-1(XXVIII) chain,39649,0.0336780238909557,0.00848001745574949,0.0170571896776867,0.0502988581042247,7.18874535867229e-05
NMR metabolomics,X23412.Phospholipids in VLDL,PFDN2,Prefoldin subunit 2,41839,0.0225160306890612,0.00568430506787385,0.0113747927560284,0.0336572686220939,7.49999871119379e-05
NMR metabolomics,X23412.Phospholipids in VLDL,PCDH12,Protocadherin-12,39934,0.0104216884099183,0.00263365906950196,0.00525971663369442,0.0155836601861421,7.63234134156935e-05
NMR metabolomics,X23412.Phospholipids in VLDL,CSF3,Granulocyte colony-stimulating factor,41913,0.0194887658090229,0.0049485235185445,0.00978965971267567,0.0291878719053701,8.24795133515182e-05
NMR metabolomics,X23412.Phospholipids in VLDL,DSG4,Desmoglein-4,42018,0.0194270421065765,0.00493864101949556,0.00974730570836523,0.0291067785047878,8.40756869896618e-05
NMR metabolomics,X23412.Phospholipids in VLDL,NAMPT,Nicotinamide phosphoribosyltransferase,41843,0.0210198503657515,0.005347004699165,0.0105397211553881,0.0314999795761149,8.49725022984841e-05
NMR metabolomics,X23412.Phospholipids in VLDL,IL4R,Interleukin-4 receptor subunit alpha,42119,-0.0151623615963253,0.0038578245463135,-0.0227236977070997,-0.0076010254855508,8.52667371768904e-05
NMR metabolomics,X23412.Phospholipids in VLDL,NRTN,Neurturin,41913,0.0200642765646689,0.00510897341192283,0.0100506886773001,0.0300778644520376,8.63517007106393e-05
NMR metabolomics,X23412.Phospholipids in VLDL,B4GALT1,"Beta-1,4-galactosyltransferase 1",42185,0.0112675775966466,0.00287236422960594,0.00563774370661899,0.0168974114866743,8.79733572612567e-05
NMR metabolomics,X23412.Phospholipids in VLDL,SPINK1,Serine protease inhibitor Kazal-type 1,42137,-0.0170631823147621,0.00435095732100958,-0.0255910586639409,-0.00853530596558331,8.83573773036862e-05
NMR metabolomics,X23412.Phospholipids in VLDL,MB,Myoglobin,42310,-0.0226587031941836,0.00578237131042662,-0.0339921509626198,-0.0113252554257475,8.95034974623393e-05
NMR metabolomics,X23412.Phospholipids in VLDL,GSTP1,Glutathione S-transferase P,41759,-0.0281826786311324,0.00720124408158285,-0.0422971170310348,-0.01406824023123,9.13938662587607e-05
NMR metabolomics,X23412.Phospholipids in VLDL,CEP152,Centrosomal protein of 152 kDa,39560,0.0170190536302685,0.00435211795071165,0.00848890244687371,0.0255492048136634,9.26521322428457e-05
NMR metabolomics,X23412.Phospholipids in VLDL,HSPA2,Heat shock-related 70 kDa protein 2,39919,0.0141943402927393,0.00363160262959456,0.00707639913873402,0.0213122814467447,9.33885401791927e-05
NMR metabolomics,X23412.Phospholipids in VLDL,CCND2,G1/S-specific cyclin-D2,39757,0.0149891560998991,0.0038375204696423,0.00746761597940016,0.022510696220398,9.44100827211521e-05
NMR metabolomics,X23412.Phospholipids in VLDL,GART,Trifunctional purine biosynthetic protein adenosine-3,39934,0.0108839296113873,0.00280243747399618,0.00539115216235474,0.0163767070604198,0.000103447577177486
NMR metabolomics,X23412.Phospholipids in VLDL,IFNG,Interferon gamma,41913,0.0456234026864705,0.0117737158371836,0.0225469196455907,0.0686998857273502,0.000107126365425423
NMR metabolomics,X23412.Phospholipids in VLDL,CENPJ,Centromere protein J,39757,0.0281181830014116,0.00726257540639809,0.0138835352048713,0.0423528307979519,0.000108715617893728
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,42123,0.0117283882660221,0.00303235612783549,0.00578497025546455,0.0176718062765797,0.000110359983960982
NMR metabolomics,X23412.Phospholipids in VLDL,INHBB,Inhibin beta B chain,39736,0.0208943939434741,0.00540412907991154,0.0103023009468474,0.0314864869401007,0.000111092637920586
NMR metabolomics,X23412.Phospholipids in VLDL,CCL25,C-C motif chemokine 25,42296,0.0195424738030201,0.00506149270587344,0.0096219480995082,0.0294629995065321,0.000113438304876379
NMR metabolomics,X23412.Phospholipids in VLDL,SEPTIN3,Neuronal-specific septin-3,39934,-0.0310723675862839,0.00808931078089836,-0.0469274167168447,-0.0152173184557231,0.000123119599290157
NMR metabolomics,X23412.Phospholipids in VLDL,RCC1,Regulator of chromosome condensation,39919,0.0206480587465564,0.00538330579979371,0.0100967793789608,0.0311993381141521,0.000125951978723237
NMR metabolomics,X23412.Phospholipids in VLDL,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,41900,-0.00868820206979473,0.00227891205814959,-0.0131548697037679,-0.00422153443582153,0.000138225847952266
NMR metabolomics,X23412.Phospholipids in VLDL,SULT1A1,Sulfotransferase 1A1,42249,-0.050320649441148,0.013240654517629,-0.0762723322957008,-0.0243689665865952,0.000145052107757637
NMR metabolomics,X23412.Phospholipids in VLDL,CEBPA,CCAAT/enhancer-binding protein alpha,39657,0.0142452755378215,0.0037538839768458,0.00688766294320377,0.0216028881324393,0.000148545047733673
NMR metabolomics,X23412.Phospholipids in VLDL,CDH15,Cadherin-15,42230,0.0270373130086879,0.00712791104507265,0.0130666073603455,0.0410080186570303,0.000149384255624953
NMR metabolomics,X23412.Phospholipids in VLDL,USP47,Ubiquitin carboxyl-terminal hydrolase 47,39575,0.0342294198094046,0.00902485276336449,0.0165407083932102,0.051918131225599,0.000149760012500774
NMR metabolomics,X23412.Phospholipids in VLDL,NCAM1,Neural cell adhesion molecule 1,42217,0.0127645231976092,0.00337205712064462,0.0061552912411457,0.0193737551540726,0.000154131315386944
NMR metabolomics,X23412.Phospholipids in VLDL,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,39575,-0.0122539080655553,0.00323804391630152,-0.0186004741415063,-0.00590734198960433,0.000154927452805651
NMR metabolomics,X23412.Phospholipids in VLDL,FOLH1,Glutamate carboxypeptidase 2,39657,0.0409113754982213,0.0108214850823522,0.019701264736811,0.0621214862596316,0.000157293160793546
NMR metabolomics,X23412.Phospholipids in VLDL,TRIM26,Tripartite motif-containing protein 26,39560,0.0224636190973775,0.00594281530888575,0.0108157010919614,0.0341115371027936,0.000157683866261643
NMR metabolomics,X23412.Phospholipids in VLDL,CX3CL1,Fractalkine,42016,-0.0129996384662826,0.00344372762594213,-0.0197493446131291,-0.006249932319436,0.000160778337100737
NMR metabolomics,X23412.Phospholipids in VLDL,JAM2,Junctional adhesion molecule B,42249,0.0106038864239912,0.00281447889139032,0.00508750779686621,0.0161202650511163,0.000165504505339936
NMR metabolomics,X23412.Phospholipids in VLDL,NPR1,Atrial natriuretic peptide receptor 1,39575,-0.016515533430976,0.00441311239557635,-0.0251652337263056,-0.00786583313564633,0.000183217043400016
NMR metabolomics,X23412.Phospholipids in VLDL,IGFBPL1,Insulin-like growth factor-binding protein-like 1,42145,0.0130561187774813,0.00349184432210801,0.00621210390614964,0.0199001336488131,0.000185490633331071
NMR metabolomics,X23412.Phospholipids in VLDL,RBPMS,RNA-binding protein with multiple splicing,39657,0.024925228851358,0.00666933443572005,0.0118533333573467,0.0379971243453693,0.000186952171115819
NMR metabolomics,X23412.Phospholipids in VLDL,VWF,von Willebrand factor,42310,-0.0284651619253315,0.0076328860338222,-0.0434256185516231,-0.01350470529904,0.000192801944730094
NMR metabolomics,X23412.Phospholipids in VLDL,SPESP1,Sperm equatorial segment protein 1,39958,0.0129119788237943,0.00346510388379432,0.00612037521155739,0.0197035824360311,0.000195261794933187
NMR metabolomics,X23412.Phospholipids in VLDL,NBL1,Neuroblastoma suppressor of tumorigenicity 1,42181,0.0105134781223088,0.00282363104694833,0.00497916127029005,0.0160477949743275,0.000197360539489238
NMR metabolomics,X23412.Phospholipids in VLDL,CREBZF,CREB/ATF bZIP transcription factor,39560,-0.0100416522783611,0.00269918343532127,-0.0153320518115908,-0.00475125274513139,0.000200015356581566
NMR metabolomics,X23412.Phospholipids in VLDL,KLK4,Kallikrein-4,42262,-0.0239600521705062,0.00644964343710671,-0.0366013533072353,-0.011318751033777,0.000204059999288018
NMR metabolomics,X23412.Phospholipids in VLDL,TMOD4,Tropomodulin-4,39560,-0.0153880440425693,0.00414477843608738,-0.0235118097773006,-0.00726427830783809,0.000206130307555052
NMR metabolomics,X23412.Phospholipids in VLDL,ITGBL1,Integrin beta-like protein 1,39966,0.0151003819359974,0.00406899677866343,0.00712514824981703,0.0230756156221777,0.000207359743024103
NMR metabolomics,X23412.Phospholipids in VLDL,CSPG4,Chondroitin sulfate proteoglycan 4,39966,-0.0126066982336239,0.00340860554903643,-0.0192875651097353,-0.00592583135751251,0.000217906477373086
NMR metabolomics,X23412.Phospholipids in VLDL,LSM1,U6 snRNA-associated Sm-like protein LSm1,41843,0.0206236740143098,0.00557900420382088,0.00968882577482083,0.0315585222537987,0.000219337234537443
NMR metabolomics,X23412.Phospholipids in VLDL,NOTCH2,Neurogenic locus notch homolog protein 2,39966,0.00839148783483324,0.0022727834306401,0.00393683231077864,0.0128461433588878,0.000223395316680054
NMR metabolomics,X23412.Phospholipids in VLDL,NOS1,"Nitric oxide synthase, brain",41839,-0.0223409582023362,0.00605408382674767,-0.0342069625027617,-0.0104749539019108,0.000224950310557606
NMR metabolomics,X23412.Phospholipids in VLDL,CCN3,CCN family member 3,42299,0.0128161235444828,0.00350124109710978,0.00595369099414767,0.019678556094818,0.000252717487631929
NMR metabolomics,X23412.Phospholipids in VLDL,BCL2,Apoptosis regulator Bcl-2,39930,0.0201746659409234,0.00551626612696749,0.0093627843320671,0.0309865475497796,0.000256036288237677
NMR metabolomics,X23412.Phospholipids in VLDL,NINJ1,Ninjurin-1,41843,0.0204699384869716,0.00559863141004604,0.00949662092328141,0.0314432560506619,0.000256932958280816
NMR metabolomics,X23412.Phospholipids in VLDL,FCRL2,Fc receptor-like protein 2,42229,0.0188630548862306,0.00515945077068299,0.00875053137569192,0.0289755783967692,0.000257124870640224
NMR metabolomics,X23412.Phospholipids in VLDL,GBP4,Guanylate-binding protein 4,41839,0.0184556611477998,0.00505223475272575,0.00855328103245735,0.0283580412631423,0.000260225263143725
NMR metabolomics,X23412.Phospholipids in VLDL,DEFB104A_DEFB104B,Beta-defensin 104,39586,0.0210918590443815,0.00577692969995396,0.00976907683247169,0.0324146412562912,0.00026238314428963
NMR metabolomics,X23412.Phospholipids in VLDL,PCDHB15,Protocadherin beta-15,39919,-0.0150016304711949,0.00411458022711874,-0.0230662077163476,-0.00693705322604218,0.000267580715147112
NMR metabolomics,X23412.Phospholipids in VLDL,BABAM1,BRISC and BRCA1-A complex member 1,39657,0.0111411362449774,0.00305574152617321,0.00515188285367796,0.0171303896362769,0.000267609576253519
NMR metabolomics,X23412.Phospholipids in VLDL,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,42119,0.0142067318304436,0.00389859055682617,0.00656549433906426,0.0218479693218228,0.000269366845813257
NMR metabolomics,X23412.Phospholipids in VLDL,MYBPC1,"Myosin-binding protein C, slow-type",39958,-0.0289587256977394,0.00796326083285589,-0.044566716930137,-0.0133507344653419,0.000277546119864267
NMR metabolomics,X23412.Phospholipids in VLDL,NFKB2,Nuclear factor NF-kappa-B p100 subunit,39757,0.0208038096024425,0.00573068904533272,0.00957165907359037,0.0320359601312946,0.000284418640259456
NMR metabolomics,X23412.Phospholipids in VLDL,DKK3,Dickkopf-related protein 3,42310,-0.0109725650928489,0.0030391358717682,-0.0169292714015146,-0.00501585878418323,0.000306788796303715
NMR metabolomics,X23412.Phospholipids in VLDL,GIMAP7,GTPase IMAP family member 7,39736,-0.0120182926712746,0.00333036124128559,-0.0185458007041943,-0.0054907846383548,0.000309078073923274
NMR metabolomics,X23412.Phospholipids in VLDL,HAVCR2,Hepatitis A virus cellular receptor 2,42137,-0.0134127768301313,0.00371744725349292,-0.0206989734469775,-0.00612658021328523,0.000309605545229843
NMR metabolomics,X23412.Phospholipids in VLDL,NRP2,Neuropilin-2,42137,-0.0104556812579323,0.00289847302082304,-0.0161366883787454,-0.00477467413711911,0.000310505886316002
NMR metabolomics,X23412.Phospholipids in VLDL,FCRL5,Fc receptor-like protein 5,42137,-0.0219458625988228,0.00609462445227173,-0.0338913265252754,-0.0100003986723702,0.000318306141297244
NMR metabolomics,X23412.Phospholipids in VLDL,CLEC10A,C-type lectin domain family 10 member A,42016,-0.0135469105278538,0.00376618400591891,-0.0209286311794548,-0.00616518987625271,0.000323083174105344
NMR metabolomics,X23412.Phospholipids in VLDL,SAFB2,Scaffold attachment factor B2,39934,0.0101156157687269,0.00281482409165362,0.00459856054908582,0.015632670988368,0.000327405715068669
NMR metabolomics,X23412.Phospholipids in VLDL,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,42224,-0.0129958130134133,0.00363190581057658,-0.0201143484021434,-0.00587727762468319,0.00034712285134105
NMR metabolomics,X23412.Phospholipids in VLDL,LRRC25,Leucine-rich repeat-containing protein 25,42070,0.0144966495012875,0.00405498065739816,0.00654888741278714,0.0224444115897879,0.000351422287157258
NMR metabolomics,X23412.Phospholipids in VLDL,KLRB1,Killer cell lectin-like receptor subfamily B member 1,42296,0.0142864094531185,0.00400022976173862,0.00644595912011082,0.0221268597861262,0.000356299130631345
NMR metabolomics,X23412.Phospholipids in VLDL,TNC,Tenascin,42217,-0.017746902390974,0.00497614725534806,-0.0275001510114562,-0.00799365377049176,0.000363168299810113
NMR metabolomics,X23412.Phospholipids in VLDL,AHSP,Alpha-hemoglobin-stabilizing protein,42115,0.0295508067337341,0.0082988903266135,0.0132849816935717,0.0458166317738966,0.000370976773336375
NMR metabolomics,X23412.Phospholipids in VLDL,SPTLC1,Serine palmitoyltransferase 1,39929,0.0142124609231701,0.00399686461731958,0.00637860627322376,0.0220463155731165,0.000378219992517042
NMR metabolomics,X23412.Phospholipids in VLDL,AZU1,Azurocidin,41751,0.0274977110405857,0.00775663681713057,0.0122947028790098,0.0427007192021616,0.000393893001054939
NMR metabolomics,X23412.Phospholipids in VLDL,M6PR,Cation-dependent mannose-6-phosphate receptor,39638,0.0141954526476072,0.00400896028129882,0.00633789049626152,0.0220530147989529,0.00040036038102435
NMR metabolomics,X23412.Phospholipids in VLDL,CRTAC1,Cartilage acidic protein 1,42310,0.0112681743949694,0.00319198346161269,0.00501188681020851,0.0175244619797302,0.000416688916219057
NMR metabolomics,X23412.Phospholipids in VLDL,SBSN,Suprabasin,39954,-0.0129206979769886,0.00367103612246785,-0.0201159287770256,-0.00572546717695159,0.00043383754950753
NMR metabolomics,X23412.Phospholipids in VLDL,SLITRK1,SLIT and NTRK-like protein 1,39657,0.0118231989767027,0.00336129069269027,0.00523506921902983,0.0184113287343757,0.000437449398966249
NMR metabolomics,X23412.Phospholipids in VLDL,KLK8,Kallikrein-8,41668,0.0132822038463932,0.00377801819699886,0.0058772881802754,0.0206871195125109,0.0004401587703792
NMR metabolomics,X23412.Phospholipids in VLDL,NECTIN2,Nectin-2,42129,0.0111267097391097,0.00318523748063787,0.00488364427705945,0.0173697752011599,0.000478772214947406
NMR metabolomics,X23412.Phospholipids in VLDL,AREG,Amphiregulin,42070,-0.0140609041606122,0.00403622893018906,-0.0219719128637828,-0.00614989545744169,0.000496153175771136
NMR metabolomics,X23412.Phospholipids in VLDL,RHOC,Rho-related GTP-binding protein RhoC,41963,0.0421690169841519,0.012112227773758,0.0184290505475863,0.0659089834207176,0.000500160887337541
NMR metabolomics,X23412.Phospholipids in VLDL,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,42224,0.0108759236929564,0.00312682792590502,0.00474734095818255,0.0170045064277302,0.000506253906758761
NMR metabolomics,X23412.Phospholipids in VLDL,HYAL1,Hyaluronidase-1,42077,-0.00826711567531981,0.00237806251546115,-0.0129281182056237,-0.00360611314501595,0.000509779197498592
NMR metabolomics,X23412.Phospholipids in VLDL,QPCT,Glutaminyl-peptide cyclotransferase,42170,0.00966638662796092,0.0027816546970412,0.00421434342176017,0.0151184298341617,0.00051235538337641
NMR metabolomics,X23412.Phospholipids in VLDL,RNF43,E3 ubiquitin-protein ligase RNF43,39757,0.0205569836510894,0.00592263907962157,0.00894861105503109,0.0321653562471476,0.000520648319504539
NMR metabolomics,X23412.Phospholipids in VLDL,CD8A,T-cell surface glycoprotein CD8 alpha chain,42249,0.0181290795123682,0.00523335112647123,0.00787171130448463,0.0283864477202518,0.000533555330245659
NMR metabolomics,X23412.Phospholipids in VLDL,CGREF1,Cell growth regulator with EF hand domain protein 1,42145,0.0154306551466954,0.00446195312439251,0.00668522702288606,0.0241760832705047,0.000545319740031136
NMR metabolomics,X23412.Phospholipids in VLDL,EPHB6,Ephrin type-B receptor 6,41997,0.0116708581563573,0.0033790989111293,0.0050478242905439,0.0182938920221708,0.000554379790293936
NMR metabolomics,X23412.Phospholipids in VLDL,SIRT1,NAD-dependent protein deacetylase sirtuin-1,39657,0.0308340306858726,0.00893690789013393,0.0133176912212101,0.0483503701505351,0.000562283405799733
NMR metabolomics,X23412.Phospholipids in VLDL,DCTPP1,dCTP pyrophosphatase 1,42145,0.0112439888157285,0.0032623366675,0.00484980894742847,0.0176381686840285,0.000569398994332652
NMR metabolomics,X23412.Phospholipids in VLDL,CDH3,Cadherin-3,42249,0.0130282588358857,0.00379484625090355,0.0055903601841147,0.0204661574876566,0.000598393132054228
NMR metabolomics,X23412.Phospholipids in VLDL,FMR1,Synaptic functional regulator FMR1,41843,0.0127807237091648,0.0037234628880311,0.00548273644862389,0.0200787109697058,0.000599909501871014
NMR metabolomics,X23412.Phospholipids in VLDL,DDI2,Protein DDI1 homolog 2,39736,0.0265975244321242,0.00775193716554092,0.011403727587664,0.0417913212765844,0.000603363843421603
NMR metabolomics,X23412.Phospholipids in VLDL,GSN,Gelsolin,39943,0.00671413292485924,0.0019576416200029,0.00287715534965356,0.0105511105000649,0.00060638878531465
NMR metabolomics,X23412.Phospholipids in VLDL,BAX,Apoptosis regulator BAX,41814,0.0324045178815819,0.00945377502626153,0.0138751188301093,0.0509339169330545,0.000610617583846967
NMR metabolomics,X23412.Phospholipids in VLDL,SCGB1A1,Uteroglobin,42165,0.0189010009221386,0.00552073057184631,0.00808036900131981,0.0297216328429573,0.000619707844830372
NMR metabolomics,X23412.Phospholipids in VLDL,EPO,Erythropoietin,42119,0.0256942004899567,0.00751251788911136,0.0109696654272985,0.040418735552615,0.000627635017319652
NMR metabolomics,X23412.Phospholipids in VLDL,KLK15,Kallikrein-15,39900,0.0185588835574868,0.00543082692335159,0.00791446278771768,0.0292033043272559,0.000634633874400049
NMR metabolomics,X23412.Phospholipids in VLDL,MMP12,Macrophage metalloelastase,42146,0.0192432175535317,0.00563450991214624,0.00819957812572508,0.0302868569813384,0.00063912184510578
NMR metabolomics,X23412.Phospholipids in VLDL,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",39560,0.0182199951044454,0.00537156728713294,0.00769172322166479,0.0287482669872259,0.000696468001566277
NMR metabolomics,X23412.Phospholipids in VLDL,ALCAM,CD166 antigen,42310,0.00687798554278856,0.0020291050254551,0.00290093969289656,0.0108550313926806,0.000701753941967331
NMR metabolomics,X23412.Phospholipids in VLDL,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,39929,0.0223206155595751,0.00659716318792231,0.00939017571124739,0.0352510554079029,0.000718457928877388
NMR metabolomics,X23412.Phospholipids in VLDL,FCER2,Low affinity immunoglobulin epsilon Fc receptor,42137,0.0185403658420554,0.00548437567022811,0.00779098952840828,0.0292897421557025,0.000725376622867871
NMR metabolomics,X23412.Phospholipids in VLDL,SYT1,Synaptotagmin-1,39929,0.0139318126513833,0.00414000932471485,0.00581739437494223,0.0220462309278244,0.000767520305188276
NMR metabolomics,X23412.Phospholipids in VLDL,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,42016,0.0241076467832297,0.00717740278645475,0.0100399373217784,0.038175356244681,0.000784922592740443
NMR metabolomics,X23412.Phospholipids in VLDL,KIF20B,Kinesin-like protein KIF20B,39586,0.0259519549301025,0.00773113767983019,0.0107989250776353,0.0411049847825696,0.000791149851570038
NMR metabolomics,X23412.Phospholipids in VLDL,ACHE,Acetylcholinesterase,39736,0.0118783546679761,0.00354473632021232,0.00493067148035993,0.0188260378555922,0.000807927441566921
NMR metabolomics,X23412.Phospholipids in VLDL,CPTP,Ceramide-1-phosphate transfer protein,39575,-0.0136214812453107,0.00407269265633564,-0.0216039588517286,-0.00563900363889289,0.000826808155059289
NMR metabolomics,X23412.Phospholipids in VLDL,PROCR,Endothelial protein C receptor,39575,-0.0119607095373431,0.00358119942485981,-0.0189798604100684,-0.00494155866461792,0.000840995964786566
NMR metabolomics,X23412.Phospholipids in VLDL,PADI4,Protein-arginine deiminase type-4,41814,0.0251069838435531,0.00752830392396816,0.0103515081525756,0.0398624595345307,0.00085530529422431
NMR metabolomics,X23412.Phospholipids in VLDL,LAYN,Layilin,41997,-0.0123031212136829,0.00369019078488172,-0.0195358951520511,-0.00507034727531474,0.00085836737722926
NMR metabolomics,X23412.Phospholipids in VLDL,HSPB6,Heat shock protein beta-6,42262,0.013940234887718,0.00419140912754784,0.00572507299772424,0.0221553967777118,0.00088363769309481
NMR metabolomics,X23412.Phospholipids in VLDL,QSOX1,Sulfhydryl oxidase 1,39767,0.0136902216171293,0.00412854443723781,0.00559827452014324,0.0217821687141155,0.000916096096170409
NMR metabolomics,X23412.Phospholipids in VLDL,ACP1,Low molecular weight phosphotyrosine protein phosphatase,39657,0.0151730564838361,0.00458370238481967,0.00618899980958952,0.0241571131580826,0.000935215364809127
NMR metabolomics,X23412.Phospholipids in VLDL,TBC1D17,TBC1 domain family member 17,41839,0.0146734542508903,0.00443689600375706,0.00597713808352641,0.0233697704182541,0.000945034491181974
NMR metabolomics,X23412.Phospholipids in VLDL,CD163,Scavenger receptor cysteine-rich type 1 protein M130,42217,0.0146815190695204,0.00445228400359545,0.00595504242247328,0.0234079957165675,0.000977907637332464
NMR metabolomics,X23412.Phospholipids in VLDL,FABP1,"Fatty acid-binding protein, liver",42123,-0.0322506522008271,0.00979605823091928,-0.0514509263334288,-0.0130503780682253,0.000996592790835725
NMR metabolomics,X23412.Phospholipids in VLDL,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,42122,0.0199336139640073,0.00606467467658984,0.00804685159789123,0.0318203763301234,0.00101576713004458
NMR metabolomics,X23412.Phospholipids in VLDL,S100A16,Protein S100-A16,41814,-0.0206153446309895,0.00627236609372155,-0.0329091821746838,-0.0083215070872953,0.00101635484079561
NMR metabolomics,X23412.Phospholipids in VLDL,AOC1,Amiloride-sensitive amine oxidase [copper-containing],41913,0.0181308171542467,0.00555350617708135,0.00724594504716729,0.0290156892613262,0.00109836837979627
NMR metabolomics,X23412.Phospholipids in VLDL,SOX9,Transcription factor SOX-9,39649,0.00931264273813955,0.00285430825603034,0.00371819855632008,0.014907086919959,0.00110706185109461
NMR metabolomics,X23412.Phospholipids in VLDL,CD59,CD59 glycoprotein,41638,0.00793854049984741,0.0024343187625882,0.00316727572517455,0.0127098052745203,0.00111268513714967
NMR metabolomics,X23412.Phospholipids in VLDL,KIAA0319,Dyslexia-associated protein KIAA0319,39929,0.0102878029893315,0.00316428440397118,0.00408580555754804,0.0164898004211151,0.00115244393947882
NMR metabolomics,X23412.Phospholipids in VLDL,CLSTN1,Calsyntenin-1,41839,0.0169419762502035,0.00522162009637213,0.00670760086131411,0.0271763516390929,0.00117914924694535
NMR metabolomics,X23412.Phospholipids in VLDL,MERTK,Tyrosine-protein kinase Mer,42296,0.00823311939478719,0.0025434471493572,0.00324796298204709,0.0132182758075273,0.00121083858940766
NMR metabolomics,X23412.Phospholipids in VLDL,ANXA1,Annexin A1,39699,0.0148784687953621,0.00460036551560205,0.00586175238478206,0.0238951852059421,0.00122344006299127
NMR metabolomics,X23412.Phospholipids in VLDL,SEZ6L,Seizure 6-like protein,42181,0.00916065621788729,0.00283563101349828,0.00360281943143066,0.0147184930043439,0.00123845154176532
NMR metabolomics,X23412.Phospholipids in VLDL,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,41913,0.0144372458142722,0.00447125352494683,0.00567358890537646,0.023200902723168,0.00124567094495354
NMR metabolomics,X23412.Phospholipids in VLDL,FLT1,Vascular endothelial growth factor receptor 1,42042,0.00723593519389678,0.00224113984345756,0.00284330110071996,0.0116285692870736,0.00124659179891617
NMR metabolomics,X23412.Phospholipids in VLDL,IL36G,Interleukin-36 gamma,39624,0.0223990637806601,0.00694996631694361,0.00877712979945065,0.0360209977618696,0.001272677528877
NMR metabolomics,X23412.Phospholipids in VLDL,APOH,Beta-2-glycoprotein 1,42137,-0.0121355407108805,0.0037719819066715,-0.0195286252479567,-0.00474245617380437,0.00129714429579032
NMR metabolomics,X23412.Phospholipids in VLDL,ARHGAP5,Rho GTPase-activating protein 5,39560,0.0252817482467444,0.00787603435137658,0.00984472091804631,0.0407187755754425,0.00133136421090583
NMR metabolomics,X23412.Phospholipids in VLDL,PRR4,Proline-rich protein 4,39652,-0.0235821546006051,0.00734932182464926,-0.0379868253769177,-0.00917748382429257,0.00133692653674903
NMR metabolomics,X23412.Phospholipids in VLDL,CD300E,CMRF35-like molecule 2,42232,0.0137918872742964,0.00430682041896147,0.00535051925313189,0.0222332552954609,0.00136630791806015
NMR metabolomics,X23412.Phospholipids in VLDL,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",39730,-0.0204535754174263,0.00641394137680362,-0.0330249005159614,-0.0078822503188912,0.00143198648783843
NMR metabolomics,X23412.Phospholipids in VLDL,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,42185,0.0143028605986674,0.00450129570763595,0.00548032101170098,0.0231254001856339,0.00148884047536065
NMR metabolomics,X23412.Phospholipids in VLDL,LIF,Leukemia inhibitory factor,41839,0.016387543489524,0.00515844979425895,0.00627698189277643,0.0264981050862715,0.00149233589500838
NMR metabolomics,X23412.Phospholipids in VLDL,EDN1,Endothelin-1,39638,0.00964882634601499,0.00303895639866558,0.00369247180463045,0.0156051808873995,0.00150224482974047
NMR metabolomics,X23412.Phospholipids in VLDL,SAT2,Thialysine N-epsilon-acetyltransferase,39757,0.0232393292913685,0.00733083331043322,0.00887089600291943,0.0376077625798177,0.00152808864599455
NMR metabolomics,X23412.Phospholipids in VLDL,GLP1R,Glucagon-like peptide 1 receptor,39586,-0.0122599495043499,0.00387325613652685,-0.0198515315319426,-0.00466836747675733,0.00155355488156219
NMR metabolomics,X23412.Phospholipids in VLDL,APOF,Apolipoprotein F,39990,-0.00844060511335607,0.00267672818317022,-0.0136869923523697,-0.00319421787434244,0.00161838844559818
NMR metabolomics,X23412.Phospholipids in VLDL,GGA1,ADP-ribosylation factor-binding protein GGA1,41839,0.0217049692173643,0.00688780131722518,0.00820487863560295,0.0352050597991256,0.00162952944035811
NMR metabolomics,X23412.Phospholipids in VLDL,DLL1,Delta-like protein 1,42181,-0.0099591466831788,0.00316245081070997,-0.0161575502721703,-0.00376074309418725,0.0016408061259274
NMR metabolomics,X23412.Phospholipids in VLDL,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,42119,-0.0128097500394706,0.00407248074089656,-0.0207918122916279,-0.00482768778731333,0.00166195802379638
NMR metabolomics,X23412.Phospholipids in VLDL,ICAM3,Intercellular adhesion molecule 3,42310,-0.00877328927692557,0.00279160069433521,-0.0142448266378226,-0.00330175191602857,0.00167728151939175
NMR metabolomics,X23412.Phospholipids in VLDL,DLL4,Delta-like protein 4,39638,0.0286529367959312,0.00912020540287053,0.010777334206305,0.0465285393855574,0.00168414867476458
NMR metabolomics,X23412.Phospholipids in VLDL,LY9,T-lymphocyte surface antigen Ly-9,41960,0.00983849235722719,0.00313200991441746,0.00369975292496897,0.0159772317894854,0.0016858338503045
NMR metabolomics,X23412.Phospholipids in VLDL,PLB1,"Phospholipase B1, membrane-associated",39929,0.019245752775064,0.00613195827400713,0.00722711455800999,0.0312643909921179,0.00170193723035653
NMR metabolomics,X23412.Phospholipids in VLDL,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,42310,0.0088909520373824,0.0028334266189989,0.00333743586414455,0.0144444682106202,0.00170535186835482
NMR metabolomics,X23412.Phospholipids in VLDL,LIFR,Leukemia inhibitory factor receptor,42119,-0.00775720785485787,0.00247376533617811,-0.012605787913767,-0.00290862779594877,0.00171759386479832
NMR metabolomics,X23412.Phospholipids in VLDL,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,39934,0.0101668919889151,0.00324519537107128,0.00380630906161539,0.0165274749162148,0.0017352590123584
NMR metabolomics,X23412.Phospholipids in VLDL,PREB,Prolactin regulatory element-binding protein,41913,0.00915881192057238,0.00292419717698608,0.00342738545367966,0.0148902383874651,0.00173950225809027
NMR metabolomics,X23412.Phospholipids in VLDL,CCDC28A,Coiled-coil domain-containing protein 28A,39649,0.00971677740993063,0.00311156368604353,0.00361811258528532,0.0158154422345759,0.00179604819299836
NMR metabolomics,X23412.Phospholipids in VLDL,LAMTOR5,Ragulator complex protein LAMTOR5,39919,0.0131213747310318,0.00421660931935722,0.00485682046509165,0.0213859289969719,0.00186393798693604
NMR metabolomics,X23412.Phospholipids in VLDL,UROS,Uroporphyrinogen-III synthase,39649,0.0212458071149004,0.00682826310242101,0.00786241143415523,0.0346292027956456,0.00186644747953932
NMR metabolomics,X23412.Phospholipids in VLDL,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",42070,-0.0136943661782257,0.00440346501478221,-0.0223251576071988,-0.00506357474925253,0.00187536805262309
NMR metabolomics,X23412.Phospholipids in VLDL,RNF149,E3 ubiquitin-protein ligase RNF149,39638,0.0101552998112851,0.00327227735255204,0.00374163620028307,0.0165689634222871,0.00191771705687819
NMR metabolomics,X23412.Phospholipids in VLDL,OSM,Oncostatin-M,42051,0.0220707618982053,0.00711608388704412,0.00812323747959877,0.0360182863168117,0.00192920359497954
NMR metabolomics,X23412.Phospholipids in VLDL,BCL7B,B-cell CLL/lymphoma 7 protein family member B,39919,0.0147755581048167,0.00476668739454736,0.00543285081150386,0.0241182653981295,0.00194156680229993
NMR metabolomics,X23412.Phospholipids in VLDL,ITM2A,Integral membrane protein 2A,42119,-0.0197189756792973,0.00639437188995885,-0.0322519445836166,-0.00718600677497794,0.00204785618454453
NMR metabolomics,X23412.Phospholipids in VLDL,IL1RAP,Interleukin-1 receptor accessory protein,42137,-0.0142195739387386,0.0046120697025207,-0.0232592305556792,-0.00517991732179808,0.00205253094599643
NMR metabolomics,X23412.Phospholipids in VLDL,SORBS1,Sorbin and SH3 domain-containing protein 1,39934,0.0124779622715835,0.00404745022937443,0.00454495982200959,0.0204109647211574,0.00205473100174741
NMR metabolomics,X23412.Phospholipids in VLDL,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",39560,0.0181235696706567,0.00588112555247944,0.00659656358779703,0.0296505757535164,0.00206367389864707
NMR metabolomics,X23412.Phospholipids in VLDL,EXTL1,Exostosin-like 1,39575,0.0151325665562939,0.0049216514873499,0.00548612964108809,0.0247790034714997,0.00211237046052213
NMR metabolomics,X23412.Phospholipids in VLDL,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,39635,0.012379460595786,0.00403943390694012,0.00446217013818336,0.0202967510533886,0.00218449185225025
NMR metabolomics,X23412.Phospholipids in VLDL,TTN,Titin,39575,-0.0219126804258281,0.00716092600187807,-0.0359480953895091,-0.00787726546214703,0.00221845689059122
NMR metabolomics,X23412.Phospholipids in VLDL,CRISP3,Cysteine-rich secretory protein 3,39889,-0.00859854779075848,0.00281916533003587,-0.0141241118376288,-0.00307298374388819,0.00229346602716219
NMR metabolomics,X23412.Phospholipids in VLDL,NDRG1,Protein NDRG1,41839,0.0207161033895282,0.00680277678963323,0.00738266088184708,0.0340495458972093,0.00232949915158726
NMR metabolomics,X23412.Phospholipids in VLDL,AHNAK2,Protein AHNAK2,39638,0.00979668640122262,0.00322169411279395,0.00348216594014648,0.0161112068622988,0.00236465118005693
NMR metabolomics,X23412.Phospholipids in VLDL,SEMA6C,Semaphorin-6C,39657,0.00811700107439667,0.00266932466796973,0.002885124725176,0.0133488774236173,0.00236468007998815
NMR metabolomics,X23412.Phospholipids in VLDL,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,42310,0.021969669296664,0.00722551325760618,0.00780766331175588,0.0361316752815721,0.00236577482615529
NMR metabolomics,X23412.Phospholipids in VLDL,AMPD3,AMP deaminase 3,39929,0.0216540529465282,0.00712149742897997,0.00769591798572747,0.0356121879073289,0.00236599434599739
NMR metabolomics,X23412.Phospholipids in VLDL,TERF1,Telomeric repeat-binding factor 1,39657,-0.00909435290180443,0.00300766525887463,-0.0149893768091987,-0.00319932899441016,0.00250255820187866
NMR metabolomics,X23412.Phospholipids in VLDL,FAM171B,Protein FAM171B,39919,0.0082667707183447,0.00274249388486997,0.00289148270399956,0.0136420587326898,0.00258121308496086
NMR metabolomics,X23412.Phospholipids in VLDL,CGA,Glycoprotein hormones alpha chain,42137,-0.0192198981670772,0.00637695400534567,-0.0317187280175547,-0.00672106831659967,0.00258337243291041
NMR metabolomics,X23412.Phospholipids in VLDL,PDRG1,p53 and DNA damage-regulated protein 1,39649,0.0156976206570339,0.00521681411086176,0.00547266499974486,0.025922576314323,0.00262662425926853
NMR metabolomics,X23412.Phospholipids in VLDL,MST1,Hepatocyte growth factor-like protein,39854,0.0208968719906695,0.0069669264074271,0.00724169623211242,0.0345520477492266,0.00271068855521552
NMR metabolomics,X23412.Phospholipids in VLDL,CDHR1,Cadherin-related family member 1,41839,0.0127719609962965,0.00426188606421109,0.00441866431044279,0.0211252576821503,0.00273347792936371
NMR metabolomics,X23412.Phospholipids in VLDL,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,42072,0.00829229213173711,0.0027688831299794,0.00286528119697748,0.0137193030664967,0.00275110536423475
NMR metabolomics,X23412.Phospholipids in VLDL,RAB44,Ras-related protein Rab-44,39919,0.0138190315294022,0.00463537070606816,0.00473370494550857,0.0229043581132958,0.00287718954707603
NMR metabolomics,X23412.Phospholipids in VLDL,FUCA1,Tissue alpha-L-fucosidase,42212,0.0256450703483791,0.0086245280192604,0.00874099543062872,0.0425491452661295,0.00294936241581871
NMR metabolomics,X23412.Phospholipids in VLDL,LIPF,Gastric triacylglycerol lipase,39638,0.0193150509149929,0.00650172305904603,0.00657167371926273,0.0320584281107232,0.00297704796799312
NMR metabolomics,X23412.Phospholipids in VLDL,MFAP4,Microfibril-associated glycoprotein 4,39736,-0.0101303047365885,0.00341622010253401,-0.0168260961375552,-0.00343451333562187,0.00302975147651018
NMR metabolomics,X23412.Phospholipids in VLDL,TNXB,Tenascin-X,42137,0.00798657655699498,0.00269472995129088,0.00270490585246486,0.0132682472615251,0.00304418242544608
NMR metabolomics,X23412.Phospholipids in VLDL,CEP164,Centrosomal protein of 164 kDa,41913,0.0190209133747856,0.00641850802931686,0.00644063763732454,0.0316011891122466,0.00304751991177438
NMR metabolomics,X23412.Phospholipids in VLDL,IL7R,Interleukin-7 receptor subunit alpha,42137,-0.0158263726975318,0.00537272235847953,-0.0263569085201517,-0.0052958368749119,0.00322784151915811
NMR metabolomics,X23412.Phospholipids in VLDL,CRH,Corticoliberin,41830,0.025953650919356,0.00883643305258746,0.00863424213628455,0.0432730597024274,0.00331848523497394
NMR metabolomics,X23412.Phospholipids in VLDL,RANBP2,E3 SUMO-protein ligase RanBP2,39586,-0.0100625417747439,0.00343924818057027,-0.0168034682086616,-0.00332161534082615,0.00344278424068629
NMR metabolomics,X23412.Phospholipids in VLDL,SLC12A2,Solute carrier family 12 member 2,39575,-0.00799018961372486,0.002731315445092,-0.0133435678861052,-0.00263681134134454,0.00344718515875713
NMR metabolomics,X23412.Phospholipids in VLDL,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,42137,-0.00875697674141898,0.00300382611457659,-0.0146444759259891,-0.00286947755684886,0.00355958802665904
NMR metabolomics,X23412.Phospholipids in VLDL,IL17RA,Interleukin-17 receptor A,42137,0.0133125457978027,0.00457384986967278,0.00434780005324402,0.0222772915423613,0.00361349164334001
NMR metabolomics,X23412.Phospholipids in VLDL,GM2A,Ganglioside GM2 activator,39733,0.0115711028050181,0.00398177944879046,0.00376681508538885,0.0193753905246474,0.00366787675734937
NMR metabolomics,X23412.Phospholipids in VLDL,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,39958,0.00862851346052818,0.00297081163769894,0.00280572265063827,0.0144513042704181,0.00368632162822026
NMR metabolomics,X23412.Phospholipids in VLDL,CKAP4,Cytoskeleton-associated protein 4,42247,0.00848983628212151,0.00292401696527132,0.00275876303018972,0.0142209095340533,0.00369627277646117
NMR metabolomics,X23412.Phospholipids in VLDL,ARTN,Artemin,41913,0.013508591613289,0.00466174363005254,0.00437157409838603,0.022645609128192,0.00376456870910826
NMR metabolomics,X23412.Phospholipids in VLDL,GPR158,Probable G-protein coupled receptor 158,39934,0.0103795262767947,0.00358250852741495,0.00335780956306138,0.017401242990528,0.00377135722976062
NMR metabolomics,X23412.Phospholipids in VLDL,CD5L,CD5 antigen-like,39925,0.0143629641142366,0.00496969376714985,0.00462236433062288,0.0241035638978503,0.00385837794351235
NMR metabolomics,X23412.Phospholipids in VLDL,CPA2,Carboxypeptidase A2,42205,0.0196525721403249,0.00685550589911604,0.00621578057805744,0.0330893637025923,0.00415432971961929
NMR metabolomics,X23412.Phospholipids in VLDL,TSC1,Hamartin,39657,0.0219200044219557,0.0076543814342072,0.00691741681090959,0.0369225920330018,0.00419485858787264
NMR metabolomics,X23412.Phospholipids in VLDL,OSBPL2,Oxysterol-binding protein-related protein 2,39929,0.0113190315052095,0.003970375827684,0.00353709488294887,0.0191009681274701,0.0043678346510573
NMR metabolomics,X23412.Phospholipids in VLDL,HMOX1,Heme oxygenase 1,42007,-0.0143573660327256,0.00507398442494876,-0.0243023755056251,-0.00441235655982599,0.00466749092179454
NMR metabolomics,X23412.Phospholipids in VLDL,GFRA2,GDNF family receptor alpha-2,42070,0.00607918842982456,0.00215219513260741,0.00186088596991403,0.0102974908897351,0.00474024944667665
NMR metabolomics,X23412.Phospholipids in VLDL,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,39930,-0.00885613550836976,0.00313966010862027,-0.0150098693212655,-0.00270240169547403,0.00479977052408634
NMR metabolomics,X23412.Phospholipids in VLDL,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",39649,-0.0163011749462844,0.00580321473182782,-0.027675475820667,-0.00492687407190191,0.00497843785732077
NMR metabolomics,X23412.Phospholipids in VLDL,ADGRE5,Adhesion G protein-coupled receptor E5,42248,-0.00899491082221069,0.00321337528437523,-0.0152931263795861,-0.00269669526483524,0.00512997827503513
NMR metabolomics,X23412.Phospholipids in VLDL,CNTN4,Contactin-4,42137,-0.00677527435139356,0.00242277349104499,-0.0115239103938418,-0.00202663830894538,0.00517330342118562
NMR metabolomics,X23412.Phospholipids in VLDL,CTHRC1,Collagen triple helix repeat-containing protein 1,39966,0.00820252182926359,0.00293907456695579,0.00244193567803024,0.0139631079804969,0.00526571775201106
NMR metabolomics,X23412.Phospholipids in VLDL,ART3,Ecto-ADP-ribosyltransferase 3,42217,-0.0103137092512525,0.00369606867520488,-0.017558003854654,-0.00306941464785094,0.00527074089935518
NMR metabolomics,X23412.Phospholipids in VLDL,PDIA5,Protein disulfide-isomerase A5,39560,0.0178013258594646,0.00638130129601965,0.00529397531926603,0.0303086763996631,0.00528630851260169
NMR metabolomics,X23412.Phospholipids in VLDL,HRAS,GTPase Hras,39750,0.0285124449126574,0.0102460536574464,0.00843017974406245,0.0485947100812524,0.00539871030578873
NMR metabolomics,X23412.Phospholipids in VLDL,GOT1,"Aspartate aminotransferase, cytoplasmic",39966,0.0124402433298219,0.00448102435301346,0.00365743559791553,0.0212230510617283,0.00550874585784661
NMR metabolomics,X23412.Phospholipids in VLDL,HLA_DRA,,42060,-0.010391114037448,0.00374789781227064,-0.0177369937494985,-0.00304523432539754,0.00557009253416303
NMR metabolomics,X23412.Phospholipids in VLDL,TNFSF8,Tumor necrosis factor ligand superfamily member 8,39966,0.0105493426369679,0.00381580494190803,0.00307036495082818,0.0180283203231077,0.00570767727094259
NMR metabolomics,X23412.Phospholipids in VLDL,FRMD7,FERM domain-containing protein 7,39649,0.00969556911462951,0.00351097647427414,0.00281405522505219,0.0165770830042068,0.00576311380285898
NMR metabolomics,X23412.Phospholipids in VLDL,TFF1,Trefoil factor 1,42084,-0.022910695097125,0.00829695292414016,-0.0391727228284397,-0.00664866736581028,0.00576428513753248
NMR metabolomics,X23412.Phospholipids in VLDL,CAPS,Calcyphosin,39929,0.0269761494487023,0.00981906918565266,0.00773077384482314,0.0462215250525815,0.0060179005971182
NMR metabolomics,X23412.Phospholipids in VLDL,ARG1,Arginase-1,42015,0.0142030052032675,0.00521162871838676,0.00398821291522946,0.0244177974913056,0.0064335610062118
NMR metabolomics,X23412.Phospholipids in VLDL,ERBB4,Receptor tyrosine-protein kinase erbB-4,42181,-0.00657265519794236,0.00241408616984405,-0.0113042640908367,-0.00184104630504803,0.00648478859256702
NMR metabolomics,X23412.Phospholipids in VLDL,NGF,Beta-nerve growth factor,42016,0.00341185124160516,0.00125554910433892,0.000950974997100876,0.00587272748610944,0.00658779684625913
NMR metabolomics,X23412.Phospholipids in VLDL,CPVL,Probable serine carboxypeptidase CPVL,42223,0.0114987967895751,0.00423171782125813,0.00320462985990913,0.019792963719241,0.00659024409871943
NMR metabolomics,X23412.Phospholipids in VLDL,KLK3,Prostate-specific antigen,39966,0.0321176822658565,0.0118340027069415,0.00892303696025128,0.0553123275714618,0.00665730383304573
NMR metabolomics,X23412.Phospholipids in VLDL,BATF,Basic leucine zipper transcriptional factor ATF-like,39649,0.022680385012169,0.00836309014536582,0.00628872832725198,0.039072041697086,0.00669896855866555
NMR metabolomics,X23412.Phospholipids in VLDL,CELA2A,Chymotrypsin-like elastase family member 2A,39966,0.0179949787870144,0.00664651730235795,0.00496780487439278,0.0310221526996359,0.00679077847098333
NMR metabolomics,X23412.Phospholipids in VLDL,TOP1,DNA topoisomerase 1,39930,0.0337603006713379,0.0124702997276426,0.00931851320515849,0.0582020881375174,0.00679435276132607
NMR metabolomics,X23412.Phospholipids in VLDL,ACSL1,Long-chain-fatty-acid--CoA ligase 1,39575,-0.0103905314824152,0.00384359649318867,-0.017923980609065,-0.00285708235576543,0.00687530912735018
NMR metabolomics,X23412.Phospholipids in VLDL,RAD51,DNA repair protein RAD51 homolog 1,39757,0.0146623606440944,0.00542920803958814,0.00402111288650163,0.0253036084016871,0.00693097281267944
NMR metabolomics,X23412.Phospholipids in VLDL,STX5,Syntaxin-5,39657,0.011065154831151,0.00411472101351125,0.00300030164466893,0.0191300080176331,0.00717389081693546
NMR metabolomics,X23412.Phospholipids in VLDL,GSAP,Gamma-secretase-activating protein,41843,0.0233313919466453,0.00868380345378008,0.00631113717723636,0.0403516467160542,0.00722364379905414
NMR metabolomics,X23412.Phospholipids in VLDL,CD109,CD109 antigen,42137,-0.00944872604372894,0.00351737922753632,-0.0163427893297001,-0.00255466275775776,0.0072336958587435
NMR metabolomics,X23412.Phospholipids in VLDL,CLMP,CXADR-like membrane protein,42262,0.00612203603116702,0.00228099100550874,0.00165129366036989,0.0105927784019642,0.00728485338583047
NMR metabolomics,X23412.Phospholipids in VLDL,CD99,CD99 antigen,42137,-0.00551274820314872,0.0020546061353746,-0.00953977622848294,-0.0014857201778145,0.00730281517360022
NMR metabolomics,X23412.Phospholipids in VLDL,GZMH,Granzyme H,41900,0.0217680589686226,0.00811573399178009,0.00586122034473358,0.0376748975925115,0.00732290680715826
NMR metabolomics,X23412.Phospholipids in VLDL,ENDOU,Poly(U)-specific endoribonuclease,39090,0.0156633594800911,0.00584914348614516,0.00419903824724658,0.0271276807129356,0.00742030561232561
NMR metabolomics,X23412.Phospholipids in VLDL,NAPRT,Nicotinate phosphoribosyltransferase,39929,0.00927195560811843,0.00346272063107117,0.00248502317121894,0.0160588880450179,0.00742474152602559
NMR metabolomics,X23412.Phospholipids in VLDL,LEG1,Protein LEG1 homolog,39398,-0.0195629944476148,0.00731327900680053,-0.0338970213009439,-0.0052289675942858,0.00748426963917224
NMR metabolomics,X23412.Phospholipids in VLDL,NLGN2,Neuroligin-2,39586,-0.0129146728687404,0.00483573918919353,-0.0223927216795597,-0.00343662405792108,0.00758110822692801
NMR metabolomics,X23412.Phospholipids in VLDL,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,39575,0.0127349791968555,0.00477445520082034,0.00337704700324766,0.0220929113904634,0.0076572031060533
NMR metabolomics,X23412.Phospholipids in VLDL,UMOD,Uromodulin,42274,-0.014776023829403,0.00554793317151291,-0.0256499728455683,-0.00390207481323773,0.00774601937229071
NMR metabolomics,X23412.Phospholipids in VLDL,CST7,Cystatin-F,42148,0.025907131053921,0.00972882416520475,0.0068386356901197,0.0449756264177223,0.0077556181383399
NMR metabolomics,X23412.Phospholipids in VLDL,CDH6,Cadherin-6,42145,-0.0106700853972262,0.00400991528032747,-0.018529519346668,-0.00281065144778438,0.00780180905813478
NMR metabolomics,X23412.Phospholipids in VLDL,PTPRF,Receptor-type tyrosine-protein phosphatase F,42310,-0.0077734428045082,0.00292635746110858,-0.013509103428281,-0.00203778218073539,0.0079081968761789
NMR metabolomics,X23412.Phospholipids in VLDL,EIF5,Eukaryotic translation initiation factor 5,39575,0.0116823271711978,0.00440115401443288,0.00305606530290939,0.0203085890394863,0.00795693222731356
NMR metabolomics,X23412.Phospholipids in VLDL,SNX18,Sorting nexin-18,39930,0.0119975837938518,0.00452199466445257,0.00313447425152475,0.0208606933361788,0.00798528467398473
NMR metabolomics,X23412.Phospholipids in VLDL,COL5A1,Collagen alpha-1(V) chain,39736,-0.0112639531554321,0.00424742975720126,-0.0195889154795465,-0.00293899083131759,0.00801427930845203
NMR metabolomics,X23412.Phospholipids in VLDL,SLURP1,Secreted Ly-6/uPAR-related protein 1,39908,0.00996829380459886,0.00375937356421304,0.0025999216187413,0.0173366659904564,0.00802269706534696
NMR metabolomics,X23412.Phospholipids in VLDL,EPHX2,Bifunctional epoxide hydrolase 2,41900,0.0166264458696597,0.00628555086950175,0.00430676616543625,0.0289461255738831,0.00817421985809222
NMR metabolomics,X23412.Phospholipids in VLDL,BMP4,Bone morphogenetic protein 4,41992,-0.0128961857765269,0.00488091936649567,-0.0224627877348584,-0.0033295838181954,0.0082474113616221
NMR metabolomics,X23412.Phospholipids in VLDL,ICAM2,Intercellular adhesion molecule 2,42310,-0.00891445016442502,0.00337568576702082,-0.0155307942677858,-0.00229810606106421,0.00828086866069716
NMR metabolomics,X23412.Phospholipids in VLDL,AIF1L,Allograft inflammatory factor 1-like,39638,0.0154683514637657,0.00586897801184172,0.00396515456055589,0.0269715483669754,0.0084103022904623
NMR metabolomics,X23412.Phospholipids in VLDL,TP53INP1,Tumor protein p53-inducible nuclear protein 1,41900,0.00796480260132606,0.00303695997172656,0.002012361056742,0.0139172441459101,0.00873551132021692
NMR metabolomics,X23412.Phospholipids in VLDL,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,39539,-0.0145652332904012,0.00556709795907332,-0.0254767452901849,-0.00365372129061747,0.00890089486367847
NMR metabolomics,X23412.Phospholipids in VLDL,SEPTIN8,Septin-8,39906,0.00881569868589241,0.00337181486376968,0.00220694155290383,0.015424455818881,0.0089469800462625
NMR metabolomics,X23412.Phospholipids in VLDL,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",39929,0.0151079580044431,0.0057858038969607,0.00376778236640015,0.0264481336424861,0.0090340957551077
NMR metabolomics,X23412.Phospholipids in VLDL,KIAA1549L,UPF0606 protein KIAA1549L,39757,-0.00736403112134034,0.00282765919794184,-0.0129062431493064,-0.00182181909337433,0.00921881356172638
NMR metabolomics,X23412.Phospholipids in VLDL,GPC1,Glypican-1,42262,0.00792065753779754,0.00304572203152822,0.00195104235600223,0.0138902727195928,0.00931653217185175
NMR metabolomics,X23412.Phospholipids in VLDL,PLA2G1B,Phospholipase A2,42299,-0.0118662450536852,0.00459452535638524,-0.0208715147522003,-0.00286097535517015,0.0098135463301501
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,42016,0.0107803011200781,0.00419115267712616,0.00256564187291087,0.0189949603672454,0.0101173750833615
NMR metabolomics,X23412.Phospholipids in VLDL,CSRP3,Cysteine and glycine-rich protein 3,39575,-0.0268841317913918,0.0104658910315626,-0.0473972782132544,-0.00637098536952916,0.0102200580756474
NMR metabolomics,X23412.Phospholipids in VLDL,CCAR2,Cell cycle and apoptosis regulator protein 2,39929,0.0147758654366804,0.00575351578502693,0.00349897449802764,0.0260527563753332,0.0102371241305268
NMR metabolomics,X23412.Phospholipids in VLDL,SIGLEC6,Sialic acid-binding Ig-like lectin 6,42262,0.00885797554583367,0.00345342207570927,0.00208926827744351,0.0156266828142238,0.0103286097024659
NMR metabolomics,X23412.Phospholipids in VLDL,CEP290,Centrosomal protein of 290 kDa,39757,0.0140557413596308,0.00548352246503428,0.0033080373281636,0.024803445391098,0.0103821676154118
NMR metabolomics,X23412.Phospholipids in VLDL,GUK1,Guanylate kinase,39575,-0.0106383050093188,0.00416253255746461,-0.0187968688219494,-0.00247974119668815,0.0106099171975938
NMR metabolomics,X23412.Phospholipids in VLDL,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,39958,0.0196957345185832,0.00773515434913319,0.00453483199428219,0.0348566370428843,0.0109014097640254
NMR metabolomics,X23412.Phospholipids in VLDL,IGLC2,Immunoglobulin lambda constant 2,39963,-0.00672944374574635,0.00264951991997614,-0.0119225027888996,-0.00153638470259312,0.0111024811770484
NMR metabolomics,X23412.Phospholipids in VLDL,RNF31,E3 ubiquitin-protein ligase RNF31,39657,0.00953970811971849,0.00375773457248345,0.00217454835765093,0.0169048678817861,0.0111405572684799
NMR metabolomics,X23412.Phospholipids in VLDL,NEDD9,Enhancer of filamentation 1,39657,0.00886799343580609,0.00350273447734222,0.00200263386021534,0.0157333530113968,0.0113637237205266
NMR metabolomics,X23412.Phospholipids in VLDL,CHEK2,Serine/threonine-protein kinase Chk2,41900,0.0086330287282632,0.00341360523247805,0.00194236247260621,0.0153236949839202,0.0114500619045661
NMR metabolomics,X23412.Phospholipids in VLDL,PZP,Pregnancy zone protein,39979,0.00867387924517084,0.00343622738514907,0.00193887357027866,0.015408884920063,0.0116082026381852
NMR metabolomics,X23412.Phospholipids in VLDL,HSP90B1,Endoplasmin,41774,0.0165045553360622,0.0065496540423988,0.00366723341296053,0.0293418772591638,0.0117501228375152
NMR metabolomics,X23412.Phospholipids in VLDL,AMIGO1,Amphoterin-induced protein 1,39649,0.0131906368143698,0.00524030497807749,0.0029196390573379,0.0234616345714017,0.0118448585256096
NMR metabolomics,X23412.Phospholipids in VLDL,LPCAT2,Lysophosphatidylcholine acyltransferase 2,42070,0.0106261530673202,0.0042229023475936,0.00234926446603671,0.0189030416686036,0.0118704343727727
NMR metabolomics,X23412.Phospholipids in VLDL,BCAM,Basal cell adhesion molecule,42137,-0.0063654196147864,0.00253071277816951,-0.0113256166599986,-0.00140522256957415,0.0119056946581847
NMR metabolomics,X23412.Phospholipids in VLDL,C1GALT1C1,C1GALT1-specific chaperone 1,39575,0.00847622845502213,0.00337534136372141,0.00186055938212817,0.0150918975279161,0.0120456800565681
NMR metabolomics,X23412.Phospholipids in VLDL,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,42016,0.0271795835718199,0.0108355161521101,0.0059419719136841,0.0484171952299556,0.0121403452161906
NMR metabolomics,X23412.Phospholipids in VLDL,TXNDC15,Thioredoxin domain-containing protein 15,42181,0.00713558879571205,0.00284682251284493,0.00155581667053599,0.0127153609208881,0.0122045559002918
NMR metabolomics,X23412.Phospholipids in VLDL,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,41900,0.00920706484066845,0.00367817995665373,0.00199783212562714,0.0164162975557098,0.012320957661629
NMR metabolomics,X23412.Phospholipids in VLDL,MYO6,Unconventional myosin-VI,39934,0.00965866114751919,0.00386667482837023,0.00207997848391354,0.0172373438111248,0.0125063449301203
NMR metabolomics,X23412.Phospholipids in VLDL,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,39930,0.0218334979140508,0.00874656168320367,0.00469023701497164,0.03897675881313,0.0125659401772826
NMR metabolomics,X23412.Phospholipids in VLDL,FGF9,Fibroblast growth factor 9,39539,0.0106469706091749,0.00426611730170698,0.00228538069782923,0.0190085605205206,0.0125853195480901
NMR metabolomics,X23412.Phospholipids in VLDL,RAC3,Ras-related C3 botulinum toxin substrate 3,39649,0.0178178637966037,0.0071403837774814,0.00382271159274012,0.0318130160004672,0.0125972364363095
NMR metabolomics,X23412.Phospholipids in VLDL,LMOD1,Leiomodin-1,39934,-0.00893843997681679,0.00358487677436239,-0.0159647984545671,-0.0019120814990665,0.0126676838025626
NMR metabolomics,X23412.Phospholipids in VLDL,MPO,Myeloperoxidase,42137,0.0115479283164026,0.00463697872251593,0.00245945002027138,0.0206364066125338,0.0127718626809035
NMR metabolomics,X23412.Phospholipids in VLDL,GPR101,Probable G-protein coupled receptor 101,39586,-0.0149203389934063,0.00601068435527621,-0.0267012803297477,-0.00313939765706497,0.0130684521689225
NMR metabolomics,X23412.Phospholipids in VLDL,HCG22,Protein PBMUCL2,39575,-0.0149000508838295,0.00600675395754317,-0.0266732886406141,-0.00312681312704488,0.0131328783431561
NMR metabolomics,X23412.Phospholipids in VLDL,PRKCQ,Protein kinase C theta type,41913,0.0109403110473307,0.00441117470234146,0.00229440863074148,0.01958621346392,0.0131455156197127
NMR metabolomics,X23412.Phospholipids in VLDL,LRP1,Prolow-density lipoprotein receptor-related protein 1,42070,0.00683844201580205,0.00275839110224035,0.00143199545541096,0.0122448885761931,0.0131820460931881
NMR metabolomics,X23412.Phospholipids in VLDL,CTRL,Chymotrypsin-like protease CTRL-1,39929,-0.0182269406143253,0.00735329122274254,-0.0326393914109007,-0.00381448981774991,0.0131989655553612
NMR metabolomics,X23412.Phospholipids in VLDL,SPON1,Spondin-1,42144,0.00832192166654257,0.00336129635657037,0.00173378080766465,0.0149100625254205,0.0133056676986462
NMR metabolomics,X23412.Phospholipids in VLDL,RALB,Ras-related protein Ral-B,39657,0.00757875596640641,0.00306777080401235,0.0015659251905422,0.0135915867422706,0.013509516835135
NMR metabolomics,X23412.Phospholipids in VLDL,TIE1,Tyrosine-protein kinase receptor Tie-1,42310,0.010377559675292,0.0042040441663854,0.0021376331091766,0.0186174862414074,0.0135812846495995
NMR metabolomics,X23412.Phospholipids in VLDL,PGM2,Phosphoglucomutase-2,39649,0.0154749913490992,0.00627061406800499,0.00318458777580945,0.027765394922389,0.0136074209875339
NMR metabolomics,X23412.Phospholipids in VLDL,CSF1R,Macrophage colony-stimulating factor 1 receptor,39990,0.0103896761638707,0.00421787913851713,0.00212263305237709,0.0186567192753642,0.0137831985765726
NMR metabolomics,X23412.Phospholipids in VLDL,IFNGR1,Interferon gamma receptor 1,42185,0.00546578782504492,0.00222906402149328,0.00109682234291808,0.00983475330717175,0.014216784037443
NMR metabolomics,X23412.Phospholipids in VLDL,KRT14,"Keratin, type I cytoskeletal 14",41482,0.00752949015926846,0.00307682724995112,0.00149890874936428,0.0135600715691726,0.0144119319783114
NMR metabolomics,X23412.Phospholipids in VLDL,NECTIN4,Nectin-4,42181,-0.00846676578048774,0.00346414132225828,-0.015256482772114,-0.00167704878886152,0.0145333579768724
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,39736,-0.0105638734086146,0.00432956198313188,-0.0190498148955531,-0.00207793192167615,0.0147051735160342
NMR metabolomics,X23412.Phospholipids in VLDL,ABO,Histo-blood group ABO system transferase,39990,0.0364751978414377,0.0149826399327207,0.00710922357330511,0.0658411721095703,0.0149277416396081
NMR metabolomics,X23412.Phospholipids in VLDL,CST6,Cystatin-M,41864,0.0124563337085561,0.00513045953626244,0.00240063301748172,0.0225120343996305,0.0151989999618642
NMR metabolomics,X23412.Phospholipids in VLDL,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,41843,0.0309725067732736,0.0127587178482943,0.0059654197906168,0.0559795937559304,0.0152141643484022
NMR metabolomics,X23412.Phospholipids in VLDL,KEL,Kell blood group glycoprotein,41839,0.00903059944300101,0.00372966614515728,0.00172045379849274,0.0163407450875093,0.0154789311970652
NMR metabolomics,X23412.Phospholipids in VLDL,POF1B,Protein POF1B,39657,-0.0113811781289012,0.00470153053613159,-0.0205961779797191,-0.00216617827808325,0.0155049953204511
NMR metabolomics,X23412.Phospholipids in VLDL,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,39638,0.00904285785637592,0.00374337309571865,0.00170584658876737,0.0163798691239845,0.0157212257511347
NMR metabolomics,X23412.Phospholipids in VLDL,OSMR,Oncostatin-M-specific receptor subunit beta,42230,-0.0047896669892888,0.00198290788588064,-0.00867616644561486,-0.000903167532962745,0.0157277133907187
NMR metabolomics,X23412.Phospholipids in VLDL,PDCD1,Programmed cell death protein 1,42232,0.0104198605839339,0.00431993228527755,0.00195279330478994,0.0188869278630779,0.0158765532109586
NMR metabolomics,X23412.Phospholipids in VLDL,DDX39A,ATP-dependent RNA helicase DDX39A,39657,0.00611763442983739,0.00254018507539918,0.00113887168205499,0.0110963971776198,0.0160414190010048
NMR metabolomics,X23412.Phospholipids in VLDL,LTO1,Protein LTO1 homolog,41913,0.0102320488805339,0.0042600324689552,0.00188238524138167,0.0185817125196861,0.0163250699833768
NMR metabolomics,X23412.Phospholipids in VLDL,MAEA,E3 ubiquitin-protein transferase MAEA,41843,0.00966820721547701,0.00402554222956934,0.0017781444455211,0.0175582699854329,0.0163320834812824
NMR metabolomics,X23412.Phospholipids in VLDL,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,42181,0.0112950571236045,0.0047119235409389,0.00205968698336428,0.0205304272638448,0.0165378333014879
NMR metabolomics,X23412.Phospholipids in VLDL,CRHR1,Corticotropin-releasing factor receptor 1,41900,0.0144140948958374,0.00601555491582683,0.0026236072608168,0.026204582530858,0.0165826153085426
NMR metabolomics,X23412.Phospholipids in VLDL,NTF3,Neurotrophin-3,42119,0.0084697952406088,0.00354712408211211,0.00151743203966906,0.0154221584415485,0.01696357093169
NMR metabolomics,X23412.Phospholipids in VLDL,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,39930,0.0124237159283487,0.00521745873713491,0.00219749680356426,0.0226499350531331,0.0172736308418084
NMR metabolomics,X23412.Phospholipids in VLDL,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",42144,-0.00807933960329759,0.00339330429000616,-0.0147302160117097,-0.00142846319488552,0.0172810810335243
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINA11,Serpin A11,42310,-0.0102351647694961,0.00430708726899571,-0.0186770558167277,-0.00179327372226452,0.0174983235070946
NMR metabolomics,X23412.Phospholipids in VLDL,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,39979,-0.00475460676366103,0.00200512451327018,-0.00868465080967058,-0.000824562717651479,0.0177456593331797
NMR metabolomics,X23412.Phospholipids in VLDL,THY1,Thy-1 membrane glycoprotein,42249,0.0071339934287142,0.00301218385087502,0.00123011308099915,0.0130378737764292,0.0178800648731846
NMR metabolomics,X23412.Phospholipids in VLDL,SHPK,Sedoheptulokinase,39757,-0.00977414425181355,0.00413291252760763,-0.0178746528059245,-0.0016736356977026,0.0180493686209585
NMR metabolomics,X23412.Phospholipids in VLDL,ATF2,Cyclic AMP-dependent transcription factor ATF-2,41839,0.0167088981736778,0.00707459499559485,0.00284269198231192,0.0305751043650437,0.0182000134268797
NMR metabolomics,X23412.Phospholipids in VLDL,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,42249,0.0170601706217729,0.00722998911763206,0.00288939195121411,0.0312309492923318,0.0183066807891273
NMR metabolomics,X23412.Phospholipids in VLDL,RNASE10,Inactive ribonuclease-like protein 10,39638,-0.0115456065959362,0.00489834119519124,-0.021146355338511,-0.00194485785336134,0.018438419004985
NMR metabolomics,X23412.Phospholipids in VLDL,CALB1,Calbindin,42070,0.0109926239472926,0.00466536085538746,0.00184851667073321,0.020136731223852,0.0184761438957681
NMR metabolomics,X23412.Phospholipids in VLDL,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,41619,0.00926015323215184,0.00393203991666142,0.00155335499549545,0.0169669514688082,0.0185349371744188
NMR metabolomics,X23412.Phospholipids in VLDL,TGFBR3,Transforming growth factor beta receptor type 3,42310,-0.00729119826413007,0.00309640358469735,-0.0133601492901369,-0.00122224723812327,0.0185501250521134
NMR metabolomics,X23412.Phospholipids in VLDL,DCUN1D2,DCN1-like protein 2,39560,-0.0194563377893061,0.0082634984449184,-0.0356527947413461,-0.00325988083726602,0.0185656037841801
NMR metabolomics,X23412.Phospholipids in VLDL,IL1A,Interleukin-1 alpha,41913,0.0140152193286237,0.00596849759782967,0.00231696403687758,0.0257134746203699,0.0188789967602935
NMR metabolomics,X23412.Phospholipids in VLDL,SLC13A1,Solute carrier family 13 member 1,39919,0.0145491979764569,0.00620373743752626,0.00238987259890541,0.0267085233540084,0.0190324647461881
NMR metabolomics,X23412.Phospholipids in VLDL,PPM1B,Protein phosphatase 1B,39657,0.0149462955538371,0.00638185528262206,0.00243785919989788,0.0274547319077764,0.0191984420824232
NMR metabolomics,X23412.Phospholipids in VLDL,OMD,Osteomodulin,42185,-0.00985471999481896,0.00422931655366724,-0.0181441804400068,-0.00156525954963117,0.0198155671547177
NMR metabolomics,X23412.Phospholipids in VLDL,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,41843,0.00844678094708896,0.00363988419787325,0.0013126079192574,0.0155809539749205,0.0203225797826979
NMR metabolomics,X23412.Phospholipids in VLDL,CD3E,T-cell surface glycoprotein CD3 epsilon chain,39757,0.00825721174693957,0.003595556401712,0.00120992119958405,0.0153045022942951,0.0216654881706306
NMR metabolomics,X23412.Phospholipids in VLDL,CLSPN,Claspin,41820,0.00841128841546547,0.00366396972156481,0.00122990776119844,0.0155926690697325,0.0217099742993966
NMR metabolomics,X23412.Phospholipids in VLDL,DPP7,Dipeptidyl peptidase 2,42054,0.0148639540357278,0.0064777655124592,0.00216753363130776,0.0275603744401478,0.0217707338842806
NMR metabolomics,X23412.Phospholipids in VLDL,MYL4,Myosin light chain 4,39638,-0.012205837371667,0.00533311624443899,-0.0226587452107674,-0.00175292953256657,0.0221163099638495
NMR metabolomics,X23412.Phospholipids in VLDL,ATP6V1D,V-type proton ATPase subunit D,42070,0.00610791524539006,0.00267585290444875,0.000863243552670506,0.0113525869381096,0.022469158746696
NMR metabolomics,X23412.Phospholipids in VLDL,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",39586,0.00749003915913579,0.00328192149349151,0.00105747303189243,0.0139226052863791,0.022495882662573
NMR metabolomics,X23412.Phospholipids in VLDL,PRDX2,Peroxiredoxin-2,39819,0.0142142877726281,0.0062380985665169,0.00198761458225497,0.0264409609630012,0.0227080707628192
NMR metabolomics,X23412.Phospholipids in VLDL,CASP1,Caspase-1,41839,0.0161724346837309,0.00710028891804199,0.0022558684043686,0.0300890009630932,0.0227594319441993
NMR metabolomics,X23412.Phospholipids in VLDL,ANGPTL4,Angiopoietin-related protein 4,42166,-0.0104649243468058,0.00459498125367363,-0.0194710876040061,-0.00145876108960551,0.022773763988551
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINB5,Serpin B5,41900,0.0114353943912615,0.00502170978260756,0.00159284321735073,0.0212779455651723,0.0227906035021817
NMR metabolomics,X23412.Phospholipids in VLDL,NEB,Nebulin,39575,-0.00936656256878616,0.00411657045007141,-0.0174350406509261,-0.0012980844866462,0.0229052427290674
NMR metabolomics,X23412.Phospholipids in VLDL,CXCL14,C-X-C motif chemokine 14,41913,0.0134137826137282,0.00589602941725979,0.00185756495589902,0.0249700002715574,0.022918545577976
NMR metabolomics,X23412.Phospholipids in VLDL,KIAA1549,UPF0606 protein KIAA1549,39757,0.0160929649519448,0.00707644326082541,0.00222313616072695,0.0299627937431626,0.0229752668658377
NMR metabolomics,X23412.Phospholipids in VLDL,RAB39B,Ras-related protein Rab-39B,39575,0.0217157504398522,0.00954912255822217,0.00299947022573676,0.0404320306539677,0.022978622477516
NMR metabolomics,X23412.Phospholipids in VLDL,PNMA2,Paraneoplastic antigen Ma2,39586,0.0104514653711268,0.0046025330086231,0.0014305006742255,0.019472430068028,0.023177918087912
NMR metabolomics,X23412.Phospholipids in VLDL,ADGRE2,Adhesion G protein-coupled receptor E2,42185,-0.00669678844386628,0.00295809894184535,-0.0124946623698832,-0.00089891451784939,0.0235970429007626
NMR metabolomics,X23412.Phospholipids in VLDL,BLVRB,Flavin reductase,42137,0.0148428946766853,0.0065683218403317,0.00196898386963514,0.0277168054837354,0.0238513743283962
NMR metabolomics,X23412.Phospholipids in VLDL,CTRC,Chymotrypsin-C,42122,0.0151836454485251,0.00673476723047727,0.00198350167678961,0.0283837892202605,0.0241796124862731
NMR metabolomics,X23412.Phospholipids in VLDL,MELTF,Melanotransferrin,39958,0.00699202331635171,0.00310865809731098,0.000899053445622186,0.0130849931870812,0.0245182478216181
NMR metabolomics,X23412.Phospholipids in VLDL,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",39934,0.0156489071040552,0.00696324100294027,0.0020009547382923,0.0292968594698182,0.024636204578799
NMR metabolomics,X23412.Phospholipids in VLDL,MANSC4,MANSC domain-containing protein 4,39575,0.0157848592190262,0.00702914367648992,0.00200773761310594,0.0295619808249464,0.0247475052296851
NMR metabolomics,X23412.Phospholipids in VLDL,MYH7B,Myosin-7B,39560,-0.00992622790244872,0.00444104705594036,-0.0186306801320918,-0.00122177567280561,0.0254302051327456
NMR metabolomics,X23412.Phospholipids in VLDL,SCP2,Non-specific lipid-transfer protein,41843,0.0170777920923321,0.00765132837478915,0.00208118847774533,0.0320743957069188,0.0256313881061702
NMR metabolomics,X23412.Phospholipids in VLDL,IL4,Interleukin-4,41913,0.021645896453907,0.0097349291253016,0.00256543536831591,0.0407263575394982,0.0261968731181433
NMR metabolomics,X23412.Phospholipids in VLDL,CLEC4M,C-type lectin domain family 4 member M,39945,0.011383391605521,0.00512489686267487,0.00133859375467824,0.0214281894563637,0.0263574702296099
NMR metabolomics,X23412.Phospholipids in VLDL,YY1,Transcriptional repressor protein YY1,39657,0.00640047709387865,0.00288576206964201,0.000744383437380299,0.012056570750377,0.0265784595082051
NMR metabolomics,X23412.Phospholipids in VLDL,TLR4,Toll-like receptor 4,39657,0.00649752055502908,0.00293690954586833,0.000741177845127143,0.012253863264931,0.0269617043427235
NMR metabolomics,X23412.Phospholipids in VLDL,BRK1,Protein BRICK1,41839,0.0103230103849292,0.00468097416708945,0.00114830101743392,0.0194977197524245,0.0274493041709491
NMR metabolomics,X23412.Phospholipids in VLDL,AGBL2,Cytosolic carboxypeptidase 2,39586,0.0209143586209373,0.00950906488977013,0.00227659143698782,0.0395521258048867,0.0278693440477124
NMR metabolomics,X23412.Phospholipids in VLDL,EP300,Histone acetyltransferase p300,39657,0.00699351329683111,0.00318545709170804,0.000750017397083353,0.0132370091965789,0.0281520047543567
NMR metabolomics,X23412.Phospholipids in VLDL,MTR,Methionine synthase,39575,0.0148035928350881,0.00675657751131529,0.00156070091291012,0.0280464847572661,0.0284734775661777
NMR metabolomics,X23412.Phospholipids in VLDL,PSMD1,26S proteasome non-ATPase regulatory subunit 1,39934,0.011152314218429,0.00509158737635716,0.00117280296076893,0.021131825476089,0.0285197929364588
NMR metabolomics,X23412.Phospholipids in VLDL,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",41913,0.0261233118514666,0.0119456874516751,0.00270976444618345,0.0495368592567497,0.0287715193811217
NMR metabolomics,X23412.Phospholipids in VLDL,GBA,Lysosomal acid glucosylceramidase,39649,0.0125038105948829,0.00572874490822448,0.00127547057476297,0.0237321506150029,0.0290830190827542
NMR metabolomics,X23412.Phospholipids in VLDL,CFD,Complement factor D,39979,0.00457003256896068,0.00209634720517729,0.000461192046813191,0.00867887309110818,0.029278039374906
NMR metabolomics,X23412.Phospholipids in VLDL,JCHAIN,Immunoglobulin J chain,41913,-0.0137680091803834,0.00632141449904678,-0.026157981598515,-0.00137803676225168,0.0294238996716033
NMR metabolomics,X23412.Phospholipids in VLDL,MYBPC2,"Myosin-binding protein C, fast-type",39638,-0.0197179431141112,0.00910185951096564,-0.0375575877556038,-0.00187829847261851,0.0303046939259274
NMR metabolomics,X23412.Phospholipids in VLDL,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",39586,-0.0122422158031408,0.00568020635200413,-0.0233754202530689,-0.00110901135321267,0.0311646059775023
NMR metabolomics,X23412.Phospholipids in VLDL,KLK11,Kallikrein-11,42062,0.00714546170491316,0.00332288727930327,0.000632602637478749,0.0136583207723476,0.0315431268427091
NMR metabolomics,X23412.Phospholipids in VLDL,UNG,Uracil-DNA glycosylase,39919,0.00782223331702271,0.00363864525317181,0.000690488620805971,0.0149539780132395,0.0315949093741263
NMR metabolomics,X23412.Phospholipids in VLDL,BTN2A1,Butyrophilin subfamily 2 member A1,42185,0.00602856775050179,0.00280550466905452,0.000529778599154927,0.0115273569018487,0.0316650665244748
NMR metabolomics,X23412.Phospholipids in VLDL,HTR1B,5-hydroxytryptamine receptor 1B,39586,-0.00970661069087203,0.00452052060547166,-0.0185668310775965,-0.000846390304147578,0.0317965589977909
NMR metabolomics,X23412.Phospholipids in VLDL,DNPEP,Aspartyl aminopeptidase,39929,0.0126279330038383,0.00588556050809341,0.00109223440797524,0.0241636315997014,0.0319277977314064
NMR metabolomics,X23412.Phospholipids in VLDL,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,39638,-0.00568453733085981,0.00264970839465047,-0.0108779657843747,-0.000491108877344884,0.0319470641859364
NMR metabolomics,X23412.Phospholipids in VLDL,APOD,Apolipoprotein D,39468,-0.00943799710365388,0.00439952732938049,-0.0180610706692397,-0.000814923538068116,0.0319565723655598
NMR metabolomics,X23412.Phospholipids in VLDL,SCN2B,Sodium channel subunit beta-2,39649,-0.00624646526664256,0.00291440695841656,-0.011958702905139,-0.000534227628146098,0.032110323299786
NMR metabolomics,X23412.Phospholipids in VLDL,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,39757,0.0113684575058496,0.00533134713473261,0.000919017121773738,0.0218178978899256,0.0329974006079128
NMR metabolomics,X23412.Phospholipids in VLDL,NMRK2,Nicotinamide riboside kinase 2,39560,-0.00861453944475512,0.00404435206655704,-0.0165414694952069,-0.000687609394303325,0.0331924047124954
NMR metabolomics,X23412.Phospholipids in VLDL,TIMP2,Metalloproteinase inhibitor 2,39958,-0.006267271244529,0.0029492083771174,-0.0120477196636791,-0.000486822825378892,0.0336023841784626
NMR metabolomics,X23412.Phospholipids in VLDL,CRTAM,Cytotoxic and regulatory T-cell molecule,42016,-0.0112119178716072,0.00528765726706479,-0.0215757261150542,-0.000848109628160253,0.0339911139277248
NMR metabolomics,X23412.Phospholipids in VLDL,CLEC4C,C-type lectin domain family 4 member C,42119,0.0105879707559416,0.00499672845604306,0.000794382982097211,0.020381558529786,0.0341102876106316
NMR metabolomics,X23412.Phospholipids in VLDL,ADGRE1,Adhesion G protein-coupled receptor E1,39930,0.0119139501488817,0.00562993065105381,0.000879286072816267,0.0229486142249472,0.0343511976340751
NMR metabolomics,X23412.Phospholipids in VLDL,AMBN,Ameloblastin,41913,-0.00595894564845178,0.00282168564996695,-0.011489449522387,-0.000428441774516558,0.0347188446864839
NMR metabolomics,X23412.Phospholipids in VLDL,EIF5A,Eukaryotic translation initiation factor 5A-1,41913,0.00670939920947414,0.0031878414985061,0.000461229872402196,0.0129575685465461,0.0353375120214938
NMR metabolomics,X23412.Phospholipids in VLDL,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,39575,-0.00451385059150827,0.00215336461016799,-0.00873444522743754,-0.000293255955578997,0.0360886234726519
NMR metabolomics,X23412.Phospholipids in VLDL,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,42248,0.00747340248685061,0.00356786335888689,0.000480390303432296,0.0144664146702689,0.0362210684609876
NMR metabolomics,X23412.Phospholipids in VLDL,CA3,Carbonic anhydrase 3,42287,-0.012662766221631,0.00606417065979914,-0.0245485407148373,-0.000776991728424652,0.0368047031659976
NMR metabolomics,X23412.Phospholipids in VLDL,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,41839,0.0096461157826874,0.00462450524803589,0.000582085496537059,0.0187101460688377,0.0370095173796505
NMR metabolomics,X23412.Phospholipids in VLDL,IL10RA,Interleukin-10 receptor subunit alpha,41913,0.0120077038054841,0.00578037834445273,0.000678162250356787,0.0233372453606115,0.0377910277507256
NMR metabolomics,X23412.Phospholipids in VLDL,IMPG1,Interphotoreceptor matrix proteoglycan 1,39586,-0.00650145466215503,0.00313529435812967,-0.0126466316040892,-0.000356277720220874,0.0381365111454322
NMR metabolomics,X23412.Phospholipids in VLDL,B2M,Beta-2-microglobulin,39979,0.00653258392878563,0.00315164676266603,0.000355356273960208,0.0127098115836111,0.0382177715612053
NMR metabolomics,X23412.Phospholipids in VLDL,UPK3BL1,Uroplakin-3b-like protein 1,39738,-0.0113034890865011,0.00546710100434991,-0.0220190070550269,-0.00058797111797527,0.0387056675853309
NMR metabolomics,X23412.Phospholipids in VLDL,HMCN2,Hemicentin-2,39721,-0.0123340546175882,0.00600525004188829,-0.0241043446996892,-0.000563764535487123,0.0400107687704821
NMR metabolomics,X23412.Phospholipids in VLDL,RPS10,40S ribosomal protein S10,39575,-0.00885664128633878,0.00431857064123098,-0.0173210397431515,-0.000392242829526062,0.0403074901930996
NMR metabolomics,X23412.Phospholipids in VLDL,DBH,Dopamine beta-hydroxylase,39978,0.0241492618313401,0.0117825884846935,0.00105538840134072,0.0472431352613394,0.0404291047773647
NMR metabolomics,X23412.Phospholipids in VLDL,LY96,Lymphocyte antigen 96,42016,-0.00771999207929431,0.00376805428277383,-0.015105378473531,-0.000334605685057616,0.0405010243950454
NMR metabolomics,X23412.Phospholipids in VLDL,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",39657,0.0131951804565977,0.00644518218881547,0.000562623366519343,0.025827737546676,0.0406528445803635
NMR metabolomics,X23412.Phospholipids in VLDL,GBP2,Guanylate-binding protein 2,41913,0.0127983777801454,0.00625544585254883,0.000537703909149709,0.0250590516511411,0.0407801355955245
NMR metabolomics,X23412.Phospholipids in VLDL,ENOPH1,Enolase-phosphatase E1,39919,0.011268646030899,0.0055076708429935,0.000473611178631714,0.0220636808831662,0.0407802963897677
NMR metabolomics,X23412.Phospholipids in VLDL,ALPI,Intestinal-type alkaline phosphatase,39657,-0.0264943771859571,0.0129704266890987,-0.0519164134965906,-0.00107234087532352,0.0411082038448964
NMR metabolomics,X23412.Phospholipids in VLDL,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,42016,-0.00607653485949398,0.00297560800109338,-0.011908726541637,-0.000244343177350966,0.041159600198054
NMR metabolomics,X23412.Phospholipids in VLDL,PSMD5,26S proteasome non-ATPase regulatory subunit 5,39649,-0.0114056263466479,0.00558897405009782,-0.0223600154848396,-0.000451237208456178,0.0413006894345506
NMR metabolomics,X23412.Phospholipids in VLDL,CD7,T-cell antigen CD7,39636,0.00944850939177574,0.0046324749405836,0.000368858508231889,0.0185281602753196,0.0414115053953209
NMR metabolomics,X23412.Phospholipids in VLDL,FDX2,"Ferredoxin-2, mitochondrial",39575,0.0116435536004633,0.00570988312756585,0.000452182670434209,0.0228349245304923,0.0414546766282172
NMR metabolomics,X23412.Phospholipids in VLDL,SIGLEC10,Sialic acid-binding Ig-like lectin 10,42119,0.00725394355537084,0.00356155307110471,0.0002732995360056,0.0142345875747361,0.0416959421532762
NMR metabolomics,X23412.Phospholipids in VLDL,MRPS16,"28S ribosomal protein S16, mitochondrial",39657,0.00618510519427844,0.00304533798277751,0.000216242748034527,0.0121539676405224,0.0422780781732945
NMR metabolomics,X23412.Phospholipids in VLDL,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,39649,-0.00657544021604964,0.00324165828546156,-0.0129290904555543,-0.000221789976544975,0.042541473405261
NMR metabolomics,X23412.Phospholipids in VLDL,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",39929,-0.00530777926904869,0.00262135261734348,-0.0104456303990419,-0.000169928139055469,0.04290878648157
NMR metabolomics,X23412.Phospholipids in VLDL,ITGB5,Integrin beta-5,42181,0.00800743510558945,0.0039598067922698,0.000246213792740631,0.0157686564184383,0.0431775068482822
NMR metabolomics,X23412.Phospholipids in VLDL,ATXN10,Ataxin-10,41839,0.015268162347079,0.00755947345443174,0.000451594376392809,0.0300847303177652,0.0434305873385682
NMR metabolomics,X23412.Phospholipids in VLDL,PLXDC2,Plexin domain-containing protein 2,39929,0.00572226654526249,0.00283340863320708,0.000168785624176613,0.0112757474663484,0.0434515277790635
NMR metabolomics,X23412.Phospholipids in VLDL,CLEC1A,C-type lectin domain family 1 member A,41900,-0.00701289618099175,0.00351496042413486,-0.0139022186122961,-0.000123573749687426,0.0460461790226484
NMR metabolomics,X23412.Phospholipids in VLDL,ID4,DNA-binding protein inhibitor ID-4,39757,-0.0086426571967818,0.00434078412416139,-0.0171505940801381,-0.000134720313425471,0.0465012840871588
NMR metabolomics,X23412.Phospholipids in VLDL,CA8,Carbonic anhydrase-related protein,39657,0.00548515106796689,0.00275617871487378,8.30407868142851e-05,0.0108872613491195,0.0466013151671349
NMR metabolomics,X23412.Phospholipids in VLDL,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",41839,0.0107531689438435,0.00540748119656746,0.000154505798571307,0.0213518320891157,0.0467689515393501
NMR metabolomics,X23412.Phospholipids in VLDL,PSME2,Proteasome activator complex subunit 2,41955,0.00722172038841501,0.00363609556566499,9.49730797116192e-05,0.0143484676971184,0.0470404629111637
NMR metabolomics,X23412.Phospholipids in VLDL,LYPD8,Ly6/PLAUR domain-containing protein 8,41843,0.0106500520300397,0.00537681636679154,0.000111491951128235,0.0211886121089511,0.0476415795038886
NMR metabolomics,X23412.Phospholipids in VLDL,PRR5,Proline-rich protein 5,39657,0.00965201419226765,0.00488176528987253,8.37542241174816e-05,0.0192202741604178,0.048048737540285
NMR metabolomics,X23412.Phospholipids in VLDL,OLFM4,Olfactomedin-4,39347,0.0252861587113183,0.0128237459701202,0.000151616609882662,0.0504207008127539,0.0486554080123077
NMR metabolomics,X23412.Phospholipids in VLDL,CCDC50,Coiled-coil domain-containing protein 50,39934,0.0151104410012839,0.00768577219540117,4.6327498297638e-05,0.0301745545042702,0.0493197826225027
NMR metabolomics,X23412.Phospholipids in VLDL,PEAR1,Platelet endothelial aggregation receptor 1,42310,0.00458622985407313,0.0023562941584217,-3.21066964334088e-05,0.00920456640457967,0.0516302220273149
NMR metabolomics,X23412.Phospholipids in VLDL,SOD3,Extracellular superoxide dismutase,39990,-0.0121966538313836,0.00627763660123162,-0.0245008215697976,0.000107513907030321,0.0520560524207835
NMR metabolomics,X23412.Phospholipids in VLDL,CD2,T-cell surface antigen CD2,39575,-0.00781941045008529,0.00402503301487794,-0.015708475159246,6.96542590754631e-05,0.0520785946261403
NMR metabolomics,X23412.Phospholipids in VLDL,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",39657,0.00689984583527035,0.00355325719545849,-6.45382678283006e-05,0.013864229938369,0.052182217596189
NMR metabolomics,X23412.Phospholipids in VLDL,DPEP1,Dipeptidase 1,41997,-0.0091709400163722,0.00473674826412561,-0.0184549666140584,0.000113086581313994,0.0528733165127613
NMR metabolomics,X23412.Phospholipids in VLDL,CDK1,Cyclin-dependent kinase 1,39560,0.0073148342457991,0.00377807375452829,-9.01903130763422e-05,0.0147198588046745,0.0528777098130718
NMR metabolomics,X23412.Phospholipids in VLDL,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",39575,-0.0133847802214721,0.00694145930947158,-0.0269900404680364,0.000220480025092182,0.0538513918664095
NMR metabolomics,X23412.Phospholipids in VLDL,NCAM2,Neural cell adhesion molecule 2,42137,-0.00535090141677596,0.00277779024802933,-0.0107953703029134,9.35674693615281e-05,0.0540858588367634
NMR metabolomics,X23412.Phospholipids in VLDL,FABP3,"Fatty acid-binding protein, heart",39958,0.0108092967624292,0.00562010432473218,-0.000206107714045873,0.0218247012389043,0.0544640009485852
NMR metabolomics,X23412.Phospholipids in VLDL,HEBP1,Heme-binding protein 1,41900,-0.0103056215713949,0.00536480734598465,-0.0208206439695248,0.000209400826734988,0.0547571332733359
NMR metabolomics,X23412.Phospholipids in VLDL,CDKL5,Cyclin-dependent kinase-like 5,39586,-0.0103756977559617,0.00540541581921941,-0.0209703127616318,0.000218917249708329,0.0549469092038592
NMR metabolomics,X23412.Phospholipids in VLDL,LELP1,Late cornified envelope-like proline-rich protein 1,39586,-0.0140188900050228,0.0073184658566749,-0.0283630830841056,0.000325303074060007,0.0554482822101076
NMR metabolomics,X23412.Phospholipids in VLDL,TGFBR2,TGF-beta receptor type-2,42181,0.00675842699807916,0.00353039041194608,-0.00016113820933516,0.0136779922054935,0.0555955677961884
NMR metabolomics,X23412.Phospholipids in VLDL,TPSG1,Tryptase gamma,39657,0.00517848699867568,0.00271084195774301,-0.000134763238500611,0.010491737235852,0.0561220718985016
NMR metabolomics,X23412.Phospholipids in VLDL,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,39638,-0.00785346124657245,0.00413012605965585,-0.0159485083234979,0.000241585830353018,0.0572617246341604
NMR metabolomics,X23412.Phospholipids in VLDL,CD70,CD70 antigen,42119,0.00864294974112666,0.00455528296851845,-0.0002854048771695,0.0175713043594228,0.0578035224718444
NMR metabolomics,X23412.Phospholipids in VLDL,LCN15,Lipocalin-15,39934,-0.0118899581903172,0.0062674215097393,-0.0241741043494062,0.00039418796877186,0.0578394446778993
NMR metabolomics,X23412.Phospholipids in VLDL,ATP1B4,Protein ATP1B4,39560,-0.00822569666525584,0.00433684010072518,-0.0167259032626772,0.000274509932165519,0.0578934442296873
NMR metabolomics,X23412.Phospholipids in VLDL,GAST,Gastrin,39929,0.0256422179391883,0.0135326010421458,-0.00088168010341752,0.0521661159817941,0.0581380192228009
NMR metabolomics,X23412.Phospholipids in VLDL,PGLYRP4,Peptidoglycan recognition protein 4,39575,0.0115216482323173,0.00608615672443029,-0.000407218947566077,0.0234505154122006,0.0583720578757735
NMR metabolomics,X23412.Phospholipids in VLDL,SCARB1,Scavenger receptor class B member 1,41839,0.0108331908765103,0.00572593941063294,-0.000389650368330267,0.0220560321213508,0.0585194488825711
NMR metabolomics,X23412.Phospholipids in VLDL,RYR1,Ryanodine receptor 1,39575,-0.00657251736000576,0.00349202011437612,-0.013416876784183,0.000271842064171432,0.0598416330163265
NMR metabolomics,X23412.Phospholipids in VLDL,NTRK3,NT-3 growth factor receptor,42249,0.00411076611440478,0.00218630788661417,-0.000174397343358987,0.00839592957216854,0.060097739996366
NMR metabolomics,X23412.Phospholipids in VLDL,TCL1B,T-cell leukemia/lymphoma protein 1B,41900,0.0147253539626814,0.00783754401553181,-0.000636232307760979,0.0300869402331237,0.0602905871982816
NMR metabolomics,X23412.Phospholipids in VLDL,CD160,CD160 antigen,42296,-0.00936038506819093,0.00499480897657259,-0.0191502106622732,0.000429440525891344,0.0609485782999487
NMR metabolomics,X23412.Phospholipids in VLDL,ART5,Ecto-ADP-ribosyltransferase 5,39586,-0.0119671293844786,0.00641171926205654,-0.0245340991381094,0.000599840369152204,0.0620055788190166
NMR metabolomics,X23412.Phospholipids in VLDL,CPLX2,Complexin-2,39560,-0.00591999536020278,0.00317443233507429,-0.0121418827369484,0.000301892016542832,0.0622222823545071
NMR metabolomics,X23412.Phospholipids in VLDL,NME1,Nucleoside diphosphate kinase A,39657,-0.00422971731157381,0.00226995441551701,-0.00867882796598715,0.000219393342839519,0.0624396703192661
NMR metabolomics,X23412.Phospholipids in VLDL,CCL28,C-C motif chemokine 28,42075,0.0112680301018675,0.00607065643168112,-0.000630456504227467,0.0231665167079625,0.0634544366959777
NMR metabolomics,X23412.Phospholipids in VLDL,VSTM1,V-set and transmembrane domain-containing protein 1,41839,0.00961780335019925,0.00518334467515401,-0.000541552213102607,0.0197771589135011,0.0635441153314094
NMR metabolomics,X23412.Phospholipids in VLDL,DHODH,Dihydroorotate dehydrogenase,39575,0.00890472465070488,0.00480526876491232,-0.000513602128523267,0.018323051429933,0.0638924302821139
NMR metabolomics,X23412.Phospholipids in VLDL,RAB6B,Ras-related protein Rab-6B,41839,0.00900440379272478,0.00488131149121604,-0.000562966730058663,0.0185717743155082,0.0651080326185899
NMR metabolomics,X23412.Phospholipids in VLDL,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,39586,0.0117988977954744,0.00639864881540313,-0.000742453882715773,0.0243402494736645,0.0652148482193066
NMR metabolomics,X23412.Phospholipids in VLDL,MORF4L2,Mortality factor 4-like protein 2,39560,-0.00719099401482326,0.00391088292235807,-0.0148563245426451,0.00047433651299856,0.0659843468599104
NMR metabolomics,X23412.Phospholipids in VLDL,TDGF1,Teratocarcinoma-derived growth factor 1,41839,0.0281437798229861,0.0153297714547576,-0.00190257222833876,0.0581901318743109,0.0663962855952575
NMR metabolomics,X23412.Phospholipids in VLDL,LMNB2,Lamin-B2,39929,0.0054423596421985,0.00296539121939378,-0.00036980714781332,0.0112545264322103,0.0664885924442055
NMR metabolomics,X23412.Phospholipids in VLDL,BAMBI,BMP and activin membrane-bound inhibitor homolog,41843,0.00558617476679448,0.00306953900730068,-0.000430121687514856,0.0116024712211038,0.0688007335007178
NMR metabolomics,X23412.Phospholipids in VLDL,IGFL4,Insulin growth factor-like family member 4,39657,0.013458188102542,0.00739569667164309,-0.00103737737387847,0.0279537535789625,0.0688268098719336
NMR metabolomics,X23412.Phospholipids in VLDL,MUCL3,Mucin-like protein 3,39560,-0.00802720134491639,0.00441274607076143,-0.0166761836436088,0.000621780953776024,0.0689243146855184
NMR metabolomics,X23412.Phospholipids in VLDL,SIGLEC15,Sialic acid-binding Ig-like lectin 15,41839,0.0141487571668175,0.00779782563404186,-0.00113498107590458,0.0294324954095395,0.0696312463581577
NMR metabolomics,X23412.Phospholipids in VLDL,UBE2B,Ubiquitin-conjugating enzyme E2 B,39919,0.0054248735046137,0.00299104253437438,-0.00043756986276009,0.0112873168719875,0.069749381782723
NMR metabolomics,X23412.Phospholipids in VLDL,C9orf40,Uncharacterized protein C9orf40,39930,0.0145771242600196,0.00803977882403706,-0.00118084223509302,0.0303350907551323,0.0698389886101794
NMR metabolomics,X23412.Phospholipids in VLDL,MFAP3,Microfibril-associated glycoprotein 3,41900,0.00893775092383626,0.00493258756847419,-0.00073012071037316,0.0186056225580457,0.0700118014095637
NMR metabolomics,X23412.Phospholipids in VLDL,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,41701,-0.0157643533267726,0.0087024700162842,-0.0328211945586896,0.00129248790514443,0.0700894198860953
NMR metabolomics,X23412.Phospholipids in VLDL,GH2,Growth hormone variant,41843,0.030270482272505,0.0167110890084748,-0.00248325218410554,0.0630242167291156,0.0701014564301391
NMR metabolomics,X23412.Phospholipids in VLDL,APOBR,Apolipoprotein B receptor,39638,-0.00804044694071749,0.0044429820721047,-0.0167486918020427,0.000667797920607727,0.0703701292697506
NMR metabolomics,X23412.Phospholipids in VLDL,IL5,Interleukin-5,41913,0.0257580008984232,0.0142491598008432,-0.0021703523112296,0.0536863541080759,0.0706780084913974
NMR metabolomics,X23412.Phospholipids in VLDL,ATP5PO,"ATP synthase subunit O, mitochondrial",41839,0.00775432451258323,0.00429595565125387,-0.000665748563874352,0.0161743975890408,0.0710928559352257
NMR metabolomics,X23412.Phospholipids in VLDL,RBP7,Retinoid-binding protein 7,39930,0.0116536385723307,0.00645737769154867,-0.00100282170310465,0.0243100988477661,0.0711479615423472
NMR metabolomics,X23412.Phospholipids in VLDL,MKI67,Proliferation marker protein Ki-67,39657,0.00759618928335871,0.00421101472812706,-0.000657399583770328,0.0158497781504877,0.0712764313895844
NMR metabolomics,X23412.Phospholipids in VLDL,HSBP1,Heat shock factor-binding protein 1,39638,0.0179549583864281,0.00995816354788769,-0.00156304216743176,0.037472958940288,0.0714093334778507
NMR metabolomics,X23412.Phospholipids in VLDL,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,39930,-0.0134381093502947,0.0074747165741841,-0.0280885538356956,0.00121233513510609,0.0722339662662683
NMR metabolomics,X23412.Phospholipids in VLDL,VASN,Vasorin,41975,0.00506441280221267,0.00282404224249899,-0.000470709993085357,0.0105995355975107,0.0729442778784749
NMR metabolomics,X23412.Phospholipids in VLDL,GKN1,Gastrokine-1,41538,0.00524005975994401,0.00292449388791239,-0.000491948260364279,0.0109720677802523,0.0731910208874504
NMR metabolomics,X23412.Phospholipids in VLDL,ANXA10,Annexin A10,41839,-0.0150048710546909,0.00842605178341428,-0.0315199325501829,0.00151019044080109,0.0749727460908938
NMR metabolomics,X23412.Phospholipids in VLDL,S100A14,Protein S100-A14,39934,0.00945621090291149,0.00535228007478512,-0.00103425804366735,0.0199466798494903,0.0772948218429354
NMR metabolomics,X23412.Phospholipids in VLDL,CRISP2,Cysteine-rich secretory protein 2,42262,0.00959148839575284,0.00547337194804068,-0.0011363206224069,0.0203192974139126,0.0797290086474216
NMR metabolomics,X23412.Phospholipids in VLDL,SAG,S-arrestin,39586,-0.00946045385913977,0.00540930360908733,-0.0200626889329509,0.00114178121467141,0.0803323084937152
NMR metabolomics,X23412.Phospholipids in VLDL,ALPP,"Alkaline phosphatase, placental type",42070,0.0187085270736199,0.0107454361790418,-0.00235252783730201,0.0397695819845418,0.0816946217187796
NMR metabolomics,X23412.Phospholipids in VLDL,MNAT1,CDK-activating kinase assembly factor MAT1,39757,0.00812052040932404,0.00466669359456931,-0.00102619903603181,0.0172672398546799,0.08186877400747
NMR metabolomics,X23412.Phospholipids in VLDL,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,39560,-0.0146568205874979,0.00845077487626599,-0.0312203393449793,0.00190669816998342,0.0828795180034212
NMR metabolomics,X23412.Phospholipids in VLDL,CRNN,Cornulin,41749,0.0120363225868833,0.00694423362447901,-0.00157437531709561,0.0256470204908621,0.0830688109943716
NMR metabolomics,X23412.Phospholipids in VLDL,IL15,Interleukin-15,42119,0.00588095823193377,0.00339439214572581,-0.000772050373688813,0.0125339668375563,0.0831982730301322
NMR metabolomics,X23412.Phospholipids in VLDL,PI3,Elafin,41966,0.0100104966652307,0.00579518372518251,-0.00134806343612701,0.0213690567665884,0.0841221634403632
NMR metabolomics,X23412.Phospholipids in VLDL,TEX101,Testis-expressed protein 101,39649,0.0109926911748957,0.00636397252753716,-0.00148069497907708,0.0234660773288686,0.0841360639144117
NMR metabolomics,X23412.Phospholipids in VLDL,SCN2A,Sodium channel protein type 2 subunit alpha,39586,0.00865787367304874,0.00501785958024689,-0.00117713110423517,0.0184928784503327,0.0844814240426578
NMR metabolomics,X23412.Phospholipids in VLDL,PLAUR,Urokinase plasminogen activator surface receptor,42040,-0.00505653383018924,0.00293392497938663,-0.010807026789787,0.000693959129408566,0.0848264326473934
NMR metabolomics,X23412.Phospholipids in VLDL,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,41843,0.0221441933983068,0.0130185716997293,-0.00337220713316264,0.0476605939297763,0.0889721911237611
NMR metabolomics,X23412.Phospholipids in VLDL,CLSTN2,Calsyntenin-2,42296,-0.00701083080737134,0.00412792246420858,-0.0151015588372202,0.00107989722247749,0.0894565004692744
NMR metabolomics,X23412.Phospholipids in VLDL,UNC5D,Netrin receptor UNC5D,39657,0.00456408231068316,0.00270171722802517,-0.000731283456246162,0.00985944807761249,0.0911850850653846
NMR metabolomics,X23412.Phospholipids in VLDL,PPT1,Palmitoyl-protein thioesterase 1,39649,0.0135128559826534,0.00800079649424981,-0.00216870514607628,0.029194417111383,0.0912593664506879
NMR metabolomics,X23412.Phospholipids in VLDL,CAPN3,Calpain-3,39919,-0.00678580000647083,0.00403062067538148,-0.0146858165302185,0.00111421651727687,0.0922939131993066
NMR metabolomics,X23412.Phospholipids in VLDL,PRRT3,Proline-rich transmembrane protein 3,39638,0.00674020305236219,0.00400476282375392,-0.00110913208219549,0.0145895381869199,0.0923943218936047
NMR metabolomics,X23412.Phospholipids in VLDL,SUMF1,Formylglycine-generating enzyme,39657,0.0115052139914848,0.00683598893925696,-0.00189332432945881,0.0249037523124285,0.0923963962940993
NMR metabolomics,X23412.Phospholipids in VLDL,RGMA,Repulsive guidance molecule A,42249,-0.00557293956300977,0.00331489647609177,-0.0120701366561496,0.000924257530130107,0.092750724611049
NMR metabolomics,X23412.Phospholipids in VLDL,ADAMTSL5,ADAMTS-like protein 5,39958,-0.0069578251413202,0.00414694042538158,-0.0150858283750681,0.0011701780924277,0.0934094950681631
NMR metabolomics,X23412.Phospholipids in VLDL,KIT,Mast/stem cell growth factor receptor Kit,42199,0.00503167987246211,0.00299957782258164,-0.0008474926597979,0.0109108524047221,0.0934750208899865
NMR metabolomics,X23412.Phospholipids in VLDL,CHL1,Neural cell adhesion molecule L1-like protein,42189,0.00517824530726133,0.00308712076156078,-0.000872511385397791,0.0112290019999205,0.0934930516434339
NMR metabolomics,X23412.Phospholipids in VLDL,IL18RAP,Interleukin-18 receptor accessory protein,41936,0.0291890998739986,0.0174355918677601,-0.00498466018681124,0.0633628599348085,0.094132419204499
NMR metabolomics,X23412.Phospholipids in VLDL,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",42224,-0.0118050136323748,0.00705783351433359,-0.0256383673204687,0.00202834005571899,0.0944267584625663
NMR metabolomics,X23412.Phospholipids in VLDL,TNR,Tenascin-R,42016,0.00720832570831302,0.00431708899673394,-0.00125316872528551,0.0156698201419115,0.0949982937550522
NMR metabolomics,X23412.Phospholipids in VLDL,EPN1,Epsin-1,39757,0.00746712952219796,0.00447366070607305,-0.00130124546170521,0.0162355045061011,0.0951193107942741
NMR metabolomics,X23412.Phospholipids in VLDL,LY6D,Lymphocyte antigen 6D,42041,0.00683631360292895,0.00409626912823883,-0.00119237388841916,0.0148650010942771,0.0951580671943011
NMR metabolomics,X23412.Phospholipids in VLDL,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,39919,0.00810717259335404,0.00486954730894784,-0.00143714013218373,0.0176514853188918,0.0959659872496679
NMR metabolomics,X23412.Phospholipids in VLDL,LTA4H,Leukotriene A-4 hydrolase,42262,0.0102203023932658,0.0061395922836514,-0.00181329848269097,0.0222539032692225,0.0960045560684638
NMR metabolomics,X23412.Phospholipids in VLDL,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,39560,0.00929912868373799,0.0056098256430408,-0.00169612957662198,0.020294386944098,0.0974167071334223
NMR metabolomics,X23412.Phospholipids in VLDL,FCRLB,Fc receptor-like B,41843,0.0105300651547041,0.00635508020886839,-0.00192589205467791,0.0229860223640862,0.0975527953023097
NMR metabolomics,X23412.Phospholipids in VLDL,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,39934,0.0043937174087081,0.00265376585994239,-0.000807663676778989,0.00959509849419519,0.0978196417831727
NMR metabolomics,X23412.Phospholipids in VLDL,SRPX,Sushi repeat-containing protein SRPX,39958,-0.00658229235403017,0.00398373374547529,-0.0143904104951617,0.0012258257871014,0.0985026313197362
NMR metabolomics,X23412.Phospholipids in VLDL,OGN,Mimecan,42137,0.00735073974663642,0.00445892413966738,-0.00138875156711165,0.0160902310603845,0.0992639678975492
NMR metabolomics,X23412.Phospholipids in VLDL,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,39586,-0.00537399566509862,0.00326158223752898,-0.0117666968506554,0.00101870552045819,0.0994499832970478
NMR metabolomics,X23412.Phospholipids in VLDL,EDNRB,Endothelin receptor type B,39657,0.00746248573484632,0.00453422718696538,-0.00142459955160584,0.0163495710212985,0.0998308829385307
NMR metabolomics,X23412.Phospholipids in VLDL,MBL2,Mannose-binding protein C,39826,0.0187583479992056,0.0114212288054045,-0.00362726045938726,0.0411439564577984,0.10053293435877
NMR metabolomics,X23412.Phospholipids in VLDL,MRC1,Macrophage mannose receptor 1,39990,0.00479732788864899,0.00293733548203902,-0.000959849656147492,0.0105545054334455,0.102449456427643
NMR metabolomics,X23412.Phospholipids in VLDL,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,39586,0.00989974775455761,0.00607804101461079,-0.00201321263407954,0.0218127081431948,0.10338980166949
NMR metabolomics,X23412.Phospholipids in VLDL,CALCB,Calcitonin gene-related peptide 2,39929,0.00681733697607465,0.00419988323256759,-0.00141443415975783,0.0150491081119071,0.10457007857566
NMR metabolomics,X23412.Phospholipids in VLDL,AKAP12,A-kinase anchor protein 12,39736,0.00356697448047712,0.00220061026717012,-0.000746221643176321,0.00788017060413057,0.105066882601725
NMR metabolomics,X23412.Phospholipids in VLDL,PSAPL1,Proactivator polypeptide-like 1,39930,0.00835992778121558,0.00519833214899981,-0.00182880323082405,0.0185486587932552,0.10782050864706
NMR metabolomics,X23412.Phospholipids in VLDL,CLEC4D,C-type lectin domain family 4 member D,42119,0.0102434409513312,0.00637815811838306,-0.00225774896069955,0.022744630863362,0.108293165870429
NMR metabolomics,X23412.Phospholipids in VLDL,TLR1,Toll-like receptor 1,39657,0.00443742796097294,0.00276912811202557,-0.000990063138597173,0.00986491906054306,0.109081618648206
NMR metabolomics,X23412.Phospholipids in VLDL,DCUN1D1,DCN1-like protein 1,39586,-0.0124965190053785,0.00780012267425819,-0.0277847594469245,0.00279172143616756,0.109163878746129
NMR metabolomics,X23412.Phospholipids in VLDL,DEFB118,Beta-defensin 118,39586,0.00944330440940434,0.00589580018872913,-0.00211246396050476,0.0209990727793134,0.109250669254266
NMR metabolomics,X23412.Phospholipids in VLDL,CLEC7A,C-type lectin domain family 7 member A,42296,-0.00981261785871084,0.00613378480192434,-0.0218348360704826,0.00220960035306087,0.109673660697855
NMR metabolomics,X23412.Phospholipids in VLDL,CDH23,Cadherin-23,39929,-0.00437217051337575,0.00276676747146513,-0.00979503475744741,0.00105069373069591,0.114078682891161
NMR metabolomics,X23412.Phospholipids in VLDL,PMCH,Pro-MCH,39575,-0.013454179530616,0.00853573191084452,-0.0301842140758713,0.00327585501463925,0.115004252163048
NMR metabolomics,X23412.Phospholipids in VLDL,EPHA10,Ephrin type-A receptor 10,41839,0.0106479321750855,0.00677694447882877,-0.00263487900341889,0.0239307433535899,0.116160199879591
NMR metabolomics,X23412.Phospholipids in VLDL,ARMCX2,Armadillo repeat-containing X-linked protein 2,39586,-0.00930615057906625,0.00594422104862924,-0.0209568238343796,0.00234452267624706,0.11747589583351
NMR metabolomics,X23412.Phospholipids in VLDL,FH,"Fumarate hydratase, mitochondrial",39586,0.0132942396929267,0.00851354216316433,-0.00339230294687536,0.0299807823327288,0.118425112719286
NMR metabolomics,X23412.Phospholipids in VLDL,IDI2,Isopentenyl-diphosphate delta-isomerase 2,41839,-0.0078816858766603,0.00505435397999606,-0.0177882196774526,0.00202484792413198,0.118929089019207
NMR metabolomics,X23412.Phospholipids in VLDL,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,39713,0.00789337710779552,0.00508720165578533,-0.00207753813754374,0.0178642923531348,0.120782908557278
NMR metabolomics,X23412.Phospholipids in VLDL,LPO,Lactoperoxidase,41647,-0.00983582077011038,0.00634415245197122,-0.022270359575974,0.00259871803575322,0.121075585597339
NMR metabolomics,X23412.Phospholipids in VLDL,PGR,Progesterone receptor,39657,0.0160645335322666,0.0103692042964141,-0.00425910688870502,0.0363881739532382,0.121349239550594
NMR metabolomics,X23412.Phospholipids in VLDL,SERPINA3,Alpha-1-antichymotrypsin,39951,0.00238146721067724,0.00154030308819602,-0.000637526842186958,0.00540046126354144,0.122107574427016
NMR metabolomics,X23412.Phospholipids in VLDL,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,39919,-0.0142132481505772,0.00921439849274237,-0.0322734691963523,0.00384697289519783,0.122979078958829
NMR metabolomics,X23412.Phospholipids in VLDL,ULBP2,UL16-binding protein 2,42016,0.00625123898589377,0.00405839740859466,-0.00170321993495176,0.0142056979067393,0.12350545778351
NMR metabolomics,X23412.Phospholipids in VLDL,CCNE1,G1/S-specific cyclin-E1,39657,0.0145871892554568,0.00947825046086037,-0.00399018164782951,0.0331645601587431,0.123828744081134
NMR metabolomics,X23412.Phospholipids in VLDL,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,41662,0.00987685437266511,0.00642449674306933,-0.00271515924375076,0.022468867989081,0.124225966898024
NMR metabolomics,X23412.Phospholipids in VLDL,CCL21,C-C motif chemokine 21,42185,0.00605288680331995,0.00394470470092616,-0.00167873441049532,0.0137845080171352,0.124946343502678
NMR metabolomics,X23412.Phospholipids in VLDL,DPEP2,Dipeptidase 2,42070,0.00475444473763213,0.00310189315938612,-0.00132526585476467,0.0108341553300289,0.125359519074696
NMR metabolomics,X23412.Phospholipids in VLDL,CNTN2,Contactin-2,42262,0.00695135651429622,0.00453682500417629,-0.0019408204938893,0.0158435335224817,0.125494435226358
NMR metabolomics,X23412.Phospholipids in VLDL,IL13RA2,Interleukin-13 receptor subunit alpha-2,39586,-0.00465276405597612,0.00304321407289408,-0.0106174636388485,0.00131193552689626,0.126318510697451
NMR metabolomics,X23412.Phospholipids in VLDL,PLA2G2A,"Phospholipase A2, membrane associated",42135,-0.00833764133886745,0.0054686078033729,-0.0190561126334783,0.00238082995574344,0.12737304827748
NMR metabolomics,X23412.Phospholipids in VLDL,SOD2,"Superoxide dismutase [Mn], mitochondrial",42137,0.00597192901253436,0.00392652276922653,-0.00172405561514965,0.0136679136402184,0.128303142475763
NMR metabolomics,X23412.Phospholipids in VLDL,FSHB,Follitropin subunit beta,39638,-0.00645475669225128,0.0042440159407347,-0.0147730279360913,0.00186351455158873,0.128311635234706
NMR metabolomics,X23412.Phospholipids in VLDL,EPHA2,Ephrin type-A receptor 2,41614,-0.0050346006955769,0.00333161529697327,-0.0115645666776445,0.00149536528649072,0.130772205931447
NMR metabolomics,X23412.Phospholipids in VLDL,DDA1,DET1- and DDB1-associated protein 1,39575,0.00611584025834913,0.00405086364327599,-0.00182385248247181,0.0140555329991701,0.131132935728741
NMR metabolomics,X23412.Phospholipids in VLDL,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,39560,0.00918606546288975,0.00608755664645745,-0.00274554556416686,0.0211176764899463,0.131330022756985
NMR metabolomics,X23412.Phospholipids in VLDL,CD3D,T-cell surface glycoprotein CD3 delta chain,39586,-0.00538092069485317,0.00357140501826155,-0.0123808745306458,0.00161903314093946,0.131924598951111
NMR metabolomics,X23412.Phospholipids in VLDL,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,39638,0.00336491412973198,0.00223660769930495,-0.00101883696090571,0.00774866522036968,0.13248843503092
NMR metabolomics,X23412.Phospholipids in VLDL,STX1B,Syntaxin-1B,39649,0.00619278589851112,0.00414891745880924,-0.001939092320755,0.0143246641177772,0.135563423876511
NMR metabolomics,X23412.Phospholipids in VLDL,S100A3,Protein S100-A3,39919,0.00656419744605414,0.00441047423958115,-0.00208033206352492,0.0152087269556332,0.136694355694855
NMR metabolomics,X23412.Phospholipids in VLDL,RAP1A,Ras-related protein Rap-1A,39657,-0.0106158522217099,0.00715563485039797,-0.02464089652849,0.00340919208507009,0.13795275923699
NMR metabolomics,X23412.Phospholipids in VLDL,DOC2B,Double C2-like domain-containing protein beta,39649,0.00560480877879649,0.00379218489652572,-0.00182787361839391,0.0130374911759869,0.139439140810434
NMR metabolomics,X23412.Phospholipids in VLDL,TPSAB1,Tryptase alpha/beta-1,42281,0.00792329020274355,0.00537137330618109,-0.00260460147737138,0.0184511818828585,0.140209801375869
NMR metabolomics,X23412.Phospholipids in VLDL,FHIP2A,FHF complex subunit HOOK interacting protein 2A,39575,0.00706571894290782,0.00479478419219083,-0.00233205807378621,0.0164634959596018,0.140610980443888
NMR metabolomics,X23412.Phospholipids in VLDL,CD82,CD82 antigen,39757,-0.00626143738377171,0.00428538373150245,-0.0146607894975165,0.00213791472997309,0.144012113719715
NMR metabolomics,X23412.Phospholipids in VLDL,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",39575,-0.0126600196284194,0.00866639997504501,-0.0296461635795077,0.00432612432266878,0.144094447376092
NMR metabolomics,X23412.Phospholipids in VLDL,MED21,Mediator of RNA polymerase II transcription subunit 21,39575,0.00737726838004523,0.00505159005239964,-0.00252384812265806,0.0172783848827485,0.144212806654563
NMR metabolomics,X23412.Phospholipids in VLDL,TXNL1,Thioredoxin-like protein 1,39570,0.0152549911457342,0.0105233252280883,-0.00537072630131884,0.0358807085927873,0.147188636739104
NMR metabolomics,X23412.Phospholipids in VLDL,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",39649,0.0114629693042705,0.00797721593688707,-0.00417237393202811,0.0270983125405692,0.150756638919087
NMR metabolomics,X23412.Phospholipids in VLDL,CDH1,Cadherin-1,41697,0.00592721683309929,0.00413976695253636,-0.00218672639387197,0.0140411600600705,0.152231948551168
NMR metabolomics,X23412.Phospholipids in VLDL,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",39934,0.0103550980353256,0.00723353831074944,-0.00382263705374326,0.0245328331243945,0.152303140367698
NMR metabolomics,X23412.Phospholipids in VLDL,VEGFD,Vascular endothelial growth factor D,42275,-0.00565457091509089,0.00397898831844251,-0.0134533880192382,0.00214424618905642,0.155308255584775
NMR metabolomics,X23412.Phospholipids in VLDL,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,42179,0.00712279040940624,0.00502016771975636,-0.00271673832131622,0.0169623191401287,0.155970034480036
NMR metabolomics,X23412.Phospholipids in VLDL,PPIE,Peptidyl-prolyl cis-trans isomerase E,39757,-0.00898924663247852,0.00634910412353867,-0.0214334907146143,0.00345499744965728,0.156853450045951
NMR metabolomics,X23412.Phospholipids in VLDL,SLC28A1,Sodium/nucleoside cotransporter 1,39560,0.00869652080368202,0.00616180428951326,-0.00338061560376397,0.020773657211128,0.158167035004381
NMR metabolomics,X23412.Phospholipids in VLDL,PON1,Serum paraoxonase/arylesterase 1,39990,-0.00395025439885339,0.00280223840376575,-0.00944264167023427,0.00154213287252748,0.158662026990331
NMR metabolomics,X23412.Phospholipids in VLDL,PRG3,Proteoglycan 3,39966,-0.00724925776601561,0.0051435692838719,-0.0173306535624045,0.00283213803037332,0.158749384291373
NMR metabolomics,X23412.Phospholipids in VLDL,GABARAP,Gamma-aminobutyric acid receptor-associated protein,39919,0.00703644394873823,0.0049944069573473,-0.00275259368766247,0.0168254815851389,0.15890263138389
NMR metabolomics,X23412.Phospholipids in VLDL,ADGRV1,Adhesion G-protein coupled receptor V1,39586,-0.0100385257816649,0.0071714210579892,-0.0240945110553237,0.00401745949199392,0.161602683503598
NMR metabolomics,X23412.Phospholipids in VLDL,CD33,Myeloid cell surface antigen CD33,42181,0.0114478011810738,0.00818870158622103,-0.00460205392791941,0.027497656290067,0.162136031502185
NMR metabolomics,X23412.Phospholipids in VLDL,KCNIP4,Kv channel-interacting protein 4,41839,0.00733612910297629,0.00524921777103007,-0.00295233772824264,0.0176245959341952,0.16226680545526
NMR metabolomics,X23412.Phospholipids in VLDL,ZNF174,Zinc finger protein 174,39657,0.00530980061737404,0.00380498094937008,-0.00214796204339132,0.0127675632781394,0.162897122031416
NMR metabolomics,X23412.Phospholipids in VLDL,PI16,Peptidase inhibitor 16,39990,0.00348179753781636,0.00249559372785916,-0.00140956616878758,0.00837316124442031,0.162989363053601
NMR metabolomics,X23412.Phospholipids in VLDL,AIDA,"Axin interactor, dorsalization-associated protein",39649,0.0123206477205147,0.00885162156827344,-0.0050285305533012,0.0296698259943307,0.163978110036176
NMR metabolomics,X23412.Phospholipids in VLDL,PDCD1LG2,Programmed cell death 1 ligand 2,42070,-0.00455004676881898,0.00326919949592235,-0.0109576777808268,0.00185758424318883,0.164008275311412
NMR metabolomics,X23412.Phospholipids in VLDL,TYRO3,Tyrosine-protein kinase receptor TYRO3,42145,0.00405987330580408,0.00291817301136306,-0.00165974579646751,0.00977949240807568,0.164176104958371
NMR metabolomics,X23412.Phospholipids in VLDL,CSF1,Macrophage colony-stimulating factor 1,42185,0.00386976063796928,0.00278247700551709,-0.00158389429284422,0.00932341556878279,0.164320678003223
NMR metabolomics,X23412.Phospholipids in VLDL,KIRREL1,Kin of IRRE-like protein 1,39586,-0.00802497326298848,0.00577476293268792,-0.0193435086110568,0.00329356208507984,0.164659454177125
NMR metabolomics,X23412.Phospholipids in VLDL,HEPACAM2,HEPACAM family member 2,39929,0.00627713815216299,0.00451716888075488,-0.00257651285411656,0.0151307891584425,0.164672283555864
NMR metabolomics,X23412.Phospholipids in VLDL,BOC,Brother of CDO,41900,-0.00332614061589722,0.00239815174983427,-0.00802651804557239,0.00137423681377795,0.165477195171762
NMR metabolomics,X23412.Phospholipids in VLDL,IZUMO1,Izumo sperm-egg fusion protein 1,39560,-0.00701577212250734,0.00506257958896382,-0.0169384281168764,0.00290688387186175,0.165833202601191
NMR metabolomics,X23412.Phospholipids in VLDL,ENG,Endoglin,42310,0.00246738927711872,0.00178203553959953,-0.00102540038049635,0.00596017893473379,0.166200285398842
NMR metabolomics,X23412.Phospholipids in VLDL,DUOX2,Dual oxidase 2,41900,0.00999838104192583,0.00724970216530894,-0.00421103520207969,0.0242077972859314,0.167873644121193
NMR metabolomics,X23412.Phospholipids in VLDL,PDIA2,Protein disulfide-isomerase A2,39560,0.00568944413845157,0.00413885679036062,-0.00242271517065524,0.0138016034475584,0.169270732148451
NMR metabolomics,X23412.Phospholipids in VLDL,DRAXIN,Draxin,42016,0.00601840896561963,0.0043847942585685,-0.00257578778117462,0.0146126057124139,0.169911000640439
NMR metabolomics,X23412.Phospholipids in VLDL,SEZ6L2,Seizure 6-like protein 2,42070,0.00340589170259394,0.00249467543207973,-0.00148367214428234,0.00829545554947022,0.172192745484067
NMR metabolomics,X23412.Phospholipids in VLDL,SLC51B,Organic solute transporter subunit beta,39575,-0.0101678544669686,0.00750495496544999,-0.0248775661992506,0.00454185726531334,0.1755031658019
NMR metabolomics,X23412.Phospholipids in VLDL,WASL,Neural Wiskott-Aldrich syndrome protein,39657,-0.00824140360894145,0.00608737136705293,-0.0201726514883652,0.00368984427048228,0.175811076468903
NMR metabolomics,X23412.Phospholipids in VLDL,HDAC8,Histone deacetylase 8,39657,0.00843279972307602,0.00622973543608365,-0.00377748173164794,0.0206430811778,0.175879919455012
NMR metabolomics,X23412.Phospholipids in VLDL,CLNS1A,Methylosome subunit pICln,39649,-0.00469720027919761,0.00347072796464957,-0.0114998270899108,0.00210542653151555,0.175963195105445
NMR metabolomics,X23412.Phospholipids in VLDL,PCNA,Proliferating cell nuclear antigen,39560,0.00903554226799975,0.00667702855342034,-0.00405143369670411,0.0221225182327036,0.176010699663994
NMR metabolomics,X23412.Phospholipids in VLDL,COPE,Coatomer subunit epsilon,41839,0.00645979227720973,0.00478154291705821,-0.00291203184022436,0.0158316163946438,0.176723357697291
NMR metabolomics,X23412.Phospholipids in VLDL,EVI2B,Protein EVI2B,39560,-0.00557385859307386,0.0041380595079835,-0.0136844552287215,0.00253673804257381,0.178016454026725
NMR metabolomics,X23412.Phospholipids in VLDL,ACTN4,Alpha-actinin-4,41913,0.00435950396658556,0.00325413015279815,-0.00201859113289882,0.0107375990660699,0.180371182019747
NMR metabolomics,X23412.Phospholipids in VLDL,IL19,Interleukin-19,41756,-0.0101265262856402,0.00756341491332262,-0.0249508195157525,0.00469776694447214,0.180631956919664
NMR metabolomics,X23412.Phospholipids in VLDL,RBM25,RNA-binding protein 25,39560,-0.00649203435463078,0.0048489130374483,-0.0159959039080295,0.0030118351987679,0.180642769848236
NMR metabolomics,X23412.Phospholipids in VLDL,REXO2,"Oligoribonuclease, mitochondrial",39575,-0.00642585000604721,0.00481678048734454,-0.0158667397612425,0.0030150397491481,0.182213518917047
NMR metabolomics,X23412.Phospholipids in VLDL,CHRM1,Muscarinic acetylcholine receptor M1,39649,-0.00498902898916371,0.00374047171028541,-0.0123203535413231,0.00234229556299571,0.182297971116008
NMR metabolomics,X23412.Phospholipids in VLDL,REG3G,Regenerating islet-derived protein 3-gamma,39919,0.00546881753130914,0.00410062681578835,-0.00256841102763603,0.0135060460902543,0.182344098338742
NMR metabolomics,X23412.Phospholipids in VLDL,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,42249,0.00640688345946203,0.00481258253413679,-0.00302577830744608,0.0158395452263701,0.183119911420679
NMR metabolomics,X23412.Phospholipids in VLDL,CUZD1,CUB and zona pellucida-like domain-containing protein 1,39649,0.00548407862216505,0.00412783815887746,-0.00260648416923477,0.0135746414135649,0.184020777555337
NMR metabolomics,X23412.Phospholipids in VLDL,DNAJA1,DnaJ homolog subfamily A member 1,39560,-0.00642305317298749,0.00484947034707362,-0.0159280150532518,0.0030819087072768,0.185369471628182
NMR metabolomics,X23412.Phospholipids in VLDL,GUCY2C,Heat-stable enterotoxin receptor,39757,-0.0111974044751738,0.00846792405096837,-0.0277945356150718,0.00539972666472426,0.186084825056878
NMR metabolomics,X23412.Phospholipids in VLDL,PTK7,Inactive tyrosine-protein kinase 7,41839,0.00521626005549466,0.00394489897063727,-0.00251574192695439,0.0129482620379437,0.18609785396326
NMR metabolomics,X23412.Phospholipids in VLDL,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,39649,-0.00648343961100133,0.00490880288521578,-0.0161046932660243,0.00313781404402161,0.186602700619357
NMR metabolomics,X23412.Phospholipids in VLDL,PGLYRP1,Peptidoglycan recognition protein 1,42248,-0.00569279869550704,0.00432560995262937,-0.0141709942026606,0.00278539681164652,0.188173179703086
NMR metabolomics,X23412.Phospholipids in VLDL,OTOA,Otoancorin,39586,-0.00713681598148629,0.00543643839960758,-0.0177922352447171,0.00351860328174456,0.189286473867028
NMR metabolomics,X23412.Phospholipids in VLDL,EPHA4,Ephrin type-A receptor 4,39736,0.00396930045620265,0.00302469045735874,-0.00195909284022047,0.00989769375262578,0.189446072306843
NMR metabolomics,X23412.Phospholipids in VLDL,CSPG5,Chondroitin sulfate proteoglycan 5,39586,-0.00677182777549005,0.00517160929037747,-0.0169081819846299,0.00336452643364979,0.190418251464688
NMR metabolomics,X23412.Phospholipids in VLDL,FSTL1,Follistatin-related protein 1,39638,-0.00312302349655202,0.00240534455462892,-0.0078374988236247,0.00159145183052066,0.194187879053379
NMR metabolomics,X23412.Phospholipids in VLDL,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,39757,0.0092400561396466,0.00713207277435494,-0.00473880649808908,0.0232189187773823,0.195152570774562
NMR metabolomics,X23412.Phospholipids in VLDL,CPE,Carboxypeptidase E,42134,0.00519361245438654,0.0040310711347317,-0.00270728696968759,0.0130945118784607,0.197630474941915
NMR metabolomics,X23412.Phospholipids in VLDL,RETN,Resistin,42105,-0.00570244994866195,0.00442977012177694,-0.0143847993873448,0.00297989949002085,0.198011264290178
NMR metabolomics,X23412.Phospholipids in VLDL,MRPL52,"39S ribosomal protein L52, mitochondrial",39541,0.00353742568149583,0.00275353078179469,-0.00185949465082176,0.00893434601381343,0.198928819904833
NMR metabolomics,X23412.Phospholipids in VLDL,FZD8,Frizzled-8,39586,0.00570194356804632,0.00445553600143218,-0.00303090699476076,0.0144347941308534,0.200662358571913
NMR metabolomics,X23412.Phospholipids in VLDL,CD177,CD177 antigen,42123,-0.0169845687045926,0.0132791222310844,-0.0430116482775181,0.00904251086833291,0.200903851468674
NMR metabolomics,X23412.Phospholipids in VLDL,TLR2,Toll-like receptor 2,39757,-0.00306153286276605,0.00239375680671144,-0.00775329620392047,0.00163023047838836,0.20093573315327
NMR metabolomics,X23412.Phospholipids in VLDL,NXPE4,NXPE family member 4,39575,-0.00423257145090408,0.00330961290339844,-0.010719412741565,0.00225426983975687,0.200969155441155
NMR metabolomics,X23412.Phospholipids in VLDL,GIPC2,PDZ domain-containing protein GIPC2,39929,-0.0040345489447757,0.00315624762310463,-0.0102207942860608,0.00215169639650938,0.201179056634997
NMR metabolomics,X23412.Phospholipids in VLDL,THAP12,52 kDa repressor of the inhibitor of the protein kinase,39539,0.0114290520341403,0.00894622216061414,-0.0061055434006634,0.028963647468944,0.201442905859965
NMR metabolomics,X23412.Phospholipids in VLDL,PTPRS,Receptor-type tyrosine-protein phosphatase S,42310,-0.00330162220469924,0.0025932376796418,-0.00838436805679717,0.00178112364739869,0.202980707734544
NMR metabolomics,X23412.Phospholipids in VLDL,FOS,Proto-oncogene c-Fos,39539,-0.00475103521987575,0.00373838334512107,-0.0120782665763131,0.00257619613656155,0.203798501490805
NMR metabolomics,X23412.Phospholipids in VLDL,TNPO1,Transportin-1,39757,0.00465294817203128,0.00366941452378241,-0.00253910429458225,0.0118450006386448,0.204811705143705
NMR metabolomics,X23412.Phospholipids in VLDL,SH3GL3,Endophilin-A3,39690,0.0111536122126028,0.00881429368695255,-0.00612240341382419,0.0284296278390298,0.205754358053688
NMR metabolomics,X23412.Phospholipids in VLDL,CHI3L1,Chitinase-3-like protein 1,41907,0.0108891973795197,0.00862718571919296,-0.00602008663009854,0.0277984813891378,0.206900468688737
NMR metabolomics,X23412.Phospholipids in VLDL,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,39919,-0.00574018611286176,0.00455351948959072,-0.0146650843124596,0.00318471208673606,0.20747744420441
NMR metabolomics,X23412.Phospholipids in VLDL,PLAU,Urokinase-type plasminogen activator,42137,0.00367910166479705,0.00294459992599126,-0.00209231419014582,0.00945051751973993,0.211525697307014
NMR metabolomics,X23412.Phospholipids in VLDL,H2AP,Huntingtin-interacting protein M,39560,-0.00651528969547622,0.00521733506287208,-0.0167412664187055,0.00371068702775307,0.211773203913355
NMR metabolomics,X23412.Phospholipids in VLDL,TFF2,Trefoil factor 2,42166,-0.00751030793687446,0.00602087940656535,-0.0193112315737425,0.00429061569999362,0.212280740639448
NMR metabolomics,X23412.Phospholipids in VLDL,SEMA3G,Semaphorin-3G,39736,0.00587923491784456,0.00471329619670591,-0.00335882562769902,0.0151172954633882,0.212287265186887
NMR metabolomics,X23412.Phospholipids in VLDL,AKR1B10,Aldo-keto reductase family 1 member B10,39649,0.0082802359774878,0.00669143639739608,-0.00483497936140852,0.0213954513163841,0.215950909083065
NMR metabolomics,X23412.Phospholipids in VLDL,PFDN4,Prefoldin subunit 4,39560,-0.00673428136658911,0.00546585775296489,-0.0174473625624003,0.00397879982922207,0.217951964537157
NMR metabolomics,X23412.Phospholipids in VLDL,AXL,Tyrosine-protein kinase receptor UFO,42217,-0.0034562948152719,0.00280856915729029,-0.00896109036356088,0.00204850073301707,0.218484487926444
NMR metabolomics,X23412.Phospholipids in VLDL,PSMA1,Proteasome subunit alpha type-1,41843,0.0058336044481584,0.00477323016129849,-0.00352192666798664,0.0151891355643034,0.221672564545323
NMR metabolomics,X23412.Phospholipids in VLDL,GPHA2,Glycoprotein hormone alpha-2,39930,-0.00550682018768941,0.00451301423725171,-0.0143523280927028,0.00333868771732394,0.222411085998493
NMR metabolomics,X23412.Phospholipids in VLDL,SHISA5,Protein shisa-5,39966,0.00325899555555998,0.00268328353232781,-0.00200024016780253,0.0085182312789225,0.224561075233064
NMR metabolomics,X23412.Phospholipids in VLDL,ADGRB3,Adhesion G protein-coupled receptor B3,41992,-0.00422296977130865,0.00347923445519149,-0.011042269303484,0.00259632976086667,0.224859235617866
NMR metabolomics,X23412.Phospholipids in VLDL,PODXL2,Podocalyxin-like protein 2,42181,0.0035700846330875,0.00294445119150735,-0.00220103970226689,0.0093412089684419,0.225350245961684
NMR metabolomics,X23412.Phospholipids in VLDL,RICTOR,Rapamycin-insensitive companion of mTOR,39657,-0.00575308797435321,0.0047466622408671,-0.0150565459664527,0.00355037001774631,0.225527526404091
NMR metabolomics,X23412.Phospholipids in VLDL,KLHL41,Kelch-like protein 41,39934,-0.00650552690199116,0.0054209988073686,-0.0171306845644336,0.0041196307604513,0.230140901934878
NMR metabolomics,X23412.Phospholipids in VLDL,RNASE1,Ribonuclease pancreatic,39990,0.00306065605304226,0.0025553254758199,-0.00194778187956474,0.00806909398564926,0.231037001427501
NMR metabolomics,X23412.Phospholipids in VLDL,COL9A1,Collagen alpha-1(IX) chain,42119,0.00549629706378039,0.00459538650667984,-0.0035106604893121,0.0145032546168729,0.231699295590277
NMR metabolomics,X23412.Phospholipids in VLDL,MATN3,Matrilin-3,41992,0.00406175006168769,0.0034034422292851,-0.0026089967077111,0.0107324968310865,0.232724452687399
NMR metabolomics,X23412.Phospholipids in VLDL,FGF7,Fibroblast growth factor 7,39560,-0.00960294095283968,0.00804889989410747,-0.0253787847452903,0.00617290283961096,0.23286584186042
NMR metabolomics,X23412.Phospholipids in VLDL,SMC3,Structural maintenance of chromosomes protein 3,39560,0.00643091566407156,0.00539765053357876,-0.00414847938174281,0.0170103107098859,0.233511138029695
NMR metabolomics,X23412.Phospholipids in VLDL,CXCL9,C-X-C motif chemokine 9,42185,0.00797264405469481,0.00669673937856651,-0.00515296512729556,0.0210982532366852,0.233860419474002
NMR metabolomics,X23412.Phospholipids in VLDL,MMP9,Matrix metalloproteinase-9,42125,-0.00734124269042974,0.00616860702199961,-0.019431712453549,0.00474922707268949,0.234029032311456
NMR metabolomics,X23412.Phospholipids in VLDL,HIP1,Huntingtin-interacting protein 1,39575,0.00404543331413944,0.00340799023528295,-0.00263422754701515,0.010725094175294,0.235236078961502
NMR metabolomics,X23412.Phospholipids in VLDL,TEF,Thyrotroph embryonic factor,39575,0.00521420251506528,0.00443020228500846,-0.0034689939635513,0.0138973989936819,0.239234146548228
NMR metabolomics,X23412.Phospholipids in VLDL,GFRAL,GDNF family receptor alpha-like,39574,-0.00768304905070082,0.00654546683567217,-0.0205121640486183,0.00514606594721663,0.240501836780118
NMR metabolomics,X23412.Phospholipids in VLDL,PLIN3,Perilipin-3,42145,-0.00516654774442482,0.00441383933404707,-0.0138176728391571,0.00348457735030743,0.241806848710893
NMR metabolomics,X23412.Phospholipids in VLDL,AMY2B,Alpha-amylase 2B,41300,-0.00605380908072403,0.00517504868787026,-0.0161969045089497,0.00408928634750167,0.242100528844705
NMR metabolomics,X23412.Phospholipids in VLDL,VCPKMT,Protein-lysine methyltransferase METTL21D,39560,0.0101389552990371,0.00867209702738266,-0.00685835487463294,0.0271362654727071,0.242369880037167
NMR metabolomics,X23412.Phospholipids in VLDL,SLC39A14,Zinc transporter ZIP14,41839,-0.00405376185591805,0.00347697435505572,-0.0108686315918273,0.00276110787999116,0.243680830129624
NMR metabolomics,X23412.Phospholipids in VLDL,TMPRSS11B,Transmembrane protease serine 11B,39586,0.00912873227340515,0.00785390224057524,-0.00626491611812233,0.0245223806649326,0.245131549550694
NMR metabolomics,X23412.Phospholipids in VLDL,TUBB3,Tubulin beta-3 chain,39586,-0.00342893191421282,0.00296148711391478,-0.00923344665748579,0.00237558282906016,0.246954000979585
NMR metabolomics,X23412.Phospholipids in VLDL,CA14,Carbonic anhydrase 14,42262,-0.00437573160319013,0.00378351131215631,-0.0117914137750165,0.00303995056863623,0.24748603397988
NMR metabolomics,X23412.Phospholipids in VLDL,POLR2A,DNA-directed RNA polymerase II subunit RPB1,39657,0.00357323549494351,0.00309094408430054,-0.00248501491028555,0.00963148590017257,0.247692354771382
NMR metabolomics,X23412.Phospholipids in VLDL,ENPEP,Glutamyl aminopeptidase,39575,0.00507421537798842,0.00438967353977538,-0.00352954475997133,0.0136779755159482,0.247729358003107
NMR metabolomics,X23412.Phospholipids in VLDL,STOML2,"Stomatin-like protein 2, mitochondrial",39560,0.0113902950238719,0.00985641620080297,-0.00792828072970195,0.0307088707774457,0.247860846517714
NMR metabolomics,X23412.Phospholipids in VLDL,KLK14,Kallikrein-14,42262,0.00551104239476581,0.00477479335429148,-0.00384755257964549,0.0148696373691771,0.24844044020008
NMR metabolomics,X23412.Phospholipids in VLDL,VSTM2B,V-set and transmembrane domain-containing protein 2B,39757,0.00490075196074197,0.00424697766565034,-0.00342332426393271,0.0132248281854166,0.248550011966393
NMR metabolomics,X23412.Phospholipids in VLDL,EFNA1,Ephrin-A1,42113,0.0035034193729764,0.00303639865625376,-0.00244792199328097,0.00945476073923376,0.248599527838452
NMR metabolomics,X23412.Phospholipids in VLDL,DDX1,ATP-dependent RNA helicase DDX1,39930,0.00573704734265356,0.00498070700227904,-0.00402513838181335,0.0154992330671205,0.249405373092278
NMR metabolomics,X23412.Phospholipids in VLDL,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",39575,-0.00731807985444894,0.00636657324587462,-0.0197965634163632,0.00516040370746532,0.250394081308891
NMR metabolomics,X23412.Phospholipids in VLDL,CASQ2,Calsequestrin-2,39575,0.00562050401516387,0.00492222716245526,-0.00402706122324844,0.0152680692535762,0.253536309490627
NMR metabolomics,X23412.Phospholipids in VLDL,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,39757,-0.00768811667390948,0.00679535781559524,-0.0210070179924761,0.0056307846446572,0.257920447275929
NMR metabolomics,X23412.Phospholipids in VLDL,PFDN6,Prefoldin subunit 6,39649,0.00756518223725249,0.00670090864957033,-0.00556859871590536,0.0206989631904103,0.258931386751854
NMR metabolomics,X23412.Phospholipids in VLDL,PALM3,Paralemmin-3,39575,0.00885214409190207,0.00784506080793048,-0.00652417509164166,0.0242284632754458,0.259187666788966
NMR metabolomics,X23412.Phospholipids in VLDL,SLC44A4,Choline transporter-like protein 4,39649,-0.00800844310814249,0.00711011882418147,-0.0219442760035382,0.00592738978725319,0.260044198712803
NMR metabolomics,X23412.Phospholipids in VLDL,RELB,Transcription factor RelB,39657,0.00546333451574672,0.00485365015486468,-0.00404981978778805,0.0149764888192815,0.260353549783949
NMR metabolomics,X23412.Phospholipids in VLDL,MAPT,Microtubule-associated protein tau,41839,0.00611239681900988,0.00544596710090751,-0.00456169869876884,0.0167864923367886,0.261724984352698
NMR metabolomics,X23412.Phospholipids in VLDL,CLEC12A,C-type lectin domain family 12 member A,39657,0.00235918109233264,0.00211155379039794,-0.00177946433684732,0.00649782652151261,0.263902083863162
NMR metabolomics,X23412.Phospholipids in VLDL,MMP8,Neutrophil collagenase,42224,0.00823291205166629,0.00737570530709287,-0.00622347035023574,0.0226892944535683,0.26434752984928
NMR metabolomics,X23412.Phospholipids in VLDL,GJA8,Gap junction alpha-8 protein,39560,-0.00720978449851126,0.00646276265838014,-0.0198767993089363,0.00545723031191382,0.26462272317984
NMR metabolomics,X23412.Phospholipids in VLDL,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,39575,-0.00452433863894895,0.00408489776603305,-0.0125307382603737,0.00348206098247583,0.268068832586535
NMR metabolomics,X23412.Phospholipids in VLDL,MAPRE3,Microtubule-associated protein RP/EB family member 3,39560,-0.016822221347196,0.0151952559818406,-0.0466049230716036,0.0129604803772117,0.268287696690522
NMR metabolomics,X23412.Phospholipids in VLDL,FLT3,Receptor-type tyrosine-protein kinase FLT3,41843,0.00342735833067136,0.00311706750946454,-0.00268209398787913,0.00953681064922185,0.271550078009302
NMR metabolomics,X23412.Phospholipids in VLDL,GFRA3,GDNF family receptor alpha-3,41989,0.00314736034744981,0.00286770920386557,-0.0024733496921267,0.00876807038702632,0.272435077353699
NMR metabolomics,X23412.Phospholipids in VLDL,CEND1,Cell cycle exit and neuronal differentiation protein 1,39586,0.00687436550004293,0.00626816325059727,-0.00541123447112771,0.0191599654712136,0.272791651682086
NMR metabolomics,X23412.Phospholipids in VLDL,RNASET2,Ribonuclease T2,42258,0.00302191465426804,0.00276432489451534,-0.00239616213898202,0.00843999144751811,0.274332474435612
NMR metabolomics,X23412.Phospholipids in VLDL,NUP50,Nuclear pore complex protein Nup50,39575,-0.00358116403552832,0.00328111512672051,-0.0100121496839005,0.00284982161284388,0.275100097038873
NMR metabolomics,X23412.Phospholipids in VLDL,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,42119,0.00956886083925351,0.00877381329993148,-0.00762781322861219,0.0267655349071192,0.275461340455947
NMR metabolomics,X23412.Phospholipids in VLDL,SLAMF1,Signaling lymphocytic activation molecule,41913,-0.00667906994236655,0.00615476221787393,-0.0187424038893995,0.00538426400466636,0.277858347313399
NMR metabolomics,X23412.Phospholipids in VLDL,ZP4,Zona pellucida sperm-binding protein 4,39560,0.00349004293723013,0.00323111016887377,-0.00284293299376246,0.00982301886822272,0.280104767420348
NMR metabolomics,X23412.Phospholipids in VLDL,CD209,CD209 antigen,42171,0.00434382528276141,0.00402280693639586,-0.00354087631257448,0.0122285268780973,0.280250623274684
NMR metabolomics,X23412.Phospholipids in VLDL,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",39657,0.00554773704320013,0.00513938358389575,-0.00452545478123555,0.0156209288676358,0.28040816584416
NMR metabolomics,X23412.Phospholipids in VLDL,MRPL24,"39S ribosomal protein L24, mitochondrial",39575,0.00431978019350948,0.00401030659672508,-0.00354042073607168,0.0121799811230906,0.281428197473643
NMR metabolomics,X23412.Phospholipids in VLDL,CSF2RB,Cytokine receptor common subunit beta,39657,-0.00471374319374282,0.00440135604007125,-0.0133404010322825,0.00391291464479683,0.284203954242507
NMR metabolomics,X23412.Phospholipids in VLDL,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,42123,-0.00435784716970941,0.00408792342849814,-0.0123701770895658,0.00365448275014694,0.286429316471394
NMR metabolomics,X23412.Phospholipids in VLDL,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,41900,0.00302891405106087,0.00284436819880878,-0.00254604761860434,0.00860387572072608,0.286949052322143
NMR metabolomics,X23412.Phospholipids in VLDL,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,39586,-0.00647116360073297,0.00608663332573777,-0.018400964919179,0.00545863771771307,0.28772542871671
NMR metabolomics,X23412.Phospholipids in VLDL,PRTN3,Myeloblastin,41800,-0.00527217969174411,0.00496391061549758,-0.0150014444981194,0.00445708511463115,0.288208785786333
NMR metabolomics,X23412.Phospholipids in VLDL,KCNH2,Potassium voltage-gated channel subfamily H member 2,39649,0.00846175268823172,0.00797043463930693,-0.00716029920480985,0.0240838045812733,0.28842118594266
NMR metabolomics,X23412.Phospholipids in VLDL,TRPV3,Transient receptor potential cation channel subfamily V member 3,39575,-0.0054557999711857,0.00514948099889582,-0.0155487827290215,0.00463718278665011,0.28940208813141
NMR metabolomics,X23412.Phospholipids in VLDL,CHP1,Calcineurin B homologous protein 1,39586,0.00806724516538634,0.00763640964339844,-0.00690011773567461,0.0230346080664473,0.290800242854528
NMR metabolomics,X23412.Phospholipids in VLDL,HTR1A,5-hydroxytryptamine receptor 1A,39586,-0.00785095698431809,0.00748670225473413,-0.022524893403597,0.0068229794349608,0.294360663323767
NMR metabolomics,X23412.Phospholipids in VLDL,IL20RA,Interleukin-20 receptor subunit alpha,41913,0.00477129972200518,0.00457386652970693,-0.00419347867622039,0.0137360781202308,0.296890595139111
NMR metabolomics,X23412.Phospholipids in VLDL,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",39757,0.0074606335454911,0.00715544954865263,-0.00656404756986806,0.0214853146608503,0.297132750642478
NMR metabolomics,X23412.Phospholipids in VLDL,EDDM3B,Epididymal secretory protein E3-beta,39919,0.0066164064932167,0.00634773104464225,-0.00582514635428211,0.0190579593407155,0.297282722390185
NMR metabolomics,X23412.Phospholipids in VLDL,COL3A1,Collagen alpha-1(III) chain,39966,-0.00253580914788314,0.00243793559511505,-0.00731416291430864,0.00224254461854235,0.298294163911458
NMR metabolomics,X23412.Phospholipids in VLDL,EXOSC10,Exosome component 10,39575,-0.00626621602702617,0.00603012401661485,-0.0180852590995913,0.00555282704553893,0.298756896578217
NMR metabolomics,X23412.Phospholipids in VLDL,KLRK1,NKG2-D type II integral membrane protein,39929,0.0050516817175595,0.00487193970007567,-0.00449732009458881,0.0146006835297078,0.299807709448806
NMR metabolomics,X23412.Phospholipids in VLDL,NRXN3,Neurexin-3,39649,0.00384953759538665,0.00371604523118882,-0.00343391105774344,0.0111329862485167,0.300260628294555
NMR metabolomics,X23412.Phospholipids in VLDL,GRIK2,"Glutamate receptor ionotropic, kainate 2",39934,0.0044482079005765,0.00430430704890987,-0.00398823391528683,0.0128846497164398,0.301423908123705
NMR metabolomics,X23412.Phospholipids in VLDL,GPA33,Cell surface A33 antigen,42070,0.0141749229925769,0.0137906971878912,-0.01285484349569,0.0412046894808437,0.304033564963582
NMR metabolomics,X23412.Phospholipids in VLDL,DLGAP5,Disks large-associated protein 5,39934,0.00524018929156484,0.00510726357277841,-0.00477004731108084,0.0152504258942105,0.304900849331756
NMR metabolomics,X23412.Phospholipids in VLDL,RSPO3,R-spondin-3,42262,0.00295926262851891,0.00289656754440408,-0.00271800975851309,0.00863653501555091,0.30696722423511
NMR metabolomics,X23412.Phospholipids in VLDL,ARHGEF5,Rho guanine nucleotide exchange factor 5,39586,-0.00800378493643599,0.00783552159087156,-0.0233614072545443,0.00735383738167227,0.307052211106863
NMR metabolomics,X23412.Phospholipids in VLDL,NOS2,"Nitric oxide synthase, inducible",39575,-0.00424268843088327,0.00417013023386289,-0.0124161436892545,0.003930766827488,0.308985845086903
NMR metabolomics,X23412.Phospholipids in VLDL,MAG,Myelin-associated glycoprotein,39649,0.00509518035571464,0.00502686625638135,-0.00475747750679281,0.0149478382182221,0.310800722351117
NMR metabolomics,X23412.Phospholipids in VLDL,BEX3,Protein BEX3,39560,-0.0048999360307897,0.00484423813963158,-0.0143946427844676,0.0045947707228882,0.31180058179703
NMR metabolomics,X23412.Phospholipids in VLDL,DCN,Decorin,41900,-0.00239939504943204,0.00237287719423585,-0.0070502343501343,0.00225144425127022,0.311950882002231
NMR metabolomics,X23412.Phospholipids in VLDL,SEZ6,Seizure protein 6 homolog,39649,0.00326439536690448,0.00323568150940061,-0.00307754039152071,0.00960633112532968,0.313057096398102
NMR metabolomics,X23412.Phospholipids in VLDL,TFAP2A,Transcription factor AP-2-alpha,39586,0.00618704869550139,0.00615714660098824,-0.00588095864243555,0.0182550560334383,0.314988091665693
NMR metabolomics,X23412.Phospholipids in VLDL,MYOM1,Myomesin-1,39586,0.00508408306613872,0.00506672357924043,-0.00484669514917252,0.01501486128145,0.315677379879965
NMR metabolomics,X23412.Phospholipids in VLDL,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",41839,0.00526352228002238,0.00524926192778574,-0.00502503109843768,0.0155520756584824,0.31601592553861
NMR metabolomics,X23412.Phospholipids in VLDL,DDX53,Probable ATP-dependent RNA helicase DDX53,39649,0.00375181394391161,0.00374226882486136,-0.00358303295281666,0.0110866608406399,0.31609968465559
NMR metabolomics,X23412.Phospholipids in VLDL,SCN3A,Sodium channel protein type 3 subunit alpha,39649,-0.00379409253142331,0.00379309221135878,-0.0112285532656865,0.00364036820283989,0.317204803978476
NMR metabolomics,X23412.Phospholipids in VLDL,SEMA4C,Semaphorin-4C,42070,0.00286292410349365,0.00287153741283723,-0.00276528922566732,0.00849113743265462,0.3187821990887
NMR metabolomics,X23412.Phospholipids in VLDL,AMY2A,Pancreatic alpha-amylase,41665,-0.00503224129473304,0.00504775160967583,-0.0149258344496977,0.00486135186023158,0.31881827101251
NMR metabolomics,X23412.Phospholipids in VLDL,BCL2L15,Bcl-2-like protein 15,39657,0.00583633018140781,0.00585891201783717,-0.00564713737355305,0.0173197977363687,0.319201143004746
NMR metabolomics,X23412.Phospholipids in VLDL,SOX2,Transcription factor SOX-2,39915,0.00251951253564318,0.00253761241567403,-0.00245420779907793,0.00749323287036428,0.320795830271156
NMR metabolomics,X23412.Phospholipids in VLDL,DIPK1C,Divergent protein kinase domain 1C,39649,0.00427021906030077,0.0043416371672738,-0.00423938978755588,0.0127798279081574,0.325358149077735
NMR metabolomics,X23412.Phospholipids in VLDL,GGT5,Glutathione hydrolase 5 proenzyme,42016,0.0024268567872588,0.00246866875065953,-0.00241173396403389,0.00726544753855149,0.32559418478007
NMR metabolomics,X23412.Phospholipids in VLDL,MSMB,Beta-microseminoprotein,42103,-0.00706370463048448,0.00719932600224198,-0.0211743835948787,0.0070469743339098,0.326530470860581
NMR metabolomics,X23412.Phospholipids in VLDL,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,39586,0.00757167440149124,0.00773180773797612,-0.00758266876494195,0.0227260175679244,0.327458759614989
NMR metabolomics,X23412.Phospholipids in VLDL,SLC4A1,Band 3 anion transport protein,39966,-0.00481582408355217,0.00492328979134775,-0.0144654720745937,0.00483382390748942,0.3280100951806
NMR metabolomics,X23412.Phospholipids in VLDL,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",42070,0.00348800225643027,0.00356821104326898,-0.00350569138837693,0.0104816959012375,0.328328698906334
NMR metabolomics,X23412.Phospholipids in VLDL,CTAG1A_CTAG1B,Cancer/testis antigen 1,39735,-0.00507859254530306,0.0052164944739753,-0.0153029217142946,0.00514573662368853,0.330294091142914
NMR metabolomics,X23412.Phospholipids in VLDL,HIF1A,Hypoxia-inducible factor 1-alpha,39657,0.00629914563295193,0.00647850762614763,-0.00639872931429743,0.0189970205802013,0.33091547945878
NMR metabolomics,X23412.Phospholipids in VLDL,SIRPB1,Signal-regulatory protein beta-1,42100,0.004761481679531,0.00492335392730313,-0.00488829201798314,0.0144112553770451,0.333500598763894
NMR metabolomics,X23412.Phospholipids in VLDL,MYH4,Myosin-4,39575,-0.00458154794589424,0.00474000255349052,-0.0138719529507357,0.00470885705894718,0.33377994793116
NMR metabolomics,X23412.Phospholipids in VLDL,CHGB,Secretogranin-1,42210,0.00418625538232326,0.00435763588645024,-0.0043547109551192,0.0127272217197657,0.336734572804683
NMR metabolomics,X23412.Phospholipids in VLDL,ALMS1,Alstrom syndrome protein 1,39757,-0.0043954720211699,0.00459252176644999,-0.0133968146834119,0.00460587064107208,0.338540880131616
NMR metabolomics,X23412.Phospholipids in VLDL,MAPK13,Mitogen-activated protein kinase 13,39560,0.00432348436980809,0.00451873495785648,-0.00453323614759062,0.0131802048872068,0.338693923172456
NMR metabolomics,X23412.Phospholipids in VLDL,VCAN,Versican core protein,42249,0.00296583239677302,0.00310097303810718,-0.00311207475791705,0.00904373955146309,0.338877062111061
NMR metabolomics,X23412.Phospholipids in VLDL,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,41843,-0.00767494084883278,0.00807576499740589,-0.0235034402437483,0.00815355854608275,0.341943130585945
NMR metabolomics,X23412.Phospholipids in VLDL,PNLIPRP2,Pancreatic lipase-related protein 2,42123,0.0292919573501427,0.0308625422719554,-0.0311986255028899,0.0897825402031754,0.342581467328752
NMR metabolomics,X23412.Phospholipids in VLDL,ADRA2A,Alpha-2A adrenergic receptor,39575,-0.00681448941008358,0.00718812109509374,-0.0209032067564673,0.00727422793630015,0.343139660809906
NMR metabolomics,X23412.Phospholipids in VLDL,SHH,Sonic hedgehog protein,39657,-0.00415656751519846,0.00441428838831744,-0.0128085727563006,0.00449543772590372,0.346409505406231
NMR metabolomics,X23412.Phospholipids in VLDL,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,39966,0.00262917577198407,0.00281322702404317,-0.00288474919514055,0.00814310073910869,0.350026465900627
NMR metabolomics,X23412.Phospholipids in VLDL,NAAA,N-acylethanolamine-hydrolyzing acid amidase,41954,0.00577537278077571,0.00618156780472768,-0.00634050011649055,0.017891245678042,0.350171565020444
NMR metabolomics,X23412.Phospholipids in VLDL,HBQ1,Hemoglobin subunit theta-1,42262,-0.00588587824601637,0.00633747171438828,-0.0183073228062174,0.00653556631418465,0.353039046116573
NMR metabolomics,X23412.Phospholipids in VLDL,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,39649,-0.00432686364286724,0.00469450387143869,-0.0135280912308871,0.00487436394515258,0.35671193730324
NMR metabolomics,X23412.Phospholipids in VLDL,TEX33,Testis-expressed protein 33,39757,-0.0036709245229176,0.00398879414627345,-0.0114889610496136,0.00414711200377836,0.357431025254243
NMR metabolomics,X23412.Phospholipids in VLDL,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,39575,-0.00545321266239864,0.00593048864327288,-0.0170769704032135,0.0061705450784162,0.357842999367161
NMR metabolomics,X23412.Phospholipids in VLDL,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,39575,0.00470037164892302,0.00511920822254607,-0.00533327646726728,0.0147340197651133,0.358543072325599
NMR metabolomics,X23412.Phospholipids in VLDL,VWC2L,von Willebrand factor C domain-containing protein 2-like,39934,0.00433270146147393,0.00475081826619332,-0.00497890234026497,0.0136443052632128,0.361793078236298
NMR metabolomics,X23412.Phospholipids in VLDL,RBM19,Probable RNA-binding protein 19,39575,-0.00451813793962132,0.00497452671779779,-0.014268210306505,0.00523193442726235,0.363763542113137
NMR metabolomics,X23412.Phospholipids in VLDL,CA11,Carbonic anhydrase-related protein 11,41843,-0.00285041618871415,0.00314655405886548,-0.00901766214409048,0.00331682976666219,0.365013194572394
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,42016,-0.00398087972256923,0.00442397958265449,-0.012651879704572,0.00469012025943357,0.368220841034867
NMR metabolomics,X23412.Phospholipids in VLDL,PILRA,Paired immunoglobulin-like type 2 receptor alpha,42137,0.00393778679238587,0.00439699842299667,-0.00468033011668761,0.0125559037014593,0.370502408436542
NMR metabolomics,X23412.Phospholipids in VLDL,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",39560,-0.00498417741195089,0.00558459893480314,-0.015929991324165,0.00596163650026326,0.372151987402745
NMR metabolomics,X23412.Phospholipids in VLDL,CDH4,Cadherin-4,39586,0.00429304971331896,0.00481329450785502,-0.00514100752207688,0.0137271069487148,0.372458012562661
NMR metabolomics,X23412.Phospholipids in VLDL,ACRV1,Acrosomal protein SP-10,39657,0.00979807536879254,0.0109986316068502,-0.0117592425806339,0.031355393318219,0.373031742963136
NMR metabolomics,X23412.Phospholipids in VLDL,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,39649,-0.00383549146349575,0.00431868133190777,-0.012300106874035,0.00462912394704349,0.374497506093615
NMR metabolomics,X23412.Phospholipids in VLDL,IL24,Interleukin-24,41913,-0.00440063266352668,0.00497437175040941,-0.0141504012943291,0.00534913596727578,0.376355475324015
NMR metabolomics,X23412.Phospholipids in VLDL,OBP2B,Odorant-binding protein 2b,41979,0.00522435617388101,0.00590754490119605,-0.00635443183246325,0.0168031441802253,0.376521475844454
NMR metabolomics,X23412.Phospholipids in VLDL,PCDH17,Protocadherin-17,42145,0.00338697601438603,0.00386024370706818,-0.0041791016514676,0.0109530536802397,0.380285230012963
NMR metabolomics,X23412.Phospholipids in VLDL,PSCA,Prostate stem cell antigen,39930,0.0235602849784281,0.0268682639478143,-0.0291015123592879,0.0762220823161441,0.380569569391074
NMR metabolomics,X23412.Phospholipids in VLDL,CTNNA1,Catenin alpha-1,39586,-0.00306726077758098,0.00349902389049442,-0.00992534760295004,0.00379082604778807,0.380720554357494
NMR metabolomics,X23412.Phospholipids in VLDL,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,39586,0.00586308776012794,0.00672536892499786,-0.00731863533286786,0.0190448108531237,0.383343755840401
NMR metabolomics,X23412.Phospholipids in VLDL,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,39934,-0.00269585819942856,0.00310193450934967,-0.0087756498377539,0.00338393343889679,0.384816672900444
NMR metabolomics,X23412.Phospholipids in VLDL,IL20RB,Interleukin-20 receptor subunit beta,39657,0.00376157483794618,0.00433780287631452,-0.00474051879963028,0.0122636684755226,0.385872448052734
NMR metabolomics,X23412.Phospholipids in VLDL,IL36A,Interleukin-36 alpha,39657,-0.00515272106585993,0.00594414050683503,-0.0168032364592566,0.00649779432753672,0.386039060962577
NMR metabolomics,X23412.Phospholipids in VLDL,ISM2,Isthmin-2,39966,0.00388819651495251,0.00448734033524563,-0.00490699054212893,0.0126833835720339,0.386244563990889
NMR metabolomics,X23412.Phospholipids in VLDL,ESR1,Estrogen receptor,39657,0.0051161651524232,0.00591407260608282,-0.00647541715549914,0.0167077474603455,0.387011865350618
NMR metabolomics,X23412.Phospholipids in VLDL,IL10,Interleukin-10,41913,-0.00685905445518285,0.00793347156637743,-0.0224086587252826,0.00869054981491691,0.387289526066411
NMR metabolomics,X23412.Phospholipids in VLDL,RGS8,Regulator of G-protein signaling 8,41913,-0.00569726216739338,0.0065917751850031,-0.0186171415299995,0.0072226171952127,0.387439442454993
NMR metabolomics,X23412.Phospholipids in VLDL,DUSP29,Dual specificity phosphatase 29,39649,-0.0060030754280315,0.00695908713837547,-0.0196428862192474,0.00763673536318442,0.38836296517049
NMR metabolomics,X23412.Phospholipids in VLDL,LRP2BP,LRP2-binding protein,39649,-0.00691820192094078,0.00802919345956818,-0.0226554211016944,0.00881901725981286,0.388909309682714
NMR metabolomics,X23412.Phospholipids in VLDL,ARNT,Aryl hydrocarbon receptor nuclear translocator,41913,0.00325586650258291,0.0038186672828517,-0.00422872137180643,0.0107404543769722,0.393886219087163
NMR metabolomics,X23412.Phospholipids in VLDL,IGFBP7,Insulin-like growth factor-binding protein 7,42310,0.00272344625084181,0.00320599226824998,-0.00356029859492816,0.00900719109661178,0.395625628283967
NMR metabolomics,X23412.Phospholipids in VLDL,MORF4L1,Mortality factor 4-like protein 1,39757,-0.00346151072983104,0.0040754636645601,-0.0114494195123688,0.00452639805270675,0.395702652097059
NMR metabolomics,X23412.Phospholipids in VLDL,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",39586,-0.00397821732094245,0.00468825314471309,-0.0131671934845801,0.0052107588426952,0.396150213604755
NMR metabolomics,X23412.Phospholipids in VLDL,KIRREL2,Kin of IRRE-like protein 2,41839,0.00348585294795547,0.00410914407595157,-0.00456806944090961,0.0115397753368205,0.396277308246399
NMR metabolomics,X23412.Phospholipids in VLDL,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,39757,-0.00325915777193699,0.00384266678477604,-0.010790784670098,0.00427246912622405,0.396372642958931
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,42137,-0.00271027490470252,0.0031972048205274,-0.00897679635293622,0.00355624654353118,0.39661929091402
NMR metabolomics,X23412.Phospholipids in VLDL,TNN,Tenascin-N,39966,0.00378711895192743,0.00446910068787401,-0.00497231839630563,0.0125465563001605,0.396789669827888
NMR metabolomics,X23412.Phospholipids in VLDL,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",39934,-0.0036705027360736,0.00433381206152114,-0.012164774376655,0.00482376890450782,0.397043367843655
NMR metabolomics,X23412.Phospholipids in VLDL,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",39586,-0.00469960477820498,0.00555104397318211,-0.0155796509656419,0.00618044140923196,0.397227419502368
NMR metabolomics,X23412.Phospholipids in VLDL,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",39657,0.00244773076346295,0.00289604098111465,-0.00322850955952177,0.00812397108644767,0.398018063157853
NMR metabolomics,X23412.Phospholipids in VLDL,RTKN2,Rhotekin-2,39575,-0.00444851754411846,0.00526775014944997,-0.0147733078370404,0.00587627274880349,0.398418804772576
NMR metabolomics,X23412.Phospholipids in VLDL,CD248,Endosialin,39966,-0.00353303519360256,0.00418603511855768,-0.0117376640259756,0.0046715936387705,0.398684291396955
NMR metabolomics,X23412.Phospholipids in VLDL,DENND2B,DENN domain-containing protein 2B,39575,-0.00427095232874371,0.00506865571292364,-0.014205517526074,0.00566361286858662,0.399459181633278
NMR metabolomics,X23412.Phospholipids in VLDL,CORO6,Coronin-6,39586,-0.00339821288269928,0.00403981981856189,-0.0113162597270806,0.00451983396168202,0.400265793167286
NMR metabolomics,X23412.Phospholipids in VLDL,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,39657,0.0029383747027901,0.00350147295802209,-0.0039245122949332,0.00980126170051339,0.401385068991999
NMR metabolomics,X23412.Phospholipids in VLDL,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,39560,0.00230139493194766,0.00276208598295672,-0.00311229359464751,0.00771508345854283,0.404745017796226
NMR metabolomics,X23412.Phospholipids in VLDL,SLC34A3,Sodium-dependent phosphate transport protein 2C,39560,0.00417426412197245,0.00501055197994985,-0.00564641775872925,0.0139949460026742,0.404809496237536
NMR metabolomics,X23412.Phospholipids in VLDL,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,39649,0.00433678967751065,0.00521083779567025,-0.00587645240200303,0.0145500317570243,0.405278261629533
NMR metabolomics,X23412.Phospholipids in VLDL,GBP6,Guanylate-binding protein 6,39575,-0.00384643288953504,0.00462544714940463,-0.0129123093023681,0.00521944352329803,0.405663713732377
NMR metabolomics,X23412.Phospholipids in VLDL,ITGB2,Integrin beta-2,42079,-0.00245771637221627,0.00296240920994619,-0.00826403842371081,0.00334860567927826,0.406760254586984
NMR metabolomics,X23412.Phospholipids in VLDL,USP28,Ubiquitin carboxyl-terminal hydrolase 28,39929,0.00311739524912111,0.00377186916171875,-0.00427546830784763,0.0105102588060899,0.408546133855069
NMR metabolomics,X23412.Phospholipids in VLDL,SSB,Lupus La protein,41839,0.00500810297447461,0.00606840173350528,-0.00688596442319573,0.016902170372145,0.409230096074272
NMR metabolomics,X23412.Phospholipids in VLDL,HNF1A,Hepatocyte nuclear factor 1-alpha,39649,0.00593175678033255,0.00721966336706366,-0.00821878341911222,0.0200822969797773,0.411315901548162
NMR metabolomics,X23412.Phospholipids in VLDL,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,39575,0.00430906345432811,0.00525325051128772,-0.00598730754779582,0.014605434456452,0.41208222600946
NMR metabolomics,X23412.Phospholipids in VLDL,RBP1,Retinol-binding protein 1,39649,0.00594792973090217,0.00725819572693078,-0.00827813389388215,0.0201739933556865,0.412531580768639
NMR metabolomics,X23412.Phospholipids in VLDL,OSTN,Osteocrin,39649,0.0034252070874128,0.00418098373173343,-0.00476952102678473,0.0116199352016103,0.41267017227664
NMR metabolomics,X23412.Phospholipids in VLDL,FGF3,Fibroblast growth factor 3,39657,0.00250575921510652,0.00306500234091581,-0.00350164537308846,0.0085131638033015,0.413638037345068
NMR metabolomics,X23412.Phospholipids in VLDL,BSND,Barttin,39560,0.00282095285885919,0.00347510579483284,-0.00399025449901317,0.00963216021673155,0.416946825996684
NMR metabolomics,X23412.Phospholipids in VLDL,PTTG1,Securin,39757,0.00349187653186621,0.00430411631445878,-0.004944191444473,0.0119279445082054,0.417217790890011
NMR metabolomics,X23412.Phospholipids in VLDL,LYPLA2,Acyl-protein thioesterase 2,39586,0.00908651988704393,0.0112416908535334,-0.0129471941858815,0.0311202339599693,0.418942512135547
NMR metabolomics,X23412.Phospholipids in VLDL,FCRL6,Fc receptor-like protein 6,42119,-0.0057040804676077,0.00707360541722152,-0.0195683470853619,0.00816018615014647,0.420032538552159
NMR metabolomics,X23412.Phospholipids in VLDL,TSPAN7,Tetraspanin-7,39586,-0.00810198447695996,0.0100940621686677,-0.0278863463275487,0.0116823773736288,0.422195255014017
NMR metabolomics,X23412.Phospholipids in VLDL,SUSD4,Sushi domain-containing protein 4,39919,0.00319032219602374,0.00398143667943413,-0.00461329369566715,0.0109939380877146,0.422975249231432
NMR metabolomics,X23412.Phospholipids in VLDL,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,39575,-0.00280933767147704,0.00351937187433814,-0.0097073065451798,0.00408863120222572,0.424742851978147
NMR metabolomics,X23412.Phospholipids in VLDL,GID8,Glucose-induced degradation protein 8 homolog,39934,0.00279843660628206,0.003511546090255,-0.00408419373061775,0.00968106694318187,0.425511657851173
NMR metabolomics,X23412.Phospholipids in VLDL,CREB3,Cyclic AMP-responsive element-binding protein 3,39560,0.00463329548576297,0.00581582313617879,-0.00676571786114745,0.0160323088326734,0.425659601684568
NMR metabolomics,X23412.Phospholipids in VLDL,HDDC2,5'-deoxynucleotidase HDDC2,39930,-0.0036064832210904,0.00452700043625161,-0.0124794040761436,0.00526643763396277,0.42566482171673
NMR metabolomics,X23412.Phospholipids in VLDL,TP53BP1,TP53-binding protein 1,39657,-0.00702190007251293,0.00889804789463063,-0.024462073945989,0.0104182738009631,0.43004089584288
NMR metabolomics,X23412.Phospholipids in VLDL,IL12RB2,Interleukin-12 receptor subunit beta-2,39657,-0.00337360799390734,0.00428050683077627,-0.0117634013822288,0.00501618539441414,0.430635905117069
NMR metabolomics,X23412.Phospholipids in VLDL,EVPL,Envoplakin,39757,0.00271230400953643,0.00345352768303539,-0.00405661024921294,0.00948121826828579,0.432252158401478
NMR metabolomics,X23412.Phospholipids in VLDL,IL20,Interleukin-20,41913,0.00377843697621296,0.00481285485216946,-0.00565475853403917,0.0132116324864651,0.432425399658322
NMR metabolomics,X23412.Phospholipids in VLDL,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,39919,0.00479921090816659,0.00612728329917766,-0.00721026435822163,0.0168086861745548,0.433495147632739
NMR metabolomics,X23412.Phospholipids in VLDL,NPHS2,Podocin,39657,-0.00824971647066416,0.0105435754142537,-0.0289151242826014,0.0124156913412731,0.433972716032175
NMR metabolomics,X23412.Phospholipids in VLDL,CDSN,Corneodesmosin,42246,0.00351805029797869,0.00451547587844319,-0.00533228242376996,0.0123683830197273,0.435928706252052
NMR metabolomics,X23412.Phospholipids in VLDL,STEAP4,Metalloreductase STEAP4,39586,0.00579822849277906,0.00753263150481011,-0.00896572925664876,0.0205621862422069,0.441465905060913
NMR metabolomics,X23412.Phospholipids in VLDL,PLXDC1,Plexin domain-containing protein 1,41843,-0.00255196154280027,0.00332096913509115,-0.00906106104757893,0.00395713796197839,0.44224023824026
NMR metabolomics,X23412.Phospholipids in VLDL,FOLR3,Folate receptor gamma,42132,-0.015203091985385,0.019788206861272,-0.0539879774334782,0.0235817934627082,0.44232800511983
NMR metabolomics,X23412.Phospholipids in VLDL,DOCK9,Dedicator of cytokinesis protein 9,39586,0.00933505514666796,0.0121582704633315,-0.0144951549614618,0.0331652652547977,0.442625688794125
NMR metabolomics,X23412.Phospholipids in VLDL,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,42016,0.00238888778915125,0.00311158706209956,-0.00370982285256389,0.00848759843086639,0.442655572506344
NMR metabolomics,X23412.Phospholipids in VLDL,NPTX2,Neuronal pentraxin-2,39966,0.00269782255517934,0.00353872221812628,-0.00423807299234818,0.00963371810270685,0.445853863274748
NMR metabolomics,X23412.Phospholipids in VLDL,ERCC1,DNA excision repair protein ERCC-1,39560,0.00262095782738069,0.00346166885823633,-0.00416391313476252,0.0094058287895239,0.448984021582696
NMR metabolomics,X23412.Phospholipids in VLDL,TMEM132A,Transmembrane protein 132A,39638,0.00490801408826734,0.0064934151894989,-0.00781907968315051,0.0176351078596852,0.44975838379847
NMR metabolomics,X23412.Phospholipids in VLDL,PDCL2,Phosducin-like protein 2,39560,-0.00405297236588114,0.00540799942220761,-0.0146526512334081,0.00654670650164576,0.453607992052402
NMR metabolomics,X23412.Phospholipids in VLDL,TPPP2,Tubulin polymerization-promoting protein family member 2,39757,-0.00585100921880088,0.00788708211159555,-0.0213096901575281,0.00960767171992639,0.45819557816309
NMR metabolomics,X23412.Phospholipids in VLDL,TJP3,Tight junction protein ZO-3,39586,-0.0031822855101051,0.00430370244311298,-0.0116175422986066,0.00525297127839634,0.459661897356997
NMR metabolomics,X23412.Phospholipids in VLDL,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",39575,-0.00323489732914833,0.00440788905517577,-0.0118743598772928,0.00540456521899618,0.463032616723182
NMR metabolomics,X23412.Phospholipids in VLDL,GAD2,Glutamate decarboxylase 2,39657,-0.00343882154031211,0.0046879659689754,-0.0126272348395039,0.00574959175887967,0.463243264520895
NMR metabolomics,X23412.Phospholipids in VLDL,IL3RA,Interleukin-3 receptor subunit alpha,41913,0.00237786459488186,0.00324197612095996,-0.00397640860219966,0.00873213779196339,0.46328993044052
NMR metabolomics,X23412.Phospholipids in VLDL,SIGLEC1,Sialoadhesin,42185,-0.00313274860094515,0.00428553351117333,-0.0115323942828449,0.00526689708095458,0.464788396142074
NMR metabolomics,X23412.Phospholipids in VLDL,BTNL10,Butyrophilin-like protein 10,39560,-0.00301003495826017,0.00413031317745345,-0.0111054487860689,0.00508537886954859,0.46615991819579
NMR metabolomics,X23412.Phospholipids in VLDL,ACTA2,"Actin, aortic smooth muscle",41900,0.00325364389960782,0.00449897840026941,-0.00556435376492023,0.0120716415641359,0.469572095912217
NMR metabolomics,X23412.Phospholipids in VLDL,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,39966,-0.00194667029155066,0.00269212278697428,-0.00722323095402025,0.00332989037091893,0.469634172045783
NMR metabolomics,X23412.Phospholipids in VLDL,TNNI3,"Troponin I, cardiac muscle",41900,0.00624155419717619,0.00866109065668934,-0.0107341834899349,0.0232172918842873,0.471141867164385
NMR metabolomics,X23412.Phospholipids in VLDL,PAPPA,Pappalysin-1,41913,0.00350720451602699,0.00489352869931029,-0.00608411173462117,0.0130985207666751,0.473570222377818
NMR metabolomics,X23412.Phospholipids in VLDL,ERVV_1,,39575,0.00322385579919291,0.00450813062941571,-0.00561208023446188,0.0120597918328477,0.474549913205318
NMR metabolomics,X23412.Phospholipids in VLDL,THBS2,Thrombospondin-2,42137,0.00284217529538754,0.00398298564804793,-0.0049644765747864,0.0106488271655615,0.475499789709105
NMR metabolomics,X23412.Phospholipids in VLDL,CNTN1,Contactin-1,42310,0.00195109513179292,0.00275439070181895,-0.00344751064377222,0.00734970090735807,0.47873491061769
NMR metabolomics,X23412.Phospholipids in VLDL,FGF6,Fibroblast growth factor 6,39657,0.00285964638688991,0.00404310011214719,-0.00506482983291859,0.0107841226066984,0.479400860912355
NMR metabolomics,X23412.Phospholipids in VLDL,FDX1,"Adrenodoxin, mitochondrial",39575,0.00457768219905916,0.00651585661262056,-0.00819339676167714,0.0173487611597955,0.482354275923833
NMR metabolomics,X23412.Phospholipids in VLDL,CLEC11A,C-type lectin domain family 11 member A,42118,-0.00350640575895444,0.00500469288232138,-0.0133156038083043,0.00630279229039547,0.483550028001198
NMR metabolomics,X23412.Phospholipids in VLDL,OLR1,Oxidized low-density lipoprotein receptor 1,42017,0.00419829384248824,0.00603849522365904,-0.00763715679588347,0.0160337444808599,0.486907566530253
NMR metabolomics,X23412.Phospholipids in VLDL,DEFA1_DEFA1B,Neutrophil defensin 1,41879,0.00383068689602928,0.00552063000957738,-0.00698974792274239,0.0146511217148009,0.487765953001981
NMR metabolomics,X23412.Phospholipids in VLDL,IGLON5,IgLON family member 5,39560,-0.0066455550100056,0.00959569485906653,-0.025453116933776,0.0121620069137648,0.488602972042775
NMR metabolomics,X23412.Phospholipids in VLDL,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,39575,-0.00339228445656441,0.00490108404869488,-0.0129984091920064,0.00621384027887756,0.488857888772346
NMR metabolomics,X23412.Phospholipids in VLDL,DKKL1,Dickkopf-like protein 1,42070,-0.00597690790441938,0.00863695519606729,-0.0229053400887113,0.0109515242798725,0.488939447816424
NMR metabolomics,X23412.Phospholipids in VLDL,ECSCR,Endothelial cell-specific chemotaxis regulator,39586,0.00355748079224014,0.00518039193437034,-0.00659608739912572,0.013711048983606,0.492273436845072
NMR metabolomics,X23412.Phospholipids in VLDL,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,39966,-0.00982754660434097,0.0143308398963363,-0.0379159928011602,0.0182608995924782,0.492877137642614
NMR metabolomics,X23412.Phospholipids in VLDL,GAD1,Glutamate decarboxylase 1,39560,0.00186929258462355,0.00272747727795998,-0.00347656288017802,0.00721514804942512,0.493133873938707
NMR metabolomics,X23412.Phospholipids in VLDL,PRC1,Protein regulator of cytokinesis 1,39919,0.00311990718265445,0.00455706926437622,-0.00581194857552294,0.0120517629408318,0.493591330918967
NMR metabolomics,X23412.Phospholipids in VLDL,GIPR,Gastric inhibitory polypeptide receptor,39657,0.00318798732613919,0.00467327620805876,-0.00597163404165599,0.0123476086939344,0.49514324948587
NMR metabolomics,X23412.Phospholipids in VLDL,HK2,Hexokinase-2,41900,0.00190456151722166,0.00281573549135058,-0.00361428004582547,0.00742340308026879,0.498798923399907
NMR metabolomics,X23412.Phospholipids in VLDL,NMI,N-myc-interactor,39875,0.00507366119848194,0.00753167390574274,-0.00968841965677384,0.0198357420537377,0.500551965541464
NMR metabolomics,X23412.Phospholipids in VLDL,KCNC4,Potassium voltage-gated channel subfamily C member 4,39586,0.00382009518726918,0.00569468013068807,-0.00734147786887944,0.0149816682434178,0.50235044144249
NMR metabolomics,X23412.Phospholipids in VLDL,NLGN1,Neuroligin-1,39649,0.00457643486910207,0.00694136645089848,-0.00902864337465896,0.0181815131128631,0.509717625647104
NMR metabolomics,X23412.Phospholipids in VLDL,FBN2,Fibrillin-2,39649,0.00404387744764435,0.00620808303418947,-0.008123965299367,0.0162117201946557,0.514808910443196
NMR metabolomics,X23412.Phospholipids in VLDL,PRL,Prolactin,42249,0.00490111202788581,0.00758496344371594,-0.00996541632179743,0.019767640377569,0.518185576486366
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,42296,0.00261967537281206,0.00409568192118373,-0.00540786119270806,0.0106472119383322,0.522431120778322
NMR metabolomics,X23412.Phospholipids in VLDL,LAMA1,Laminin subunit alpha-1,39575,-0.00341067820254803,0.00534671811084171,-0.0138902456997978,0.00706888929470172,0.523551268114183
NMR metabolomics,X23412.Phospholipids in VLDL,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,39586,-0.00405952560119932,0.00636633371410676,-0.0165375396808486,0.00841848847844993,0.523711463657274
NMR metabolomics,X23412.Phospholipids in VLDL,THRAP3,Thyroid hormone receptor-associated protein 3,39575,-0.0069603414705347,0.0109603490222385,-0.0284426255541222,0.0145219426130528,0.52541072087823
NMR metabolomics,X23412.Phospholipids in VLDL,CLINT1,Clathrin interactor 1,39560,0.00328040784939183,0.00517571764846832,-0.00686399874160607,0.0134248144403897,0.526219787237564
NMR metabolomics,X23412.Phospholipids in VLDL,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,39990,-0.00240736839407783,0.00381174329026809,-0.00987838524300329,0.00506364845484763,0.527683024295242
NMR metabolomics,X23412.Phospholipids in VLDL,SPINT1,Kunitz-type protease inhibitor 1,42081,0.00173779680746467,0.00275498924666453,-0.00366198211599781,0.00713757573092715,0.528193961936664
NMR metabolomics,X23412.Phospholipids in VLDL,PSMC3,26S proteasome regulatory subunit 6A,39560,-0.0019824026066139,0.00315385671246907,-0.00816396176305328,0.00419915654982548,0.529647256385477
NMR metabolomics,X23412.Phospholipids in VLDL,CDAN1,Codanin-1,39929,0.0014181528457625,0.00226037903682162,-0.00301219006640788,0.00584849575793289,0.530412310329913
NMR metabolomics,X23412.Phospholipids in VLDL,CLEC2L,C-type lectin domain family 2 member L,39649,-0.0033051366264681,0.00529145776246549,-0.0136763938409005,0.00706612058796427,0.532235089845027
NMR metabolomics,X23412.Phospholipids in VLDL,CDC123,Cell division cycle protein 123 homolog,39560,0.00404821974239706,0.0065010504556173,-0.00869383915061286,0.016790278635407,0.533493058713824
NMR metabolomics,X23412.Phospholipids in VLDL,IKZF2,Zinc finger protein Helios,41843,0.00566239325197795,0.00916498370936291,-0.0123009748183733,0.0236257613223293,0.536698650649082
NMR metabolomics,X23412.Phospholipids in VLDL,GLI2,Zinc finger protein GLI2,39657,-0.00211055327145143,0.0034345401356598,-0.00884225193734464,0.00462114539444178,0.538892162908502
NMR metabolomics,X23412.Phospholipids in VLDL,NCLN,Nicalin,41913,0.00323817228580923,0.00528281838348863,-0.00711615174582848,0.0135924963174469,0.539911265545156
NMR metabolomics,X23412.Phospholipids in VLDL,OMP,Olfactory marker protein,39586,-0.00299862197984703,0.0049611655603768,-0.0127225064781856,0.00672526251849151,0.545577688720979
NMR metabolomics,X23412.Phospholipids in VLDL,MSLN,Mesothelin,42048,0.00360183918002009,0.00599316054895286,-0.0081447554959275,0.0153484338559677,0.547855706641331
NMR metabolomics,X23412.Phospholipids in VLDL,JUN,Transcription factor AP-1,41913,0.0029909366416069,0.00498040886681852,-0.0067706647373574,0.0127525380205712,0.548156379851595
NMR metabolomics,X23412.Phospholipids in VLDL,IL18BP,Interleukin-18-binding protein,42217,0.00194257958613121,0.00323541894162577,-0.0043988415394553,0.00828400071171771,0.548242667098122
NMR metabolomics,X23412.Phospholipids in VLDL,ELAVL4,ELAV-like protein 4,39586,0.0050542169632078,0.00848176962390437,-0.0115700514996448,0.0216784854260604,0.551259788103324
NMR metabolomics,X23412.Phospholipids in VLDL,TFRC,Transferrin receptor protein 1,42200,0.00229756100226707,0.00386302084118047,-0.00527395984644666,0.00986908185098079,0.552015408214622
NMR metabolomics,X23412.Phospholipids in VLDL,IL2,Interleukin-2,41913,-0.00196208590661912,0.00329901051496327,-0.00842814651594712,0.00450397470270888,0.552020822945631
NMR metabolomics,X23412.Phospholipids in VLDL,LTBR,Tumor necrosis factor receptor superfamily member 3,42063,0.00182069772876782,0.0030619966937154,-0.00418081579091436,0.00782221124845001,0.552113340399877
NMR metabolomics,X23412.Phospholipids in VLDL,TMPRSS5,Transmembrane protease serine 5,41946,0.0023470730649032,0.00397702164273176,-0.00544788935485105,0.0101420354846575,0.555094394209353
NMR metabolomics,X23412.Phospholipids in VLDL,SHC1,SHC-transforming protein 1,39560,-0.00711456443102835,0.012116365587425,-0.0308626409823814,0.0166335121203247,0.557090657274685
NMR metabolomics,X23412.Phospholipids in VLDL,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,39586,-0.00344061245146357,0.00591272628488566,-0.0150295559698395,0.00814833106691232,0.560646319376713
NMR metabolomics,X23412.Phospholipids in VLDL,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,39586,0.00293112942201846,0.00505483981618622,-0.00697635661770652,0.0128386154617434,0.562016920001438
NMR metabolomics,X23412.Phospholipids in VLDL,AGR2,Anterior gradient protein 2 homolog,41740,-0.00598836063047882,0.0103381400507784,-0.0262511151300045,0.0142743938690469,0.562430883865286
NMR metabolomics,X23412.Phospholipids in VLDL,MET,Hepatocyte growth factor receptor,42158,0.00114267230485444,0.00197908673999768,-0.00273633770554101,0.00502168231524988,0.563696736208311
NMR metabolomics,X23412.Phospholipids in VLDL,IL25,Interleukin-25,39510,0.00205421793734931,0.00355802341258589,-0.00491950795131903,0.00902794382601766,0.563716263010053
NMR metabolomics,X23412.Phospholipids in VLDL,OPTC,Opticin,42070,-0.0026988411271365,0.00467998625890634,-0.0118716141945929,0.00647393194031992,0.564167208974407
NMR metabolomics,X23412.Phospholipids in VLDL,ATP5F1D,"ATP synthase subunit delta, mitochondrial",39575,0.00296097631574647,0.00513946610643875,-0.00711237725287349,0.0130343298843664,0.564542323515098
NMR metabolomics,X23412.Phospholipids in VLDL,RNF168,E3 ubiquitin-protein ligase RNF168,39657,0.00242702643871836,0.0042208263058237,-0.00584579312069609,0.0106998459981328,0.565294774816445
NMR metabolomics,X23412.Phospholipids in VLDL,TGM2,Protein-glutamine gamma-glutamyltransferase 2,42120,0.0043303800139098,0.00753673311504796,-0.0104416168915842,0.0191023769194038,0.565591771694308
NMR metabolomics,X23412.Phospholipids in VLDL,SPARCL1,SPARC-like protein 1,42169,-0.00161377006167549,0.00281907563380326,-0.00713915830392988,0.00391161818057891,0.567028985480619
NMR metabolomics,X23412.Phospholipids in VLDL,WNT9A,Protein Wnt-9a,41913,-0.00170940330857244,0.00300644248819497,-0.00760203058543459,0.00418322396828971,0.569650737358044
NMR metabolomics,X23412.Phospholipids in VLDL,KRT6C,"Keratin, type II cytoskeletal 6C",39575,-0.00224733595222859,0.00395307791418813,-0.00999536866403732,0.00550069675958015,0.569705221372042
NMR metabolomics,X23412.Phospholipids in VLDL,TSPAN15,Tetraspanin-15,39575,-0.00294280615521545,0.00520239521284322,-0.0131395007723882,0.00725388846195726,0.571633976239956
NMR metabolomics,X23412.Phospholipids in VLDL,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,39757,0.00368420098242859,0.00654924482627981,-0.00915231887707983,0.016520720841937,0.573760625841109
NMR metabolomics,X23412.Phospholipids in VLDL,INSL4,Early placenta insulin-like peptide,39919,-0.0027751928830097,0.00497363030228096,-0.0125235082754804,0.00697312250946098,0.576868164298262
NMR metabolomics,X23412.Phospholipids in VLDL,RBFOX3,RNA binding protein fox-1 homolog 3,39934,-0.00228935892811231,0.00411088382676884,-0.0103466912285792,0.00576797337235462,0.577605466812073
NMR metabolomics,X23412.Phospholipids in VLDL,TYMP,Thymidine phosphorylase,42070,0.00380243335514989,0.00685375845433597,-0.00963093321534862,0.0172357999256484,0.57904385639798
NMR metabolomics,X23412.Phospholipids in VLDL,OFD1,Oral-facial-digital syndrome 1 protein,39757,-0.00378895336480603,0.00684106327623001,-0.0171974373862169,0.00961953065660479,0.579689557411173
NMR metabolomics,X23412.Phospholipids in VLDL,ANKRA2,Ankyrin repeat family A protein 2,39560,-0.003146384115324,0.00570018251291385,-0.0143187418406352,0.00802597360998715,0.580973626478695
NMR metabolomics,X23412.Phospholipids in VLDL,UGDH,UDP-glucose 6-dehydrogenase,39575,0.00567790725781866,0.0103231510740953,-0.0145554688474081,0.0259112833630454,0.582318994454779
NMR metabolomics,X23412.Phospholipids in VLDL,PILRB,Paired immunoglobulin-like type 2 receptor beta,42145,0.00324326404967376,0.00594842335681861,-0.00841564572969072,0.0149021738290382,0.585603719250723
NMR metabolomics,X23412.Phospholipids in VLDL,CLGN,Calmegin,39649,0.00257038692485974,0.0047203112167089,-0.0066814230598897,0.0118221969096092,0.586082573220537
NMR metabolomics,X23412.Phospholipids in VLDL,CD164L2,CD164 sialomucin-like 2 protein,39649,-0.00205408226360801,0.00377836053686871,-0.00945966891587068,0.00535150438865466,0.586697584291096
NMR metabolomics,X23412.Phospholipids in VLDL,RRP15,RRP15-like protein,39586,0.00512788801440299,0.00943569258909641,-0.013366069460226,0.023621845489032,0.586826593608919
NMR metabolomics,X23412.Phospholipids in VLDL,VNN2,Vascular non-inflammatory molecule 2,42070,0.00263921474801927,0.0048767195466324,-0.00691915556338024,0.0121975850594188,0.588387996342532
NMR metabolomics,X23412.Phospholipids in VLDL,ATRAID,All-trans retinoic acid-induced differentiation factor,39930,-0.0016522183834096,0.0030671916613306,-0.00766391403961759,0.00435947727279839,0.590121953898953
NMR metabolomics,X23412.Phospholipids in VLDL,FGF20,Fibroblast growth factor 20,39657,-0.00240085486111082,0.00446597275715194,-0.0111541614651286,0.00635245174290697,0.590872103812455
NMR metabolomics,X23412.Phospholipids in VLDL,SPINK5,Serine protease inhibitor Kazal-type 5,42137,-0.00196138748701788,0.0036579778925336,-0.00913102415638373,0.00520824918234797,0.591832971091557
NMR metabolomics,X23412.Phospholipids in VLDL,CHIT1,Chitotriosidase-1,42207,-0.00865399962025555,0.0161443042010574,-0.0402968358543281,0.022988836613817,0.591939377039733
NMR metabolomics,X23412.Phospholipids in VLDL,BTN1A1,Butyrophilin subfamily 1 member A1,39894,0.00211783497431398,0.00395499106437486,-0.00563394751186076,0.00986961746048871,0.592325668148322
NMR metabolomics,X23412.Phospholipids in VLDL,IL3,Interleukin-3,39560,0.00339332280134,0.00634274002400617,-0.00903844764571209,0.0158250932483921,0.592665410971031
NMR metabolomics,X23412.Phospholipids in VLDL,DNAJA4,DnaJ homolog subfamily A member 4,39929,0.00381667688156157,0.00714446776453409,-0.0101864799369252,0.0178198337000484,0.593203755536921
NMR metabolomics,X23412.Phospholipids in VLDL,PALLD,Palladin,39657,0.00209711494338821,0.00394543274029972,-0.00563593322759924,0.00983016311437565,0.595062397453584
NMR metabolomics,X23412.Phospholipids in VLDL,PSMG4,Proteasome assembly chaperone 4,39657,-0.00306524960321455,0.00578955459385045,-0.0144127766071614,0.00828227740073233,0.596507553036937
NMR metabolomics,X23412.Phospholipids in VLDL,IL15RA,Interleukin-15 receptor subunit alpha,41913,0.00186886695721144,0.00358001630629587,-0.00514796500312848,0.00888569891755135,0.601659869777842
NMR metabolomics,X23412.Phospholipids in VLDL,MN1,Transcriptional activator MN1,39649,-0.00314190305298326,0.00608659965581368,-0.0150716383783781,0.00878783227241156,0.605725024634308
NMR metabolomics,X23412.Phospholipids in VLDL,NEFL,Neurofilament light polypeptide,41797,0.00250849393374612,0.00487547936283004,-0.00704744561740076,0.012064433484893,0.606902503012718
NMR metabolomics,X23412.Phospholipids in VLDL,REST,RE1-silencing transcription factor,39560,-0.00182226350958671,0.00354524891884297,-0.00877095139051894,0.00512642437134552,0.6072612558471
NMR metabolomics,X23412.Phospholipids in VLDL,TBR1,T-box brain protein 1,39649,0.00252496269868879,0.00495742193858654,-0.00719158430094083,0.0122415096983184,0.61053124846238
NMR metabolomics,X23412.Phospholipids in VLDL,OSCAR,Osteoclast-associated immunoglobulin-like receptor,42144,-0.00181963493699284,0.00358063038467715,-0.00883767049096006,0.00519840061697438,0.611329479835838
NMR metabolomics,X23412.Phospholipids in VLDL,TG,Thyroglobulin,39919,-0.00549388375289419,0.0108236952444642,-0.0267083264320441,0.0157205589262557,0.611758293838524
NMR metabolomics,X23412.Phospholipids in VLDL,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,39575,-0.00345993343727452,0.00682460380296743,-0.0168361568910907,0.00991629001654165,0.612179469115596
NMR metabolomics,X23412.Phospholipids in VLDL,ARG2,"Arginase-2, mitochondrial",39919,-0.00220565838001475,0.00435743300267482,-0.0107462270652574,0.00633491030522789,0.612738067177973
NMR metabolomics,X23412.Phospholipids in VLDL,CD58,Lymphocyte function-associated antigen 3,42100,0.000904422234851613,0.00179551735941986,-0.00261479178961131,0.00442363625931454,0.614472543780049
NMR metabolomics,X23412.Phospholipids in VLDL,MFAP3L,Microfibrillar-associated protein 3-like,39649,-0.00333758649608123,0.00665707331021171,-0.0163854501840962,0.00971027719193372,0.616128173490431
NMR metabolomics,X23412.Phospholipids in VLDL,CDH22,Cadherin-22,39757,0.00141965652138598,0.00285100344636068,-0.00416831023348095,0.00700762327625291,0.618529258206677
NMR metabolomics,X23412.Phospholipids in VLDL,FAM3D,Protein FAM3D,39930,-0.00448796497882897,0.00904974393653321,-0.0222254630944341,0.0132495331367761,0.619959229491437
NMR metabolomics,X23412.Phospholipids in VLDL,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,39930,0.00877871142375952,0.0177976028410017,-0.0261045901446039,0.0436620129921229,0.621843773107402
NMR metabolomics,X23412.Phospholipids in VLDL,NRN1,Neuritin,39934,0.00177287453855525,0.00359434918176313,-0.00527204985770049,0.00881779893481099,0.62185301660863
NMR metabolomics,X23412.Phospholipids in VLDL,PGA4,Pepsin A-4,39990,0.00380085149025295,0.00774957829114655,-0.0113883219603943,0.0189900249409002,0.623818485673076
NMR metabolomics,X23412.Phospholipids in VLDL,CBLN1,Cerebellin-1,39586,0.00468091394476413,0.0095866570979665,-0.0141089339672502,0.0234707618567785,0.625365628477969
NMR metabolomics,X23412.Phospholipids in VLDL,TPT1,Translationally-controlled tumor protein,41913,0.00320385139732128,0.00660916273305653,-0.00975010755946952,0.0161578103541121,0.627855254763641
NMR metabolomics,X23412.Phospholipids in VLDL,GHRHR,Growth hormone-releasing hormone receptor,41839,0.00267605094878636,0.00557384882552713,-0.00824869274924681,0.0136007946468195,0.631158336058841
NMR metabolomics,X23412.Phospholipids in VLDL,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,39934,-0.00119794749388653,0.00249636287561234,-0.00609081873008672,0.00369492374231365,0.631324012500758
NMR metabolomics,X23412.Phospholipids in VLDL,ITGB7,Integrin beta-7,42262,0.0022793803064287,0.0047555789769638,-0.00704155448842035,0.0116003151012777,0.631728211976168
NMR metabolomics,X23412.Phospholipids in VLDL,UPK3A,Uroplakin-3a,39586,0.00240124949184834,0.00501227880722244,-0.00742281697030764,0.0122253159540043,0.631895941647508
NMR metabolomics,X23412.Phospholipids in VLDL,TPBGL,Trophoblast glycoprotein-like,39649,-0.00199315385040024,0.00419986735857114,-0.0102248938731997,0.00623858617239919,0.635099002728796
NMR metabolomics,X23412.Phospholipids in VLDL,EFNB2,Ephrin-B2,39649,-0.00277764610409866,0.00597802561029792,-0.0144945763002826,0.00893928409208525,0.642196486790128
NMR metabolomics,X23412.Phospholipids in VLDL,ZP3,Zona pellucida sperm-binding protein 3,39638,-0.0126432221035453,0.0275812859930324,-0.0667025426498888,0.0414160984427983,0.646675142307618
NMR metabolomics,X23412.Phospholipids in VLDL,VTCN1,V-set domain-containing T-cell activation inhibitor 1,41843,-0.00149742221020214,0.00327879934313018,-0.0079238689227373,0.00492902450233302,0.647895376022532
NMR metabolomics,X23412.Phospholipids in VLDL,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,39575,-0.0017190768873877,0.00376994536987465,-0.00910816981234201,0.0056700160375666,0.64840247238089
NMR metabolomics,X23412.Phospholipids in VLDL,IL21R,Interleukin-21 receptor,39657,-0.00255047215361926,0.00560246875859832,-0.013531310920472,0.00843036661323346,0.648944976012373
NMR metabolomics,X23412.Phospholipids in VLDL,COL4A4,Collagen alpha-4(IV) chain,39743,-0.00251356465686858,0.00554306172956226,-0.0133779656468106,0.00835083633307345,0.650225346377909
NMR metabolomics,X23412.Phospholipids in VLDL,EPB41L5,Band 4.1-like protein 5,39649,0.00283774614429784,0.00642620524471608,-0.00975761613534568,0.0154331084239414,0.658794769297116
NMR metabolomics,X23412.Phospholipids in VLDL,SAT1,Diamine acetyltransferase 1,39575,-0.0022093321785339,0.00500382944464323,-0.0120168378900346,0.00759817353296682,0.65883929561603
NMR metabolomics,X23412.Phospholipids in VLDL,CTSB,Cathepsin B,42153,0.00230500263696828,0.0052326050596012,-0.00795090327985006,0.0125609085537866,0.659576487461332
NMR metabolomics,X23412.Phospholipids in VLDL,S100G,Protein S100-G,39934,-0.00221546183709263,0.0050560551033622,-0.0121253298396826,0.00769440616549729,0.661264211937688
NMR metabolomics,X23412.Phospholipids in VLDL,CINP,Cyclin-dependent kinase 2-interacting protein,39757,0.00191133166662091,0.00436251718240153,-0.0066392020108861,0.0104618653441279,0.661303519026506
NMR metabolomics,X23412.Phospholipids in VLDL,REG4,Regenerating islet-derived protein 4,42144,0.00229661271112796,0.00525601854569429,-0.00800518363843286,0.0125984090606888,0.662155209287733
NMR metabolomics,X23412.Phospholipids in VLDL,TGOLN2,Trans-Golgi network integral membrane protein 2,39990,0.00118509285467524,0.002728695512158,-0.00416315034915444,0.00653333605850492,0.664073404144488
NMR metabolomics,X23412.Phospholipids in VLDL,IFNL2,Interferon lambda-2,39586,-0.00262887505162044,0.00605656093076805,-0.0144997344759258,0.00924198437268494,0.66425768567259
NMR metabolomics,X23412.Phospholipids in VLDL,CNGB3,Cyclic nucleotide-gated cation channel beta-3,39586,-0.00241640165071604,0.00556955445394336,-0.013332728380445,0.00849992507901295,0.664399311410928
NMR metabolomics,X23412.Phospholipids in VLDL,LYPD1,Ly6/PLAUR domain-containing protein 1,41839,0.00264307577560006,0.00622400604045714,-0.00955597606369594,0.0148421276148961,0.671092693175249
NMR metabolomics,X23412.Phospholipids in VLDL,SPINK8,Serine protease inhibitor Kazal-type 8,39575,-0.00156952273284766,0.00369918199586852,-0.00881991944474995,0.00568087397905463,0.671363277603552
NMR metabolomics,X23412.Phospholipids in VLDL,NOP56,Nucleolar protein 56,39575,0.00488442682092175,0.0115880232443651,-0.0178280987380339,0.0275969523798774,0.673393539592387
NMR metabolomics,X23412.Phospholipids in VLDL,VSIG2,V-set and immunoglobulin domain-containing protein 2,39919,-0.00268034269520902,0.00641039102885089,-0.0152447091117568,0.00988402372133873,0.675863893625271
NMR metabolomics,X23412.Phospholipids in VLDL,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,42129,0.0013847805835482,0.00337357477618811,-0.0052274259777805,0.00799698714487691,0.681461326704113
NMR metabolomics,X23412.Phospholipids in VLDL,DEFB116,Beta-defensin 116,39586,0.00318419976419998,0.00776851255679383,-0.0120420848471159,0.0184104843755159,0.681898018592811
NMR metabolomics,X23412.Phospholipids in VLDL,ARID3A,AT-rich interactive domain-containing protein 3A,39586,0.00170541993571016,0.004167865630459,-0.00646359669998948,0.0098744365714098,0.682413315324437
NMR metabolomics,X23412.Phospholipids in VLDL,MRPL28,"39S ribosomal protein L28, mitochondrial",39934,-0.00150926267003435,0.00374495955195574,-0.00884938339186759,0.0058308580517989,0.686947188563111
NMR metabolomics,X23412.Phospholipids in VLDL,BRD2,Bromodomain-containing protein 2,39586,0.00145743611295692,0.00362469195226252,-0.00564696011347761,0.00856183233939146,0.687628918362393
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,42016,-0.00139420177266837,0.00349471399293698,-0.00824384119882485,0.00545543765348812,0.689939426875916
NMR metabolomics,X23412.Phospholipids in VLDL,HDAC9,Histone deacetylase 9,39586,0.00274542581935849,0.00690330180846544,-0.0107850457252338,0.0162758973639508,0.690860913015471
NMR metabolomics,X23412.Phospholipids in VLDL,SPRING1,SREBP regulating gene protein,39560,0.00254590697773896,0.00642916647742851,-0.0100552593180209,0.0151470732734988,0.692117664591804
NMR metabolomics,X23412.Phospholipids in VLDL,PHLDB2,Pleckstrin homology-like domain family B member 2,39560,0.00371565862229478,0.0094794067999071,-0.0148639787055231,0.0222952959501127,0.695086790305869
NMR metabolomics,X23412.Phospholipids in VLDL,TP73,Tumor protein p73,39649,0.00138549278612675,0.00354122462893457,-0.00555530748658501,0.00832629305883852,0.695622366406927
NMR metabolomics,X23412.Phospholipids in VLDL,CBX2,Chromobox protein homolog 2,39575,-0.00159222822551957,0.00408336845796999,-0.00959563040314075,0.00641117395210161,0.69659581058847
NMR metabolomics,X23412.Phospholipids in VLDL,BTLA,B- and T-lymphocyte attenuator,39560,0.00344629607463632,0.00887430243292575,-0.0139473366938981,0.0208399288431708,0.697767858011001
NMR metabolomics,X23412.Phospholipids in VLDL,KLK12,Kallikrein-12,41843,0.00529948903889629,0.0137548277196554,-0.0216599732916283,0.0322589513694209,0.700034602870208
NMR metabolomics,X23412.Phospholipids in VLDL,MSLNL,Mesothelin-like protein,39649,0.001487338548504,0.00391851165546344,-0.00619294429620435,0.00916762139321235,0.704273997366048
NMR metabolomics,X23412.Phospholipids in VLDL,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,42179,-0.00225711305306767,0.00596935154950815,-0.0139570420901036,0.00944281598396831,0.705349621234292
NMR metabolomics,X23412.Phospholipids in VLDL,IFNL1,Interferon lambda-1,41839,0.00175535026726798,0.00468586485687197,-0.00742894485220107,0.010939645386737,0.707959958288902
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,42284,0.00145230380760596,0.00395366928045035,-0.00629688798207673,0.00920149559728864,0.713378093486332
NMR metabolomics,X23412.Phospholipids in VLDL,CRYBB2,Beta-crystallin B2,39929,0.00259074136175037,0.00723146776684004,-0.0115829354612561,0.0167644181847569,0.720155867397128
NMR metabolomics,X23412.Phospholipids in VLDL,IL13,Interleukin-13,41913,-0.00179044286371635,0.00501325057618188,-0.0116164139930328,0.00803552826560013,0.720991085760941
NMR metabolomics,X23412.Phospholipids in VLDL,THSD1,Thrombospondin type-1 domain-containing protein 1,39585,0.00127222839771671,0.00357418559008917,-0.00573317535885806,0.00827763215429147,0.721885466326484
NMR metabolomics,X23412.Phospholipids in VLDL,RASA1,Ras GTPase-activating protein 1,41839,0.00117829568889224,0.00335999042825016,-0.00540728555047807,0.00776387692826255,0.725830830060535
NMR metabolomics,X23412.Phospholipids in VLDL,HBZ,Hemoglobin subunit zeta,39958,-0.00389024134696284,0.0111006100712996,-0.02564743708671,0.0178669543927843,0.726005306783611
NMR metabolomics,X23412.Phospholipids in VLDL,FCAR,Immunoglobulin alpha Fc receptor,42119,0.00175786035888325,0.00502075561156279,-0.00808282063977982,0.0115985413575463,0.726255082123922
NMR metabolomics,X23412.Phospholipids in VLDL,CLEC6A,C-type lectin domain family 6 member A,41843,0.0017104599928358,0.00488623304831913,-0.0078665567818697,0.0112874767675413,0.726301501391239
NMR metabolomics,X23412.Phospholipids in VLDL,CASP4,Caspase-4,39757,0.00593156746399355,0.0171659550068967,-0.0277137043495239,0.039576839277511,0.72969305974163
NMR metabolomics,X23412.Phospholipids in VLDL,RPGR,X-linked retinitis pigmentosa GTPase regulator,39649,0.0014089093239997,0.00418046385573073,-0.00678479983323253,0.00960261848123193,0.736106530477331
NMR metabolomics,X23412.Phospholipids in VLDL,CRX,Cone-rod homeobox protein,41900,0.00372876854431806,0.0110929154515573,-0.0180133457407342,0.0254708828293704,0.736770874325213
NMR metabolomics,X23412.Phospholipids in VLDL,IL2RG,Cytokine receptor common subunit gamma,39919,0.00122712819563092,0.00367596471547158,-0.00597776264669338,0.00843201903795523,0.73851795026028
NMR metabolomics,X23412.Phospholipids in VLDL,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",39575,0.00173917708619503,0.00522587568685136,-0.00850353926003363,0.0119818934324237,0.739290797547722
NMR metabolomics,X23412.Phospholipids in VLDL,FZD10,Frizzled-10,39649,0.0020483678944342,0.00616401750736045,-0.0100331064199923,0.0141298422088607,0.739661097080344
NMR metabolomics,X23412.Phospholipids in VLDL,RLN1,Prorelaxin H1,39934,0.00150881901569651,0.00458049938823163,-0.00746895978523748,0.0104865978166305,0.741859039308003
NMR metabolomics,X23412.Phospholipids in VLDL,BHLHE40,Class E basic helix-loop-helix protein 40,39586,-0.00240176865468314,0.00733610794323168,-0.0167805402234172,0.0119770029140509,0.743379138587531
NMR metabolomics,X23412.Phospholipids in VLDL,TMED1,Transmembrane emp24 domain-containing protein 1,39757,0.00180614184718395,0.00556173383974468,-0.00909485647871562,0.0127071401730835,0.745380626200358
NMR metabolomics,X23412.Phospholipids in VLDL,SKIV2L,Helicase SKI2W,39575,-0.00132897537734461,0.00409389382202546,-0.0093530072685145,0.00669505651382528,0.74547199767571
NMR metabolomics,X23412.Phospholipids in VLDL,CEP350,Centrosome-associated protein 350,39560,0.00122273573138923,0.00378591425495246,-0.00619765620831758,0.00864312767109604,0.746724322442314
NMR metabolomics,X23412.Phospholipids in VLDL,PAEP,Glycodelin,42016,-0.00346404494885615,0.010798015237575,-0.0246281548145031,0.0177000649167908,0.748364032151468
NMR metabolomics,X23412.Phospholipids in VLDL,MYOC,Myocilin,42137,-0.00147288618320029,0.00461160852222313,-0.0105116388867576,0.00756586652035705,0.749438263553523
NMR metabolomics,X23412.Phospholipids in VLDL,LSM8,U6 snRNA-associated Sm-like protein LSm8,39757,-0.00263736018017634,0.00828075612229305,-0.0188676421798707,0.013592921819518,0.750117210595474
NMR metabolomics,X23412.Phospholipids in VLDL,RUVBL1,RuvB-like 1,41843,0.00324975097198193,0.0102041707484415,-0.0167504236949634,0.0232499256389272,0.750131335500728
NMR metabolomics,X23412.Phospholipids in VLDL,TXK,Tyrosine-protein kinase TXK,39757,-0.00240662365227863,0.00757346647615838,-0.0172506179455491,0.0124373706409918,0.750665033981362
NMR metabolomics,X23412.Phospholipids in VLDL,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,39575,0.00158838862756957,0.00500397209226248,-0.0082193966732649,0.011396173928404,0.750926756062274
NMR metabolomics,X23412.Phospholipids in VLDL,DAND5,DAN domain family member 5,39657,0.00179042915840813,0.00565900336455215,-0.00930121743611409,0.0128820757529304,0.751715551987052
NMR metabolomics,X23412.Phospholipids in VLDL,HMMR,Hyaluronan mediated motility receptor,39541,0.00157114192039398,0.00500729620623802,-0.00824315864383253,0.0113854424846205,0.75370132001454
NMR metabolomics,X23412.Phospholipids in VLDL,ATP2B4,Plasma membrane calcium-transporting ATPase 4,39575,0.00203749158136484,0.00650258162469099,-0.0107075684030295,0.0147825515657592,0.754031512391214
NMR metabolomics,X23412.Phospholipids in VLDL,IL9,Interleukin-9,39757,-0.00180133643656617,0.00580755028405386,-0.0131841349933117,0.00958146212017941,0.756436354709263
NMR metabolomics,X23412.Phospholipids in VLDL,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,42249,0.000886530710948655,0.00288053564950885,-0.00475931916208869,0.006532380583986,0.758265149828699
NMR metabolomics,X23412.Phospholipids in VLDL,COMMD9,COMM domain-containing protein 9,39919,0.00126745846086773,0.00411886804160435,-0.00680552290067679,0.00934043982241224,0.75830099016441
NMR metabolomics,X23412.Phospholipids in VLDL,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,39575,0.000833371057847712,0.00271944717072023,-0.00449674539676393,0.00616348751245935,0.759268844559014
NMR metabolomics,X23412.Phospholipids in VLDL,MMP15,Matrix metalloproteinase-15,39958,0.00151950327699787,0.00502796392458438,-0.00833530601518752,0.0113743125691833,0.762497166540032
NMR metabolomics,X23412.Phospholipids in VLDL,IL11,Interleukin-11,41913,0.00189192367770011,0.0062846438238758,-0.0104259782170965,0.0142098255724967,0.763389361378422
NMR metabolomics,X23412.Phospholipids in VLDL,CADPS,Calcium-dependent secretion activator 1,39649,0.00125014555795292,0.00421551965155101,-0.00701227295908705,0.0095125640749929,0.766809648196259
NMR metabolomics,X23412.Phospholipids in VLDL,RNASE6,Ribonuclease K6,39937,0.000982054687500672,0.00333642599121411,-0.00555734025527897,0.00752144963028032,0.768500965931477
NMR metabolomics,X23412.Phospholipids in VLDL,SUSD5,Sushi domain-containing protein 5,39695,-0.00102631945885278,0.00356580890171054,-0.00801530490620544,0.00596266598849988,0.773488112360734
NMR metabolomics,X23412.Phospholipids in VLDL,CGN,Cingulin,39649,-0.00111199813623544,0.00386773888207914,-0.00869276634511055,0.00646877007263967,0.77373030010838
NMR metabolomics,X23412.Phospholipids in VLDL,TPSD1,Tryptase delta,39934,-0.00104710765353114,0.00377939992957925,-0.00845473151550646,0.00636051620844419,0.781741706841763
NMR metabolomics,X23412.Phospholipids in VLDL,ZNF830,Zinc finger protein 830,39919,-0.00221457391136558,0.00801967987569359,-0.017933146467725,0.0135039986449939,0.782443712007413
NMR metabolomics,X23412.Phospholipids in VLDL,SLC1A4,Neutral amino acid transporter A,39649,0.00144782416315902,0.00524999954980133,-0.00884217495445159,0.0117378232807696,0.782725233701024
NMR metabolomics,X23412.Phospholipids in VLDL,SCG3,Secretogranin-3,42144,-0.000917356840474815,0.0034305996581689,-0.00764133217048586,0.00580661848953623,0.789162018900514
NMR metabolomics,X23412.Phospholipids in VLDL,CD3G,T-cell surface glycoprotein CD3 gamma chain,39657,0.002412681769006,0.00904145325313833,-0.0153085666071451,0.0201339301451571,0.789592189047776
NMR metabolomics,X23412.Phospholipids in VLDL,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,39934,-0.00323368852770254,0.0121860684446043,-0.0271183826791269,0.0206510056237218,0.790737390120145
NMR metabolomics,X23412.Phospholipids in VLDL,RNF4,E3 ubiquitin-protein ligase RNF4,39757,-0.00176994682285579,0.00675555840363729,-0.0150108412939849,0.0114709476482733,0.793327360697651
NMR metabolomics,X23412.Phospholipids in VLDL,CNTNAP4,Contactin-associated protein-like 4,39649,-0.00283091883206836,0.0109061587667417,-0.024206990014882,0.0185451523507453,0.795199806553155
NMR metabolomics,X23412.Phospholipids in VLDL,CD48,CD48 antigen,42166,-0.000818572000676392,0.00316816124816225,-0.00702816804707441,0.00539102404572163,0.79612183322084
NMR metabolomics,X23412.Phospholipids in VLDL,SEPTIN7,Septin-7,39757,-0.0014155647412941,0.00550307233835927,-0.0122015865244783,0.00937045704189006,0.797004645275773
NMR metabolomics,X23412.Phospholipids in VLDL,VWA5A,von Willebrand factor A domain-containing protein 5A,39560,-0.00202043790076827,0.00799121890553082,-0.0176832269556087,0.0136423511540721,0.800402582558915
NMR metabolomics,X23412.Phospholipids in VLDL,CNTNAP2,Contactin-associated protein-like 2,42119,-0.00111451676231997,0.00442398636285446,-0.00978553003351471,0.00755649650887477,0.801102166486766
NMR metabolomics,X23412.Phospholipids in VLDL,ZPR1,Zinc finger protein ZPR1,39586,0.00250096768419462,0.00997088994575445,-0.0170419766094841,0.0220439119778733,0.801952613010186
NMR metabolomics,X23412.Phospholipids in VLDL,SPINT3,Kunitz-type protease inhibitor 3,39930,-0.004244052582405,0.0171732215832144,-0.0379035668855052,0.0294154617206952,0.804810547582479
NMR metabolomics,X23412.Phospholipids in VLDL,BRME1,Break repair meiotic recombinase recruitment factor 1,39586,0.00105637256499616,0.00427887256716956,-0.00733021766665618,0.00944296279664849,0.805004893053341
NMR metabolomics,X23412.Phospholipids in VLDL,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,39757,0.00121770612773352,0.00496293192883927,-0.00850964045279146,0.0109450527082585,0.806182031343163
NMR metabolomics,X23412.Phospholipids in VLDL,TET2,Methylcytosine dioxygenase TET2,39750,-0.00254766009630034,0.0103904111777124,-0.0229128660046167,0.017817545812016,0.8063112099058
NMR metabolomics,X23412.Phospholipids in VLDL,SLK,STE20-like serine/threonine-protein kinase,39757,0.00196260765313206,0.00816939996799904,-0.0140494162841461,0.0179746315904102,0.8101494732766
NMR metabolomics,X23412.Phospholipids in VLDL,SAP18,Histone deacetylase complex subunit SAP18,39757,-0.00178553875920324,0.00747627800034415,-0.0164390436398778,0.0128679661214713,0.81124394177249
NMR metabolomics,X23412.Phospholipids in VLDL,ITGAX,Integrin alpha-X,39757,0.00124956043541446,0.00534140747752071,-0.00921959822052613,0.011718719091355,0.815037076669177
NMR metabolomics,X23412.Phospholipids in VLDL,SPRR1B,Cornifin-B,39757,-0.00208526721209561,0.00893609144472535,-0.0196000064437573,0.0154294720195661,0.81549128620687
NMR metabolomics,X23412.Phospholipids in VLDL,PKLR,Pyruvate kinase PKLR,42143,-0.00148289550463298,0.00642219469268034,-0.0140703971022865,0.0111046060930205,0.817394678233168
NMR metabolomics,X23412.Phospholipids in VLDL,GAGE2A,G antigen 2A,39560,-0.00153911169728856,0.00676889687898581,-0.0148061495801007,0.0117279261855236,0.820132520467966
NMR metabolomics,X23412.Phospholipids in VLDL,TAP1,Antigen peptide transporter 1,39757,0.00136889913363152,0.00603408128507707,-0.0104579001851195,0.0131956984523826,0.820535802296865
NMR metabolomics,X23412.Phospholipids in VLDL,ARHGAP30,Rho GTPase-activating protein 30,39757,-0.000942007893159454,0.00416010586217732,-0.00909581538302701,0.0072117995967081,0.820864579485247
NMR metabolomics,X23412.Phospholipids in VLDL,NGFR,Tumor necrosis factor receptor superfamily member 16,39958,-0.000701507056112124,0.00311151802373582,-0.00680008238263433,0.00539706827041008,0.821629445235488
NMR metabolomics,X23412.Phospholipids in VLDL,NENF,Neudesin,39919,0.00261720177008963,0.0116138972317915,-0.0201460368042216,0.0253804403444009,0.821710402007285
NMR metabolomics,X23412.Phospholipids in VLDL,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,42162,-0.00150387398640352,0.00678442546735418,-0.0148013479024177,0.0117935999296107,0.824577520510177
NMR metabolomics,X23412.Phospholipids in VLDL,CYTH3,Cytohesin-3,39560,0.00167083052379061,0.00757043867157769,-0.0131672292725017,0.0165088903200829,0.825326572396225
NMR metabolomics,X23412.Phospholipids in VLDL,CYB5A,Cytochrome b5,39560,0.00162122790684143,0.00737287641960964,-0.0128296098755935,0.0160720656892763,0.825960274282472
NMR metabolomics,X23412.Phospholipids in VLDL,PRAME,Melanoma antigen preferentially expressed in tumors,39560,-0.000575758015563611,0.00263172879853417,-0.00573394646069059,0.00458243042956336,0.826828937681531
NMR metabolomics,X23412.Phospholipids in VLDL,LHB,Lutropin subunit beta,41843,0.00199412713575447,0.00912245900053079,-0.0158858925052859,0.0198741467767948,0.826968642277584
NMR metabolomics,X23412.Phospholipids in VLDL,MYL6B,Myosin light chain 6B,39649,0.00204786306688926,0.00942976120147874,-0.0164344688880091,0.0205301950217876,0.828079722147034
NMR metabolomics,X23412.Phospholipids in VLDL,FSTL3,Follistatin-related protein 3,42084,0.000727262168815268,0.00337342839881455,-0.00588465749286126,0.00733918183049179,0.829314138393186
NMR metabolomics,X23412.Phospholipids in VLDL,DPP6,Dipeptidyl aminopeptidase-like protein 6,42070,-0.000738282780615963,0.00353038603823727,-0.00765783941556101,0.00618127385432908,0.834355855461849
NMR metabolomics,X23412.Phospholipids in VLDL,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,39586,-0.000699580546105172,0.00335484038329075,-0.00727506769735504,0.0058759066051447,0.834820031798708
NMR metabolomics,X23412.Phospholipids in VLDL,SHD,SH2 domain-containing adapter protein D,39554,0.00177308299635566,0.00853287829253591,-0.0149513584570147,0.018497524449726,0.835393489867802
NMR metabolomics,X23412.Phospholipids in VLDL,SLAMF8,SLAM family member 8,41843,-0.00114795359226654,0.005553682418207,-0.0120331711319523,0.00973726394741918,0.836246289396599
NMR metabolomics,X23412.Phospholipids in VLDL,ANK2,Ankyrin-2,39575,-0.00148552689888247,0.00723077285282297,-0.0156578416904155,0.0126867878926506,0.83722819215593
NMR metabolomics,X23412.Phospholipids in VLDL,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,42119,-0.00311017372666116,0.0154617164017365,-0.0334151378740647,0.0271947904207424,0.840581810912106
NMR metabolomics,X23412.Phospholipids in VLDL,WFDC12,WAP four-disulfide core domain protein 12,42223,-0.00131641380753207,0.00656827308618366,-0.014190229056452,0.0115574014413879,0.841155049428862
NMR metabolomics,X23412.Phospholipids in VLDL,GSTM4,Glutathione S-transferase Mu 4,39575,-0.00152642352298344,0.00773014692155123,-0.0166775114892239,0.013624664443257,0.843468330998566
NMR metabolomics,X23412.Phospholipids in VLDL,FAM171A2,Protein FAM171A2,39934,0.00315645687327423,0.016142793821199,-0.0284834190162758,0.0347963327628243,0.844978824687405
NMR metabolomics,X23412.Phospholipids in VLDL,IL33,Interleukin-33,41913,0.00074660175950329,0.00406926559656077,-0.00722915880975581,0.00872236232876239,0.854429427628931
NMR metabolomics,X23412.Phospholipids in VLDL,NCR1,Natural cytotoxicity triggering receptor 1,42095,-0.000706239826870111,0.00395373112225079,-0.00845555282648167,0.00704307317274144,0.85823392978521
NMR metabolomics,X23412.Phospholipids in VLDL,IL17F,Interleukin-17F,41913,-0.00133407629045553,0.00757091138778928,-0.0161730626105225,0.0135049100296115,0.860131023015845
NMR metabolomics,X23412.Phospholipids in VLDL,GAL,Galanin peptides,42185,0.00118731017453643,0.00686343631301377,-0.0122650249989706,0.0146396453480434,0.862661369634465
NMR metabolomics,X23412.Phospholipids in VLDL,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,42016,-0.00109539600931124,0.00634295130289911,-0.0135275805629935,0.011336788544371,0.862893775014037
NMR metabolomics,X23412.Phospholipids in VLDL,TCN1,Transcobalamin-1,39806,-0.000631124868534917,0.00368647789573068,-0.00785662154416704,0.00659437180709721,0.864069629969369
NMR metabolomics,X23412.Phospholipids in VLDL,CSH1,Chorionic somatomammotropin hormone 1,39990,-0.000501521675299313,0.00294733613076352,-0.00627830049159582,0.00527525714099719,0.864886540851504
NMR metabolomics,X23412.Phospholipids in VLDL,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,39930,0.000376792152478351,0.00222389594028351,-0.00398204389047733,0.00473562819543403,0.865462349915308
NMR metabolomics,X23412.Phospholipids in VLDL,DCDC2C,Doublecortin domain-containing protein 2C,39560,0.00109571417078358,0.00657664802264095,-0.0117945159535927,0.0139859442951598,0.867682529551545
NMR metabolomics,X23412.Phospholipids in VLDL,SMPD3,Sphingomyelin phosphodiesterase 3,39657,-0.000975461717197513,0.00590861563062873,-0.0125563483532298,0.0106054249188348,0.868875047879517
NMR metabolomics,X23412.Phospholipids in VLDL,TPRKB,EKC/KEOPS complex subunit TPRKB,39560,-0.0011645174552042,0.00706837055748736,-0.0150185237478794,0.012689488837471,0.86914341935644
NMR metabolomics,X23412.Phospholipids in VLDL,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,39757,-0.00115423266390877,0.00705870982127579,-0.0149893039136093,0.0126808385857918,0.87011283299119
NMR metabolomics,X23412.Phospholipids in VLDL,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,39919,0.00123727697718442,0.00781119290679722,-0.0140726611201381,0.016547215074507,0.874146051380368
NMR metabolomics,X23412.Phospholipids in VLDL,TMED10,Transmembrane emp24 domain-containing protein 10,39575,0.00075736602941193,0.00482240868754591,-0.00869455499817805,0.0102092870570019,0.875207229314744
NMR metabolomics,X23412.Phospholipids in VLDL,TMED4,Transmembrane emp24 domain-containing protein 4,39575,-0.000898585920429958,0.00573104814886967,-0.0121314402922145,0.0103342684513546,0.875411191818014
NMR metabolomics,X23412.Phospholipids in VLDL,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,39575,0.00109634397436717,0.00705858073256462,-0.0127384742614595,0.0149311622101938,0.876571323173578
NMR metabolomics,X23412.Phospholipids in VLDL,WIF1,Wnt inhibitory factor 1,42262,-0.00053423107185689,0.00346916751891093,-0.00733379940892232,0.00626533726520854,0.877616720792052
NMR metabolomics,X23412.Phospholipids in VLDL,GAMT,Guanidinoacetate N-methyltransferase,39575,-0.000562007069660525,0.0036598394129934,-0.00773529231912759,0.00661127817980654,0.877959042616776
NMR metabolomics,X23412.Phospholipids in VLDL,KRT17,"Keratin, type I cytoskeletal 17",39575,0.000599625797571541,0.00417667102694689,-0.00758664941524437,0.00878590101038745,0.885846233759613
NMR metabolomics,X23412.Phospholipids in VLDL,SCIN,Adseverin,39586,-0.00109434437444481,0.00763490139110273,-0.0160587511010062,0.0138700623521165,0.886028680135613
NMR metabolomics,X23412.Phospholipids in VLDL,LMOD2,Leiomodin-2,39586,0.000905802644509278,0.00636236091106765,-0.0115644247411833,0.0133760300302019,0.886791197325734
NMR metabolomics,X23412.Phospholipids in VLDL,ZCCHC8,Zinc finger CCHC domain-containing protein 8,39575,0.000864652600487192,0.00612264097356358,-0.0111357237076974,0.0128650289086718,0.887697030035838
NMR metabolomics,X23412.Phospholipids in VLDL,WFDC2,WAP four-disulfide core domain protein 2,41430,-0.000604657014846038,0.00433658349860287,-0.00910436067210767,0.00789504664241559,0.889111248008208
NMR metabolomics,X23412.Phospholipids in VLDL,CDC25A,M-phase inducer phosphatase 1,39560,-0.000573087966985688,0.00414855173636415,-0.00870424937025942,0.00755807343628805,0.890130971906943
NMR metabolomics,X23412.Phospholipids in VLDL,MAGEA3,Melanoma-associated antigen 3,39757,0.00117373550898642,0.00891214674890968,-0.0162940721188766,0.0186415431368494,0.895223447072568
NMR metabolomics,X23412.Phospholipids in VLDL,DDX4,Probable ATP-dependent RNA helicase DDX4,39657,0.000738007810355465,0.00560617072014163,-0.0102500868011221,0.0117261024218331,0.895269818407245
NMR metabolomics,X23412.Phospholipids in VLDL,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,39336,-0.000702141424357969,0.00533382970155652,-0.0111564476394088,0.00975216479069282,0.895272093067178
NMR metabolomics,X23412.Phospholipids in VLDL,RANGAP1,Ran GTPase-activating protein 1,41843,0.000647289301215532,0.00496491936803441,-0.00908395266013191,0.010378531262563,0.896273646959394
NMR metabolomics,X23412.Phospholipids in VLDL,IL22,Interleukin-22,39919,0.000936527774979092,0.00727484647895174,-0.0133221713237663,0.0151952268737245,0.897569582055763
NMR metabolomics,X23412.Phospholipids in VLDL,GNPDA1,Glucosamine-6-phosphate isomerase 1,39638,-0.000444346799221155,0.00348964248468755,-0.00728404606920876,0.00639535247076645,0.898679127495063
NMR metabolomics,X23412.Phospholipids in VLDL,TCP11,T-complex protein 11 homolog,39757,0.000736633101496588,0.00598202272573924,-0.0109881314409523,0.0124613976439455,0.90199755175688
NMR metabolomics,X23412.Phospholipids in VLDL,DNLZ,DNL-type zinc finger protein,39586,0.00103034155143945,0.00873960179572972,-0.0160992779681908,0.0181599610710697,0.906154261666611
NMR metabolomics,X23412.Phospholipids in VLDL,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,42145,-0.000386820285590087,0.00332154867516362,-0.00689705568891078,0.00612341511773061,0.907291447526045
NMR metabolomics,X23412.Phospholipids in VLDL,MEGF11,Multiple epidermal growth factor-like domains protein 11,39575,0.000386378530504814,0.00339317953068663,-0.00626425334964098,0.00703701041065061,0.90934358966181
NMR metabolomics,X23412.Phospholipids in VLDL,FGF12,Fibroblast growth factor 12,39657,0.000531228261936488,0.00469129727226363,-0.00866371439170023,0.0097261709155732,0.909844746587327
NMR metabolomics,X23412.Phospholipids in VLDL,MORC3,MORC family CW-type zinc finger protein 3,39929,0.000325344871743271,0.00290275278603375,-0.00536405058888287,0.00601474033236941,0.910760775541647
NMR metabolomics,X23412.Phospholipids in VLDL,SCN3B,Sodium channel subunit beta-3,39586,0.000521706899001673,0.00482035578726775,-0.00892619044404311,0.00996960424204645,0.913815258869664
NMR metabolomics,X23412.Phospholipids in VLDL,CNTF,Ciliary neurotrophic factor,39586,-0.000368037095538023,0.00357527264344096,-0.0073755714766823,0.00663949728560625,0.918012796172626
NMR metabolomics,X23412.Phospholipids in VLDL,DTX2,Probable E3 ubiquitin-protein ligase DTX2,39649,-0.000632675306511436,0.00615900015916641,-0.0127043156184776,0.0114389650054547,0.91818412463887
NMR metabolomics,X23412.Phospholipids in VLDL,PXDNL,Peroxidasin-like protein,39919,-0.000605535065481881,0.00591235046479566,-0.0121937419764814,0.0109826718455176,0.918426180107099
NMR metabolomics,X23412.Phospholipids in VLDL,UBQLN3,Ubiquilin-3,39575,-0.000589125109190185,0.00581725238735403,-0.0119909397884041,0.0108126895700237,0.919336348225022
NMR metabolomics,X23412.Phospholipids in VLDL,CD200,OX-2 membrane glycoprotein,42119,-0.000281326660129686,0.00280279165485104,-0.00577479830363773,0.00521214498337835,0.920049111165014
NMR metabolomics,X23412.Phospholipids in VLDL,CALY,Neuron-specific vesicular protein calcyon,39575,-0.000400037850165538,0.00402084844944711,-0.00828090081108188,0.0074808251107508,0.92075032613048
NMR metabolomics,X23412.Phospholipids in VLDL,PRND,Prion-like protein doppel,39929,0.000499682699033205,0.00505460883558467,-0.00940735061871274,0.0104067160167792,0.921253680066509
NMR metabolomics,X23412.Phospholipids in VLDL,MAMDC2,MAM domain-containing protein 2,39958,0.000353443152362282,0.00367719674091983,-0.00685386245984059,0.00756074876456516,0.923428906391188
NMR metabolomics,X23412.Phospholipids in VLDL,BCL7A,B-cell CLL/lymphoma 7 protein family member A,39560,0.000628026007988336,0.00664868220912877,-0.0124033911219041,0.0136594431378807,0.924746499565407
NMR metabolomics,X23412.Phospholipids in VLDL,APOA4,Apolipoprotein A-IV,39979,-0.000334967943021922,0.00356312440031912,-0.0073186917676474,0.00664875588160355,0.925103176321508
NMR metabolomics,X23412.Phospholipids in VLDL,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,39919,0.000940125121159478,0.0103606297971604,-0.0193667092812748,0.0212469595235938,0.927700671254937
NMR metabolomics,X23412.Phospholipids in VLDL,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,41900,0.000448929299913241,0.00501546832775248,-0.00938138862248162,0.0102792472223081,0.928678789449129
NMR metabolomics,X23412.Phospholipids in VLDL,TOP1MT,"DNA topoisomerase I, mitochondrial",39560,-0.000431273514226738,0.00499279615019894,-0.0102171539686167,0.00935460694016318,0.931166594527548
NMR metabolomics,X23412.Phospholipids in VLDL,IL2RB,Interleukin-2 receptor subunit beta,41913,0.000321181190365899,0.00375402378530173,-0.00703670542882549,0.00767906780955729,0.931820254625032
NMR metabolomics,X23412.Phospholipids in VLDL,MLLT1,Protein ENL,39560,-0.000572238001367115,0.00687165853263926,-0.0140406887253401,0.0128962127226058,0.933634325441096
NMR metabolomics,X23412.Phospholipids in VLDL,PITHD1,PITH domain-containing protein 1,39539,-0.000627450979847616,0.00799788492736358,-0.0163033054374802,0.015048403477785,0.937469855207067
NMR metabolomics,X23412.Phospholipids in VLDL,PCARE,Photoreceptor cilium actin regulator,39586,-0.000661031026086988,0.00861330658646437,-0.0175431119355572,0.0162210498833832,0.938827543047908
NMR metabolomics,X23412.Phospholipids in VLDL,PADI2,Protein-arginine deiminase type-2,41913,0.000436744848053104,0.00588215189688801,-0.0110922728698474,0.0119657625659536,0.940813243829815
NMR metabolomics,X23412.Phospholipids in VLDL,FBLN2,Fibulin-2,39966,-0.000241065384867237,0.00332172526040635,-0.00675164689526368,0.0062695161255292,0.942147712735909
NMR metabolomics,X23412.Phospholipids in VLDL,TAGLN3,Transgelin-3,39560,0.000437856074522772,0.00621558543899746,-0.0117446913859123,0.0126204035349578,0.943840868395487
NMR metabolomics,X23412.Phospholipids in VLDL,SIGLEC5,Sialic acid-binding Ig-like lectin 5,42137,-0.000846824674410415,0.0122489490063189,-0.0248547647267955,0.0231611153779747,0.944883599704239
NMR metabolomics,X23412.Phospholipids in VLDL,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,39757,0.000296016760122268,0.00462301188222302,-0.00876508652903485,0.00935712004927938,0.948946571924103
NMR metabolomics,X23412.Phospholipids in VLDL,KLK1,Kallikrein-1,42016,0.000834224737906805,0.0131779305173915,-0.0249945190761806,0.0266629685519942,0.949524828401179
NMR metabolomics,X23412.Phospholipids in VLDL,ENO1,Alpha-enolase,42119,-0.000509884252091927,0.00811230127971327,-0.0164099947603299,0.0153902262561461,0.949884315872053
NMR metabolomics,X23412.Phospholipids in VLDL,ANXA5,Annexin A5,41780,0.000191609457730704,0.00313349385596622,-0.00595003849996309,0.00633325741542449,0.951241614778848
NMR metabolomics,X23412.Phospholipids in VLDL,CTLA4,Cytotoxic T-lymphocyte protein 4,39966,-0.000185292315488593,0.00312821372003601,-0.00631659120675918,0.00594600657578199,0.952767864241969
NMR metabolomics,X23412.Phospholipids in VLDL,ESPL1,Separin,39560,-0.000310416537138228,0.00552749926205237,-0.0111443150907609,0.0105234820164844,0.955216497127836
NMR metabolomics,X23412.Phospholipids in VLDL,PYDC1,Pyrin domain-containing protein 1,39638,-0.000237589551640986,0.00426761106486422,-0.00860210723877485,0.00812692813549288,0.955603533021126
NMR metabolomics,X23412.Phospholipids in VLDL,IL6,Interleukin-6,42070,0.000370565420716676,0.00770121493833221,-0.0147238158584145,0.0154649466998478,0.961623083950179
NMR metabolomics,X23412.Phospholipids in VLDL,TSLP,Thymic stromal lymphopoietin,41900,0.000298056167033132,0.00621230798011778,-0.0118780674739977,0.012474179808064,0.9617342326568
NMR metabolomics,X23412.Phospholipids in VLDL,ATF4,Cyclic AMP-dependent transcription factor ATF-4,39560,0.000158229625924019,0.00347493827059415,-0.00665264938444051,0.00696910863628854,0.963682094661686
NMR metabolomics,X23412.Phospholipids in VLDL,NPTN,Neuroplastin,41843,0.000362854734209632,0.00807418446233319,-0.0154625468119634,0.0161882562803827,0.964155723913551
NMR metabolomics,X23412.Phospholipids in VLDL,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,39575,0.0002225400090204,0.0057883463712118,-0.0111226188785547,0.0115676988965955,0.969332613235889
NMR metabolomics,X23412.Phospholipids in VLDL,KIAA2013,Uncharacterized protein KIAA2013,39919,-0.000207861963319385,0.00555032284250667,-0.0110864947346325,0.0106707708079937,0.970126525933277
NMR metabolomics,X23412.Phospholipids in VLDL,KHDC3L,KH domain-containing protein 3,39560,-0.000255606057417196,0.00694988814076335,-0.0138773868133134,0.013366174698479,0.970662333072761
NMR metabolomics,X23412.Phospholipids in VLDL,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",39657,0.000150784072713428,0.00441763036681857,-0.00850777144625096,0.00880933959167782,0.972772234026916
NMR metabolomics,X23412.Phospholipids in VLDL,FOLR1,Folate receptor alpha,42110,-0.000103745691725881,0.00304109236408977,-0.00606428672534184,0.00585679534189007,0.972786259070367
NMR metabolomics,X23412.Phospholipids in VLDL,DCLRE1C,Protein artemis,39560,0.000105226569821028,0.0031530165314693,-0.0060746858318588,0.00628513897150086,0.973377508222144
NMR metabolomics,X23412.Phospholipids in VLDL,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,39560,-0.000144210125284835,0.00455662450541663,-0.00907519415590143,0.00878677390533176,0.974752977560608
NMR metabolomics,X23412.Phospholipids in VLDL,MORN4,MORN repeat-containing protein 4,39560,-0.0002490559146885,0.00810607904271547,-0.0161369708384108,0.0156388590090338,0.975489743851119
NMR metabolomics,X23412.Phospholipids in VLDL,ZNF75D,Zinc finger protein 75D,39757,-0.000176931424403421,0.00632617216011057,-0.0125762288582201,0.0122223660094133,0.977688042380758
NMR metabolomics,X23412.Phospholipids in VLDL,ALDH2,"Aldehyde dehydrogenase, mitochondrial",39919,-0.000146246209723833,0.00541119396158009,-0.0107521863744208,0.0104596939549731,0.978438989336102
NMR metabolomics,X23412.Phospholipids in VLDL,KDM3A,Lysine-specific demethylase 3A,39657,-0.000217089733174537,0.00917488564290999,-0.0181998655932781,0.017765686126929,0.98112320145242
NMR metabolomics,X23412.Phospholipids in VLDL,UHRF2,E3 ubiquitin-protein ligase UHRF2,39575,-8.03193605349526e-05,0.00355794533492699,-0.00705389221699185,0.00689325349592195,0.981989977707244
NMR metabolomics,X23412.Phospholipids in VLDL,HLA_A,,39934,-6.16617508175531e-05,0.00339219480651734,-0.00671036357159155,0.00658704006995644,0.985497541525577
NMR metabolomics,X23412.Phospholipids in VLDL,EPGN,Epigen,39919,-8.4667997114349e-05,0.00478506935808025,-0.00946340393895164,0.00929406794472294,0.98588311570469
NMR metabolomics,X23412.Phospholipids in VLDL,TGFBR1,TGF-beta receptor type-1,39657,-3.17300233516988e-05,0.00227482564176105,-0.00449038828120335,0.00442692823449995,0.988871453744453
NMR metabolomics,X23412.Phospholipids in VLDL,IL31,Interleukin-31,39657,2.92103222604153e-05,0.00575300340502021,-0.0112466763515792,0.0113050969961,0.99594892677712
NMR metabolomics,X23412.Phospholipids in VLDL,LRP2,Low-density lipoprotein receptor-related protein 2,39649,-1.5500398803397e-05,0.00379124955990141,-0.00744634953621015,0.00741534873860336,0.99673795818283
NMR metabolomics,X23412.Phospholipids in VLDL,IFNW1,Interferon omega-1,39575,1.37943885945999e-05,0.0036501730373945,-0.00714054476469861,0.00716813354188782,0.996984786019187
NMR metabolomics,X23412.Phospholipids in VLDL,KRT8,"Keratin, type II cytoskeletal 8",39586,-1.31072148998263e-06,0.00868100672056736,-0.017016083893802,0.017013462450822,0.999879532331703
